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Comparison of antihypertensive effects of various antihypertensive
regimens on young and elderly patients. B. Agrawal, A. Berger, and K
Wolf Boehringer Mannheim GmbH, Mannheim, Germany. Recent studies
have underlined the importance of treatment of hypertension in elderly
patients. Carvedilol is a non-cardioselective J3 blocker with vasodilating
properties due mainly to a1-blockade. It has antianginal properties and
salutory effects in patients with CHF. The present study assesses the
antihypertensive effects of various monotherapy regimens after open label
treatment for 3 months (10—14 weeks) in general practices in Germany.
Responders were defined as diastolic BP  90 mm Hg or reduction of
DBP of 10 mm Hg. The results are summarized in the following table.
Treatment group
Carvedilol ACE-I p-blocker
monotherapy monotherapy monotherapy
N 3198 435 528
Age <65 years
Baseline BP 166.8 17.5/
100.3 9.0
161.7 17.9/
97.4 9.4
157.3 17.0/
96.7 10.3
BP after 3 146.3 12.8/ 149.4 15.3/ 146.0 13.6/
months of 87.8 7.4 89.3 9.1 89.4 9.4
treatment
BP reduction 20.1 15.6/
12.2 9.5
12.0 17.6/
7.9 10.2
11.1 15.6/
7.1 9.7
Responders 87.9% 76.1% 73.5%N 988 156 70
Age 65 years
Baseline BP 173.8 17.4/
98.9 9.0
169.4 17.8/
96.5 10.1
165.8 16.3/
94.1 10.3
BP after 3 152.0 14.3/ 153 14.3/ 156.1 16.3/
months 87.3 7.5 87.3 7.5 87.6 9
treatment
BP reduction 20.3 17.3/
11.2 9.6
15.8 17.2/
8.6 9.4
9.5 18.5/
6.4 12.2
Responders 86.2% 78.2% 78.6%
These results show that the response rate was highest in patients of both
age groups treated with carvedilol. The dual acting carvedilol is more
effective in reducing systolic and diastolic BP in elderly and non-elderly
patients.
Prevalence of microalbuminuria (MAU) in hypertensive, non-diabetic
patients with/without end-organ damage. B. Agrawal, K Wolf and A.
Beger, Boehringer Mannheim GmbH, Mannheim, Germany. Hypertension
is commonly associated with cardiovascular end-organ damage, especially
renal failure. It has been shown that microalbuminuria (MAU) is an early
marker for renal damage and can be an indication for poor prognosis. The
present study was conducted to assess prevalence of positive MAU by a
dipstick test in patients with hypertension without diabetes. Patients were
advised to test on 3 consecutive days. A total of 8,768 patients was
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evaluable (age 18—94, x = 57.2 12) of both genders (51% male, 49%
females): 38.3% of patients were positive, whereby the percentage in-
creased with increasing severity of hypertension (36.3% in mild, 46.8% in
moderate, and 49.9% in severe hypertensives). There was an increase in
positive MAU patients with age (23.5% of patients 26—36 vs. 48.8% of
patients 76—85 years of age). Patients with concomitant end-organ
damage (CAD, PAOD, LVH, MI) had a higher percentage of positive
MAU. MAU is an early positive marker in every second or third patient
with hypertension. A positive microalbuminuria may also be an early
predictor for associated morbidity.
Prevalence of microalbuminuria (MAU) in non-diabetic hypertensive
patients with other concomitant diseases. B. Agrawal, A. Beiger, and K
Wolf Boehringer Mannheim GmbH, Mannheim, Germany. Hypertension is
often associated with other concomitant diseases. MAU is an early marker
of end-organ (renal) damage in patients with hypertension and diabetes
mellitus. The present study was therefore conducted to assess the preva-
lence of MAU in non-diabetic hypertensives in general practices through-
out Germany. A total of 11,888 patients was examined by using a dipstick
for MAU by the patient on 3 consecutive days. MAU was positive if one
of the three tests was positive (8,478 had evaluable microalbuminuria).
The prevalence of MAU in various diseases is as follows:
Concomitant
disease MAU +
% CAD MI PAOD
Cerebral
insult
Patients with 48.7% 53.3% 53.2% 48.4%
concomitant
diseases
Patients without 37.7% 37.5% 37.9% 36.0%
concomitant
diseases
Concomitant
disease MAU + Fundus All
% LVH hypertension Hyperlipidemia hypertensives
Patients with 56.5% 54.7% 41.3% 38%
concomitant
diseases
Patients without 36.2% 36.2% 35.2%
concomitant
diseases
These results show that patients with concomitant diseases have mi-
croalbuminuria much more often than patients without such diseases.
The effect of antihypertensive treatment on microalbuminuria (MAU).
B. Agrawal, K Wolf and A. Berger, Boehringer Mannheim GmbH, Mann-
heim, Germany. MAU has been shown to be commonly associated with
hypertension and represents an early marker for end-organ damage.
Carvedilol is a non-selective $3 blocker with vasodilating properties due to
a1-blockade. It has been shown to have antianginal properties and salutoiy
effects on patients with CHF. The aim of the present study was to see
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whether MAU is reversible on antihypertensive treatment and whether
there is a difference in the various treatment regimens. A total of 11,713
patients evaluated (18—94 years, x = 57.2 12, BP 166.4 19.1/98.7
10.1) (6000 on monotherapy) were examined on various treatment regi-
mens in an open label study over a period of 3 months (10—14 weeks). The
following table summarizes the results.
Treatment group
Carvedilol
monotherapy
ACE-I
monotherapy
Other
monotherapies
N 4014 592 1394
N of MAU + patients 1525 (38%) 221 (37.3%) 268 (28.6%)
at baseline N (%)
N of MAU + patients 638 (15.9%) 119 (25.2%) 268 (19.2%)
after 12 weeks N
(%)
This shows that there is a difference in the effects of various treatment
regimens on microalbuminuria. Carvedilol seems to be superior to other
groups of antihypertensives.
The effect of various antihypertensive regimens on microalbuminuria
(MAU) in elderly patients. B. Agrawal, A. Berger, and K Wolf Boehringer
Mannheim GmbH, Mannheim, Germany. Recent findings have stressed the
necessity of the treatment of hypertension in elderly patients. MAU is
considered an important early indicator for end-organ damage in patients
with hypertension and diabetes. Carvedilol is a non-selective f3 blocker
with vasodilating properties due to a1-blockade. The present study was
conducted to assess the effect of various antihypertensive monotherapy
regimens on MAU. Elderly patients were defined as 65 years of age. In
this open label study, the MAU test was conducted as a dipstick test on
three consecutive days by the patients before and after the 3 month (10—14
weeks) treatment period. The results are as follows:
Treatment group
Carvedilol
monotherapy
ACE-I
monotherapy
/3 blocker
monotherapy
Age <65 years
N 3029 428 510
N of MAU + at 1155(38.1%) 141 (32.9%) 130(25.5%)
baseline N %
N of MAU + at 3 471 (15.6%) 93 (21.7%) 82(16.1%)
months N %
Improvement % at 59.2% 34% 36.9%
3 months
Age 65 years
N 937 158 71
N of MAU + at 350 (38%) 77 (48.7%) 12 (16.9%)
baseline N %
N of MAU + at 3 169 (17.0%) 53 (33.5%) 12 (16.9%)
months N %
Improvement % at 51.7% 31.2% 0%
3 months
These results show that there is a difference between the various treatment
regimens in regard to their effect on microalbuminuria. Carvedilol seems
to be effective in all patients groups in improving MAU.
Deleterious effect of graft related HLA-antibodies in kidney transplan-
tation. K Albrecht, U I/ogeler, Th. Rudy, and F. W. Eigler, Department of
General Surgeiy, University Hospitals, Essen, Germany. With an increasing
number of highly immunized patients the number of HLA antibodies
which can be identified has increased. Especially in 2nd transplantations,
specific antibodies against the 1st graft can be detected. So far, a negative
cross match before a kidney transplantation was supposed to be a
sufficiently safe method to prevent a hyperacute rejection, Yet hyperacute
rejections were observed in grafts expressing an antigen against which the
recipient had developed specific HLA antibodies, in spite of a negative
cross match. Methods: In a retrospective analysis the follow-ups of all
kidney transplantations from 1972 on with a negative cross match and
donor specific antibodies were analyzed. Results: The 5 year graft survival
in 45 grafts (30 1st and 15 2nd grafts) with donor specific HLA antibodies
and a negative actual cross match was 15% compared to 60% (P < 0.0001)
in grafts without specific antibodies (1318 1st and 216 2nd grafts). The rate
of never functioning organs was 35%. There was no negative impact of
unspecific antibodies on graft survival. Conclusion: Any transplantation
against specific HLA antigenes should be avoided, even if the actual cross
match is negative.
Changes of arterial and venous vessels independent of blood pressure
in uremia. K Amann, R. NeusuJ3, J. Tömig T. hzyniec, G. Mall, and E. Ritz,
Departments of Pathology Heidelberg, Darmstadt, and Department of Inter-
nal Medicine, Heidelberg, Germany. Background: Cardiovascular compli-
cations are a well-known problem in renal failure. Besides left ventricular
hypertrophy and structural intramyocardial changes, striking alterations of
vascular structure are common in chronic uremia. Aim of the study: To
investigate whether the vascular changes in uremia are limited to the
arterial system and whether changes of peripheral arteries (3rd order
mesenterial arteries) are comparable with those of small intramyocardial
arteries and of the aorta, respectively. Design and methods: Using
morphometrical techniques, 3rd order mesenterial arteries and veins were
investigated in perfusion fixed subtotally nephrectomized male SD rats
with uremia of 14 days duration (or their sham-operated controls). The
following stereological parameters were determined: wall thickness of
mesenteric arteries and veins; wall:lumen area and wall:lumen ratio of
mesenteric arteries. To eliminate a potential influence of hypertension,
subgroups of animals received antihypertensive treatment (furosemide
and dihydralazine) in the drinking fluid (15 and 20 mg/kg/day). Results: At
the end of the experiment systolic blood pressure was 110 13.3 mm Hg
and 99.4 8.1 mm Hg in untreated and treated controls and 132 20.2
mm Hg and 103 13 mm Hg in untreated and treated uremic animals.
Wall thickness of mesenteric arteries was 15.5 2.82 g and 15.2 3.45
in uremic animals versus 18.8 1.53 bt bzw. 10.1 3.4 .t incontrol groups.
Wall thickness of mesenteric veins was also significantly increased in
uremia, irrespective of the antihypertensive treatment (5.22 0.69 .t and
5.57 1.97 .ivs.3.70 0.69 p bzw 3.36 1.01 pr). A comparable increase
was seen in wall and lumen area of mesenteric arteries of uremic animals.
Conclusions: In parallel to our previous findings of blood pressure
independent thickening of the aorta and of small intramyocardial arteries
in uremia we found similar changes in mesenteric arteries and veins. These
findings confirm and extend clinical findings of small vessel disease in
uremic patients.
Long-term results of systemic lupus erythematodes (SLE) with renal
involvement—Histology and clinical course. D. Bach, H. C. Voilmar, C.
Specker, and B. Grabensee, Departments of Nephrology and Rheumatology,
Heinrich Heine University, Düsseldorf Germany. The renal involvement of
SLE may present with different histological manifestations during the
clinical course. Between 1980 and May 31, 1994, we investigated retro-
spectively 47 patients (39 F, 8 M, mean age at time of diagnosis 26.09
14.38 years) with biopsy-proven renal involvement and at least 4 ARA
criteria. Results: The mean time of investigation was 62.91 60.62
months. A total of 78 renal biopsies was performed, resulting in the
following WHO classes: WHO II (6 patients), III (6 patients), IV (26
patients), V (7 patients), VI (2 patients). At the time of first diagnosis, 10
patients had no renal impairment (21.28%), 33 patients suffered from mild
renal insufficiency (70.21%), and 4 patients needed renal replacement
therapy (8.5 1%). During the clinical course, 10 patients presented with a
change in WHO classification. Forty-five patients received an immuno-
suppressive drug therapy with steroids and cyclophosphamide/azathio-
prine, 11 patients needed a plasmapheresis therapy, 7 of them with WHO
class IV. Concerning renal function at the end of the investigation, 29
patients had a mild renal insufficiency (61.70%), 18 patients (38.30%) had
developed ESRD, 13 of them coming from WHO class IV and 6 of them
being treated with plasmapheresis. There was no statistically significant
difference in renal survival between class IV and the other classes. Five
patients (10.64%) were grafted, with 2 having a stable graft function.
Within the investigational period, 9 patients died (19.15%), 4 due to
septicemia, 5 due to cardiovascular reasons. Conclusions: (1) Although
the WHO class IV presents with a tendency of worse renal prognosis
compared to the other histological classes, our data do not show a
statistically significant difference. (2) There is no proof for a definite
therapeutic advantage of an additional plasmapheresis therapy; neverthe-
less, its therapeutic use in severe clinical courses does not lead to an
increased mortality because of infectious reasons.
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Measurement of intrapelvic pressure by antegrade pyelography in renal
transplants with an acutely dilated pyelon. D. Bach, G. Grützner, H.-W.
Kniemeyer, and B. Grabensee, Departments of Nephrology, Diagnostic
Radiology and Vascular Surgeiy with Renal Transplantation, Heinrich Heine
University, Düsseldorf Germany. Introduction: Acute postrenal build up
after kidney transplantation (TP) is one of the most frequent postopera-
tive complications. A rapid differential diagnosis of the acutely dilated
pyelon is necessary in order to prevent permanent damage to the graft.
Patients and methods: We report the dynamic measurements of intrapel-
vic pressure during antegrade pyelography (AP) in 6 patients (5 M, 1 F,
mean age 47.2 years) with an acute postrenal build up after TP. The mean
time distance between TP and examination was 1.4 years (range 1 week—6
years); all patients had an acute graft deterioration apart from the dilated
pyelon. By positioning a 21 gauge fine needle into the pelvic, the adequate
intrapelvic pressures were measured while inserting the contrast medium.
Results: The existence of an extreme negative baseline pressure led to the
diagnosis of an interstitial infection causing the build up (2x pyelone-
phrosis); an increasing pyelon pressure over the baseline pressure while
inserting the contrast medium led to the surgically proven diagnosis of a
scarring ureter stenosis. External ureter compressions (for example,
lymphoceles) did not present with a homogenous pressure profile and a
missing increase. Conclusion: The measurement of intrapelvic pressure
during antegrade pyelography may provide an early differential diagnosis
in acutely dilated renal grafts and therefore possibly prevent permanent
graft damage in the case of urodynamically relevant build-up.
Serum concentrations of the metabolites homocysteine, cystathionine,
methylmalonic acid, and 2-methylcitric acid are increased in chronic
uremia. J. Bachmann, H. Raidt, M Tepel, R. Riezler, U Graefe, and W.
Zidek Medizinische Poliklinik der Universitdt and Kfl-i-Dialysezentrum,
Münster, Germany. Hyperhomocysteinemia is an independent risk factor
for vascular disease, and elevated serum concentrations of homocysteine
and methylmalonic acid were detected in neuropsychiatric disorders. Since
the risk of occlusive vascular disease is increased in chronic uremia, we
measured serum concentrations of the metabolites homocysteine (HC),
cystathionine (CT), methylmalonic acid (MMA) and 2-methylcitric acid(2-MCA) in 28 patients with chronic renal failure on conservative
treatment and in 48 hemodialysis patients by capillary gas chromatography
and mass spectrometry. Linear regression analysis showed a significant
correlation between creatinine clearance and HC (r =
—0.69; P < 0.0001),
CT (r =
—0.73; P < 0.0001), MMA (r = —0.48; P = 0.006) and 2-MCA(r =
—0.61; P = 0.001) serum concentrations in the non-dialyzed patients.
Predialysis serum metabolite concentrations were markedly elevated in 28
hemodialysis patients not receiving any vitamin supplements (HC 33.5
3.2 jmol/liter, CT 3168.4 650.3 nmol/liter, MMA 1269.3 221.7
nmol/liter, 2-MCA 3203.4 698.5 nmol/liter; mean SD). HC was
significantly lower in 20 hemodialysis patients receiving regular oral
vitamin supplements including folic acid, vitamins B-6 and B-12. We
conclude that elevated serum metabolites are present from the early stage
of chronic renal failure and may increase the risk for occlusive vascular
disease in chronic uremia.
Distribution of nitric oxide synthase (NOS) and compounds of the
renin-angiotensin system in the juxtaglomerular apparatus of the devel-
oping kidney. E. Fischer, J. Schnermann, J. Briggs, W Kriz, and S.
Bachmann, Department of Anatomy and Cell Biology, University of Heidel-
beig, Heidelbeig, Germany, and Department of Physiology, The University of
Michigan, Ann Arbor, Michigan, USA. Presence of NOS in cells of the
macula densa (MD) has led to considerations suggesting a role for
arginine-derived nitric oxide in the transmission of tubulovascular infor-
mation transfer. To investigate the histochemical distribution of the
neuronal isoform of NOS and RAS compounds in the developing rat
kidney, perfusion-fixed tissue from postnatal stages of 2, 6 and 15 days was
investigated (N = 4 per group). The neuronal NOS isoform was localized
by NADPH diaphorase histochemistry, immunohistochemistry and in situ
hybridization. Likewise, compounds of the renin system were localized
immunohistochemically [renin, angiotensinogen (AOGEN), angiotensin
converting enzyme (ACE), angiotensin II (Ang II)] and by in Situ
hybridization (renin, AOGEN). For quantification, a "status" of renin-
and NOS-positive glomeruli was evaluated in all stages, and a distinction
between the juxtamedullary and remaining midcortical and superficial
glomeruli was accomplished. In addition, the number of NOS-positive MD
cells was evaluated. Presence of NOS was encountered in all stages
investigated. Full development of MD NOS signal was seen as soon as a
glomerular urinary space was developed. As soon as a distinct MD was
formed, double labeling with NADPH-d and antibody to Tamm Horsfall
protein (THP) indicated mutual exclusiveness of NADPH-d positive MD
cells and neighboring THP positive distal tubule cells. Intensity of renin
status was 2 days >6 days >15 days, whereas NOS label was inversely
related with 2 days <6 days and 6 days = 15 days. AOGEN was strongest
on day 2 and was localized throughout in the convoluted part of the
proximal tubule (PT). ACE was localized to PT brush border and to
vascular endothelia. Ang II was generally colocalized with renin. Our data
indicate an early involvement of MD NO synthesis in the organization of
the JGA during nephronogenesis and suggest an interdependent relation
with the RAS.
Experiences with zinc protoporphyrin as a marker of endogenous iron
availability in chronic hemodialysis patients. M. Baldus, A. Salopek, J.
Reddig, U Gansert, J. Schliesser, and H. Brass, Medizinische Klinik A and
Abteilung für Medizinische Dokumentation am Klinikum der Stadt 67063,
Ludwigshafen am Rhein, Germany. In the treatment of renal anemia with
recombinant human erythropoietin (rHuEPO), zinc protoporphyrin
(ZPP) has been proposed as a valid marker of endogenous iron availability
among other established markers, such as ferritin and percentual trans-
ferrin saturation. Patients and methods: We determined in 121 patients,
including 113 chronic hemodialysis patients, the following parameters:
hemoglobin, eiythrocytes, hematocrit, mean corpuscular volume (MCV),
iron, ferritin, transferrin, transferrin saturation as well as ZPP; 38.9% of
our dialysis patients have been treated with rHuEPO at the time of
examination in a cross-sectional study. In 27.5% of this population
intravenous iron was administered while a simultaneous treatment with
iron and rHuEPO was performed in 13.3% of the patients. A median
ferritin of > 300 nglml and a median transferrin saturation > 20% has
been determined. In 28 of our dialysis patients elevated ZPP (> 40
smol/mol Hb) and a decreased transferrin saturation (< 20%) was found
while 40 cases had been classified as concordantly negative. However, as
many as 53 cases (43.8%) showed discrepant results: in 13 cases ZPP was
elevated while transferrin saturation was in the normal range; in 40 cases
ZPP was normal while transferrin saturation was < 20%. We did not find
any significant correlation between ZPP and any other above-mentioned
parameter of iron availability. Conclusion: Thus, in dialysis patients with
conventional parameters of endogenous iron availability in the upper
normal range as in our study population ZPP does not offer any advantage
in comparison to transferrin saturation in the laboratory follow-up of
rHuEPO treated end-stage renal disease patients.
A longitudinal study of vessel wall properties in normotensive and in
hypertensive renal transplant recipients. M Barenbroc/ç C. Spieker,
A.P.G. Hoeks, and K-H. Rahn, University of Munster, Germany, University
of Limburg, Limbuig, The Netherlands. The present prospective, longitu-
dinal study evaluates the role of hypertension for the mechanical vessel
wall properties in renal transplant recipients. Arterial distensibility of the
common carotid artery was determined in 24 normotensive and 24 treated
hypertensive renal transplant recipients 6—12 weeks after transplantation
and after 2 years using a multigate pulsed Doppler system. Arterial
distensibility showed a very significant correlation after 2 years when
compared with the initial value (r = 0.81, P < 0.0001 in the normotensive,
r = 0.76, P < 0.0001 in the hypertensive group). Arterial distensibility
decreased significantly after 2 years in the hypertensive (DC 15.4 1.2
103/kPa before, 12.4 1.1 103/kPa after 2 years, P < 0.01) but not in the
normotensive group (DC 15.9 1.3 103/kPa before, DC 14.4 1.1
103/kPa after 2 years, NS). The decrease of distensibility was significantly
higher in the hypertensive than in the normotensive group decrease of
DC 3.0 0.7 103/lcPa in the hypertensive, 1.4 0.5 10 IkPa in the
normotensive group, P < 0.05). The high correlation between arterial
distensibility at enrollment and after 2 years suggests that mechanical
vessel wall properties are influenced by long-term structural rather than by
short-term functional changes. It can be concluded that hypertension
accelerated distinctly the time-related decrease of arterial distensibility in
renal transplant recipients due to structural vessel wall changes.
The role of hyperhydration for the vessel wall properties of large
arteries in end-stage renal failure. M. Barenbrock, C. Spieker, A.P. G.
Hoe/cs, and K-H. Rahn, Medical University Poliklinik, Munster, Germany,
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and Department of Biophysics, University of Limburg, Limbur The Neth-
erlands. Arterial distensibility is decreased in hemodialysis patients hut
could either be affected by structural vessel wall changes or by functional
changes due to fluid volume expansion and to hypercirculation. In the
present study the role of volume expansion on arterial distensibility was
investigated. Therefore, the mechanical vessel wall properties of the
common carotid artery were studied before and after ultrafiltration (UF)
during hemodialysis in 10 patients with no blood pressure response to UF
(age 37.4 4.0 years, body wt 66.5 2.9 kg before, 62.7 2.6 kg after
UF). Arterial distension was measured by a multigate pulsed Doppler
system, and blood pressure curve was recorded by fingerplethysmography.
Blood pressure was 149 10/89 6 mm Hg before and 144 12/85 7
mm Hg after UF. There was a substantial decrease of the end-diastolic
vessel diameter (7.8 0.4 mm before, 7.2 0.4 mm after UF; P < 0.01).
Despite the decrease of the vessel diameter, volume depletion was not
associated with a significant change of arterial distensibility (distension
6.5 1.2% before and 6.3 1.4% after UF, NS; distensibility coefficient
2.14 0.44 103/mm Hg before and 2.26 0.45 103/mm Hg after UF,
NS). The results suggest that the decreased arterial distensibility in
hemodialysis patients is due to structural vessel wall changes and may
contribute to the high cardiovascular risk in hemodialysis patients.
Determinants of atherosclerosis in CAPD patients: Role of apopro-
tein(a) isoform, lipoprotein(a) and fibrinogen serum levels. W. Bartens, M
Nauck, P. Schollmeyer, and C. Wanner, Department of Medicine, University
Clinic Freibwg, Freiburg, Germany. Lipoprotein(a) [Lp(a)] serum concen-
trations and apoprotein(a) isoforms were measured in 47 uremic patients
treated with continuous ambulatory peritoneal dialysis (CAPD) and
compared with those in 118 normal controls. The mean Lp(a) values were
43 5 mg/dl (sEM) (median 33 mg/dl) in CAPD patients and 22 3 mg/dl
(9 mg/dl) in controls (P < 0.01). Within all apo(a) isoform classes, higher
concentrations of Lp(a) were seen in the CAPD patients compared with
the controls (P < 0.05). These results were not influenced by differences
in the frequency distribution of the apo(a) isoforms. We also found
elevated fibrinogen levels in the CAPD patients (538 61 mgldt)
compared with healthy controls (346 46 mg/dl) (P < 0.01). Twenty-one
CAPD patients (45%) were suffering from coronary artery disease (CAD).
Patients with CAD had higher Lp(a) levels (54 5 mg/dl vs. 34 4 mg/dl)
as well as higher fibrinogen concentrations (628 59 mg/dI vs. 459 46
mg/dl) than patients without CAD (P < 0.01). Furthermore, a positive
correlation between the fibrinogen levels and the Lp(a) serum concentra-
tion was observed (r = 0.45, P = 0.01). The apo(a) isoform distribution
also differed between CAPD patients with and without CAD whereas 63%
of the patients with CAD exhibited low molecular weight isoforms S2
only 31% of the CAPD patients without CAD did. Conclusion: In addition
to the typical dyslipidemia found in CAPD patients, high levels of Lp(a)
and fibrinogen as well as a specific apo(a) isoform pattern may contribute
to the elevated risk of coronary artery disease and other cardiovascular
complications. Therefore, we propose the apoprotein(a) isoform as a
genetic marker for atherosclerosis in patients undergoing CAPD treat-
ment.
Persistent hyperparathyroidism after kidney allotransplantation: A
retrospective, case controlled study. W. Schweitzer and U Binswanger,
Department Internal Medicine, Division of Nephrology, University Hospital,
Zurich, Switzerland. Forty-two parathyroidectomized transplanted patients(PTX) were compared with age and sex matched controls (C). Time on
dialysis was 59.9 6 and 40.3 6.1 months for PTX and C, respectively.
Serum calcium concentrations were 2.37—1.06 for PTX and 2.28—0.07
mmol/liter for K (P < 0.03). Patients receiving triple immunosuppression
(prednisone, azathioprine and cyclosporine A) were more often parathy-
roidectomized (36/42) than those receiving double therapy (prednisone
and azathioprine, 6/42; P < 0.01). Potential mechanisms involved include
slow involution of hyperplastic glands by apoptosis which might be
influenced by cyclosporine A, stimulation of PTH secretion by the
immunosuppressive treatment, skeletal PTH resistance due to PTH itself,
as well as inhibition of cytokine-related bone resorption.
Distribution of ochratoxin A in kidney and renal cell lines. K. Bauer, M
Gekle, and S. Silbernagl, Department of Physiology, University of Wurzburg,
Wurzburg, Germany. To investigate the intracellular accumulation of the
mycotoxin ochratoxin A (OTA) in kidney tissues, male Wistar rats were
injected once intraperitoneally with (1) 1.2 mg/kg body wt OTA or, (2)
received 0.5 mg/kg body wt daily for a period of 6 days. Furthermore,
cultured kidney cells (OK, MDCK) were exposed to OTA for 48 hours.
OTA concentrations in the plasma of rats were 90 and 23 tmol/liter with
protocol (1) and (2), respectively. The table shows the concentration of
OTA in kidney tissues in iO mol/kg wet weight allowing for vascular
OTA content.
Inner Outer
Papilla medulla medulla Cortex
1.13 0.54 1.17 0.19 0.56 0,08 0.62 0.09(1) Acute
exposure
(2) 6 day exposure 0.34 0.04 0.41 0.04 0.14 0.03 0.34 0.07
The highest concentration of OTA was found in the inner medulla and
papilla of the rat kidney. This may provide an explanation for the
"postproximal" damages observed in our earlier studies. Exposing cul-
tured renal cells to OTA also revealed differences in the accumulation of
the toxin. In OK cells, deriving from the proximal tubule, OTA accumu-
lated intracellularly independently of the applied concentration. In con-
trast, MDCK-C7 cells which resemble the principal cells of the collecting
duct did not accumulate OTA. MDCK-C11 cells which resemble the
intercalated cells of the collecting duct accumulated OTA in a dose-
dependent manner. We conclude that differences in intracellular OTA
accumulation in kidney cells could be caused by differential binding
processes and/or cell-specific plasma membrane transporters. They are
probably responsible for the long-term site-specific nephrotoxic effects of
this mycotoxin.
Simultaneous analysis of proteins from different brush-border mi-
crodomains in human urine as markers of proximal tubular injury. H.-W.
Birk H. Schoepe, K Laudenbach, and G. Schutterle, Zentrum für Innere
Medizin, Medizinische Klinik II, Justus-Liebig-Universitat, Giessen, Ger-
many. Urinary excretion of Na-D-glucose cotransporter (microvillar
membrane), villin (microvillar core) and kidney-specific glycoprotein 400
(intermicrovillar membrane) was analyzed under physiological conditions
and after application of nephrotoxins. Urine samples were filtered through
nitrocellulose membrane and immobilized brush-border proteins detected
with monoclonal antibodies as described before. Quantification was
performed by Marttx 96 multi-sample J3 counter and RiaSmart software
(Canberra-Packard) employing a human kidney cortex preparation as
standard. In healthy subjects (N = 82) NatDglucose cotransporter,
villin, and glycoprotein 400 were excreted in a ratio of 12:1:4, indicating
detachment from the brush-border by different mechanisms. Excretion
was independent from sex and age. After radiocontrast media (N = 19)
and cisplatinum (N = 8) urinary excretion of markers from different
microdomains was found to be elevated to different degrees. Overpropor-
tional increase in villin excretion indicates exfoliation of microvillar
fragments. In toxic acute tubular necrosis after repeated cisplatinum
therapy all markers were excreted in similar amounts (ratio 1.5:1:2),
suggesting exfoliation of the whole brush-border during cell lysis. Simul-
taneous analysis of renal proteins from different brush-border microdo-
mains in human urine might be helpful for the detection and assessment
of the severity of proximal tubular injury.
Is the K conductance of the proximal tubule regulated by cytosolic
pH? M Bleich, M Hug, A. Gyoiy, and R. Greger, Albert-Ludwigs Universität,
Freiburg Germany. A high K conductance of proximal tubule cells is a
prerequisite for luminal Na uptake and basolateral NaHCO3 cotrans-
port. Patch-clamp and fluorescence measurements were performed on
freshly isolated proximal tubules of rat kidney to study if there is a link
between intracellular pH and cellular K conductance. Basic properties of
freshly isolated proximal tubules were: the membrane voltage (Vm) was
—57 2 mV (N = 40), an increase of extracellular K by 20 mmol/liter
depolarized Vm by 19 2 mV (N = 19), and glucose (10 mmol/liter)
depolarized Vm by 12 2 mV (N = 19). In fluorescence measurements
the effects of changes in extracellular pH or CO2 and HC03 on
intracellular pH were examined [changes in emission ratio (&atio) are
given as a measure of intracellular pH]. The effects on Vm and single
channel open probability (P0) were determined in separate experiments.
Cells were alkalinized by an increase in extracellular HC03 and CO2 at
constant external pH: &atio of fluorescence measurements was 13 2%
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(N = 11), membrane potential hyperpolarized: Vm = —7 2 mV (N
30) and channel open probability increased: P0 changed from 0.26 to 0.56
(N = 2). Intracellular pH was also increased by reduction of CO2 at
constant external HC03: Aratio = 18 3% (N = 3), Vm = —8 1 mV(N = 5), and by DIDS (10—a mol/liter): &atio =6 2 (N = 8), Vm =
—4 1 mV (N = 4). Cells were acidified by an increase in CO2 at constant
HC03: &atio = —17 2% (N = 6), LVm = +12 2 mV(N = 4), and
P0 changed from 0.27 0.08 to 0.08 0.03 (N 3). Intracellular pH was
also decreased by removal of CO2 and HCO3 at constant pH: ratio =
—20 2 (N = 4), LVm = +8 1 mV (N = 5) and P0 changed from 0.23
to 0.11 (N = 2). The use of the ammonium-pulse technique for variation
of intracellular pH could not be applied in this preparation because
NH4/NH3 itself blocked K channels (N = 3) in this preparation. The
present data indicate that proximal tubular K conductance is pH-
regulated. Membrane potential may serve as a direct feedback signal for
basolateral electrogenic NaHCO3 transport maintaining intracellular
pH in a physiological range despite of high HC03 transport rates.
Cyclosporin A increases plasma prorenin in bone marrow and renal
transplant patients. HA. Boc/c, K Weber, M. Zeiler, M. Mihatsch, and G.
Thiel, Abteilung Nephrologie, Kantonsspital Basel, Switzerland. Of all vas-
cular segments, cyclosporin A (C5A) associated arteriolopathy exclusively
affects the terminal afferent arteriole which is also distinguished by its
capacity for renin biosynthesis. We hypothesized that CsA damage at this
site might alter the processing of prorenin to renin, which—if true—
should result in an increase of plasma prorenin relative to renin. Plasma
prorenin and renin were therefore prospectively measured in CsA treated
bone marrow (BMT) and renal transplant (RT) recipients and—as
controls—in living related kidney donors (LRKD) not receiving CsA.
Prorenin was measured as trypsin-activatable renin activity in the presence
of excess human renin substrate. The ratio of prorenin to the log of renin
(ProLogR, normal range: 63—286) was used as the target parameter;
patients receiving ACE inhibitors were excluded. Although ProLogR in
BMT recipients inversely correlated with inulin clearance, multivariate
analysis showed this to be due to the presence or absence of CsA therapy
(that is, there was no correlation within the groups with or without C5A).
Mean values of ProLogR are given below.
BMT
No CsA On CsA
Pre-transplant
At 1—3 weeks
At 6 months
Atlyear
177 11(35)
227 36 (4)
215 21(9)
343 29 (18)''
396 29 (fl)ab
LRKD RT
Pre-transplant
At 1—3 weeks
At 6 months
At 1 year
174 8 (46)
189 10 (49)
190 9 (25)
209 21(21)
455 17 (98)'
472 35 (25)'
484 33 (22)'
Values are (N)
'P < 0.05 vs. pre-transplant, b vs. no CsA.
In biopsied RT recipients, ProLogR at biopsy was significantly higher, if
the latter showed CsA associated arteriolopathy [605 74 (7)1 than if it
did not [456 24 (98); P < 0.05]. In conclusion, CsA therapy rapidly and
markedly increases plasma prorenin in a largely reversible manner.
Although there is some association with histological arteriolopathy in RT
recipients, there is no correlation with GFR impairment. This is consistent
with the concept that altered processing of prorenin to renin occurs early
in the pathogenesis of human CsA arteriolopathy.
Effect of polyethylene coating of cellulose membrane: Biocompatibility
of AMBIO dialyzer compared with Cuprophane and Polysulfone. J.
Bohler, M Andre, A. Kramer, G. Dobos, and P. Schollmeyer, Department of
Nephrology, University of Freiburg, Freiburg, Germany. Cellulosic mem-
branes have a poor biocompatibility, as measured by complement or
granulocyte activation. Modification of the cellulose surface improves
biocompatibility. A so-called "sandwich technique" has been used in
AMBIO membranes: the blood side of the cellulosic dialyzer capillary is
covered with polyethylene to improve biocompatibility. This study was
undertaken to compare this new dialyzer (AMBIO-65 1.3 m2, Asahi,
Japan) with a cellulosic membrane (CUP = cuprophane 1.25 m2 E3-
Fresenius) and with biocompatible polysulfone (PS 1.25 m2, F60-Frese-
nius). Three groups of stable chronic HD patients were studied using
capillary dialyzers made from CUP (N = 8), PS (N = 14) and AMBIO(N = 11), respectively. Prior to dialysis and after 15 and 180 minutes,
plasma levels of complement fragment C3a, and granulocyte components
elastase and lactoferrin were measured by EIA. Results were compared by
Student's 1-test or Mann-Whitney rank sum test, as appropriate.
The figure shows C3a, elastase and lactoferrin concentrations (difference
from baseline). Maximal C3a levels were seen with CUP, significantly
higher than with PS or AMBIO. Elastase release from granulocytes was
significantly lower in PS than in AMBIO or CUP. Lactoferrin levels were
highest in CUP, low in PS and in AMBIO. In summary, elastase release
from granulocytes is still high with AMBLO membranes. However, com-
plement activation and lactoferrin release are markedly reduced by
coating the inner surface with polyethylene, resulting in improved biocom-
patibility compared to CUP. The technique of combining polymer layers
in order to improve the properties of the dialysis capillaries deserves
further interest.
CAPD long-term experience (1982—1993): Observation of 164 patients
at one nephrological center. W. Hirth, B. Oser, R. Strupp, and W.H.
Boesken, II. Medizinische Abteilung Krankenhaus der Barmhe.'z, Brtider,
Germany. Though peritoneal dialysis has been used for 15 years as an
alternative renal replacement therapy, there is only little information
available on long-term treatment. From 1982 to September 1993, 164
patients (92 males, 72 females) were treated for ESRF by CAPD in the
nephrological center in Trier. At the beginning of the treatment the mean
age was 58.8 years (18—87 years; 40% > 65 years.) The average survival
was 24.4 19 months, and 21 patients could be observed for at least 4
years (maximum 11 years). The cumulative patient survival rate at 2 years
was 68%, at 4 years 38%, whereas the technique survival at 2 years was
70% and 40% at 4 years. The 219 catheters (surgical or peritoneoscopic
implantation) showed a 2-year survival rate of 67.5% (Tenckhoff/TWH II).
There was no significant difference between the technique survival rates of
the 1st and 2nd catheter. The overall peritonitis incidence was 1/27
months. The patients mean weight increased from 66.3 kg 13.5 kg to
67.5 kg 14.8 kg. Under CAPD a significant permanent reduction of the
antihypertensive medication could not be observed. Observing a total of
305 patient years only 11 patients were transferred to hemodialysis, 4 of
them because of recurrent peritonitis. Six patients received cadaveric
kidney transplantation, and 6 patients changed to another treatment
center. One patient's renal function recovered, while 69 patients died, 2
due to fungal peritonitis. Seventy-one patients are still on CAPD; a
clinically relevant loss of ultrafiltration did not occur. In the case of severe
cardiovascular and/or cerebrovascular diseases, CAPD is preferred be-
cause of the smaller alteration of fluid volume. Better communication
among patients makes them choose CAPD more frequently. According to
our experience in the nephrological center in Trier [24% CAPD patients
(1992)] CAPD can be considered a good alternative to hemodialysis. Due
to careful selection and training of CAPD patients, a higher quality of life
and social and professional integration can be attained more easily.
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Localization of nitric oxide synthase in the kidney of various mamma-
han species. JIM. Bosse, St Falkenhahn, R. Rosner, and S. Bachmann,
Department of Anatomy and Ceilbiology I, University of Heidelberg, Heidel-
berg Gennany. Nitric oxide (NO) is generated from L-arginine by NO
synthase (NOS). We have investigated the localization of constitutive
NOS isoforms in rat, mouse, guinea pig, rabbit, pig and human kidney.
NADPH diaphorase reaction (NADPH-d) was used for histochemical
detection of NOS enzyme activity, neuronal NOS I and endothelial NOS
III were identified by specific antibody, and in situ hybridization was
applied for NOS I mRNA detection. Strong presence of NOS I in the
macula densa (MD), previously detected in rat, was found in all species,
including humans. Additional NOS I positive cells of the thick ascending
limb (TALH) were defined. A clear-cut distinction between Tamm
Horsfall protein positive cells of the TALH and NOS I positive cells of the
TALH was shown. Ultrastructurally, NOS I was located in the cytosol.
Intimate spatial relation between NOS I positive cells and renin contain-
ing preglomerular afferent arteriole suggests an effect of MD derived NO
on the juxtaglomerular granular cells. Glucose-6-phosphate dehydroge-
nase, which is probably functionally linked to the L-arginine-NO system,
was localized in the MD and extraglomerular mesangium. In the renal
vasculature, both NADPH-d and NOS III were located in the endothelium
of cortical and medullary vessels, while the muscle layer was unrcactive.
The glomerular arterioles showed stronger labeling in the efferent, than in
the afferent endothelium, and effcrent endothehium selectively contained
both NOS I and NOS III. The unique morphology of effercnt endothelial
cells indicates a particular role for NO in this vessel segment. At the
capillary level, only the glomerular tuft showed NOS positive endothehia.
A subpopulation of renal nerves containing NOS I was found in perivas-
cular connective tissue and near pelvic epithelium. These results demon-
strate a wide distribution of two constitutive NOS isoforms in the kidney
of various animal species including humans. The distinct location of both
isoforms in the cortex confirms that NO plays a crucial role in local
glomerular signaling events.
Characterization of pressure-dependent ream-secretion during the
development of Inherited autosomal dominant polycystic kidney disease
(RAN: SPRD). C. Braun, C. Ltidecke, V. Burst, St Strauch, P. Rohmeiss,
and N. Gretz, Nephrologische Klinilç Klinikum Manheim, Universitat Hei-
delberg Mannheim, Germany. Introduction: The role of the renin-angio-
tensin system (RAS) in the progression of polycystic kidney disease is not
known. The Han: SPRD rat is a new model for inherited autosomal
dominant polycystic kidney disease, which develops end-stage renal failure
within 16 months. Therefore, we investigated in the present study pres-
sure-dependent renin secretion in 3 and 9 month old Han: SPRD rats
(N = 7, each group) as compared to Sprague-Dawley rats (SD; N = 7,
each group). Methods: All experiments were performed on conscious
chronically instrumented rats. The animals were provided with a/v femo-
ralis catheters, an inflatable cuff around the aorta above the orifice of the
right renal artery. Renal perfusion pressure (RIP) was lowered in 10 mm
Hg steps by means of a servo-controlled electropneumatic device. Each
pressure step was kept constant for at least 20 minutes. During each
pressure step 100 ml blood for termination of plasma-renin activity (PRA)
were taken. Results: No significant differences in basal PRA were seen in
3 and 9 month old Han: SPRD rats as compared to age matched SD.
Three month old Han: SPRD showed an autoregulatoty plateau of
pressure-dependent renin secretion down to a threshold pressure of 80
6.7 mm Hg (x saM). Nine month old SPRD revealed an autoregulatory
plateau down to a threshold pressure of 60 5.8 mm Hg. In contrast, in
3 and 9 month old SD a linear increase of PRA in response to reduction
of renal perfusion pressure was observed (no autoregulatory plateau).
Conclusion: Han: SPRD rats did not show a basal activation of the RAS.
However, Han: SPRD revealed a significant shift of threshold pressure for
pressure dependent rcnin release to lower pressures as compared to age
matched controls. This observation is in accordance with immune-histo-
logical studies demonstrating an impaired expression of renin mRNA in
this model. Whether the leftward shift of pressure-dependent renin
secretion has an influence on autoregulation of renal blood flow cannot be
answered on the basis of our data.
Non-Invasive measurement of coronary artery calcifications by ultra
fast computer tomography In hemodialysis (I-ID) patients B, Johann, 0.
Manfre4, St Werner, and Z. Eberhard, Hemodialysis Unit Numbeg, Center
of Diagnostic Radiology, Community Hospital Numbe,g, Department of
Cardiology, Medical Clinic H, University of Erlangen-Nurnberg Nurnberg
Germany. Purpose: EDTA data show a 16—19 fold higher cardiovascular
mortality in HD patients than in the common population. Non-invasive
diagnostic procedure of coronary artery disease (CAD) in HD patients is
limited due to anemia and muscle weakness. We therefore used ultrafast
computer tomography (UFCT) as a non-invasive imaging method without
contrast medium to detect and quantifi coronary artery calcifications.
Method: Electron Beam Tomographic Scanner EVOLUTION (Siemens
AG, Erlangen, Germany), with 30 axial slices/patient, 100 msec scan
time/slice, 3 mm distance between slices, surface area >0.51 mm2 and
density value >130 HU was used. The calcium (Ca) score was determined
by multiplying the area of calciication by a weighted density score as
described by Agataston et al. Subjects: We investigated 49 HD patients,
age 28—74 years, on maintenance hemodialysis for 3—264 months and as a
control population 99 patients, age 32—73 years, without renal disease who
had undergone coronary artery angiography because of suspected CAD.
Seventy-seven of these patients had signs of CAD in one or more vessels
whereas 22 patients had regular coronary arteries. Thirteen HD patients
had normal resting ECG and no symptoms of coronary artery disease
(AS-HD), and 36 HD patients had abnormal resting ECG and/or angina
pectoris. Results: The total coronary calcium scores (m su) of the CAD,
non-CAD, the symptomatic (S-HD) and the asymptomatic (AS-HD)
hemodialysis patients divided into different age groups are summarized in
the table.
Age
years
Control group
CAD (N = 77) Non-CAD (N = 22)
28—39
40—49
50—59
60—69
70—74
1.64 0.70 (N = 2) 0.00 (N = 1)
158.66 50.34 (N = 15) 351 0.94 (N = 4)
587.05 169.59 (N = 36) 58.59 45.85 (N = 8)
657.51 196.25 (N = 22) 21.97 21.34 (N = 7)
692.31 428.28 (N = 2) 0.00 (N = 2)
Age
years
HD patients
S-HD (N = 36) AS-HD (N = 13)
28—39
40—49
50—59
60—69
70—74
— 89.72 116.60 (N = 6)
1649.85 1969.63 (N= 5) 164.95 113.49 (N=3)
1536.71 1742.80 (N=17) 831.80/11.2 (N = 2)
1987.71 1397.77 (N=12) 578.06 (N = 1)
1216.38 132.83 (N = 2) 111.22 (N = 1)
We found 3 vessel coronary artery disease in the coronary angiography
performed after UFCT in 8 symptomatic HD patients with Ca scores
508—778—972—1122—1768—3360—3545 and 4651. In the AS-HD group 5/13
patients (38.4%) had Ca scores <50. Two patients with Ca scores 16 and
42 were under the age of 40 years. In these age groups such coronary
calcium scores may be of clinical significance. Only 1 symptomatic HD
patient (2.7%) had calcium scores C 50. The mean Ca score in the age
group from 40—49 years in the symptomatic HD patients is about 10 fold
higher than in the CAD patient group, and 25 and 3.0 fold higher in the
age groups from 50—59 and 60—69 years, respectively. We found no linear
correlation between the total Ca scores and the Fifi time, between Ca
score and serum i-PTH, and between Ca score and serum Ca concentra-
tions. HD patients with histories of hypertension have significantly higher
Ca scores than normotcnsive HD patients. Conclusions: UFCT is a highly
sensitive (94%) and specific (76%) screening imaging method to detect
CAD. We found an accelerated calcified CAD in HD patients. This might
be one of the reasons for the increased cardiovascular mortality in this
high risk patients group.
Protein-A immunoadsorption in a case of life-threatening systemic
lupus erythematosus. N. Braun, A. Fritsche, F. Lottspeich, A. DiNicuolo, St
Guagnin, C. Erley, and 7'. Risler, Department of Internal Medicine III,
University of Tubingen, and MPI of Biochemistry, Martinsried, Gennany.
The main cause of death in systemic lupus erythcmatosus (SLE) is either
a renal or a cerebral manifestation. No curative treatment is known. Since
circulating immune complexes may play an important role in the patho-
genesis of SLE, an extracorporcal method for removal of these complexes
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may be effective in the therapy of active lupus disease. A 17 year old
caucasian girl with membranoproliferative lupus nephritis first diagnosed
in 1987 was asymptomatic until September 1993, and received azathio-
prine and corticosteroids. She was admitted because of worsening ankle
edema (anti-ds-DNA Ab > 200 lU/mI; ELIAS, Freiburg). A specific
therapy was started according to protocol A of the Lupus Plasmapheresis
Study Group (Euler, Kiel). The patient was discharged but had to be
admitted as an emergency the following month because of weight gain >
6 kg/week and worsening of renal function (serum creatinine 1.5 mg/dl,
proteinuria 12 g/24 hr). A plasmapheresis synchronization therapy accord-
ing to Euler was started. The condition of the patient improved tempo-
rarily. Finally, fever > 40°C, joint pain, lymphoma, pulmonary infiltrates,
pleura and pericardial effusions developed. The patient had to be admit-
ted to the intensive care unit with three grand mal seizures. Renal function
deteriorated until intermittent dialysis was necessary. Scintillating sco-
toma and hemianopia were noticed despite high dose prednisolone
therapy. Immunoadsorption with a protein A column (Excorim, Sweden)
was begun thrice a week without additional immunosuppression for the
first 2 weeks. Anti-ds-DNA Ab declined to 40—60 lU/mi before single
immunoadsorption. A 21 kD protein was isolated from the eluant and a
direct sequential protein analysis was performed. Symptoms resolved
within a week. The patient was started on oral cyclophosphamide and
immunoadsorption was stopped after 6 weeks (creatinine 1.0 mg/dl,
proteinuria 3.6 g/24 hr). The 21 kD protein could not further be found in
the eluant. The patient is still well for more than 6 months after
(anti-ds-DNA Ab 50—90 LU/mI). This is the first report on a successful
therapy of a life-threatening lupus disease with protein A immunoadsorp-
tion.
1,25-Dihydroxycholecalciferol increases ICAM-1 expression on human
tubular epithelial cells. S. Brzoska, B. Kreft, Hf. Deuber, F.J. van der
Woude, MR. Daha, and K Sac/c, Klinik für Innere Medizin, Medizinische
Universitiit zu Lübeck, HoJfinann-LaRoche, Grenzach-Wyhlen, Germany,
and Department of Nephrology, Academisch Ziekenhuis, Leiden, The Neth-
erlands. 1,25-Dihydroxycholecalciferol (1,25-D3) has been shown to stim-
ulate cytokine and MHC class II expression in monocytes and epithelial
cells. Therefore 1,25-D3 is central for the expression of immunoregulatory
proteins in different cells. However, regulatory effects of 1,25-D3 on the
expression of intercellular adhesion molecule-i (ICAM-1) in renal tubular
epithelial cells (TEC) are not known. This might be of particular
importance since ICAM-1 plays an important role in lymphocyte adhesion
to TEC in vivo and has been proposed to be co-stimulatory in antigen
presentation by TEC in vitro. We investigated effects of 1,25-D3 on
ICAM-1 expression in primary and SV4O transfected TEC. The cells were
grown to confluency in microtiter plates and incubated with y-interferon
(y-IFN), 1,25-D3, or a combination of both for 24 hours. ICAM-1
expression was detected with an ELISA using a monoclonal anti-ICAM-1
antibody and a peroxidase conjugated anti-mouse IgG. y-IFN (5—500
U/mI) and 1,25-D3 (10— 16_10_6 mol/liter) increased the expression of
ICAM-1 on primary and SV4O transfected TEC. The expression of
ICAM-1 on primary and continuous TEC was further enhanced by
costimulation with 7-IFN and 1,25-D3. Our results suggest that constitu-
tive and y-IFN enhanced ICAM-1 expression on renal tubular epithelial
cells is regulated by 1,25-D3. Dysregulated expression of ICAM-1 in
1,25-D3 deficiency and uremia may contribute to reduced immune capac-
ity present in impaired renal function.
Is acute renal failure (ARF) after kidney transplantation influenced by
multivariants? B. Bulling, A. Westhoff R. Willers, and B. Grabensee,
Department of Nephrology, Duesseledorf University, Dusseldorf Germany.
Postischemic acute renal failure is a common problem after kidney
transplantation. ARF influences long-term function of the transplant,
duration of patients' admission, and early detection of acute organ
rejection. Until now it has remained unclear whether ARF after trans-
plantation is an unaffectable, multivariate process. Methods: Data from
200 organ donors (1/1990—6/1992), registered by the Eurotransplant
Foundation, were included in this retrospective study. Parameters, ob-
served in 200 graft recipients transplanted at the Duesseldorf University,
were compared with data investigated in 200 patients, who were trans-
planted with the contralateral kidney at another transplant center. The
aim of this multicenter study was to identify specific donor or recipient
variants influencing and/or predicting the development of ARF. Results:
Ninety-five of the Duesseldorf patients (47.5%) developed ARF versus 78
(42.0%) patients transplanted at another center. In 21 of these (11.4%)
patients there was a lack of information. Using Mantel-Haenszel and
Pearson i-tests no statistical relevance was seen in the following variants:
donor's or recipient's age, age difference, anastomosis time, kind and
volume of perfusate, catecholamine therapy of the donor, extent of organ
donation, origin of the graft (local or shipped), HLA compatibility and
preformed lymphocytotoxic antibodies of the recipient. Duration of cold
ischemic time (CIT) was the only significant parameter influencing
primary graft function.
CIThours
0—14 15—20 21—23 24—26
ARF 25% 38.5% 41.7% 35%
Duesseldorf N = 2/8 N = 15/39 N = 15/36 N = 14/40
ARFb 22% 40.5% 35.5% 46.2%
Partner N = 7/9 N = 15/37 N = 11/31 N = 18/39
27—28 29—30 31—35 >36
ARF° 68.4% 70% 55.3% 80%
Duesseldorf N = 13/19 N = 7/10 N = 21/38 N = 8/10
ARFb 47.1% 25% 55% 57.1
Partner N = 8/17 N = 3/12 N = 11/20 N = 8/14
°P < 0.001; bp < 0.03
Conclusion: Characteristics of the donor and selection of perfusion
solution as well as unfavorable immunological prerequisites are not
relevant for initial transplant function. Extension of cold ischemic time
leads to an increase of the ARF incidence. A maximum of tolerable CIT
was not defined. As a result of this study the general recommendation is
to keep duration of cold ischemic time as short as possible to reduce the
ARF rate to a minimum.
Infradian bioperiodicity in urinary enzyme excretion: Age-dependency.
U Burchardt, A. Gerasch, D. Balschun, and M Kiagge, Klinikum Frankfurt,
Oder; Evangelisches Krankenhaus Lutherstift, Frankfurt and Seelow; and
Institute of Neurobiology, Magdeburg, Germany. In previous studies we
demonstrated an infradian biorhythm of urinary dipeptidyl peptidase IV
(DP IV), N-acetyl-I3-D-glucosaminidase (NAG), y-glutamyltransferase(GGT), and alanine aminopeptidase (AAP) excretion in healthy adults
(26—55 years old). Patients with pyelonephritis treated with gentamicin in
therapeutic dosages had a shorter periodicity. This study was designed to
clarify the influence of age. Therefore, we studied the same enzymes over
70 days in the morning urine of 6 girls (1—3 years) and of 7 older volunteers
(65—87 years). Relevant periodicities in the time series were detected in
three steps: (1) Obvious trends were removed by subtraction of the
moving-average over 10 values. (2) Dominant periods were detected by a
spectral cosinor method and the maximum entropy method. (3) The
spectral maxima of both spectral methods were used as initial values for a
cosine fit to the data resulting in estimates of period, amplitude, mesor
and phase. Children showed a significantly higher enzyme excretion per
urinary creatinine of DP IV and NAG in comparison with elderly subjects.
The periodicity in girls was about 13 days and that in older volunteers
about 11.3 days. This finding is in contradiction to reports on marked
changes in the spectral order of physiological rhythms in the course of
ontogenesis. Possibly, the influence of stress and social environment can
mask age-dependent changes in the period length.
Expression in Xenopus oocytes of an HC03 conductance related to
renal NaHCOj cotransport. B. -C. Burckhardt, P. Thelen, and G.
Burckhardt, Zentrum Physiologie und Pathophysiologie, Georg-August Uni-
versität, Gottingen, Germany. In the kidneys the majority of filtered HC03
is reabsorbed in proximal tubules. Exit of HC03 from proximal tubule
cells into the interstitium involves an electrogenic NaHCO3 cotrans-
porter in the basolateral membrane. As an initial step towards identifica-
tion of the NaHCO3 cotransporter we attempted the functional expres-
sion of an HC03 conductance in oocytes from Xenopus laevis injected
with mRNA from rat kidney cortex. Using a two-electrode voltage clamp,
oocytes were monitored for HCO3- and Na-dependent currents on days
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4 to 5 following injection. HCO3-dependent currents were defined as the
difference in current measured by switching the bath perfusion from
nominally HCO3-free buffer, pH 7.5, to a buffer containing 30 mM
HC03, PCO2 5.3 kPa, pH 7.5. Fractionation of renal mRNA by sucrose
density gradient centrifugation and injection of 40 ng mRNA of each
fraction revealed the highest currents at a size of 2—3 kb. When clamped
to —60 mV, these oocytes exhibited a maximal HC03-dependent out-
ward current of 476 268 nA (N = 4) as compared to 28 25 nA for
H20-injected control oocytes (N = 12). In addition, these mRNA-injected
oocytes hyperpolarized by switching from HC03-free to HC03-con-.
taming bath perfusion are consistent with the entry of negative charges.
Cation substitution experiments revealed the Na4 dependence of the
expressed HC03 conductance: in the presence of N-methyl-D-glucamine
the HC03-dependent outward current was reduced to 49 95 nA (N =
4) in mRNA (2—3 kb) injected oocytes, whereas in H20 injected control
oocytes a current of 6 12nA (N = 12) was observed in the absence of
Na4. The expressed HC03-conductance was partially inhibited by 4,4'-
diisothiocyano-2,2'-stilbene disulfonate (DIDS) and by acetazolamide (1
mM each). Since the activity of an endogenous, electrogenic NaHCO3
cotransporter is very low, Xenopus laevis oocytes are well suited for the
functional expression of renal HC03 transporters. The characteristics of
the HC03 conductance found after injection of rat renal mRNA suggest
that we have expressed the Na4HCO3 cotransporter.
Effect of immunoglobulin light chains on PMN functions. G. Cohen, B.
Ma, M. Haag- Weber, and W.H. Horl, Division of Nephrology, Department of
Medicine, University of Vienna, Vienna, Austria. Circulating plasma mole-
cules are considered to be one of the main factors responsible for the
disturbances of PMNs observed in uremic patients. Recently, our group
reported the molecular and functional characterization of a PMN-inhib-
iting plasma factor, granulocyte inhibitory protein I (GIP I) isolated from
uremic patients. This 28 kD polypeptide inhibited the uptake of deoxy-
glucose, chemotaxis, oxidative metabolism, and intracellular bacterial
killing by PMNs. The first 20 amino acids of GIP I show a strong homology
to immunoglobulin (Ig) light chains (about 80% identity to kappa chains
and 40% to lambda chains). Furthermore, we find that GIP I reacts with
antibodies against kappa and against lambda light chains in an immuno-
diffusion assay. Therefore, we tested Ig light chains for their ability to
interfere with PMN functions in our in vitro assays. We used kappa and
lambda light chains isolated from the serum of uremic patients by
inimunoaffinity chromatography as well as Bence Jones proteins from
pooled urines. Our results show that those light chains inhibit the uptake
of deoxyglucose, oxidative metabolism, and chemotaxis of PMNs. To our
knowledge this is the first report on the effect of isolated unmodified Ig
kappa and lambda chains on PMN function in vitro.
Therapy of hyperkalemia by I32-adrenoceptor-indnced potassium-shift
into the intracellular space. A.E. Dau1 R.R. Wenzel, D. Pape, and T.
Philipp, Abteilung für Nieren- und Hochdruckkrankheiten, Medizinische
Klinilç Universitat Essen, and Medizinische Klinik II, Alftied-Krupp Kran-
kenhaus Essen, Essen, Germany. Hyperkalemia-induced cardiac arrhyth-
mias are one of the main causes of death in hemodialysis patients. We
treated severe hyperkalemia [serum potassium (K) 6.9—10.1 mmol/literj in
8 patients on maintenance hemodialysis and 2 patients with acute renal
failure (mean age 56 14 years) with the selective f32-adrenoceptor-
agonist terbutaline (TER) in order to lower K rapidly, even before
hemodialysis could be started. Prior to administration of TER, 3 patients
had bradyarrhythmia < 50 bpm and 2 additional patients had intraven-
tricular conduction defects (QRS 0.14 and 0.24 s, respectively). TER was
administered as continuous i.v. infusion at a dose of 100—200 ng/kg/min
over 45—90 minutes in 7 patients; 3 patients received i.v. bolus injections of
0.5—2.0 mg. Results: In 8 patients TER reduced K below 6 mmol/liter
within 30—60 minutes (60 mm: K —1.7 1.3 mmolJliter). There was a
blunted hypokalemic effect of TER in 2 patients treated with digitoxin and
they required higher doses of TER. In all 3 patients with bradyarrhythmia
a stable sinus rhythm developed within 60 minutes. Likewise, intraventric-
ular conduction disturbances disappeared in both patients. There were no
de novo cardiac arrhythmias and all patients tolerated TER without
adverse effects. Blood lactate rose with maximum increases of 3.5 mmol/
liter. Conclusions: Life-threatening hyperkalemia can be rapidly and
effectively treated by the selective f32-adrenoceptor-agonist TER. As the
hypokalemic effect of p2-adrenoceptor-agonists is mediated by a stimula-
tion of Na/K-ATPase, it is blunted in digitoxin-treated patients. TER also
induces an increase in LAC and may therefore aggravate a pre-existing
metabolic acidosis.
Exercise-induced changes in serum potassium in patients with chronic
renal failure.A.E. Daul, K VOlker, D. Hering, R.F. Schafers, and 1'. Philipp,
Abteilung für Nieren- und Hochdruckkrankheiten, Medizinische Klinilç
Universitüt Essen, Essen, and Bereich Sportmedizin der Universitat Dort-
mund, Dortrnund, Germany. Exercise-induced changes in serum potassium
(K) have been implicated as a cause of sudden death, We investigated in
6 patients (5 males, 1 female, aged 35 13 years) on maintenance
hemodialysis (HD) and in 6 patients (6 males, aged 49 7 years) with a
functioning renal transplant (TX) (serum creatinine 1.6 0.3 mg/dl),
changes in heart rate (HR), systolic blood pressure (RR5), capillary lactate
(LAC) and, in arterial and venous forearm blood, K and acid-base status
during a bicycle exercise test (WHO protocol). Blood was drawn simulta-
neously from the a-v fistula and from a contralateral antecubital vein prior
to exercise, at each work load level, and at 1, 3, 5, and 10 minutes after
exercise. Results: HD (TX) reached a maximum work load of 100 16
Watts (115 22 Watt). During exercise HR increased from 99 16
(72 8) to 155 28 (138 23) bpm, RRs from 108 27 (150 22) to
159 45 (209 10) mm 1-Ig, and capillary LAC from 0.9 0.5 (1.2 0.4)
to 4.0 1.1 (4.9 0.6) mmol/liter, respectively. In the arterial blood,
exercise induced a metabolic acidosis and a rise in K from 5.3 0.6
(4.3 0.4) to 6.1 0.8 (5.4 0.4) mmol/liter. Three minutes after
cessation of exercise K had returned to baseline values in all patients; in
4 HD and 2 TX there was even a fall of K up to 0.6 mmol/liter below
baseline level. In contrast, metabolic acidosis even increased up to 5
minutes post-exercise. In venous blood samples exercise-induced meta-
bolic acidosis and hyperkalemia as well as the fall in K during the early
post-exercise phase were significantly less pronounced compared to the
changes in the arterial blood. Conclusions: In HD and TX bicycle exercise
induces a release of K and LAC from the working musculature leading to
hyperkalemia and lactic acidosis. Already during exercise there is a
re-uptake of K and LAC by the non-working muscles of the forearms.
Measurement of potassium from venous (antecubital) blood will under-
estimate changes in K in (coronary) arterial blood.
Hypokalemia and lactatemia following administration of fi2-adrenocep-
tor-agonists. A.E. Daul M. Schuster, R.F. Schafers, and T. Philipp, Abtei-
lung für Nieren- und Hochdruckkrankheiten, Medizinische Klinik Universität
Essen, Essen, Germany. f32-adrenoceptor-agonists (132-AR) reduce serum
potassium (K). In order to examine whether changes in acid-base balance
contribute to this hypokalemic effect we administered the selective p2-AR
terbutaline (TER) and the physiological /32-AR adrenaline (ADR) as
continuous intravenous infusion at doses of 50 and 75 ng/kg/min for 60
mm in 5 healthy male volunteers (mean age 25 3 years). Systolic (RRs)
and diastolic (RRd) blood pressure, heart rate (HR) and from a vein in
the contralateral forearm K, lactate (LAC) and acid-base status were
measured every 5 minutes. Results: TER and ADR caused a dose-
dependent increase in RRs (1'ER 75: imax 21 3, ADR 75: max 27
6 mm Hg) and in HR (TER 75: max 22 4, ADR 75: Ls max 25 8
bpm) and a decrease in RRd (TER 75: max —15 2, ADR 75: max
—18 4 mm Hg). K was reduced by both drugs (TER 75: max —0.7
0.1; ADR 75: i max —1.0 0.2 mmol/liter). There was an obvious
dissociation in the time-course of TER-induced changes in RRd and K:
RRd reached steady state within 20 minutes, whereas K started to fall
after only 25 minutes, reaching a minimum at 60 minutes. The decline in
K was associated with a concomitant increase in LAC (TER 75: max
+0.9 0.2 mmol/liter) and a reduction in serum-bicarbonate and pH.
During ADR infusion K was decreased from 5 minutes onwards, reaching
a minimum at 50 minutes, whereas RRd had reached steady state after 15
minutes. The ADR-induced reduction in K was also associated with a
concomitant increase in LAC (ADR 75: max +1.5 0.4 mmol/liter).
Conclusions: The reduction in K induced by the 132-AR TER and ADR is
associated with an increase in venous LAC. There is a close relationship
in the time-course of changes in K and LAC. This temporal relationship
may reflect a causal link between intracellular LAC formation and K
uptake into the cells.
Mineral metabolism and bone histology in CAPD during 1 year after
lowering dialysate calcium to 1.25 mmol/liter. S. Degenhardt, J. Vogt, G.
Dellin& and B. Grabensee, Klinik für Nephrologie, Heinrich-Heine Univer-
sität Düsseldorf Düsseldorf Germany. Exposing peritoneal dialysis patients
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to a dialysate calcium (dca) of 1.75 mmollliter favors extraosseous
calcifications and adynamic bone histology. Peritoneal dialysis solutions of
a lesser calcium content should instead activate bone metabolism and
allow an improved phosphate control. However, data on the effects of
lowering the dialysate calcium in CAPD on bone histology have not been
published. In a prospective randomized study 26 patients on CAPD were
switched to a dca of 1.25 mmol/liter. After 1 year 16 patients completed
the study with a control bone biopsy. Data for ionized calcium (iCa), PTH,
AP and phosphate are shown below (data for iCa, phosphate and AP are
given as mean SEM, PTH as median).
Table 1.
Month
0 3
iCa mmol/liter
PTH pmol/liter
P04 mmol/Iiter
APU/liter
1.19 0.05
8.7
2.27 0.09
100±8
1.05 0.04
16.1
2.29 0.15
110±9
Month
6 9 12
iCa mmol/liter
PTHpmol/liter
P04 mmol/liter
AP U/liter
1.08 0.04 1.16 0.02
22.2 24.4
2.45 0.13 2.38 0.15
119 13 114 10
1.22 0.03
15.8
2.30 0.13
126 11
Table 2.
Bone histologies
Aplastic Osteomalacia Mixed Mild
Before change
After 1 year
6 2 3 5
5 2 6 (1 PTX) 3
As a result, a dca of 1.25 mmol/liter without an immediate increase in
calcium intake through phosphate binders and vitamin D metabolites
leads to hypocalcemia and negative bone balance. Although the initial
values for iCa were achieved again after 1 year through an increased
consumption of calcium containing phosphate binders, phosphate control
remained poor. Table 2 shows changes from mild to mixed bone histology
in 2 patients and from aplastic to mixed in 1 patient. Aplastic bone and
osteomalacia were unchanged in 7/8 patients. One patient (initially mixed
uremic osteodystrophy) required parathyroidectomy because she had
severe bone pain from normocalcemic hyperparathyroidism. Dialysis
solutions low in calcium create headroom for the treatment of renal
osteodystrophy and may decrease the frequency of adynamic or mild bone
histologies; however, they increase the risk of frank hyperparathyroidism
in patients with poor compliance. On the other hand, in hyperphos-
phatemia treated with larger doses of calcium salts, a dca reduction to 1.25
mmol/liter is not enough to activate a once dynamic bone metabolism.
The dose of dialysis and nutritional parameters in hemodialysis (HD)
patients: A comparison between a new on-line dialysate method and
one-compartment (blood) urea kinetic modeling (UKM). F. Dellanna, M
Polio/c and CA Baldamus, Medizinische Clinic V University of Cologne,
Koln, Germany. Serum BUN was measured immediately before and 5
minutes after HD in 10 chronic HD patients and more than 90 routine
treatments. Therefore, Kt/V was calculated by a "standard" UKM (Dau-
girdas 1989) and also by an improved one-compartment UKM (Daugirdas
1993). Urea reduction ratio (URR) and protein catabolic rate (nPCR)
were calculated as well. During the same HD sessions BUN was measured
in the dialysate outflow by the Baxter Urea Monitor UM 1000 every 5 to
10 minutes directly in an automated way. From the decrease of dialysate
BUN concentrations and the total amount of removed urea Kt/V, URR
and nPCR are calculated by the monitor using a two-compartment model.
The analysis of the different methods shows these results:
Two-compartment model
Urea Monitor UM 1000
One-compartment model
(BUN before/after HD)
Kt/V 1.60 0.23 1.66 0.3122
1.74 0.2666
URR % 0.740 0.053 0.753 0.065
nPCRg/kg/Tag 0.9 0.17 0.75 0.13
In comparison to the "standard" model the new improved one-compart-
ment model leads to significantly lower Kt/V values in the range over
>1.5. Correlation between the standard model and the improved one-
compartment model is very high (r = 0.99). In contrast, the results of the
two-compartment model are correlated to the one-compartment model as
following: Kt/V: r = 0.56, URR: r = 0.60, nPCR: r 0.47. This implies
that although the median results as in the above table show a very good
concordance the results of Kt/V, URR or nPCR may be very different in
a single dialysis session depending on how they are measured (blood vs.
dialysate) and on how they are calculated (one- vs. two-compartment
model). Therefore, the method of how a urea kinetic index is derived is
crucial and must be cited precisely. Single session results should be verified
by an independent method to be regarded as true and representative. The
urea monitor UM1000 has the advantage of a higher numeric accuracy
due to repeated measurements and needs a minimum of extra time
spending for a complete calculation (6—8 mm per dialysis).
The detennination of renal tubular excretion of P-amino hippurate
(TmPAH) without examination of urine. S. Devaux, J. Gellermann, and E.
Wischniewsk4 Children's Hospital of the Humboldt University (Charité),
Berlin, Germany. For the assessment of acute renal failure, hereditary or
acquired tubular syndrome or the toxicity of drugs, information about the
function of the renal tubulus is required. The method to determine the
tubular excretion rate of the proximal tubulus (tubular maximal transport
of p-aminohippurat = TmPAH) is difficult and stressful, particularly, for
small children. Therefore, we searched for a method to determine the
TmPAH without the examination of urine. TmPAH is defined as the
clearance of PAH under conditions of high plasma level of PAH (PPAH).
We get the equal result when we determine the single injection clearance
of
'231-Hippurate (ClhIP) under the same conditions. The higher the
serum level of PAH the smaller the ClhjPp dependent on the excretion
ability of the proximal tubulus. In a very simple method in which the
examination of urine is not required we calculate the TmPAH by the
following formula:
TmPAH(mg/min) = PFMI . {€lhjpp- (0.78 . OEtyrA)]
0.78 CIEOTA is the filtered amount of PAH. The clearances of 51Cr-
EDTA (CIEDTA) and ClhjpP are examined after the single injection of both
nuclids by external registration of the nuclid half-life time. The correlation
between both methods, with and without urine collection, was observed in
8 children suffering from different tubular disorders (r = 0.97). In 33
children 10 to 14 months after kidney transplantation we determined the
TmPAH = 40.1 18.0 mImin/1.73 m2 (normal value for one kidney =
39.0 3.1 mglmin/1.73 m ). Conclusion: A simple and exact method for
the determination of TmPAH in children basing on the single injection
ClhI has been developed without urine examinations being necessary.
De novo diabetic glomerulosclerosis (dGS) to complicate kidney trans-
plantation. G. Ditscherlein, P. Reinke, and J. Lippert, Departments of
Pathology and Internal Medicine V, Charité Hospital, The Humboldt Uni-
versity of Berlin, Berlin, Germany. While the dGS recurrence in kidney
transplants has already been reported by several research groups, we
observed—apparently for the first time—dGS after the development of
steroid diabetes in deceased patients with kidney transplants. In 3 cases
the typical picture of the nodular dGS appeared not later than 13 years
after transplantation and 9 years after the beginning of steroid diabetes. In
other cases with a shorter transplant retention and duration of diabetes a
diffuse augmentation of mesangium matrix and thickening of the glomer-
ular basement membrane was observed which correspond to earlier stages
of dGS but are not specific. For this reason the demonstration of
morphological findings is concentrating on cases with classical dGS (focal
nodules, so-called fibrinoid caps, capillary aneurysms and arteriolosclero-
sis of the vas efferens). Here, also the combination with chronic transplant
glomerulopathy occurred. The patients showed proteinuria, hypertension
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and decreased, but stable, renal function. None of the patients died of
renal insufficiency. Apparently, this is not a dangerous complication but
should be taken into account in the differential diagnosis for patients with
long transplant retention time and steroid diabetes. It should be delimited
from glomerulonephritis and chronic transplant glomerulopathy and from
other glomerular findings in differential diagnosis.
Characterization of the Cl conductance in porcine renal brush-border
membrane vesicles. A. Dölle, W. Krick, and G. Burckhardt, Zentrum
Physiologic und Pathophysiologie, Georg-August Universitat, Gottingen, Ger-
many. Renal brush-border membrane vesicles (BBMV) are conductive for
Cl and may possess C1 channels. Since BBMV cannot be investigated by
patch clamp methods, we determined the characteristics of the C1
conductance and compared them with properties of known C1 channels.
K diffusion potential-driven Cl efflux caused vesicle shrinking that was
visualized by an increase in scattered light (900, 470 nm). Scattered light
intensity was inversely proportional to vesicle volume as validated by
parallel D-[3H]glueose uptake experiments. Anion conductance was tem-
perature-sensitive and increased for gluconate, S042, aspartate2 < F
<Cl <BC <1, N03, and SCN. Preloading BBMV with 5 mM Ca2
or depleting them of Ca2 by 2 mvt EGTA did not influence C1
conductance. Intravesicular Mg2 was also without effect, but 2 mM Cd2
and Zn2 inhibited C1 conductance by —80%. Flufenamate and 5-nitro-
2-(3-phenylpropylamino)benzoate inhibited half-maximally at 310 and 360
zM, respectively, and diphenylamine-carboxylate at 920 jzM. DIDS (1C5(,
200 !.LM) was more effective than SITS and DNDS. Steroid hormones
(10—100 ATP, ADP, AMP (1—5 mM) and prostaglandins E2 and D2(20—100 !LM) were without effects. Partial inhibitions by quinine and
verapamil suggested the involvement of P-glycoprotein. However, P-
glycoprotein requires ATP for functioning as a volume-sensitive C1
channel. Ca2 independence, preference of 1 over Cl— and sensitivity to
DIDS are reminiscent of outwardly rectif'ing epithelial Cl channels and
of swelling-activated Cl — channels. Porcine renal BBMV may therefore
possess a related C1 channel.
A new extracorporeal blood purification method based on simultaneous
adsorption and filtration. D. Falkenhagen, C. Weber, G. Vogt, H. Moser, C.
Rajnoch, F. Loth, and H. Schima, Institute of Bioengineering, Science
Academy of LowerAustria, and Centre of Biomedical Research, University of
Vienna, Vienna, Austria; and Fraunhofer Institute of Polymen-esearch,
Teltow, Germany. A new blood purification procedure has been estab-
lished which is based on high adsorption dynamics. Since the binding
capacity of an adsorbent particle lies on the outer surface area, advantage
is taken of the fact that the specific surface area of the adsorbent is
inversely proportional to the diameter squared of a particle. In principle,
this method is based on "high speed" recirculation of micro (2—10 jsm) or
nano (200—300 nm) spheres in a secondary circulation system of a
membrane filter. The high recirculation speed (up to 8 liters/mm) is
achieved with the aid of a centrifugal pump. Consequently, the negative
pressure gradient generated at the blood inlet of the dialyzer produces an
effective flow rate of filtrate which is, in turn, backfiltrated through the
membrane at the outlet of the filter. Hence, through adsorption, specific
substances can be eliminated from the blood of the patient which is
pumped through the plasma filter (primary circuit). This new procedure
has been applied to eliminate endotoxins from the blood. Endotoxins are
filtered and almost completely removed by cationically modified cellulose
adsorbents. In addition, mierospheres are particularly suitable for immu-
noadsorption and for the removal of cytokines and LDL. With continuous
operation of the system, several different adsorbent materials can be
utilized sequentially, in addition to biocompatible biological materials
such as immobilized receptors and cultured cells. Therefore, it is possible
to use the system over several days, for example, on patients suffering from
endotoxin shock. Moreover, this newly developed blood purification
technology offers a future with remarkable therapeutical applications to
different diseases, including multi-organ failure.
Early urinary detection of renal dysfunction following heavy metal
exposure: Clinical routine application. L.M. Fels, U. Eisenberger, C.
Herbort, K Jung, M. Pergande, and H. Stolte, Department of Nephrologie,
Medizinische Hochschule Hannover; and GBM, Bochum, Department of
Urologie, Humboldt-Universität, Berlin, Germany. The diagnostic potential
of a variety of urinary analytes (for example, tubular enzymes, tubular
brush border antigens, extracellular matrix proteins, eicosanoids) has been
evaluated in a cross-sectional study performed within a European collab-
orative research project. About 300 subjects with different degrees of
chronic environmental exposure to cadmium (Cd) or lead (Pb) were
examined. Twenty-six different urinary markers were tested under the
aspects of specificity, sensitivity and applicability for routine use. In
contrast to previous studies that often failed to demonstrate a glomerular
involvement during the early phase of Cd and Pb nephrotoxicity, glomer-
ular alterations could be observed for both toxins (increased high molec-
ular weight proteinuria and eicosanoid excretion for Cd and Pb, decreases
in fibronectin following Pb exposure). The most prominent quantitative
tubular changes after Cd exposure were found in subjects with high
cadmium body burden (>5 jg Cd/g Cr). The results confirmed that the
proximal tubule is the main target of cadmium but that it is also affected
by lead [e.g. increased excretion of a1-microglobulin, N-acetyl-/3-D-
glucosaminidase (NAG), intestinal alkaline phosphatase [lAP], and brush
border antigens]. The study showed that: (i) cadmium and lead affect both
glomerular and tubular function; and (ii) similar combinations of param-
eters can be used to detect early functional changes induced by these
toxins. It is recommended that a first diagnostic approach should comprise
NAG and a1-microglobulin. Although these are not the most sensitive
parameters, they are easy to measure and reference values have been
well-defined. A more extended differential diagnostic approach should
further comprise glomerular markers and very segment specific proximal
tubular markers (such as lAP).
Protection of cytostatic induced nephrotoxicity by silibinin and super.
oxide dismutase (SOD). L.M. Fels, J. Gaedeke, S. Stockmann, C. Bokem-
eyer, T Dunn, H.J. Schmoll, and H. Stolte, Departments of Nephrologie,
Hdmatologie/Onkologie, Medizinische Hochschule Hannover, GBM, Bo-
chum, Germany. Antitumor drugs like cisplatin (CP) or adriamycin (ADR)
are known for their toxic side effects. Cytoprotective agents could help
ameliorate functional disorders induced by these drugs and help elucidate
nephrotoxic mechanisms. Silibinin, exhibiting membrane stabilizing, anti-
oxidant and RNA-stiniulating properties, and the antioxidant SOD were
tested in a follow-up study on rat models of CP or ADR nephropathy. A
possible interference of silibinin with the cytostatic action of CP was tested
with the sulforhodamine B cytotoxicity assay in human non-seminomatous
germ cell lines. In vivo studies: CP induced glomerular and tubular
damage. It led to 5-fold increases in proteinuria (10 vs. 2 mg124 hr/100 g
body/wt) 3 days after application. Silibinin prevented this increase. Similar
protective effects were observed, for example, for the GFR (creatinine
clearance) and the proximal tubular markers alanin-aminopeptidase and
Mg2 excretion. Silibinin diminished morphological alterations in the
S3-segment of the proximal tubule. SOD had no protective effects. ADR
caused more severe kidney damage. Rats showed 100-fold increases in
proteinuria and a decline in GFR. Neither silibinin nor SOD significantly
reduced these nephrotoxic effects. In vitro studies: Concentrations of
silihinin comparable to plasma levels in rats (<0.05 mg/ml) did not
compromise the cytotoxicity of CP in the cell lines 577ML, H32, 2l02Ep,
1777NR Cl-A. There were no major interferences at higher concentrations
(>0.1 mg/mI) where silibinin is itself inhibitory. Conclusions: Silibinin
protected against glomerular and tubular damage in CP nephropathy.
Oxidative stress does not seem to be the major mechanisms of CP toxicity
in the rat model studied. ADR nephrotoxicity could to be too severe to be
ameliorated by single applications of the substances applied or not
mediated by the mechanisms addressed. Silibinin might prove a potential
protective agent for clinical studies into CP-induced nephrotoxicity.
Preformed human alloantibodies against DR-typed lymphoblastoid cell
lines and capillary deposition of complement fragment C4d in 'early renal
graft dysfunction.' SR. Lederer, H. Schneebetger, E. Albert, J. Johnson, D.J.
Schendel, W. Land, K Burkhardt, G. Hillebrand, and HE. Feucht, Mediz-
inische Klinik, Klinikum Innenstadt Institut für Immunologic; Abreilung für
Transplantationschinwgie, Medizinische Klinik I, Klinikum GroJlhadem und
Kinderpoliklinik der Universität München, Munich, Germany. Capillary
deposition of complement fragment C4d in cadaver renal transplants is
present in about 50% of grafts with the complex syndrome of "early
dysfunction" and is highly associated with early graft loss. As a pbssible
cause of the presumed vascular complement activation, preformed MHC
class II reactive antibodies were sought in pretransplant sera from 86
biopsied recipients with early dysfunction. In order to discriminate
between complement-activating and non-activating human IgG alloanti-
bodies against a representative panel of 11 EBV-transformed DR-typed
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homozygous lymphoblastoid cell lines, a two-color flow cytometry method
was developed. Thus, deposition of IgG alloantibodies on LCL was
detected by a PE-labeled antiserum, whereas the induced activation of the
classical complement cascade was simultaneously measured by a FITC-
labeled antiserum to complement fragment C4c. Using this method,
reactivity against LCL was detected in 43 sera. In 18 cases complement-
activating antibodies were present. In 14 cases complement-non-activating
antibodies were detected, whereas in 11 cases complement deposition on
LCL could be demonstrated in the absence of IgG. Conventional panel-
reactivity was observed in 20 sera only. Both LCL-reactivity (P = 0.031)
and panel-reactivity (P = 0.015) are significantly correlated with capillary
deposition of complement fragment C4d in early graft biopsies. Conse-
quently, the combination of LCL and panel reactivity is even more
predictive of subsequent C4d deposition in renal transplants (P = 0.003).
In the LCL-reactive group 13 graft losses within the first year after
transplantation were observed as compared to 7 graft losses in the
LCL-non-reactive group. In the panel-reactive group (20 sera), 7 graft
losses were seen compared to 13 losses in the panel-non-reactive group. In
conclusion, two-color FACS analysis seems to be a useful supplement to
conventional panel-reactivity in assessing the immunological risk of pro-
spective kidney transplant recipients.
Ca2 influx into epithelial cells. K-G. Fischer, G. Kerst, J. Leipziger, R.
Nitschke, and R. Greger, Physiologisches Institut, Universität Freiburg,
Freiburg; Germany. To investigate stimulated Ca2 entry as a signal of
stimulation-response coupling in epithelial cells we used colonic and
pancreatic duct adenocarcinoma cell lines (HT29 and CFPAC-1). We have
shown that ATP, carbachol (CCH) and hypotonic cell swelling induce
biphasic increases of intracellular Ca2 ([Ca2]1). The elevated plateau
phase reflects transmembraneous Ca2 influx as demonstrated by its
requirement for extracellular Ca2t Using the fura-2 measurement of
tCa2]1, the Mn2-fura-2-quenching technique and the nystatin slow
whole cell patch clamp technique we found the following factors to inhibit
agonist- or thapsigargin (TG)-stimulated Ca2 entry: (1) membrane
depolarization, (2) flufenamate and structurally related compounds, (3)
Ni2, Gd3, La2 and Mn2, (4) cell shrinkage, (5) extracellular acidifi-
cation, (6) SKF 96365 and (7) econazole. Whereas Ni2 was a potent
inhibitor of the agonist- or TG-stimulated Ca2 entry this was not the case
for the Ca2 influx induced by hypotonic cell swelling. Here Ni2 was
found to quench the fura-2 fluorescence. These data indicate that hypo-
tonic cell swelling induces a Ni2 permeable Ca2 entry pathway which
may be distinct from that induced by ATP or CCH. Electrophysiological
experiments using the fast whole cell technique and high intracellular
BAPTA to deplete the intracellular Ca2 stores indicated that in HT29 and
CFPAC-1 cells the stimulated Ca2 influx occurs via a non-selective cation
channel, as the observed inward current was carried not only by Ca2, but
also by Nat The fact that known channel blockers of non-selective cation
currents in other epithelial preparations (flufenamate and Gd3) were
found to be potent inhibitors of stimulated Ca2 entry supports the
concept that the Ca2 release activated current (CRAC) in epithelial cells
may have the properties of a non-selective cation channel.
Effect of moxonidine on urinary sodium excretion and renal hemody-
namics in healthy volunteers. D. Fliser, A. Wiecelç M Nowicki, and E. Ritz,
Department of Internal Medicine, Ruperto-Carola University, Heidelberg,
Germany. Moxonidine exerts its antihypertensive effect probably via
interaction with imidazoline receptors located in the CNS. Imidazoline
receptors have been recently found in the renal proximal tubule as well. In
experimental studies interaction of imidazolines with these receptors
decreased the activity of the Na/H antiporter and induced natriuresis.
To quantitate the effect of moxonidine on urinary sodium excretion,
proximal tubular transport, GFR (CIN) and ERPF (CPAH), we examined
ten healthy normotensive males (25 4 years) in a double-blind placebo-
controlled study using a cross-over design. On the 7th and 10th day of a
low salt diet (50 mmol/day) subjects randomly received either iv. placebo
(P) or i.v. 0.2 mg moxonidine (M). Injection of moxonidine did not
increase fractional sodium excretion (FENa) or lithium clearance (CILI).
Specifically, antinatriuresis was not observed after injection of moxonidine
despite a significant decrease in MAP and increase in PRA. MAP and
PRA did not change with administration of placebo. Injection of mox-
onidine did not affect GFR, whereas ERPF decreased slightly but not
significantly.
Baseline 0 hr—2 hr 2 hr—4 hr 4 hr—6 hr
P 0.47 0.25 0.59 0.31 0.68 0.36 0.64 0.41 FENa (%)
M 0.48 0.34 0.58 0.42 0.58 0.47 0.62 0.47
P 17.5 7.6 13.6 2.7 13.5 4.4 12.8 4.3 CILI (mI/mm)
M 14.8 6.8 14.3 4.5 13.4 2.7 15.8 7.7
Acute administration of moxonidine does not significantly affect proximal
tubular sodium handling and renal hemodynamics. However, the absence
of an antinatriuretic response despite a decrease in blood pressure is
consistent with a modest natriuretic effect of moxonidine.
Polyamines in red blood cells (REC) and plasma of hemodialysis (lID)
patients. M Fuchs, E. Riedel, H. Hampl, and G. Wendel, Freien University
Berlin, Institut für Biochemie und Kuratorium für Dialyse und Nierentrans-
plantation, Berlin, Germany. Polyamines (putrescine, spermidine, sper-
mine, cadaverine) are elevated in HD patients in plasma and erythrocytes.
Polyamines are generally increased in proliferating cell systems such as
erythopoiesis, regenerating liver and different malignancies. On the other
hand spermine inhibits erythroid colony (CFU-E) formation. In 22 HD
patients we measured polyamines in younger and elder RBC's (PER-
COLL density gradient centrifugation) and in plasma, both in comparison
to a healthy control group (N = 10) by fluorescenz-HPLC. In younger
RBC's increase of polyamines was significant (P < 0.05), compared to
elder RBC's and controls and depend on severity of anemia. Plasma levels
of polyamines are significantly increased (P < 0.01) dependent of severity
of anemia too, but in particular, putrescine is decreased below control
values in presence of modest anemia. We assume that elevated polyamine
levels in RBC's and plasma in anemic HD patients reflect the increased
proliferation rate of RBC's and come only to a minor degree into
consideration as factors causing anemia.
Polyamines in red blood cells (RBC) and plasma of hemodialysis (lID)
patients. M Fuchs, E. Riedel, H Hampl, and G. Wendel, Institut für
Biochemie der Freien University and Kuratorium für Heimdialyse, Berlin,
Germany. In nitrogen metabolism participating polyamines (putrescine,
spermidine, spermine, cadaverine) are elevated in chronic renal failure in
plasma and erythrocytes. Polyamines are generally increased in prolifer-
ating cell systems such as erythropoiesis, regenerating liver and different
malignancies. In 22 HD patients we have measured polyamines in younger
and older RBC's (PERCOLL density gradient centrifugation); and in
plasma, both in comparison to a healthy control group (N = 10).
Polyamines were determined as o-Phthaldialdehyde derivatives in fluores-
cence HPLC. In younger RBC's increase of polyamines was significant
(P < 0.05) compared to older RBC's and controls and depends on the
degree of anemia. In plasma, levels of polyamines were found to be
significantly increased (P < 0.01) with severity of anemia too, but in
particular putrescine is decreased below control values in a state of modest
anemia. We assume that elevated polyamine levels in RBC's and plasma
reflect the increased proliferation rate of RBC's in anemic HD patients
and come only to a minor degree into question as factors causing anemia.
Is there a correlation between the secretion of dysmorphic erythrocytes
and histopathological renal changes in glomerulonephritis? R. Funfstuclc
S. Klinzing, G. Stein, W. Schulz, T Risler, Rita Rbsch, and H-P. Doll,
Department of Medicine Jena, Bambe,', TObingen, Dessau and Gera,
Germany. Dysmorphic erythrocytes, especially acanthocytes, are a typical
symptom of glomerular damage. In 101 patients with glomerulonephritis
the rate of dysmorphic erythrocytes was compared with histological
findings and the pattern of urinary proteins. The medium excretion of
dysmorphic cells amounted to 68 24% (17 16% acanthocytes).
Significant differences in the rate of dysmorphic eiythrocytes in different
forms of glomerulonephritis were not found. The portion of dysmorphic
erythrocytes was increased in changes of the basement membrane (split-
ting, ruptures, spikes), increase of mesangial matrix, mesangial cell
proliferation and deposit of immune globulins (IgG, IgA); a statistically
significant relation did not exist. The rate of dysmorphic cells was
increased with 71 23% versus 59 28% (P = 0.05) in cases of
interstitial changes. In a glomerular protein pattern (types I—Ill) in SDS
polyacrilamide gel electrophoresis, an increased excretion of dysmorphic
erythrocytes (78 27% vs. 64 26% in mixed proteinuria type V) was
evident. There was no relation detectable between the rate of dysmorphic
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erythrocytes, total protein excretion, IgA, IgG and albumin concentration
in the urine. The excretion of glomerular erythrocytes refers to patholog-
ical changes in the glomerular sphere. A differentiation of the histological
disturbances by means of the morphological assessment of the erythro-
cytes does not seem to be possible.
The influence of host-specific genetic factors on the virulence of
uropathogenic E. co/i strains in patients with pyelonephritis. R. Fünfstück,
N. Jacobsohn, H. Tschape, and G. Stein, Department of Internal Medicine
IV University of Jena, Jena; Federal Office of Health, Department of
Experimental Epidemiology, Wernigerode, Germany. The progress of pyelo-
nephritis is, among other things, determined by the host-to-infective agent
response. In 53 patients, ABO, P1, and Lewis blood group phenotypes as
well as the secretor status were investigated in relation to virulence
properties of isolated E. coli strains and the degree of bacterial adherence
to uroepithelial cells. Pathogenicity was determined in 144 E. coli strains
over 3 years. Patients with P1 antigens (N = 40/76%) had fewer microor-
ganisms with the ability to produce hemolysin and mannose-resistant
hemagglutination. The difference was statistically significant (P = 0.05).
This correlation was increased in patients with blood group B (N =
13/23%), especially in the presence of B secretors (N = 9/16%; P <
0.0005). This association was not found in patients of blood group A.
Cases of nonsecretor or Le(a+) phenotype (N = 9/17%) had significantly
more strains with Ki antigens (P = 0.0004). The secretor status had no
detectable influence on bacterial adherence to uroepithelial cells. Micro-
organisms isolated from patients with blood group B phenotype had
significantly higher levels of antibody coating (81 20%) than those from
patients with other ABO antigens (63 31%; P < 0.05). The phenotypic
expression of virulence properties of E. co/i is quite probably determined
by host-specific factors, with the antigens P1 and B as the secretor status
playing some role as well.
Functional relevance of high serum levels of soluble CDI4 in hemodi-
alysis patients. M. Girndt and H. Köh/er, Medical Department ii' University
of Homburg, Homburg, Germany. In patients with chronic renal failure
who are on regular hemodialysis there is an accumulation of serum
proteins that physiologically can interfere with the immune system. There
is little information on whether these enhanced serum levels have
functional consequences. One of those serum proteins is the soluble CD14
molecule (sCD14). The CD14 molecule is a receptor for endotoxin (LPS)
on the surface of rnonocytes in peripheral blood. The receptor is shedded
by proteolytic cleavage and secreted into serum. We examined serum
levels of sCD14 in 31 patients on regular hemodialysis in comparison to
the levels in 14 healthy controls. By means of flow cytometiy we
investigated the influence of different sera on the binding intensity of
endotoxin to normal mononuclear cells. We further related the production
of TNF by these normal cells in the presence of patient's sera to their
content of sCD14. Hemodialysis patients showed higher serum levels of
sCD14 (7.05 g/ml 1.8 sg/ml) than healthy controls (3.79 sWml 1.3
.g/ml, P < 0.001). Sera with a higher concentration of sCD14 induced a
more intense binding of endotoxin than those with less sCD14, The more
intense binding of endotoxin also led to a stronger production of TNF by
these cells. We conclude that the elevation of sCD14 enhances the effect
of an accidental endotoxinemia in hemodialysis patients and contributes to
the overproduction of monokines commonly seen in these patients.
Antiendothelial antibodies (AECA) in Wegener's granulomatosis with
renal involvement. U. Gobel, D. Sima, R. Kettritz, U. Thieme, and S.
Gel/rich, First Medical Clinic Berlin-Buch, and Department of Dermatology
of the Humboldt University (Charité), Berlin, Germany. C-ANCA are
described as sensitive diagnostic markers of active Wegener's granuloma-
tosis (WG). New longitudinal studies pointed out that the interindividual
variation between disease activity and C-ANCA titer is high. AECA were
evaluated in 36 patients with histologically proven WG in different phases
of the disease. AECA were tested by a special ELISA, and some sample
of WG sera were proven by Western blot technique, ANCA by immuno-
fluorescence technique (van der Woude), anti-proteinase 3-Ab (PR3) and
anti-myeloperoxidase-Ab (anti-MPO-Ab) by commercial ELISA. They
were evaluated by means of a combination of various laboratory data:
erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), serum
creatinine level, and proteinuria. Results: We have found AECA with high
titers (2485 + 1299) in the active phase and in clinical relapse. Mean titers(1050 + 1255) have been found in total remission as well as in partial
remission. Four patients with active disease without ANCA and PR3 had
high titers of AECA, as well as all patients with "serological relapse".
(N = 4) Compared to patients with chronic glomerulonephritis (N = 50)
and arteriosclerosis (N = 17), AECA were not detected. Five patients with
ANCA and AECA positive WG exhibiting 66 kD protein required further
protein analysis. AECA are unspecific antibodies but usually a good
marker in monitoring WG. Especially in ANCA negative, histologically
proven cases and in patients with serological relapse without clinical signs,
AECA are additional markers to CRP and ESR.
Influence of chloride and protein intake on the evolution of hyperten-
sion and renal failure in a rat strain suffering from polycystic kidney
disease. N. Gretz, K Mehitretter, B. Kränzlin, and M. Strauch, Department of
Nephrology, Klinikum Mannheim, University of Heidelberg, Mannheim,
Germany. Patients having polycystic kidney disease (PKD) often suffer
from hypertension, which is noted earlier than the loss of renal function.
With the PKD rat model at hand there is the opportunity to shed some
light on the pathogenesis of this problem. We analyzed the impact of
chloride and protein feeding on the development of hypertension in 360
male PKD rats, which were divided into 5 different diet groups (N =
15—20) and which were followed from birth up to the age of 2, 4, 6 or 9
months. Group 1: 24% protein + HC1 enriched drinking water (pH 2,
often used when breeding animals!); Group 2: 18% protein + HCI
enriched drinking water; Group 3: 24% protein +normal drinking water;
Group 4: 18% protein + normal drinking water; Group 5: 18% protein +
0.4% NaCl enriched drinking water. Chloride resulted in a significant rise
in blood pressure in (mm Hg): Group 1: 157; Group 2: 150; Group 5: 155
versus Group 3: 136; Group 4: 137 (ANOVA: P < 0.05).The rise in blood
pressure occurred already at the age of 2 months. Kidney weight (g/100 g
body wt) was significantly higher in Group 5 than in all other groups (1.59
vs. 1.27, 1.25, 1.25, and 1.19, respectively). The protein rich diet (24%)
induced a significant reduction in serum urea, serum creatinine, and
cholesterol. We conclude that already a small chloride load resulted in a
significant rise in blood pressure, which did not influence the progression
rate of chronic renal failure up to the 9th month in this rat model of PKD.
Influence of coculture with interstitial cells on sodium transport of
papillary collecting duct cells. C. T Grupp, B. Ziehike, and H.-E. Franz
Department of Nephrology, University of GOttingen, GOttingen; and Section
of Nephrology University of U/rn, U/rn, Germany. In order to evaluate
potential interactions between the interstitium and tubular cells with
respect to the regulation of ion transport in the papilla, we examined the
effect of interstitial cells (IC) on sodium transport of inner medullasy
collecting duct cells (IMCD). Therefore, we cocultured impure IMCD or
pure IMCD on filter supports with IC grown on the bottom of the well.
Impure IMCD were obtained by enzymatic digestion of rat papillae and
differential centrifugation. They still contained 5—10% IC as evaluated by
antibody- and lectin-staining. Practically pure IMCD were obtained using
an additional purification step with DBA-lectin-coated beads. These
preparations were cultured either in the absence or presence of IC, which
were isolated by differential centrifugation and lectin-coated beads. Nei-
ther impure IMCD nor pure IMCD preparations showed significant
differences between coculture and monoculture conditions regarding total
protein content of IMCD, transepithelial resistance RT, transepithelial
potential difference PD and transepithelial sodium-permeability PNA.
Conversely, sodium uptake UpNA (in the presence of 10 mrvi ouabain) of
pure IMCD was significantly higher in cocultures (18.6 1.6 nmol Na/mg
prot 10 mm.) than in monoculture (15.6 1.4; P < 0.05). These
differences were not seen in impure IMCD preparations (monocultures
20.6 2.0; cocultures 21.0 1.6, NS). In summary, these results suggest
an effect of IC on sodium-transport of LMCD; the underlying mechanisms
and the involved transport systems remain to be determined.
Effect of endothelin and dopamine on the production of prostaglandin
E2 (PGE2) by papillary cell types. C. T. Grupp, M Begher, C. Lenz, and F.
Keller, Department of Nephrology, University of Gottingen, Gottingen; and
Section of Nephrology, University of U/rn, Ulm, Germany. Both endothelin(ET) and dopamine (DP) exert at least some of their effects in renal
papillae via PGE2. We characterized stimulation of POE2 production of
papillary collecting duct cells (PCD), thin Henle's loop cells (TLH), and
interstitial cells (IC) by these hormones in 3 to 6 day old primary cultures.
PCD, TLH, and IC were isolated by enzymatic digestion, differential
centrifugation and lectin-coated beads. The purity of the cell populations
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was evaluated by antibody- and lectin-staining and was above >90%,
respectively. There was no significant contamination with endothelial cells.
ET-1 (10 nM) stimulated [in PCD cultured on permeable supports
(transepithelial resistance RT: 447 20 Ohm cm2)] PGE2-release into
the basolateral incubation medium only from basolateral (269 33 vs. 181
16 ng PGE2!mg prot/30 mm; p < 0.05) but not from luminal (198 26
vs. 197 23, NS). In subconfluent TLH there was also a significant
increase of PGE2 production by ET (20 5.2 vs. 13 1.9, P < 0.05);
however there was no effect observed in IC (2.9 0.3 vs. 2.7 0.3, NS).
On the contrary, DP (100 LM) stimulated PGE2 production in all cell
fractions; proportionally the effect was greatest in IC (+440%: 24.8 2.3
vs. 4.6 0.4, P < 0.001). Stimulation was found to be lower in the TLH
(+220%: 44.0 4.4 vs. 13.7 2.0, P < 0.001) and least in the PCD
cultured on permeable supports (RT 414 37 Ohm - cm2): DP showed no
side-dependence of the stimulatory effect (from luminal: 253 32; from
basolateral: 283 38: P < 0.05 vs. control: 169 24, P < 0.05). These
results are considered to be a basis for further investigations of the role of
these hormones in the renal papillae.
K permeability disorders in chronic renal insufticiency. S. Gruska, E.
Wolf R. Ihrke, and G. Kraatz, Clinic of Internal Medicine, E.-M-Arndt
University, Greifswald, Germany. As decreased intracellular K concentra-
tions are found in addition to the well-known disturbance of the K
excretion, the K and Na permeability of erythrocyte membranes was
investigated in hemodialysis (HD) patients. Previously, we have shown
increased K permeability in patients with compensated renal insuffi-
ciency (RI) which may be due to a hypothetic "endogenous digitalis like
factor" (ELDF). The aim of this study was to describe the effects of
dialysis on ion-permeability. Another question was whether the ELDF is
removable by dialysis. K and Na permeability was defined as the
relative change of K or Na concentration in whole blood resulting from
K and Na fluxes across erythrocyte membrane, not taking into account
possible interactions between the various ion transport systems. K and
Na concentration in blood were monitored at 37°c over 4 hours with
measurements after every 60 minutes by ion sensitive electrodes. The
non-linear K effiux in HD (N 47) is significantly increased (P < 0.05)
compared with healthy volunteers (N = 48). K and Na permeability is
decreased after hemodialysis. The ELDF as determined by the digoxin
assay (Abbott TDX) didn't show significant differences prior to and after
dialysis (0.39 ng/ml vs. 0.40 ng/ml). The results do not support the
assumption that a decreased K effiux after dialysis is caused by removing
the "digitalis like factor." However, further experiments are required to
investigate the nature of disturbances of K permeability.
Interferon gamma (IFN) is not important in the etiology of bacterial
polysaccharide (LPS)-induced glomerulonephritis. C. Haas, B. Car, B.
Ryffel, and M. Le Hir, Institut für Toxikologie der ETH und Universität
Zurich, Zurich, Switzerland. IFN can be expected to play a role in the
etiology of inflammatory processes since it activates macrophages, influ-
ences the migration of leucocytes, and up-regulates the expression of
MHC antigens. In this study we tested the role of IFN in a model of
glomerulonephritis. A systemic lupus-like disease was induced by injection
of 50 zg LPS twice a week for 4 weeks in wild-type and in IFN
receptor-deficient (IFN R—/---) mice. The renal cortex was examined by
immunofluorescence and by routine histology. There was no obvious effect
of LPS in tubules or in the interstitium. LPS provoked a deposition of
immune complexes and of complement in the glomeruli. The mesangium
showed an increase of extracellular matrix and hypercellularity. ICAM-1
immunoreactivity increased in the mesangium and in glomerular capillar-
ies. The number of intraglomerular leukocytes, detected by MHC class II
and LFA-1, increased roughly 4-fold. Since leukocyte infiltration, up-
regulation of ICAM-1 expression, and expansion of the mesangium
following LPS treatment were not affected by disruption of IFN R gene, it
seems that those events, which appear to play a cardinal role in various
types of glomerulonephritis, do not require the mediation of IFN.
The 5' regulatory region of the rat 72 kD type IV collagenase gene
contains a strong, mesangial specific enhancer. S. Harendza, AS. Pollock,
and D.H. Lovett, Department of Medicine, University of California!
SFVAMC, San Francisco, California, USA. Glomerular mesangial cells
(MC) secrete a defined spectrum of matrix metalloproteinases. The 72 kD
type IV collagenase (MMP2) is regulated by MC in an apparently unique
manner, with induction following exposure to IL-i, TNF, TGF-/31,
phorbol ester, and second mesenger analogs as previously shown by
studies from our laboratory. To evaluate the transcriptional processes
involved in this complex response, overlapping genomic clones encoding
the 5' upstream region of rat MMP2 were obtained from a rat genomic
library and sequenced. A set of defined 5' deletion constructs was
directionally cloned into a promoterless luciferase expression vector and
transiently transfected into rat MC. These constructs were also transfected
into glomerular epithelial cells (GEC) which do not synthesize MMP2,
and into promonocytic U937 cells which produce MMP2 after stimulation
with phorbol ester. A proximal basal promoter, operative in all cell types
tested, was found between —57 and —3 bp relative to the transcriptional
start site. A 5 to 20-fold enhancement in basal activity was obtained in MC
with a construct including 1200 bp of the 5' upstream sequence, whereas
this construct did not enhance luciferase activity in GEC and U937 cells.
Further fine mapping of this region revealed the strongest enhancer
activity within an 80 bp fragment (—1109 to —1029 bp). This region does
not show any homologies to known transcription factor binding sites.
Gelshift and footprinting experiments revealed the binding of several
nuclear proteins to this sequence. These data indicate that the proximal 5'
regulatory region of the rat MMP2 gene contains a very strong enhancer
element. In combination with its basal promoter the expression of the
MMP2 is regulated in a cell specific manner by MC.
Erythropoietin in patients with acute renal failure. P. Heering, S.
Morgera, K ivens, and B. Grabensee, Medizinische Klinik und Poliklini/
Heinrich-Heine-Universitbt Düsseldorf Düsseldorf Germany. Acute renal
failure (ARF) is often accompanied by anemia. We studied erythropoietin
in patients with acute renal failure and who were treated in intensive care
with continuous hemofiltration and were artificially ventilated. Between
1/4/1993 and 1/6/1994, 40 patients were studied. Patients with previous
impairment of renal function or patients who were treated less than 48
hours were eliminated from the study. Regular controls were performed
for hemoglobin, erythropoietin, FE, Ferritin, B12, and folic acid transfu-
sions. Patients were controlled by a group of 6 patients who were
artificially ventilated without renal replacement therapy. In patients with
artificial ventilation and acute renal failure, erythropoietin was increased
at the beginning and decreased with time (reference range 4.1—22.2
mU/mi). At the beginning (day 0—2) there was a mean erythropoietin level
of 87.6 mU/mi 9.7 and from days 3—5 67.7 7.4 mU/mi. Erythropoietin
decreased at days 12-44 to 43 11.2 mU/mi. Hemoglobin was 9.9 0.9
mg/dl, and there was no correlation between erythropoietin and hemo-
globin. B12, ferritin and folic acid were in the normal range. In the control
group erythropoietin was 38.5 7 mU/mi. Increased erythropoietin levels
were found in patients with oligoanuric and polyuric acute renal failure.
Erythropoietin secretion was increased in acute renal failure compared to
controls. During acute renal failure there was a decrease of erythropoietin;
this decrease was more pronounced in patients with oligoanuric acute
renal failure compared to nonoligoanuric patients. It must be considered
whether anemia in patients with acute renal failure is due to an inappro-
priate erythropoietin secretion.
Impairment of renal functional reserve in renal graft recipients. P.
Heering, C. Hankemann, G. Keller, H. Strobach, K SchrOr, and B. Gra-
bensee, Medizinische Klinik und Poliklinik, Klinik für Nephrologie, Institutfi'
Pharmakologie, Heinrich-Heine-Universitdt Düsseldorf Düsseldorf Ger-
many. Renal graft recipients in patients treated with CsA have an
increased renal vascular resistance compared to patients with conven-
tional immunosuppressive treatment. We studied renal function and renal
function reserve after amino acid (AA) loading in renal graft recipients
randomized to treatment with CsA (Group 1, N = 8) or azathioprine(Group 2, N = 8). We studied C1,,, PRA, aldosterone, TXB2 and
6-OXO-PGF1-alpha in urine and plasma under basal condition and during
Amino Acid loading. In renal graft recipients treated with CsA, creatinine
was increased compared to Group 2 (1.6 0.5 vs. 1.1 0.1 mg/dl, P <
0.05) and giomerular filtration rate (GFR) was significantly decreased.
GFR in Group 1 increased from 72.3 18.4 ml to 78 19.4 mI/mm (NS).
In graft recipients treated with azathioprine, GFR increased from 84 4.2
to 85.8 7.6 ml (NS). There was a slight increase in CPAH in both groups
(NS). There was no significant difference in plasma renin activity and
aldosterone. TXB2 concentration in plasma was 60 11 pg/ml in both
groups. There was no difference in basal excretion of urinary TXB2 (103
22 ng/g creatinine) and of 6-OXO-PGF1-alpha (164 23 pg/mI). In
patients treated with CsA after AA loading TXB2 increased to 268 21;
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there was no increase in renal graft recipients treated with azathioprine.
During AA loading there was no significant increase of 6-OXO-PGF1-
alpha in urine and in plasma. In renal graft recipients treated with CsA,
GFR was impaired. During AA loading GFR did not increase in graft
recipients treated either with CsA or conventional treatment. AA loading
induced an increase in TXB2 in patients treated with CsA which might
impair RFR.
Cyclosporine A monotherapy compared to azathloprine: Cyclosporine
A double therapy in long-term iminunosuppression after kidney allo-
transplantation. 1'. Hegner, and U. Binswanger, Nephrologische Abteilung
Universitdtsspital Zurich, Zurich, Switzerland. Long-term cyclosporine A
(CsA) monotherapy after kidney allotransplantation was compared with
double therapy azathioprine (Aza) + CsA. After induction (ALG or
ATG) in case of transplant ischemia or recipient sensitization and triple
therapy CsA + Aza + prednisone (P), the latter was weaned after 6
months, which was successful in 46% of the patients. After another 6
months, patients treated by CsA + Aza were randomized in group II to
continue with this therapy or group I to be weaned from Aza. During
follow-up, 4 patients had to be restarted on Aza during years 2 and 4; 2
and 3 patients of group II received P during years 2 and 5, respectively,
due to rising serum creatinine levels. Twenty-nine patients in each group
were evaluated for cumulative graft survival of organs up to 6 years; 11
patients in each group were observed for 6 years. No differences for graft
survival (I vs. II: 78 vs. 80%), changes in serum creatinine concentration,
hypertension or blood lipids were found. These data indicate that CsA
monotherapy for long-term immunosuppression is an acceptable option
after selecting patients who do not need steroids and who exhibit stable
renal function after withdrawal of Aza. Omitting Aza might protect
against neoplastic disease.
FK.506 salvage in OKT III resistant rejection in renal transplantation.
S. Herget, J. Erhard, T.H. Philipp, and K Wagner, Departments of Nephrol-
ogy and Suigemy, Universitatsklinikum Essen, Essen, Germany. The new
immunosuppressive agent FK506 has been successfully used in recent
years for intractable rejection in liver transplantation. We report on 7
renal transplant recipients who were converted from cyclosporine A (C5A)
to FK506. Indications were biopsy proven steroid- and OKT Ill-resistant
rejection. The patients (4 females, 3 males; average age 36 years; 2
glomerulonephritis, 2 polycystic kidney disease, 2 diabetic nephropathies,
and 1 pyelonephritis; mean panel reactive antibodies 5%; 6 primary and 1
second cadaver kidney recipients; average of 3 HLA mismatches) initially
received immunosuppression with CsA and prednisone in adequate doses.
Six patients developed acute interstitial rejection, and 1 patient developed
vascular rejection within 3 weeks after transplantation, which histologi-
cally and clinically did not resolve by i.v. steroids and subsequent OKT III.
At an average of 6 weeks post-transplantation the patients were switched
to FK506 and steroids. Results: During the 7 months mean follow-up after
conversion we observed stable transplant functions measured by serum
creatinine (Se,) and creatinine clearance (Car). Graft function at the time
of the switch was S 3.8 mg/dl and Ccr 18.1 mI/mm. Six months after
conversion Sr and Cr had significantly improved (Sr 3.3 mg/dl, Cr 30.6
mI/mm, P < 0.05). There was 1 graft loss due to chronic rejection after 8
months on FK506. The average oral FK506 dose was 0.17 mg/kg/day. Oral
prednisone was not reduced in combination with FK506 and a mean daily
dose of 11 mg was given. One further acute rejection episode reversing to
increased FK506 doses was noticed in our patients since the switch to
FK506. With 3 CMV infections pre-, 2 CMV—, 1 HSV— and 1 oral
Candida infection post-conversion, patients seemed more prone to oppor-
tunistic infections on FK506. The following adverse events occurred which
could be attributed to FK506: 2 patients developed transient diabetes
mellitus, 1 tremor, and in 2 pre-existing hypertension worsened, Conclu-
sions: These data suggest that FK506 could be beneficial in reversing
steroid- and OKT Ill-resistant acute rejection in renal transplantation on
primary CsA immunosuppression. At the same time FK506 seems to be a
immunosuppressant with few side effects. Results of long-term follow-up
have to be studied to draw stronger conclusions regarding the success of
FK506 salvage therapy.
Predisposing factors for the development of post-renal transplant
erythrocytosis. S. Heiget, R. Zotz, T.H. Philipp, and K Wagner, Department
of Nephrology, Universitatsklinikum Essen, Essen, Germany. Post-renal
transplant eiythrocytosis (PTE) is a well-known complication. We ana-
lyzed 600 cadaver kidney transplants with sufficient function for longer
than 3 months in respect to factors initiating PTE. PTE was defined as Hct
> 50% and Hb> 16.5 g/liter on more than 3 consecutive measurements
during 4 weeks, leading to phlebotomy, while 147 patients (24.5%) with
PTE were identified with a mean PTE onset at 9 months and duration of
20 months. Diuretics were applied to a similar percentage to PTE and
non-PTh patients so spurious polycythemia could be excluded. Results:
Compared to non-PTh patients significantly more PTE patients were male
(80.9% vs. 46.8%; P < 0.0001), had hypertension pre-transplant (78.1% vs.68.0%; P < 0.02), and glomerulonephritis as the underlying disease
leading to ESRD (56.9% vs. 45.9%; P z 0.01). Fewer PTE patients were
identified with analgesic nephropathy (1.4% vs. 4.7%; p < 0.01), uni- or
bilateral nephrectomy of the native kidneys (13.6% vs. 26.3%; P < 0.005),
and anemia (37.4% vs. 43.1%; NS) pre-transplantation. A higher number
of PTE patients were found to be supplemented with iron post-transplant
(31.3% vs. 15.9%; p < 0.01). Significantly fewer showed chronic rejection(9.5% vs. 13.7%; P < 0.02), uni- or bilateral nephrectomy of the native
kidneys post-transplant (2.7% vs. 6.2%; NS), or were treated with
azathioprine (27.9% vs. 49.3%; p < 0.0001). No significant differences
between PTE and non-PTE patients occurred regarding age of recipient,
duration of dialysis, cold and warm ischemic time, initial graft function,
renal artery stenosis of the graft, immunosupressive agents other than
azathioprine, and number of renal transplantations or acute rejections.
Both groups showed similar graft function when comparing yearly Sr
values for a period of up to 18 years. ConclusIons: (1) Male gender,
glomerulonephritis, pre-transplant hypertension, and post-transplant iron
supplementation predispose to PTE. (2) Significantly less PTE develops in
patients with analgesic nephropathy, anemia pre-transplant, nephrectomy
of the native kidneys pre- or post-transplant, azathioprine based imniu-
nosuppression and chronic rejection.
What are the risk factors for post-renal transplant dIabetes? S. Heiget,
R. Wagner, T.H. Philipp, and K Wagner, Departments of Nephrology and
Endocrinology, Universitatsklinikum Essen, Essen, Germany. Occurrence of
diabetes mellitus is a common complication in renal transplant recipients.
However, its pathogenesis is not completely understood and it is still
difficult to identii' patients who will subsequently develop the disease. In
order to identi' risk factors for the occurrence of diabetes we have
retrospectively examined 684 kidney transplant patients. All received
cyclosporine A and prednisone with or without azathioprine. Those 60
patients developing diabetes post-transplantation were matched according
to sex, body mass index (BMI) and time since transplantation to a
non-diabetic control group. Results: Diabetic patients were signfficantly
older than the controls (55 10 vs. 47 11 years; P < 0.0001), had a
significant higher fasting blood glucose value (86 9 vs. 80 9 mg/dl;
P < 0.01) but no significant difference in the 2 hour blood glucose level
after oral glucose challenge (OGTT) before transplantation (150 41 vs.
127 17 mg/dl). Diabetic patients also showed a significantly higher
increase in BMI until diagnosis of diabetes (2.16 2.49 vs. 0.87 1.25;P < 0.0001) and received more prednisone since transplantation com-
pared to the control group (11,800 11,600 vs. 9,900 9,700 mg; P <
0.01). HLA-DR3 and DR4 phenotype associated with type 1 diabetes
occurred more frequently in diabetic patients (30/60 vs. 22/60; P < 0.01).
Non-diabetics showed more often the HLA-DR2 phenotype which seems
"protective" against IDDM (20/60 vs. 11/60; P < 0.005). ConclusIons: (1)
Age, weight gain, cumulative prednisone dose, and fasting blood glucose
value before transplantation are risk factors for post-transplantation
diabetes mellitus. OGTF is a poor marker for subsequent development of
diabetes. (2) The frequent occurrence of HLA-DR3 and DR4 phenotype
in diabetic patients suggests that at least some might have autoinimune
type 1 diabetes. This is supported by the increased finding of HLA-DR2
phenotype in non-diabetic controls. Studies of islet-cell and insulin
antibodies will be presented and discussed.
Renal response to angiotensin (1—7) in anesthetized rats. N. Heyne, W
Beer, B. Mühlbauer, and H. Osswal4, Department of Phannacology, Faculty
of Medicine, University of Tubingen, Tubingen, Germany. Recent studies
implicate angiotensin I metabolites, in addition to angiotensin II, as 'having
biological activity. One of those metabolites, Ang (1—7), has been shown to
induce sodium diuresis in the isolated perfused kidney. The aim of the
present study was to investigate whether these findings can be extended to
in vivo conditions. Methods: Mean arterial pressure (MAP), urine volume
(UV), GFR, absolute (UNaV) and fractional sodium excretion (FE)
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were assessed in three groups of thiobutabarbital anesthetized male SD
rats (260—310 g) with normal (NS, N = 8), low (LS, N = 7) or high sodium
intake (HS, N = 8). Via the right jugular vein animals received isotonic
saline (or 5.5% glucose in LS), 1.65 ml/hr, containing 3H-inulin for
assessment of GFR. A second catheter was inserted into the abdominal
aorta via the left carotid artery, and isotonic saline was infused at a rate of
1.2 mI/hr. Blood pressure was monitored via the right femoral artery.
Urine was collected via a catheter inserted into the bladder. Following
equilibration, baseline values (CON) were assessed during two 20 minute
collecting periods. Thereafter Ang (1—7) (100 pmol/min/kg) was infused
via the arterial line and another two 20 minute clearance periods were
performed, followed by two recovery periods of the same duration. In 3
additional groups, experiments were repeated with continuous adminis-
tration of the bradykinin (BK) antagonist Hoe 140 (3 nglminlkg i.v.; all
N = 6). Results: Systemic blood pressure was not altered by Ang (1—7).
GFR rose with the onset of Ang (1—7) infusion, UV and UNaV increased
with a delay of approximately 20 minutes. During recovery, GFR and UV
returned to baseline levels, whereas UNaV remained elevated. The BK
antagonist blunted (NS, HS) or abolished (LS) the response to Ang (1—7).
UV pJ/minIlOO g
CON Ang (1-7)
NS
LS
HS
NS + Hoe
LS + Hoe
HS + Hoe
16 1.1
15±1.6
17 0.6
16±0.4
15 0.8
17 0.7
26 1.la
19±1.2a
25 o.7
23±0.8a
10 0.6
22 2.2a
GFR ml/min/100 g
CON Ang (1—7)
UNaV pEq/min/100 g
CON Ang (1—7)
NS
IS
HS
NS + Hoe
LS + Hoe
HS + Hoe
0.92 0.02 1.06 0.02a
0.84 0.04 1.04 0.04a
0.97 0.03 1.11 0.02a
0.87 0.02 0.93 0.04
0.75 0.03 0.74 0.04
0.82 0.02 0.89 0.03
1.02 0.10 2.79 0.24a
0.01 0.002 0.02 0.004
1.84 0.05 3.3 o.21
1.20 0.11 2.4 0.12a
0.04 0.01 0.03 0.08
1.58 0.21 2.68 0.29a
Values are means SE. P < 0.05 vs. CON (paired comparison)
Conclusion: In anesthetized rats, Ang (1—7) elicits a dose-dependent
natriuresis and diuresis and an increase in GFR. Since FENa was elevated
by more than 100%, the diuretic effect appears to be of tubular origin.
Both hemodynamic and tubular actions are susceptible to bradykinin
antagonism.
Expression of endothelin receptor subtypes in the kidneys of sponta-
neously hypertensive rats. Renal and hemodynamic effects of a non-
selective (A/B) endothelin receptor antagonist. B. Hocher, P. Rohmeiss, D.
Metz, M. Fakhuiy, R. Zart, F. Diekmann, V. Vogt, F. Abou-Rebyeh, N. Gretz,
F. KOrber, C. Bauer, and A. Distler, Abteilung jIis Innere Medizin, Klinikum
Steglitz, Berlin, Inst itut für Molekularbiologie und Biochemie, Freie Univer-
sität Berlin, Berlin, and Nephrologische Klinik, Klinikum Mannheim, Uni-
'ersität Heidelberg, Heidelberg Germany. There are indications that the
renal endothelin/endothelin receptor system is involved in the develop-
ment and maintenance of hypertension in spontaneously hypertensive rats
(SHR). However, little is known about the expression and cellular
distribution of the endothelin receptor subtypes in the kidney of SHR. We
therefore analyzed the age-dependent expression of endothelin receptor
subtypes in the kidneys of SHR using Scatchard analysis, receptor
autoradiography, Northern blot analysis, and in situ hybridization. Wistar
Kyoto rats (WKY) served as controls. Furthermore, we analyzed the
effects of the non-selective (A/B) endothelin receptor antagonist bosentan
(Ro 47-0203) on the arterial blood pressure (BP), renal blood flow (RBF)
and glomerular filtration rate (GFR) in 16-week-old WKY and SHR. Our
study revealed an overexpression of the endothelin B receptor (EtB) in
outer medullary tubules of 4-week-old prehypertensive SHR and a very
strong up-regulation of EtB in the glomeruli of 16-week-old SHR with
established hypertension. The endothelin A receptor (EtA) was up-
regulated in the glomeruli and smooth muscle cells of small sized renal
arteries of prehypertensive SHR and SHR with established hypertension.
GFR, BP and RBF were altered by the mixed (A/B) endothelin receptor
antagonist bosentan only in SHR (GFR decreased by 48 4%, N = 6,
P < 0.01 compared to WKY; mean arterial blood pressure decreased by
29 5 mm Hg, N = 6, P < 0.01 compared to WKY); bosentan did not
alter GFR, BP and RBF in WKY at all, indicating that the observed
alterations in the expression of glomerular and vascular endothelin
receptors in the kidneys of spontaneously hypertensive rats are involved in
the regulation of renal blood flow and glomerular filtration rate and
contribute to the development and maintenance of hypertension in these
animals.
Renal expression of endothelin receptor subtypes in rats with liver
cirrhosis. B. Hocher, R. Zart, F. Diekmann, W. Reutter, A. Distler, P. Gross,
and C. Bauer, Abteilung für Innere Medizin, Klinikum Steglitz, and Institut
für Molekularbiologie und Biochemie, Freie Universitdt Berlin, Berlin, Ger-
many. Cirrhotic patients and rats with experimental cirrhosis have in-
creased endothelin-1 plasma concentrations and show a tendency towards
sodium retention. We therefore analyzed the renal endothelin system in
cirrhotic rats (Cir) and control rats (Con), since the renal endothelin/
endothelin receptor system is involved in the regulation of water and
sodium excretion. Cirrhosis was induced by CC!4 administration. Light
microscopic examination revealed a micronodular cirrhosis. Plasma bil-
irubin was increased in the cirrhotic rats. We analyzed the expression of
endothelin receptor subtypes in the renal cortex and medulla using
Scatchard analysis and receptor autoradiography, and measured plasma
and renal tissue endothelin-1 concentrations using a specific radioimmu-
noassay. Furthermore, we analyzed the effects of the non-selective (A/B)
endothelin receptor antagonist bosentan (Ro 47-0203) on water and
sodium excretion and glomerular filtration rate. Our study revealed an
overexpression of the endothelin B receptor (EtB) in outer medullary
tubules of rats with experimental cirrhosis (Cir: Bm,,, 2775 499 fmol/mg;
Con: 1695 655 fmol/mg; N = 6; P < 0.01),whereas the density of EtB
in the cortex and the endothelin A receptor (EtA) in the cortex and
medulla were similar in both cirrhotic and control rats. The highest
endothelin-1 concentrations were observed in the renal medulla of
cirrhotic rats. (Cir: 251 68 pg/g wt/wt; Con: 163 36 pg/g wt/wt; N = 6;
P < 0.01). GFR was slightly decreased in cirrhotic rats, but not altered
after bosentan treatment in cirrhotic and control rats. Bosentan decreased
sodium excretion in both cirrhotic and control rats to a similar extent,
whereas water excretion was reduced by bosentan in cirrhotic rats only
(Cir: 12.5 2.2 mI/day, Con: 8.7 4.5 mI/d; N = 6; P < 0.05). We
therefore suggest that the up-regulation of medullary EtB in cirrhotic rats
is involved in the regulation of water excretion in rats with CC!4 induced
cirrhosis.
Imidazoline receptor agonists: Renal site and mechanism of action. H.
Hohage, E. Schlatter, and J. Greven, Medizinische Poliklinik D, Universität
Munster, Munster; and Institut für Pharmakologie and Toxikologie, Aachen,
Germany. Imidazoline receptor agonists are a new, centrally acting class of
drugs in the therapy of arterial hypertension. Recently, we found addi-
tional functional evidence for renal receptors in rats. The present study is
designed to characterize further the site and mechanism of action of this
group of drugs. Addition of moxonidin (0.25 mg/kg body wt, i.v.) increased
single nephron filtration rate in micropuncture experiments from 39.4
2.25 nI/mm to 50.3 3.58 nI/mm (N = 14, P < 0.01). Fractional
reabsorption of fluid and NaCI along the proximal tubule decreased
significantly by approximately 10% (N = 13). Experiments with isolated
cortical collecting duct cells were conducted to look for other sites of
action and a possible mechanism of action. Recovery of cellular pH (pH)
as a measurement of Na/H exchange was recorded after acid loading of
the cells with 20 mmol/liter NH4/NH3 using the BCECF fluorescence.
After removal of NH4/NH3, pH decreased by 0.55 0.06 pH U (N
22). Control recovery rate of pH, was 0.28 0.05 pH U/mi Moxonidine
(10 zmol/liter), amiloride (1 mmol/Iiter), and HOE 694 (1 jzmol/liter)
reduced recovery of pH1 significantly by 0.07 0.05 (N = 7), 0.11 0.02(N = 9), and 0.14 0.02 (N = 7) pH U/mm, respectively. These data
suggest that moxonidine influences excretion of fluid and electrolytes in
the kidney by a glomerular action and inhibition of proximal tubular
reabsorption. At least in the collecting duct the inhibition is a possible
mechanism of action.
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Metabolic changes in kidney transplant patients with FKSO6 immuno-
suppression. H. Hohage, C. Spieker, B. Suwe/aclç B. Buchholz, and W.
Zidelç, Medizinische Poliklinik und Chirurgische Klinik der Westfalischen
Wilhelms Universitat Munster, Munster, Germany. Changes in metabolic
functions are seen in most of the patients after kidney transplantation,
which may be due to functional changes of the transplant organ or to
immunosuppression. First, a reduced glucose tolerance and an increase of
(pre)-beta lipoproteins and uric acid are observed. The purpose of the
present study was to investigate possible advantages of FK506 immuno-
suppression on metabolic functions compared to cyclosporine A treat-
ment. The patient groups showed no statistical difference in number, age,
body weight, sex distribution and time after transplantation.
Metabolic parameters in patients with FKSO6 and cyclosporine A
treatment
Cholesterine Triglyceride
mg/dl
FK group 232 35.5 172.75 57.93
(N =9)
CsA group 258.67 24.0 NS 205.56 95.38 NS
(N =9)
LDL- HDL-
cholesterol cholesterol Lp(a) Glucose
mg/dl
FK group 136.13 34.19 61.25 14.75 16.00 12.75 137.88 33.56
(N =9)
CsA group 165.22 30.02 52.89 15.67 30.33 22.14 115.44 19.48
(N =9)
NS NS NS NS
FK506 treated patients show a slight but not statistic significant advantage
in metabolic parameters compared to CsA immunosuppression. This
effect may indicate a better outcome after prolonged treatment with this
new immunosuppressive drug.
Evidence that CAMP acts as a second messenger of the renal transport
system for organic anions. H. Hohage, U. Metgelsberg, and J. Greven,
Medizinische Poliklinik der Universilät Mflnster, Munster; und Institut für
Phannakologie und Toxikologie derRW7HAachen, Germany. Recently, we
demonstrated that proteinkinase C is involved in the regulation of the
basolateral organic anion transporter. The purpose of the present study
was to investigate the influence of the CAMP/adenylate cyclase system,
which is known as an important second messenger in a wide variety of cells
and tissues, on the regulation of this transporter in isolated S2 segments of
non-perfused proximal tubules of the rabbit kidney. In this segment the
highest density for the organic anion transporter is found in the basolat-
eral membrane. The bath concentration of paraaminohippuric acid (PAH)
was 6.5• iO M, and the incubation time was 10 minutes. Addition of the
CAMP derivative Br Cyclo AMP induced a bell shaped concentration!
effect curve of the transport activity with a transport maximum at a
concentration of io- M. Addition of the proteinkinase C inhibitor
staurosporine (10_9_10_8 M) abolished these effects, Incubation with the
adenylatecyclase inhibitor dideoxyadenosine (10_8_10_6 M) reduced cel-
lular PAR transport significantly, whereas the phosphodiesterase inhibitor
theophylline in concentrations ranging from iO—iO M had no effect.
These results clearly demonstrate that the CAMP/adenylate cyclase
system is, in addition to proteinkinase C, an important modulator of the
renal transport system for organic anions.
24 hour blood pressure monitoring of kidney transplant patients with
FK506 and cyclosporine A immunosuppression. H. Hohage, C. Spieker, B.
Buchholz, and W. Zidek Medizinische Poliklinik und Chirwyische Klinik der
Westfalischen WilheIms Universitdt, Münster, Germany. Hypertension and
reduced diurnal blood pressure alterations are observed in about 60% of
kidney transplant patients. In the present study, 24 hour blood pressure
profiles of 9 FK506 treated patients were compared to those of cyclospo-
rifle A (CsA) treated patients, which showed no statistical difference
concerning age, body weight, sex distribution, body size, and time after
transplantation. Systolic, diastolic, and mean arterial pressure during day
and night were statistically identical, whereas CsA treated patients
showed, in contrast to FK506 immunosuppression, a significant systolic
day/night difference.
Differences In day/night rhythm of blood pressure and pulse rate as
expression of diurnal alterations
IRR day/night
systolic mm Hg
RR day/night
diastolic mm Hg iPR day/night
FK506 group 0.57 7.22 3.43 5.06 5.71 4.81
CsA group 4.71 5.10
NS
4.29 4.08
NS
11.00 6.28
P<0.05
The results show: (1) CsA treated patients have a significant systolic
day/night rhythm. (2) Diurnal alterations of blood pressure were identical
in CsA and FKSO6 treated patients. (3) Diurnal alterations of pulse rate
showed a significant difference. Our results clearly demonstrate that
FK506 has no advantage compared to CsA in hypertension and diurnal
blood pressure alterations.
Comparison of serum electrolytes and kidney function parameters of
kidney transplant patients with FKSO6 and cyclosporine A immunosup-
pression. H. Hohage, C. Spieker, B. Suwelack; B. Buchholz, and W. Zide/ç,
Medizinische Poliklinik und Chirurgische Klinik der Westfalischen Wilhelms
Universität Munster, Mflnster, Germany. Nephrotoxicity is a major disad-
vantage of cyclosporine A, which might be important after kidney
transplantation. The purpose of the present study was to compare kidney
function parameters of cyclosporine A treated patients to FKSO6 immu-
nosuppression. The study groups showed no statistical difference concern-
ing number (N = 9), age, body weight, sex distribution, and time after
transplantation.
Kidney function and serum electrolytes of FKSO6 and cyclosporine A
treated patients
Magnesium Potassium
mmol/liter
FK group
CsA group
0.747 0.07
0.795 0.044
NS
5.2 0.30
4.51 0.313
P<0.01
Creatnine Urea-N Uric acid
mg/d
FK group
CsA group
1.84 0.45 44.0 9.33
1.48 0.26 28.6 7.52
NS P<0.05
7.92 1.29
7.57 1.65
NS
The results show: (1) After 6 months, FK506 and CsA treated patients
have no significant differences in kidney function parameters excepted
serum urea, (2) FK506 treated patients had significantly higher serum
potassium, whereas serum magnesium levels, which may be related to
neurological complications under FK506 therapy, showed no difference.
Further studies need to be done to compare kidney function parameters of
FK506 versus cyclosporine A after a longer observation period.
Changing pattern of Permcath complications? R. Hofbauer, G. Sunder-
Plassmann, P. Lopez, and W. Drum!, Medizinische Klinik III, Klinische
Abteilung für Nephrologie und Dialyse, Universität Wien, Osterreich, Ger-
many. Between July 1992 and December 1993, 107 flexible implantable
catheters for vascular dialysis access were inserted and prospectively
evaluated. Reasons for insertion were: (48%) first hemodialysis; (37%)
fistula thrombosis; (7%) hemodialysis after kidney transplantation; (2%)
running out of vessels; (1%) catheter replacement; (1%) infection of the
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fisutula; (1%) bone fracture on the fistula arm; and (3%) plasmapheresis.
Catheters were placed into internal jugular (45%) or subclavian vein
(55%), and 2000—5000 IU were used as heparin-lock. In case of throm-
bosis or decreased blood flow a standard lysis protocol consisting of 2 mg
rTPA flush in each limb was used, and this was repeated up to 3 times until
resolution of clotting. In 7% of patients the jugularis vein was occluded
because of previous temporary catheters. Thirty-five cultures of catheter
tips (elective removal) grew bacteria (51% gram-positive, 49% gram-
negative), and 9 blood cultures grew gram-positive (89%) and gram-
negative (11%) species. Two cultures from exit sites were gram-positive.
None of the catheters had to be removed because of clotting; only 2
catheters were removed because of recurrent infection. We observed a
striking number of vena jugularis occlusions because of previous punc-
tures. The frequency of gram-negative bacterial infections is commonly
underestimated. Nevertheless, implantable catheters for permanent vas-
cular access are safe and are associated with a calculable risk of infections
and thrombosis. We recommend sonography guided punctures of the
internal jugular vein in patients with previous catheters. Random antio-
biotic treatment of catheter associated infections should cover both
gram-positive and gram-negative species.
ABPM in patients with essential hypertension: Comparison with casual
blood pressure measurement and effect of salt intake on blood pressure
variability. M Hollenbec/ç J. Plum, S. Moigera, H. ROwemeier, M Koch,
and B. Grabensee, Klinik für Nephrologie, Heinnch-Heine-Universität Düs-
seldorf; Düsseldorf Germany. The question of salt-sensitivity in some
patients with essential hypertension is a matter of interest. We examined
the influence of a low- and a high-sodium diet on blood pressure (BP)
measured by a nurse and by ABPM and the effect of sodium intake on BP
variability in salt-sensitive and salt-resistant patients. Patients and meth-
ods: Thirty-five patients with essential hypertension have had a diet
containing 50 or 200 mmol sodium per day for 7 days subsequently. At the
end of each period BP was measured by a nurse after a 15 minute rest. Ten
measurements with a zero-random-device were taken in intervals of 3
minutes. ABPM was performed with Spacelabs 90207 with intervals of 15
minutes during the day and 30 minutes during the night. Salt-sensitivity
was defined as a drop in daytime mean arterial pressure of more than 7
mm Hg during the low-sodium diet. Results: Casual blood pressure did
not differ between low- and high-sodium diets (143 21/96 9 vs. 149
25/99 14mm Hg; P = NS). In contrast, with ABPM a sodium-dependent
effect on daytime BP could be shown [134 15/89 10 mm Hg
(low-sodium) vs. 140 13/92 9 mm Hg (high-sodium) (systolic P <
0.005; diastolic P = 0.03)]. There was no effect seen on mean heart rate.
The drop of systolic BP during the night was 10.9 7.9 (low-sodium)
versus 11.2 7.3 mm Hg (high-sodium), and for diastolic BP 12.3 6.6
versus 13.3 6.2 mm Hg (P = NS). Mean heart rate dropped 18.3 7.5
versus 14.9 5.2 (P = 0.015). According to our definition, 13 patients
were salt-sensitive and 22 were salt-resistant. During low-sodium diet,
salt-sensitive patients had significantly lower BP values during the day as
well as during the night. During high-sodium diet, BP did not differ in
sodium-sensitive and sodium-resistant patients. The decline of BP and
heart rate during the night was not different in sodium-sensitive and
sodium-resistant patients during low-sodium diet. With high-sodium diet,
sodium-resistant patients had a smaller BP (11.8 5.4 mm Hg) and heart
rate decrease (13.2 4.7 min1) during the night than sodium-sensitive
patients (15.9 6.9 mm Hg (P < 0.05) and 17.8 4.9 min (P < 0.01).
Conclusions: Changes in BP during low- or high-sodium diet were shown
with ABPM better than by casual BP readings. This issue is important
when reviewing studies on the effect of low-sodium diet which used casual
BP measurement. Our data support the opinion that ABPM should be
used in those studies. We found differences in BP variability depending on
sodium-sensitivity. It has recently been found that BP variability correlates
with cardiovascular mortality, and this relationship should be investigated
in longitudinal studies.
Relation between renin mRNA, renin secretion, and blood pressure in
unilateral renal artery stenosis (2K1C). S.R. Holmer, K Schncker, M
Hamann, B.K Kramer, G.A.J. Riegger, and A. Kurtz, University of Regens-
burg, Regensbu, Germany. To characterize mechanisms regulating renin
expression in kidneys after unilateral renal artery stenosis, we examined
the interrelation between renal renin-mRNA level, renin secretion, and
arterial blood pressure in rats at 1 or 2 days after implantation of a
unilateral renal clip (0.2 mm inner diameter) in male Sprague-Dawley rats
(N = 18) and in sham-operated rats. Analysis of renin mRNA of both
kidney was performed by a quantitative RNase protection assay and
correlated with plasma renin activity (PR.A) as well as mean arterial
pressure. Renin mRNA in stenosed kidneys increased by 3.0- and 4.3-fold
after 1 or 2 days, respectively, whereas in contralateral kidneys, renin
expression was suppressed to 52 or 26% of control. PRA was elevated
after clip (control 8 ng AT/hr • ml;after 1 day of clip 16.5; after 2 days 30.5).
Arterial blood pressure was also increased (control 114 mm Hg; after 1
day 123; after 2 days 137). PRA was closely correlated with renin mRNA
of stenosed kidneys (r2 = 0.49; P < 0.001) and with blood pressure (r2 =
0.31; P < 0.05). In contrast, PRA and blood pressure were not correlated
with renin mRNA of contralateral kidneys. In normal kidneys, treatment
with the ACE inhibitor ramipril (10 mg/kg/day) for 2 days resulted in an
increase of renin mRNA by 400%. Ramipril treatment in addition to
unilateral clip caused a further increase of renin mRNA in stenosed
kidneys to 640% of control. In contralaterals, renin mRNA level was 330%
of control, only slightly lower than that of sham-operated ramipril treated
animals (NS). These data indicate that endogeneous angiotensin II is a
potent inhibitor of renin expression in normal kidneys and kidneys with
reduced perfusion as well as contralateral kidneys. Neither elevated
plasma renin nor increased blood pressure is involved in the suppression
of renin expression in contralateral kidneys after unilateral blood flow
reduction.
Post-induced ureteric bud (UB) cells in primary culture are a model
system to study the ontogeny of epithelial polarity. S. Huber and M
Horster, Physiologisches Inst it ut der Ludwig-Maximilians-Universita4
MOnchen, Germany. Ampullary UB cells have been postulated to repre-
sent a stem cell population of the mammalian metanephros. During
post-inductive branching morphogenesis of the primary duct, UB cells
express basolateral prior to apical membrane marker proteins. To char-
acterize the expression of their functional and structural polarity, cells
from the intial (UB) and from the final (CCD) stage of ontogeny were
microdissected and grown in primary culture. UB explants formed a
confluent monolayer of uniform cells within 2—3 days of culture. Scanning
electron micrographs of the cell surface revealed a well-differentiated
apical membrane with a central cilium and a peripheral line of microvilli.
This principal cell-like morphology is identical to that of ureteric bud
epithelium in vivo. To approach plasma membrane functions in cultured
UB and CCD cells, we performed whole cell patch clamp recordings in
UB and in CCD cells. At a cytoplasmic free Ca2 concentration (Ca12) of
10 nM, whole cell currents, as recorded with KCI in the pipette and the
bath solution, were identical in UB and CCD cells. Elevating Ca2 to 100
nM in CCD cells evoked a significant (P  0.01; t-test) increase in whole
cell current at depolarizing holding potentials, while in UB cells a current
response to Ca2 was not expressed. Present single channel analysis
intends to attribute these findings to different levels of functional expres-
sion of the apical Ca2-activated maxi K channel during apical mem-
brane ontogeny.
Practical experience with CAPD quantification: Relationship to clinical
outcome and adaptation of therapy. U Huynh and U. Binswanger,
Nephrology, Department Internal Medicine, University Hospital, Zurich,
Switzerland. Twenty-nine patients with end-stage renal disease on CAPD
(N = 23) or CCPD (N = 6)were prospectively followed during 1 year. The
quantification of peritoneal dialysis (PD) was evaluated every 3 months
with the dialysis index by Teehan (DI), weekly Kt/V and weekly creatinine
clearance/1.73 rn2 (Car). The adequacy of dietary protein intake was
assessed by the body mass index (BMI), serum albumin (SA), and the
protein catabolic rate, normalized for actual weight (nPCRa) or for ideal
body weight (nPCRi). Clinical outcome parameters included: asthenia,
anorexia, restless legs, pruritus. They were recorded on a scale from 0—2
points according to severity of each symptom. The DI was 1.25 0.53, the
Kt/V was 2.35 0.63, and the Cr was 90.3 32 liter/w/1.73 m2. BMI was
23.2 3.3 kg/rn, SA was 37.5 4.3 g/liter, nPCRa was 0.96 0.23
g/kg/day, and nPCRi was 1 0.25 g/kg/day (mean SD). The clinical score
(CS) varied from 0 (good outcome) to 6 (poor outcome), with a mean of
1.5. There was a strong non-linear correlation between KT/V and Cr (r =
0.79, P < 0.001) and a good correlation between Kt/V and nPCRa (r =
0.56, P < 0.001). Compared with Kt/V, C. reflected better patient-
reported symptoms (r = —0.60 for Kt/V vs. CS, r = —0.71 for Cr vs. CS).
Age, low serum albumin and low nPCR were the best predictors of
morbidity. As a consequence of quantification of PD, 1 patient was
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switched to CCPD, Ito Tidal CCPD, 1 performed 4 X 2.5 liter instead of
4 x 2 liter exchanges daily and 2 performed 5 X 2 liter instead of 4 X 2
liter exchanges daily. Increasing dialysis delivery led to improvement of
uremia symptoms as well as objective parameters. In conclusion, surveil-
lance of PD patients by means of regular urea and creatinine kinetic
modeling proved to be of help by offering objective data on treatment
efficiency. Dialysis prescription can be increased prior to appearance of
overt symptoms of underdialysis. As in hemodialysis patients, urea mod-
eling should be integrated into the management of PD patients.
Cardiovascular events after renal transplantation. K Ivens, S. Aker, P.
Heering, and B. Grabensee, Department of Nephroloy, Heinrich Heine
University, Düsseldorf Germany. Cardiovascular events (CVE) are the
most common long-term complications in patients after renal transplan-
tation (TPX) and represent approximately 30% of all fatal events in this
patient population. The present study was outlined to evaluate retrospec-
tively the incidence of CVE (that is, CAD, PAOD, cerebrovascular
insufficiency) and the mortality in patients who underwent renal trans-
plantation at the University Hospital in Düsseldorf in the years between
1987 and 1992. The data base of 414 patients (239 males, 175 females;
mean age: 45.5 11.9 years; duration of hemodialysis: 4.3 3.5 years)
was evaluated retrospectively. Before renal transplantation, 386 (93.2%)
and 28 (6.8%) patients were treated by hemodialysis and by CAPD,
respectively. Twenty-nine patients (7%) suffered from diabetes mellitus.
Mean follow-up after renal transplantation was 2.5 1.74 years. The
incidence of cardiovascular risk factors before and after renal transplan-
tation is summarized in the table:
Cardiovascular risk factor
Befor
N
e TPX
% N
After TPX
%
Hypertension 370 89.4 348 93.8 NS
Cholesterol >250 mg/dl 141 35.5 214 67.3 NS
Mean Cholesterol mg/dl 231 63 278 68 NS
Nicotine abuse 165 41.0 83 23.0
Results: (1) Before renal transplantation, 68 patients (16.4%) were
treated by PTCA, coronary artery bypass grafting or desobliteration of one
or both aa. carotis. After renal transplantation, a cardiovascular event was
observed in 50 patients (12.8%). Out of these, 25 patients experienced a
myocardial infarction. Mortality due to cardiovascular events was 1.7%
(overall mortality: 8.2%). (2) A significant correlation was detected
between the incidence of cardiovascular events after renal transplantation
and age (>55 years), D.M., and nicotine. Methodology of renal replace-
ment therapy, duration of dialysis, gender, hypertension, and cholesterol
did not correlate with the incidence of cardiovascular events. Conclusion:
The incidence of cardiovascular events after renal transplantation (12.8%)
in our patient population was lower than expected from the literature. The
present data suggest that age, D.M., and nicotine positively correlate with
the incidence of cardiovascular events in patients who have undergone
renal transplantation. Method of renal replacement therapy, hyperten-
sion, gender, and cholesterol do not seem to significantly correlate with
the incidence of CVE, at least after renal transplantation.
Manifestation of metabolic risk factors after renal transplantation I:
Association with long-term allograft function. U. Jacobs, J. Ferber, and
H,-U. Klehr, Medical Department, University Hospital, Bonn, Germany.
Whereas there is no exact definition of pathogenetic mechanisms involved
in "chronic rejection" there is strong evidence from experimental animal
data for different factors such as CMV, hypertension and hyperlipidemia
leading to "chronic transplant damage" for example, by arteriosclerosis.
To analyze the possibility of a corresponding impact of risk factors from
clinical data we followed 123 patients by clinical investigation 4—6 weeks
after renal allotranspiantation (TX). After a follow-up period of 4.6 3.1
years (median 3.8, range 0.3—21) patients were characterized by an age of
44.3 12.2 years, serum creatinine of 1.62 0.84 mg/dl, and proteinuria
of 0.69 1.17 g/day. There was a highly significant increase in body weight
of 8.1 6.6 kg (P < 0.0001). Lipoproteinanalysis revealed a striking
elevation of serum cholesterol from 213 61 to 269 61 mg/dl (P <
0.0001) and triglycerides from 193 105 to 259 211 mg/dl (P = 0.0038),
both parameters resulting in mean empty values of pathological signifi-
cance. HDL (52 18), LDL (176 58) and VLDL cholesterol (65 66
mg/dl) significantly correlated with these elevated values; there was a
severe reverse decrease in HDL associated with increase in body weight(P = 0.004) and cholesterol (P = 0.008). Prevalence of hypertension
needing treatment was 83% (102); 68% more than one antihypertensive
agent. Despite medical treatment for uric acid serum levels> 10 mg/dl in
37% of patients there still remained uricemia with 8.4 2.4 mg/dl for the
study group. Pearson correlation analysis revealed a highly significant
correlation between the actual serum creatinine as a parameter of
long-term transplant (TP) function and the following factors: increase in
cholesterol (P < 0.01), hypertension (P < 0.0001), uricemia (P < 0.0001),
time interval after TX (P < 0.0001), and number of previous rejections(P < 0.005).There remained no significant impact of histocompatibility or
CMV for the long-term period. In 27 patients (21%) we finally performed
TP biopsy because of increasing serum creatinine. In 85% histological
examination revealed interstitial fibrosis and nephrosclerosis to be the
pathological correlate for a chronic TP damage being significantly associ-
ated with time interval after TX. In all patients rejection and CMV were
excluded. Conclusion: Whereas in the long-term TP period infection and
rejection play minor roles there is strong evidence from our clinical data
for manifestation of risk factors associated with long-term TP function
that are known to induce chronic TP damage by allograft sclerosis in
experimental studies. To define all risk factors and eliminate them after
TX is performed, a further attempt at the amelioration of long-term
allograft function and survival is recommended.
Manifestation of metabolic risk factors after renal transplantation II:
Impact of maintenance therapy. U Jacobs, J. Ferber, and H-U. Klehr,
Medical Department, University Hospital, Bonn, Germany. Animal studies
reveal metabolic risk factors to induce arteriosclerosis and chronic trans-
plant (TP) damage in the follow-up after allografting. This could be
observed for hypertension, hyperlipidemia and uricemia. Presumably,
these risk factors present comorbid parameters for the development of a
deterioration of long-term transplant function as we demonstrated highly
significant associations from our clinical data in the long-term follow-up
period after renal allotranspiantation (TX). We investigated the possible
association of immunosuppressive as well as antihypertensive and diuretic
maintenance therapy with the development of "sclerogenic" risk factors
during the long-term post-transplant period: manifestation of hyperten-
sion, significant increase in body weight, in cholesterol and triglycerides,
uricemia and polyglobulia in 123 patients, mean age 44 12 years
followed 4—6 times a week over 4.5 3years (median 3.8; range 0.3—21)
after allogenic kidney TX. After the follow-up TP function was charac-
terized by serum creatinine of 1.6 0.8 mg/dl and proteinuria of 0.68
1.17 g/day. Mean cortisone (Cort) dosage was 8.6 2 mg/day, cyclospo-
rifle A (CsA) 215 64 mg/day with blood levels within therapeutic range
(310 41 ng/ml; polyclonal TDX method). Fifty-eight percent of patients
were on triple immunosuppression including azathioprine (AZA), and
42% on Cort and CsA. Prevalence of hypertension was 83%, with 68% of
patients needing more than one antihypertensive or diuretic agent: Ca
antagonists (CAA) 72%, j3 blockers (RB) 49%, furosemide (Fur) 64%,
ACE inhibitors (ACEI) 11%, others 44%. Pearson correlation analysis
revealed hypertension (P = 0.0074) and increase in body weight after TX(P = 0.0012) being significantly correlated with Cort maintenance dosage.
There also was an association of Cort with manifestation of uricemia (P =
0.0093), degree of hypertension (P = 0.001) and triglycerides after TX(P = 0.05). Patients on B therapy (P = 0.012) as well as patients on Fur(P = 0.0007) showed significantly elevated uric acid serum levels; indica-
tion for application of both drugs significantly correlated with Cort. We
could not find an impact of CsA dosage or CsA blood level on uric acid.
Whereas CsA dosage significantly correlated with body weight after TX,
there was no association with body weight increase as it was found for
Cort. Concerning all metabolic risk factors investigated, there was no
impact from AZA, CAA and ACEI. Polyglobulia manifestating in 41% of
patients after TX can be improved by a side effect of ACEI but the drug
enhances anemia in patients with deteriorated TP function. As long as
there seems to be no definite factor concerning induction of a "chronic TP
rejection" and experimental data more obviously reveal metabolic param-
eters to play a comorbid role in the development of a chronic TP damage,
for example via allograft arteriosclerosis, we should focus on avoidance of
all risk factors contributing to this phenomenon. From our clinical data
there is strong evidence for a significant effect from long-term mainte-
nance therapy, especially from Cort, B and Fur, whereas CSA, AZA and
CAA are of no corresponding impact and under this aspect should be
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preferred as first step agents in the maintenance therapy of the TP
population.
Manifestation of metabolic risk factors after renal transplantation HI:
Impact on cerebrocardiovascular complications. U Jacobs, J. Ferber, and
H.-U Klehr, Medical Department, University Hospital, Bonn, Germany.
Overcoming CMV and acute rejection in the early transplant period by
means of potent and safe virustatic and antirejective agents there is need
to ameliorate long-term allograft and patient survival. It is a striking fact
from world-wide data that renal transplantation (TX) could not improve
patient long-term survival rate compared to patients on chronic hemodi-
alysis. Allografting turned out to increase the risk of cerebrocardiovascu-
lar complications. We tried to evaluate risk factors manifesting in the
chronic transplant (TP) period being associated with these complications
in the long-term follow-up. One hundred twenty-three patients were
followed over 4.6 3.1 years (median 3.8; range 0.3—21 years) after renal
allo, TX. After this time interval the patient group was characterized by an
age of 44.3 12.2 years, serum creatinine of 1.62 0.84 mg/dl, and
proteinuria of 0.69 1.17 g/day. During the long-term TP period they
developed several metabolic risk factors, partly being significantly associ-
ated with immunosuppressive, antihypertensive and diuretic maintenance
therapy. Besides a significant increase in body weight (P < 0.0001), serum
cholesterol (P < 0.0001), and triglycerides (P = 0.0038), 83% of patients
revealed hypertension and 37% of patients had uricemia >10 mg/dl,
requiring treatment. Four patients manifestated diabetes mellitus post-
TX, and the prevalence of polyglobulia requiring regular phlebotomy or
ACE inhibitor therapy was 41%. Ten patients (8%) developed cerebro-
cardiovascular complications 6.8 5.5 years (median 6.5; range 1.8—14
years) after TX. These 54.5 5.4 year old patients (9 males, 1 female)
were characterized by significant increase in body weight from 70 9 kg
before TX to 82 12kg after TX, serum cholesterol from 227 72 to 276
53 mg/dl, and triglycerides from 349 241 to 404 407 mg/dl.
Lipoproteinanalysis revealed HDL being only 43.4 17.7, LDL 139 72,
and VLDL cholesterol 104 84 mg/dl. The severely depressed HDL
turned out to be significantly associated with an increase in body weight
and cholesterol. The patient group did not differ from the entire study
group concerning TP function (creatinine 1.6 0.3 mg/dl; proteinuria 0.6
0.5 mgldl). Prevalence of antihypertensive therapy was 100%, treatment
for polyglobulia 40%, for uricemia 50% with a remaining uric acid of 8.6
2.8 mg/dl. Cyclosporine A (C5A) dosage was 228 44 mg and CsA
blood levels were within therapeutic range (309 57 ng/ml; polyclonal
TDX method). Three patients were on triple immunosuppressive therapy
including azathioprine. Mean cortisone dosage was 9.75 0.8 mg/day.
Prevalence of diabetes was significantly higher in these patients (40%)
compared to the whole study group (10%). Statistical analysis revealed a
significant association of cerebrocardiovascular complications with age
(P = 0.0094), time interval after TX (P = 0.0137), body weight after TX(P = 0.0238), serum triglycerides before (P = 0.0001) and after TX (P =
0.0229), degree of hypertension evaluated from number of antihyperten-
sive drugs (P = 0.0053), with status of retirement (P = 0.0049), diabetes(P = 0.0007) and cortisone dosage (P = 0.0364). To improve long-term TP
results we have to focus on metabolic "sclerogenic" risk factors manifes-
tating after TX that require elimination from the very beginning by means
of prevention and treatment. This is recommended as an important
attempt to ameliorate long-term patient and graft survival.
Cancer after transplantation—are there associated factors? U Jacobs,
J. Ferber, and H-U Klehr, Medical Department, University Hospital, Bonn,
Germany. The increased risk of cancer (CA) after transplantation (TX) is
related to immunosuppression. We analyzed all 13 patients (5.4% of 242
patients) after renal allografting who developed CA in the follow-up
period from May 1985 to 1994 to evaluate the impact of different
immunosuppressive regimens and eventually all other associated constel-
lations. The patient group [3 female (f), 10 male (m)j is characterized by
age at TX (50 14 years), duration of previous hemodialysis (HD, 5.0
3.8 years), and number of blood transfusions (BT, 18 20). Serum
creatinine as a parameter of TP function is 1.47 0.2 mg/dl at onset of
CA. Mean number of acute rejections is 1.8 1.5 (range 0—5), cortisone
pulses 1.3 1.1 (0—3), ATG 9 6 (0—24 days), OKT3 7.6 10.7 (0—28
days), and ALG 1 2 (0—6 days). Immunosuppression is maintained with
prednisone 8.8 3.0 (range 0—12.5 mg/day) in 12 patients plus cyclospo-
rifle A (CsA) 220 59 (100—300 mg/day) in all patients, resulting in
trough blood levels (TDX method) of 306 47 ng/ml plus azathioprine
(AZA) 44 43 (0—100 mg/day) in 8 patients. CA is diagnosed 3.3 2.1
years after TX (median 2.6 years, range 2 months—7.3 years). At that time
there is a significant decrease of leukocytes from 8.6 2.6 before to 6.5
2.5 after TX (P = 0.049), revealing a correlation with AZA (P 0.047)
and ALG (P = 0.05). The time interval of onset of CA significantly
correlates with CsA blood levels (P = 0.032) and inversely with prednisone
dose (P = 0.036), associated with elevated CsA levels in 2 patients; one
developed an EBV induced malignant lymphoma that was completely
cured after CsA reduction and AZA withdrawal, and the other patient was
out of control and manifestated pancreas CA. In 2 m patients renal cell
tumors occurred; both had been treated with OKT3 for rejection. All 3 f
patients suffered from breast cancer; in each there was a first manifesta-
tion prior to TX. De novo CA (2) or relapse (1) occurred 1.4 2.6 years
after TX; OKT3 prevalence was 1/3. Six patients developed skin CA
significantly associated with male patients (P = 0.0001), CsA blood levels
(0.0047) and inversely with number of BT (P = 0.0022). In the CA patients
there was a predominance (62%) of blood group A exceeding our grafted
patients' distribution. By statistical analysis we could exclude an associa-
tion of CA with cytotoxic AB, CMV infection, CMV disease, gancyclovir,
ATG, family history, age, HD, TP function and HLA mismatches.
Immunological work-up in 4 patients with solid CA revealed a significant
increase (P < 0.05) of CD57(HNK1), CD25 (IL-2 Rec) and HLA-DR+ at
diagnosis of CA. In contrast to PHI and CA-15-3, ferritine as an unspecific
marker turned out to be less sensitive in patients with low initial values
after long-term dialysis. From our limited data we conclude CA incidence
is 5.4%. CsA needs early reduction to a minimum. Regarding our overall
OKT3 therapeutic frequency of 30% (73 of 242 patients) the association
of OKT3 with CA is 6.8%, although CA incidence remains almost
unaltered by OKT3 excluding one patient with a CA relapse after TX
(5.5%). The same is true for the ALG group (6%). Lymphocyte subsets
might be reliable indicators. There is a disproportional prevalence of
blood group A and male patients in the CA group.
Immunological analysis of immunodeficiency and involvement of EBV
in malignant lymphoma after transplantation. U Jacobs, B. Klein, and
H.-U Klehr, Medical Department, University Hospital, Bonn, Germany. The
increased risk of malignant lymphoproliferative disorders after transplan-
tation (TX) is well documented. This case report focus on its etiology,
course and therapy, which differs greatly from non-Hodgkin lymphomas in
immunosufficient patients. A 20 year old male patient with mesangiopro-
liferative glomerulonephritis and X-linked Alport syndrome was kidney-
allografted after being on hemodialysis for 2.8 years. There is 1 episode of
rejection responding to steroid pulse. The patient is on triple immuno-
suppression with prednisone (10 mg), CsA (380 mg) and AZA (100 mg);
he was never treated with ATG, ALG or OKT3 when he developed fever,
angina tonsillaris and failed to gain weight 8 weeks after TX. CsA trough
blood levels have been elevated with 780 ng/ml (TDX method). There is
a significant leukocyte decrease from 15.8 to 5.7/ni with lymphocytosis (7
to 50%). Lymphocyte subsets reveal a highly significant elevation of CD3,
CD57 (HNK-1), CD5 (slg + B-NHL) as well as CD4/CD8 inversion to
27/54 and significant decrease of CD11b (Mo). CD2O shows absolute
elevation and relative decline. The CD8 increase correlates with decrease
of CD2O (P = 0.0001). A striking drop in IgA, almost to absence, indicates
a dysfunction in B cells. Statistical analysis reveals a significant association
of IgA decrease with increase in CD8 (P = 0.045) and CD5 (P = 0.029)
as well as with decrease in CD2O (P = 0.045) and CD! lb (P = 0.0039). For
the lymphocyte subsets the increase of CD3 is most pronounced, related
to the increase of CD5 (P = 0.0001). At that time the IgG negative patient
presents primary EBV infection with EBV-IgM AB (immunofluores-
cence). Histological diagnosis of tonsillar tissue is non-Hodgkin lymphoma
of high malignant grade, diffus polymorphic centroblastic and immuno-
histologically monotypical expression of IDG with light chain lambda. It is
neither by withdrawel of AZA nor by combined iv. acyclovir alone but by
further dose reduction of CsA that the iymphoma regresses as verified by
repeat biopsy and curation of hitherto nonresponding intracerebral mul-
tiocular manifestation causing severe convulsions. With this therapeutic
regimen the lymphoma is cured after 5 months. Up to that date genomic
blood cell in situ hybridization of EBV has remained positive, as well as
IF-EBAN, IF-EBVEA and EBV-VCA-IGM. There has not been any
relapse during the following years and TP function is maintained with
serum creatinine of 1.5 mg/dl continuing long-term immunosuppression
with 10 mg prednisone and extremely low dose CsA (1.1 mI/day, 75 ng/ml
level). The pathogenesis of this lymphoma seems to be eludicated by the
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immunological data and therapeutic implications indicating predomi-
nantly CSA induced CD4 dysfunction that favors EBV infected B cell
escape from T cell surveillance resulting in true B cell lymphoma and
other B cell disorders, as seen from the IgA depletion, probably related to
selective suppression of IgA synthesis by predominating CD8. There are
some similarities to the X-linked proliferative syndrome in young males
with EBV. In our patient there is also a concomitant reduction of
monocytes/macrophagcs possibly associated with impaired cell antigen
presenting and phagocytic capability. Because of fatal courses after
chemotherapy described in literature, we cannot overemphasize the
simple step of therapy that is required in the early transplant patient group
to overcome these life-threatening lymphoproliferative disorders.
Aortic valve regurgitation—Distinctive components of early hyperten-
sive nephrosclerosis in kidney transplant. U. Jacobs, K-A. Brensing, and
H.-U Klehr, Medical Department, University Hospital, Bonn, Germany.
Pathogenetic mechanisms for manifestation of "chronic rejection" may
primarily be related to similar inductive inflammatory lesions resulting
from very different factors. For the development of a hypertensive
nephrosclerosis experimental data from animal studies reveal "inflamma-
tory" alterations with progressive infiltration of T-helper cells and mac-
rophages into the interstitium as a consequence of expression of adhesion
molecules, ICAM-1 and LFA-1, increase of interstitial volume with
accumulation of collagen and fibronectin, as well as tubular cell prolifer-
ation. Mesangial cells seem to play a central role in the initiation of an
early glomerulosclerosis by proliferation and increased production of
extracellular matrix. We report on a 59 year old female patient kidney
allografted in 1988. Renal diseases prior to transplantation were chronic
pyelonephritis and malignant nephrosclcrosis. The pen- and post-trans-
plant status was characterized by: (1) "full house" kidney (Al A2 B7 B8
DR2 DR3 donor and recipient); (2) no acute rejection episodes; (3) no
primary or recurrent cytomegaloviral disease. The patient was on immu-
nosuppressive maintenance therapy with cyclosporine A and cortisone. In
the long-term follow-up after 3.5 years she developed deterioration of
transplant function with a striking increase of serum creatinine from 1.5 to
2.1 mg/dl. The only risk factor was severe hypertension resulting from
aortic valve regurgitation II which was not being treated completely
satisfactorily with Ca antagonists, nitrites, ACE inhibitors and furosemide.
A Cimino fistula had been ligatured soon after TX because of a shunt
volume of 2.4 liters/mm. There remained a characteristic high blood
pressure amplitude typical of the aortic valve disease with widened arterial
pulse pressure resulting from the markedly increased left ventricular
stroke volume being ejected into a high pressure aortic zone. Histological
examination of transplant biopsy could exclude rejection and mesangio-
proliferative glomcrulonephritis (triple technique), but the histological
work-up revealed all distinctive components of hypertensive nephroscle-
rosis at a stage of inflammation with discreetly infiltrating lymphocytes.
For the glomeruli there was a small broadening of the measangium with
increase of mesangial matrix and corresponding mesangial cell prolifera-
tion; the single glomcrulus also had signs of reduced perfusion. For the
kidney vessels there were spots of hyalinosis of the walls with respect to
focal stenosis by intimal fibrosis. The epithelia were partly swollen and
partly flattened. The interstitium was widened with fibrosed areas. Taking
into account recent animal study data concerning alterations in hyperten-
sive nephrosclerosis, these pathological findings in the allograft reflect
almost the same lesions at the stage of investigation. A correspondence is
obvious, especially after exclusion of any other risk factors for TP
deterioration. In more progressive and less typical stages with TP nephro-
sclerosis and interstitial fibrosis on one hand and more clinical risk factors
on the other, the possibility of evaluation of eventually one defined
inductive risk factor and pathogenetic determinant for a chronic TP
damage will be more difficult.
Anselioration of kidney allograft survival—Evaluation of risk factors,
complications and impact of therapeutic regimens- U Jacobs, D. Paar,
W.-D. Miersch, and H-U Klehr, Medical and Urological Departments,
University Hospital, Bonn, Germany. To optimize long-term transplant
outcome, acute rejection (AR), CMV infection and development of
chronic transplant (TP) nephropathy need to be avoided. Factors influ-
encing these complications and their treatment were analyzed in 113
patients followed after renal allografting. The number of AR (0 in 19%; 1
in 39%; >2 AR in 42%) significantly correlated with younger recipient
age, elder donor, cytotoxic antibodies, blood transfusions after TP, and
triglycerides and body weight before TP. Triple therapy with CsA,
cortisone and OKT-3 in steroid resistant histologically proven AR after
triple induction therapy with ATG revealed a. potent antirejective option
in interstitial AR, combined with plasmapheresis in vascular AR plus ALG
"consolidation" in recurrent AR (1 year graft survival 97%). There was no
severe complication due to primary or recurrent CMV as CD4/CD8
inversion accompanied with onset of excessive nocturnal hyperhidrosis
predicted (100% sensitivity) the infection before manifestation of viral
parameters. Virustatic treatment with gancyclovir was safe in all 38
patients with antigenemia. During the long-tcrm period all 113 patients
were followed 4—6 times a week over 2.7 1.2 years with a resulting
serum creatinine of 1.38 0.48 mg/dl; another group of 123 patients
followed over 4.6 3.1 years revealed a crcatinine of 1.62 0.84 mgldl.
Actual creatinine as a parameter of long-term TP function significantly
correlated with time interval after transplantation, number of previous
AR, hypertension, uriccmia, increase in cholesterol and body weight after
TP. There remained no impact of histocompatibility or CMV after
adequate and early therapy. By means of efficient treatment in AR, early
intervention in CMV infection as well as evaluation and elimination of risk
factors manifestating during long-term follow-up, we could improve the 4
year allograft survival rate in our transplant care unit up to 95%.
Pressimmun "consolidation" in acnte rejection episode relapses. U
Jacobs, D. Paar, H.-U Klehr, and D. Heimbach, Medical and Urological
Departments, University Hospital, Bonn, Germany. There are ailografted
patients who present acute rejection (AR) relapses even after consecutive
treatment with cyclosporine A (CsA) and cortisone (Cort) combined with
ATG and OKT3. We report on 13 patients who were treated with horse
anti-human lymphocyte globulin (Pressimmun) (0.5 mI/kg/day) after 1—3
triple therapy courses including OKT3 (and previously ATG) in all
patients. Recipient age was 34.8 11.2 and donor age was 41.5 13.6
years. All patients exposed >2 AR, histological prevalence of vascular AR
besides interstitial AR implied 5>< plasmapheresis (9 patients) combined
with OKT3, Cort, and CsA in the immunosuppressive regime prior to
Pressimmun. This agent was added over 5 days after ending OKT3 courses
of 14 days. In all but I patient the severe recurrent AR could finally be
overcome and transplant (TP) function stabilized soon after Pressimmun
with a resulting serum creatinine of 1.74 0.77 mg/dl (follow-up period
2.7 1.2 years). As Gancyclovir was given prophylactically in the CMV
risk group according to donor/recipient status, no patients developed
CMV disease, Weekly cyto- and bioimmunological blood monitoring over
10 weeks during the relapse, severe AR revealed a significantly (P C 0.05)
recurrent increase in CD2, CD3, CD8, CD57, HL.ANB, CD8HLA,
CD8HN, and IgG associated with a significant decrease in CD4, CD25,
CD2O, CD11B, CD3CD, CD4HLADR and beta2-microglobulin. From
factors analyzed to assess their influence on the development of relapsing
AR we could demonstrate a significant correlation with younger recipient
age, elder donor, blood transfusions after TP, level of persisting cytotoxic
antibodies and second TP. Especially within the younger TP recipients we
have to be aware of "highreactive" rejectors. Pressimmun therapy turned
out to be an immunosuppressive agent with a safe consolidating efficiency
in this risk group.
Patient and graft survival in diabetic and non-diabetic patients. B. Jurk
At Koch, F. Kemmer, and B. Grabensee, Department of Nephrology,
University of Düsseldorf Düsseldorf Germany. Introduction: Diabetics on
dialysis have a higher cardiovascular mortality than non-diabetics. Is the
high mortality reduced in diabetics who were grafted? Patients and
methods: Thirty-nine diabetic patients (22 males, 17 females) with a mean
age of 38 10 years at time of transplantation were compared with 39
non-diabetic patients. Both groups were matched according to age, sex,
duration of dialysis, immunosuppression and numbers of HLA mis-
matches. At time of transplantation, 47% of diabetic patients but only 3%
of the control group had a coronary heart disease, diagnosed by angiog-
raphy, and 90% compared to 74% were hypertensive. Cholesterol and
triglycerides were not different in both groups. Results: Nine of 39 diabetic
patients and 7 of 39 non-diabetic patients lost their graft after a mean time
of 3.8 and 3.2 years, respectively. Seven of 39 diabetic patients and 4 of 39
non-diabetic patients died after a mean time of 4.3 and 4.2 years,
respectively; 82% of diabetic patients and 89% of the control group
survived longer than 5 years. After transplantation, newly diagnosed
coronary heart disease and progression of an existing coronary heart
disease developed in 15 of 37 diabetic patients and in 6 of 39 non-diabetic
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patients. Conclusions: (1) Cumulative survival rate during the first 5 years
in diabetic and non-diabetic patients is nearly the same although the
diabetic group has a higher cardiovascular risk profile. (2) Cumulative
graft survival in both groups is not different. (3) These results can be
obtained when diabetic patients are grafted at the early stage of dialysis.
Examination with coronary angiography is highly recommended.
Renal insufficiency, pharmacokinetic dose adjustment and the thera-
peutic drug monitoring of anti-infective therapies. F. Keller, A. Eckhardt,
and K. Bomer, Medical Department, University Hospital Ulm; and University
Hospital Benjamin Franklin, Berlin, Germany. We measured the drug levels
of 3 anti-infective therapies in 113 patients. Renal function was impaired
in 53% of the patients (35 dialysis, 25 renal insufficiency), leading to a
schematic dose reduction. Aminoglycosides (Gentamicin, Tobramycin,
Amikacin) were given to 44 patients. In 15 dialysis-dependent patients, the
half-life was less than expected, but significantly prolonged (P = 0.001) as
compared to 15 patients with normal kidney function (19 8 vs. 4 2
hrs). The aminoglycoside peak levels were significantly lower in 9 patients
who died from infective complications (P 0.01) as compared to 19
patients with anti-infective success (3.9 2.3 vs. 6.0 2.4 mg/liter).
Ototoxicity (N = 3) and nephrotoxicity (N = 4) were observed in 7
patients (16%). Vancomycin was given to 35 patients. In 16 dialysis-
depended patients, the half-life again was less than expected, but signifi-
cantly prolonged (P = 0.05) as compared to 15 patients with normal
kidney function (41 6 vs. 12 9 hrs). The vancomycin peak levels
tended to be lower in 6 patients who died of the infection as compared to
18 responders (20 6 vs. 26 9 mg/liter). Ototoxicity (N = 2) and
nephrotoxicity (N = 3) were observed in 5 patients (14%). Ciprofloxacin
was given to 25 patients. The half-life was significantly prolonged in 6
dialysis-dependent patients (P = 0.02) as compared to 8 patients with
normal kidney function (7.7 2.3 vs. 4.6 2.0 hrs). No toxic side-effects
were observed. In 8 of the 14 successfully treated patients, the dosage was
increased due to low ciprofloxacin peak levels (1.9 0.5 mg/liter). This
proportion (8/14) is significantly higher (P = 0.04) than that in the 11
patients with no success (8/14 vs. 2/11). Conclusions: The therapeutic drug
monitoring of anti-infective therapies reveals a high association between
low drug levels and treatment failure. The recommended dosing schemes
must be further adjusted to individual pharmacokinetic parameters in
one-third of the patients.
Severe hypertension in patients with a unilateral small kidney caused
by renal artery occlusion: Is there a benefit for nephrectomy? G. Keller, M.
Hollenbeck, B. Kutkuhn, and B. Grabensee, Abteilung für Nephrologie,
Heinrich Heine University, Düsseldorf Germany. Introduction: Nephrec-
tomy in patients with a unilateral small kidney without excretory function
and severe arterial hypertension is controversial. We examined the effect
of nephrectomy on blood pressure regulation in these patients who had a
pathological response of plasma renin activity (PRA) to Captopril.
Patients and methods: We studied 7 patients (4 females, 3 males) with a
mean age of 55 (5 1—69) years and a unilateral nonfunctioning small
kidney. All patients had a normal kidney function (99Tc-DTPA-clearance
210 mI/mm). The small kidney participated to 4.1% (0—10%). Plasma
renin activity (PRA) was measured after a rest of 30 minutes in the supine
position. Blood samples were drawn from a cubital vein before and after
60 minutes of the oral administration of 25 mg Captopril. An increase of
at least 2.6-fold was considered pathological. ACE inhibitors and diuretics
were withdrawn at least 3 weeks before the test. Results: PRA at rest was
17.2 (0.8—52) which increased 3.8-fold in average after Captopril stimu-
lation. Pre-operative blood pressure (Riva-Rocci) was 226 36/135 20
mm Hg; post-operatively it decreased significantly in all patients to mean
values of 133 10/80 9 mm Hg. Medication could be reduced from 3.3
(2—5) different antihypertensive drugs pre-operatively to 1.7 (0—4) post-
operatively. Conclusions: A renin-dependent form of hypertension has to
be considered in patients with a unilateral small kidney without excretory
function. It can be caused by residual perfusion in patients with an
occluded renal artery, especially when they suffer from arteriosclerosis.
According to these results patients with a pathological response of PRA to
Captopril will benefit from nephrectomy.
Release of uroclilatin from isolated perfused rat kidney and neonatal
rat kidney cells. K Kirchhojf V. Stadie, and W. G. Forssmann, Niedersach-
sisches Institut für Peptid Forschung (IPF), Hannover, Germany. Urodilatin
(URO) is a 32 amino acid peptide hormone which has been isolated from
human urine. It is an analogue to the circulating natriuretic peptide
CDD/ANP-99-126, extended by four amino acids at the N-terminus. Both
peptides exhibit vasorelaxant and natriuretic activities. URO is involved
also in salt and body fluid regulation. However, it is still a matter of
question whether URO is synthesized in the kidney or whether it results
from another mode of processing. URO has not been measured in rat
urine. Therefore, we investigated if rURO is produced by the isolated rat
kidney or rat kidney cells. For this purpose, a rURO specific competitive
radioimmunoassay (rURO-RIA) was developed using [1251] rURO as
competitive antigen and an antibody prepared against the hypothetical
rURO-N-terminus, Ala-Gly-Pro-Arg, as suggested by the precusor se-
quence of rat CDD/ANP-1-126. The derived antibody showed no cross-
reactivity with synthetic rCDD/ANP-99-126. The urine produced by the
perfused kidney was collected after an equilibration period of 20 minutes
in 10 minute fractions for 80 minutes. These urine fractions were analyzed
with the rURO-RIA. After an initial slight decrease the rURO production
of the isolated kidney was stable during the perfusion time of 100 minutes,
during which 620 fmol/ml of rURO were detected. Synthesis and secretion
of rURO are discovered also in primary neonatal rat kidney cell cultures.
The supernatants of cells incubated in serum-free medium for 45 minutes
secreted rURO at a rate of maximum 239 7.5 fmol/hr/mg protein. These
results indicate that the natriuretic peptide produced in rat kidney
represents the putative rat urodilatin (rURO).
Drug kinetics in hemodialysis (HD)—Netilmicin elimination by adsorp-
tion to the polyacrylonitrile (PAN) membrane. T. Kirschner, J. Bohler, B.
Xrumme, P. Schollmeyer, and E. Keller, Department of Nephrology, Univer-
sity of Freiburg, Freibu,g, Germany. Drug elimination in HD is mainly
determined by known parameters, such as diffusion and convection.
Adsorption to the dialyzer, however, might be an additional pathway in
certain membrane materials. Three different in vitro experiments (Di-
anorm® equilibrium dialyzer, single loop and closed loop system) were
related to in vivo data from an anuric patient (continuous veno-venous
hemodialysis CVVHD, PAN dialyzer) to investigate netilmicin elimina-
tion. Different membrane materials (PAN, cellulose acetate CA, polysul-
fone PS) were used in the in vitro study: netilmicin was dissolved in
electrolyte solution, fresh frozen plasma and human albumin solution with
and without heparin. PAN membranes extracted netilmicin completely
from the medium in each of the three in vitro experiments. Netilmicin
clearance was 100 ml/min (2.5 mg/mm) in the single loop system. Up to
230 mg of netilmicin were adsorbed per m2 membrane area without
indication of saturation. The drug appears to be firmly bound, since less
than 1% of the adsorbed drug was removable from the dialyzer by eluation
with 0.9% NaCl solution. CA and PS did not adsorb netilmicin at all. In
vivo netilmicin kinetics were investigated in an anuric patient during
CVVHD treatment (PAN dialyzer 0.8 m2, blood flow 150 mI/mm.,
ultrafiltration rate 1.5 liters/br). Initially, systemic netilmicin levels were
8.4 mg/liters and decreased to 5.8 mg/liters within 3 hours. Netilmicin
concentrations in samples taken from the venous line of the extracorporal
system rose from initially 1.5 mg/liters to 2.4 mg/liters. Netilmicin clear-
ance by CVVHD was 120 mI/mm, decreasing to 62 mI/mm after 3 hours,
corresponding to an elimination of 1.0 mg/mm and 0.51 mg/mm, respec-
tively. Ultrafiltrate concentrations increased from 0 (complete netilmicin
adsorption to the dialyzer) to 3.5 mg/liters after 3 hours, indicating the
beginning of membrane saturation. Conclusion: Drug elimination in HD
depends on individual membrane properties. Netilmicin is firmly adsorbed
to PAN, but not to CA and PS. In vitro results confirmed by in vivo data
suggest that netilmicin clearance by PAN dialyzers is determined mainly
by adsorption, whereas diffusion and convection proved to be minor
pathways. Thus, drug monitoring and dose adjustment may be required in
CVVHD with use of PAN dialyzers, to prevent underdosage in critically ill
patients.
Local antibiotic treatment with Sulmycin® Implant: A new therapeutic
modality for the management of exit site infections as a complication of
peritoneal dialysis. T Kirschner, J. Bohler, H. Pavenstädt, and P. Schollm-
eyer, Department of Nephrology, University of Freiburg, Freiburg, Germany.
Problem: Infection of the Tenckhoff catheter exit site is a complication of
peritoneal dialysis. Therapy consists of local treatment (for example, H202
rinsing) supported by systemic antibiotics. Local antibiotic treatment is
controversial, but may be an additional therapeutic modality in some
circumstances. In this case report a persistent exit site infection was
treated by local application of a new gentamicin-loaded "sponge". Case
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report: A 72-year-old critically ill patient suffered 2 exit site infections
(S aureus) within 2 years of peritoneal dialysis (IPD). In the first episode
antibiotic treatment with ofloxacin had to be discontinued due to drug
intolerability. The infection persisted during treatment with i.p. vancomy-
cm over 4 weeks. After another 4 weeks of oral flucloxacillin the patient
recovered from the exit site infection but suffered a relapse 6 months later,
when S aureus was detected again. Vancomycin i.p. over 4 weeks failed
again, nor did cephaclor p.o. over another 4 weeks improve the situation.
In an attempt to achieve higher antibiotic concentrations at the site of
infection, gentamicin eye drops were applicated locally. However, no
improvement of the local inflammatoty symptoms was observed. As an
ultima ratio therapy the exit site infection was treated locally with
Sulmycin® implant, a gentamicin sponge (matrix: collagen from bovine
tendon), which can be easily introduced in the infected catheter exit region
after soaking in an aseptic 0.9% saline solution. Treatment was performed
daily over 2 weeks and after local inflammation had subsided was
continued every second day for another week until the catheter was
completely free of inflammatory symptoms. Summary: Therapy-resistant
infections of the Tenkhoff catheter exit in peritoneal dialysis can be
treated antibiotically by local application of the Sulmycin® Implant, a
gentamicin-loaded "sponge" which is introduced into the inflammatory
region after soaking in an aseptic solution. In individual cases the infection
may clear up completely with this method.
Magnesium transport considering cell membranes in renal insuffi-
ciency. K Kisters, C. Spieker, M Tepel, F. Wenserski, and W Zidek,
Medizinische Universitat Polik1inik Munster, Germany. Plasma magnesium,
cytosolic and membrane magnesium concentrations were determined in
15 controls compared to 12 patients with renal insufficiency due to chronic
glomerulonephritis (serum creatinine 2.5 0.8 mg%). Plasma magnesium
content was determined by atomic absorption spectroscopy (AAS). Cyto-
solic free magnesium was measured in lymphocytes with the fluorescent
indicator Mag Fura 2. Measurements of membrane magnesium content
were performed in erythrocytes by AAS, referred to membrane protein
content (Bradford's method). Plasma magnesium was 0.91 0.08 in
controls versus 0.95 0.09 mmol/liter in renal insufficiency. Cytosolic free
magnesium content was 2.38 0.75 mmol/liter in controls and 2.61 0.35
mmol/liter in the renal failure group. Membrane magnesium concentra-
tions were found significantly increased in renal failure patients as
compared to controls (2.85 0.62 vs. 0.53 0.22 mmol/g protein, means
SD, P < 0.05). The results show that cell membranes may be of special
importance in renal insufficiency in avoiding magnesium overload of the
cell and in keeping free cytosolic magnesium stores stable.
Plasma and intracellular aluminum concentrations. Toxicity in renal
insufficiency and transplantation. K Kisters, C. Spieker, and J'V Zidek,
Medizinische Universität Poliklinik, Münster, Germany. Plasma and intra-
cellular aluminum concentrations were determined in 16 controls, 17
patients on regular hemodialysis treatment, and in 14 patients after renal
transplantation. Intracellular aluminum concentrations were measured in
lymphocytes. Plasma and lymphocytic aluminum concentrations were
measured by atomic absorption spectroscopy. Since lymphocytic alumi-
num concentration is difficult to determine, we referred lymphocytic
aluminum content to lymphocytic protein concentration, determined
according to Bradford's method. Aluminum concentrations in lynipho-
cytes of patients on regular hemodialysis (3.4 1.6 years) were found to
be 24.1 5.0, 18.2 5.2 in controls and 13.8 8.6 ig/g lymphocytic
protein in patients after renal transplantation (15.2 5.6 months, means
SD, P < 0.05). There was no correlation between cellular and plasma
aluminum concentrations. The results show that plasma aluminum con-
centrations are of minor interest in assessing aluminum overload/toxicity
in cell immunology and that cellular aluminum concentrations may be a
better means of determining body aluminum content.
Effects of vascular endothelial growth factor (VEGF) on hemodynamics
and permselectivity of the isolated perfused rat kidney (IPRK). B. Kianke,
H.-J. Gröne, H. Gros, M. Simon, H. Stolte, and HA Weich, Department of
Nephrology, Medical School Hannover, Hannover; and Medical Center
Pathology, University of Marburg GBF, Braunschweig, Germany. VEGF
owns a specific mitogenicity on endothelial cells and is chemotactic for
monocytes. It has been reported that 'S/EGF dilates isolated arteries and
increases capillary permeability. VEGF is constitutively expressed in the
adult kidney of rat and humans; also, its specific receptors (KDR, flk-1,
fit-i) can be found on glomerular as well as on pre- and post-glomerular
endothelia. The aim of the study was to test the effects of VEGF on renal
hemodynainics, glomerular permselectivity and tubular functions. IPRKs(N = 7) were perfused with a complex medium (cell free, 5% albumin,
pressure constant 100 mm Hg) for 120 minutes (recirculation with
dialysis). After 40 minutes the IPRKs were preconstricted with 1.5 X i0
M norepinephrine. Twenty minutes later VEGF (150 pM) was added. The
renal perfusion rate significantly increased after VEGF (minute 70, it SE:
115 5 vs. 99 1%; P < 0.005, t-test). The albumin sieving coefficient
(U/P-albumin/U/P-inulin) increased (minute 120, it SE: 470 275 vs.
230 37%). However, VEOF showed no influence on glomerular
filtration rate (GFR), 02 consumption, fractional sodium or fractional
glucose reabsorption. Conclusions: In pathophysiological conditions
VEGF, released from activated monocytes and renal cells, may counteract
the renal vasoconstriction and may mediate the increased permselectivity
with concomitant unchanged GFR.
Iodine monitoring after applicating contrast medIum in patients with
renal insufficiency. N Klause, G. Herrmann, H. Salto, W Nieman4 G.J.
Meyer, and W. Niedermayer, XlinikfurNephrologie und KlinikfurKardiolo-
gie, Christian-Albrechts-Universität, Kiel, Germany. Clinical experiences
demonstrate 15% of the cases of renal impairment to correlate with the
use of iodine which is applied in examinations with contrast medium
containing iodine. Especially invasive cardiological examinations require
partly very high amounts of contrast medium even in high risk patients
(GFR < 60 mI/mm). Previous research recommends eliminating contrast
medium by dialyzing (reduction of contrast medium about 60% at about
3 hours of dialysis) in order to avoid irreversibly detrimental effects on the
kidneys. However, our examinations (35 patients, GFR < 60 mI/mm, 275
36 ml Solutrast®300 in about 55 minutes after dialysis with F6 dialyzer,
Fa. Fresenius; comparable circumstances of dialysis) have shown that
duration of dialysis and thus the elimination of contrast medium should
follow the reduction of plasma-iodine level. The iodine level was mea-
sured with Renalyzer®(Fa. Provalid AB, Sweden); the measurements of
iodine content before dialysis were 1.95 0.21 mg/mI. It could be shown
that a dialysis of 3 hours does not always achieve safe elimination of
contrast medium. On one hand, the elimination rate was 70% after
dialyzing for 3 hours if the iodine level had been reduced to 50% after 2
hours. On the other hand, had iodine been reduced to only <40% after 2
hours, a reduction of iodine was achieved after a duration of dialysis of 3
hours in just 55% of the patients. In order to achieve a safe elimination of
contrast medium the duration of dialysis should be adapted to the iodine
reduction after 2 hours: if the reduction after 2 hours >40%, dialysis
should be applied for 3 hours. Is the reduction <40% the dialysis therapy
should last 4 hours. After dialysis the iodine content should be reduced to
<0.9 ng/ml.
Dynamics of bone mass reduction in dialysis patients. N Klause, W.
Niemand, K-H. Mahrt, R. Barkmann, and W Niedennayer, Klinik für
Nephrologie und InstitutfurAngewandte Physi/c Christian-Albrechts-Univer-
sität, Kiel, Germany. A main problem in treating hemodialysis patients is
the diagnosis and therapy of renal osteodystrophy. Previous histopatho-
logical studies have reported that the loss of the bone-3D-structure is
irreversible; hence, only preventive treatment applied in time can influ-
ence renal osteodystrophy favorably. A new type of ultrasound measuring
system has been developed at the Kiel University, Germany (precision o,
1%, hitherto existing measuring systems 1—5%) in order to obtain highly
precise noninvasive measurements with respect to levels of mineralization
of spongeous bone. This measuring system allows, for the first time, to
register significant bone mass reduction (BMR) in dialysis patients within
the shortest amount of time (days after the first dialysis).
Time days 1—14 14—21 21—38 38—42 42—165
BMR mg/cm3 2.8 5.0 6.0 7.5 14.0
% reduction 1.3 2.4 2.9 3.6 6.7
The results of our small pilot study suggest an incredible speed of bone
demineralization in patients with renal dysfunction as well as in hemodi-
alysis patients (physiological reduction >0.5%/year). Therefore, already in
the state of compensated renal insufficiency, early registration of the
individual dynamics of changes in bone mineralization and the endocrine
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function of the kidney are most important in controlling and ascertaining
the success of preventive treatment.
Effects of diadenosines on membrane voltage and contraction in rat
mesangial cells (MC). R. Kieta, J. Hirsch, S. Heidenreich, H. Schlflter, W.
Zidelç and E. Schiatter, Medizinische Poliklinik D, Universitdt Munster,
Münster, Germany. Diadenosine polyphosphates (Ap3A, Ap4A, Ap5A,
Ap6A) can act as vasoactive agents. Recently, it was shown that Ap5A and
Ap6A increase the perfusion resistance in isolated rat kidney. The aim of
this study was to examine the influence of diadenosines on membrane
voltage (Vm) and cell contraction in MC. Such effects are known for ATP
and angiotensin II (Ang II). MC of normotensive Wistar Kyoto rats
(WKY) and spontaneously hypertensive rats (SHR) were kept in primaly
and long-term culture. Vm was recorded with the slow and fast whole cell
patch clamp technique. Resting and agonist induced changes in Vm of MC
from WKY and SHR did not differ significantly. Vm was —50 2 mV
(N = 71). Increasing the extracellular K concentration by 15 mmol/Iiter
depolarized m by 14 1 mV (N = 24), decreasing the C1 concentration
by 142 mmollliter depolarized Vm by 10 2 mV (N = 4). Ap3A, Ap4A,
Ap5A, and Ap6A (each 5 molIliter) depolarized Vm by 5 2 mV
(N= 14),9 lmV(N= 24),2± lmV(N= 16),
respectively. Five imoIIliter ATP and 10 nmol/liter Ang II depolarized Vm
by 14 2 mV (N = 23) and 6 2mV (N = 7), respectively. One hundred
imol/liter of Ap4A or ATP contracted MC reversibly as observed by
differential interference contrast microscopy. These data suggest that
diadenosine polyphosphates increase the Cl conductance and contract
MC like ATP and Ang II.
High mortality from urothelial carcinoma despite regular tumor
screening in patients with analgesic nephropathy (AN) after renal trans-
plantation (RTx). V. Kliem, W. Thon, M Kolditz, S. Krautzig, M Behrend,
U. Frei, and R. Brunkhorst, Departments of Nephrology, Urology and
Abdominal and Transplant Surgeiy, Medical School of Hannover, Hannover,
Germany. In Germany the prevalence of AN among patients on renal
replacement therapy is about 5% (EDTA 1986). After RTx patients with
AN have an increased risk to develop urothelial carcinoma, reasons for
this mainly being the long course of the disease and possibly an increased
risk due to the immunosuppressive drug regimen. Between December
1968 and May 1993 in Hannover, 2371 RTx were performed on 2072
patients, 65 of whom (3.1%) had a clinically proven AN. Post-RTx a tumor
screening was performed twice a year by urine cytology and abdominal
sonography. Findings which led to further diagnostical steps were: painless
macrohematuria (N = 4); abnormal results on urine cytology (N = 3),
suspicious sonographical findings (N =2), and bone pain (N = 1). In 10
of 65 patients (15.4%; age 51—66 years; 42—108 months after initiation of
dialysis treatment; 4—75 months after RTx) a urothelial carcinoma was
diagnosed. The localization was: renal pelvis (N = 3); bladder (N = 4);
renal pelvis and bladder (N = 2); renal pelvis, ureter and bladder (N = 1).
Therapy comprised unilateral nephroureterectomy (N = 6), transurethral
resection (N = 5) and/or cystectomy (N = 2). Six patients (60%) died due
to tumor progression 17 months (4—33 months) post-operatively despite
therapy. Despite regular tumor screening after RT5c the diagnosis of a
urothelial carcinoma was made very late in our patients leading to a high
mortality due to the carcinoma. As a consequence, we suggest that in
patients with proven analgesic nephropathy a bilateral nephroureterec-
tomy should be performed prophylactically. This can be done electively in
two separate sessions. Post-operatively a cystoscopy with cytology testing
of bladder and ureter trunks should be performed twice a year.
Pharmacokinetics of pantoprazole in hemodialysis patients. V. Kliem,
M. Hartmann, R. Huber, R. Luhmann, H. Bliesath, W. Wurst, and J.
Bahlmann, Abteilung Nephrologie, Medizinische Hochschule, Hannover and
Byk Gulden, Konstanz, Germany. The new selective inhibitor of the gastric
H/K-ATPase pantoprazole is metabolized in the liver to metabolites
which are mainly cleared by the renal route. Thus, renal insufficiency and
hemodialysis might influence its pharmacokinetics. Eight patients with
end-stage renal failure (creatinine clearance <6 mi/mm, age: 45—65 years)
on regular hemodialysis (duration of hemodialysis 4—5 hr; Cuprophan-
dialyzer Hemoflow E3, surface 1.3 m2) were given single i,v. doses of 40
mg pantoprazole on the day before hemodialysis and on the day of
hemodialysis immediately before the start of dialysis. Pantoprazole con-
centrations were determined in plasma and urine over 24 hours and in
timed samples of the dialysis fluid by HPLC. Pantoprazole was found in
small amounts in the dialysis fluid (maximum 2.1% of the dose) but not in
the urine. The protein binding of pantoprazole was 96%. Pharmacokinet-
ics of pantoprazole and its main plasma metabolite M2 with dialysis were
comparable to those without hemodialysis. The plasma pharmacokinetics
of pantoprazole are summarized in the following table:
Median (mm /max) pharmacokinetic cha
of pantoprazole-Na
racteristics
AUC t% CL/kg Vd area
mg x hr/liter hr liters/hr/kg liters/kg
Without dialysis 2.49 0.68 0.213 0.226
With dialysis
(1.33/4.39)
2.32
(1.17/4.23)
(0.48/0.79) (0.14/0.37)
0.82 0.228
(0.47/1.35) (0.14/0.42)
(0.13/0.26)
0.269
(0.20/0.41)
Pantoprazole was well tolerated. In particular, there were no relevant
changes in blood count, electrolytes or liver enzymes. Conclusions:
Hemodialysis has no influence on the pharmacokinetic characteristics of
pantoprazole and its main metabolite M2. Pantoprazole is not dialyzed to
a significant degree. Thus, no dose adjustment is required during hemo-
dialysis. The comparison with healthy subjects shows that a dose adjust-
ment is not necessary in patients with end-stage renal failure even without
hemodialysis.
Serum hippuric acid concentration and erythropoietin response in
dialysis patients. A. Knoflach, J. Burger, and U. Binswanger, Nephrology
Department Internal Medicine, University Hospital, Zanch, Switzerland.
Variable EPO dosage for maintenance of near normal hematocrits is
required in dialysis patients, suggesting that inhibitory factors influence
bone marrow sensitivity. Ten patients on steady-state hemodialysis (HD)
and 11 patients on continuous ambulatory peritoneal dialysis (CAPD)
exhibiting adequate dialysis indices, ferritin >100 .tglml, transferrin
saturation >20% and low serum aluminium levels, were documented with
mean or steady-state serum hippuric acid concentration as obtained by
reversed phase HPLC technique. They were not different for serum urea
and creatinine concentrations, whereas hippuric acid was 173 34.2
mo1Jliter in HD patients and 70.4 21.2 mol/liter in CAPD patients
respectively (P < 0.02). The latter was positively correlated to serum
through EPO concentrations (r = 0.93 and 0.72), No such relationship
existed to serum urea or creatinine concentrations. For confirmation,
human bone marrow cultures were grown with 1 and 2 U EPO/mi,
respectively. HA at 52.5, 110 and 172 mol/liter inhibited CFU-E dose
dependently, but there was no CFU-G in the presence of 1 U EPO/mI; the
inhibition was abolished with 2 U EPO/ml. Serum HA is considered to be
related to therapeutic EPO response in dialysis patients.
Disturbed microcirculation as a possible cause of osteonecrosis of the
femoral head following kidney transplantation. W. Koall, B. Mukhtar; K
Kunze, H. Schmidt-Gay/c and B. Osten, Martin-Luther-University of Halle,
Department of Nephrology, Heidelberg, Germany. Osteonecrosis of the
femoral head (OFH) represents one of the most severe forms of the
inherited bone complications following renal transplantation. Microcircu-
lation disturbances are discussed as contributory factors in the etiology of
this disorder, especially in cases of ipsilateral occurrence of the necrosis as
well as in patients suffering from secondary polycythemia. Hemorheologi-
cal parameters of the microcirculation are plasma viscosity (PV) and
erythrocyte aggregation (EA). Two groups of renal transplant patients
were compared. Group A included 8 patients with OFH and group B was
composed of 8 patients without OFH. Pyridinoline (P) and desoxypyrmno-
line (DP) excreted in urine (in .tg/g Cr) were used as determinants for
bone and cartilage metabolism. As a clue for the disturbed bone and
cartilage metabolism in patients with OFH, significantly increased excre-
tions of P (316.9 149.4 vs. 142.2 49.0) and DP (58.2 30.6 vs. 25.0
11.5) were observed in group A in comparison to group B. However PTH
and alkaline phosphatase remained unchanged. Moreover, and as sign of
microcirculation disturbances, markedly elevated PV (in 4/8) and FA (in
2/8) were detected in patients with OFH compared to these without OFH.
These parameters of microcirculations can be better demonstrated con-
sidering the course of individual cases. Accordingly, these parameters
have to be considered in the etiology and the therapy of OFH in renal
transplant patients.
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Lipid profile in type I diabetic patients with and without nephropathy.
M. Koch, K Weber, and B. Grabensee, Department of Nephrology, University
Düsseldorf Düsseldorf Gennany. Introduction: Cardiovascular mortality
in diabetic patients with nephropathy is 40-fold higher than in diabetic
patients without nephropathy. Microalbuminuria and proteinuria are early
indicators for nephropathy and cardiovascular events. As nephropathy is
linked to atherosclerotic disease, we examined the lipid profile of diabetic
patients with microalbuminuria. Patients and methods: Thirty-nine type I
diabetic patients (21 males, 18 females) with nephropathy (microalbumin-
uria >20 mg/liter) and 76 type I diabetic patients without nephropathy
were compared according to age, sex, FibAic, duration of diabetes, insulin
dose, and body mass index. We measured cholesterol, LDL, HDL,
triglycerides, apolipoprotein A and B and lipoprotein (a). Results: HbAlc
is 8.75 1.85% in diabetic patients with nephropathy compared to 8.28
1.6% in patients without nephropathy: duration of diabetes 16 6 versus
15 6 years, insulin dose 45 16 versus 45 17 I.E., body mass index
25 3.7 versus 24 3 kg/rn2, age 36 11 versus 35 12 years. Systolic
and diastolic blood pressure is significantly higher in diabetic patients with
nephropathy than without (148 27 vs. 130 16 mm Hg and 87 12 vs.
79 9 mm Hg P < 0.0005).
Cholesterol LDL HDL Triglycerides Lipoprotein(a)
mg/dl
With 250 176 54 158 20
nephropathy 54 52 16 98 24
Without 217 135 63 117 15
nephropathy 36 38 19 99 19
a p < 0.001
Conclusions: Diabetic nephropathy is linked with atherosclerotic disease.
The high cardiovascular mortality may be due to the change in lipid profile
after onset of microalburninuria. Lp (a) is not significantly different in the
2 groups.
Genotype and phenotype in autosomal dominant polycystic kidney
disease (ADPKD). G. Kraatz, C. Frenzel, P. Stohlmacher, K Zerres, and B.
Jager, Department of Internal Medicine, E.-M-Arndt University Greifswald,
Greifswald, Germany. A second genetic locus (PKD-2-locus) in ADPKD
has been identified on the long arm of chromosome 4 (4 q 13-23) after
Reeders et al previously described a genetic defect in PKD-1 on the short
arm of chromosome 16 by demonstration of a strong linkage with the
hypervariable region (3'HVR). There has been no publication about any
family with chromosome 4 associated ADPKD in German-speaking
countries so far. While investigating our ADPKD family trees the lack of
association with the chromosome 16 in one Pomeranian family was
established and the linkage with chromosome 4 was proven (markers D4S
414, 400, 420, 392, 411). As did Raven et al, we found that there are also
phenotypic differences in this family's members. The expression was
markedly weaker than in the other families, and the degree of cyst
formation during the 3rd and 4th decade was extremely low. End-stage
renal failure developed markedly later or never developed. There were no
cysts in liver or pancreas, and no cardiovascular complications were
observed. No hypertension developed. Since PKD-2 occurs in 5 to 15% of
ADPKD patients, a differentiation by the genetic locus in 2 different
courses of illness could become possible. Thus, it seems that a different
phenotype is associated with the newly localized genotype.
Renal renin secretion and renal renin gene expression induced by the
renal baroreceptor mechanism: Role of prostaglandins. B.K Kramer, K
Schricker, T. Gopfrrt, S.R. Holmer, M Hamann, G.A.J. Riegger, and A.
Kurtz, Klinik und Poliklinik für Innere Med izin II and Physiologisches Inst it ut
I, University of Regensburg, Regensburg, Germany. The role of NO in
perfusion pressure mediated regulation of renin secretion has recently
been clarified; however, the role of prostaglandins is controversial.
Therefore, the effects of indomethacin were studied in a 2K-iC (0.2 mm
clip) rat model in order to obtain information about a possible role of
prostaglandins in the renal baroreceptor mechanism regulating renin
secretion and renin gene expression. In sham operated animals low doses
of indomethacin (4 mg/kg/day) tended to lower basal PRA and renin
mRNA levels. At higher doses (16 mg/kg/day) indomethacin led to a
significant rise of basal PRA and renin mRNA levels. These changes were
paralleled by falls in hematocrit and blood pressure. In vehicle treated
animals clipping increased PRA from 10 to 35 ng Ang I/hr x ml, renal
renin mRNA levels 5-fold, and systolic blood pressure by 27mm Hg. Low
doses of indomethacin markedly attenuated the rises of PRA (12 ng Ang
I/hr x ml) and of renin mRNA levels (2-fold) but not of blood pressure in
response to clipping. High doses of indomethacin again increased PRA
and renin mRNA levels in response to clipping. According to our results
prostaglandin synthesis is required for the stimulatory role of low renal
perfusion pressure on renin secretion and renin gene expression. High
concentrations of indomethacin cause gastrointestinal bleeding, thereby
stimulating renin secretion and renin gene expression. Stimulation of
renin by bleeding seems to depend less on prostaglandins than stimulation
of renin by the baroreceptor mechanism.
Endothelin-induced inhibition of renin release in juxtaglomerular cells:
Mode of action. B.K Kramer, T. Ritthaler, H. Scholz, M. Ackermann, G.A.J.
Riegger, and A. Kurtz, Klinik und Poliklinik für Innere Medizin II and
Physiologisches Institut I, University of Regensbui'g, Regensbur Germany.
Inhibition of renin release by endothelin has recently been reported in
isolated juxtaglomerular cells and in kidney slices; however, the role of
endothelin isoforms and the mode of action remained unclear. These
questions were studied in primary cultures of isolated mouse juxtaglomer-
ular cells measuring renin activity by radioimmunoassay and in juxtaglo-
merular cells in situ using whole-cell patch clamp measurements. While
the different endothelins had no consistent effect on basal renin secretion
they equipotently (IC50:3 nM) inhibited cAMP-stimulated (3 M forskolin)
renin secretion but did not change renin secretion stimulated by low (2 mi
EGTA) or high (3 m'vi Ca) extracellular calcium or by the NO donor
sodium nitroprusside (100 trM). Inhibition of renin secretion was indepen-
dent of the mode of cAMP accumulation (forskolin, isoproterenol,
8-br-cAMP, IBMX) used. The inhibitory effect of endothelins on renin
secretion was abolished by lowering extracellular calcium concentration
but was unchanged by the ETA-receptor antagonist BQ123. ETB-receptor
agonists (IRL 1620, sarafotoxin S6b, 4 Ala-ET-1) inhibited in a similar
manner renin secretion. Endothelins induced calcium oscillations in
juxtaglomerular cells that were dependent on extracellular calcium and
that were associated with prominent calcium activated chloride currents.
Our results suggest that endothelins rather selectively inhibit the cAMP-
stimulated pathway of renin secretion via a calcium sensitive process, that
is mediated via ET-receptors, and is related to activation of phospho-
lipase C, release of calcium and subsequent processes.
Impact of different dialyzer membranes on the recovery from ischemic
acute renal failure. B. Kränzlin, A. Reuss, C. Ryan, N. Gretz, and M.
Strauch, Division of Nephrology, Klinikum Mannheim, University of Heidel-
berg, Heidelberg, Germany; and Hammersmith Hospital, London, England,
United Kingdom. A study was conducted to test the hypothesis that
recovery from ischemic acute renal failure (AIRF) may be affected by the
type of membrane used in hemodialysis. Male Sprague Dawley rats were
allocated to 2 groups: In group I (N = 48) acute renal failure was inducted
by clamping of the renal arteries for 45 minutes. Group II (N = 48) rats
underwent a sham procedure. In 3 groups, rats were allocated to undergo
hemodialysis with either a Cuprophan (Cu), a Hemophan (He) or a PAN
(AN69) minidialyzer on days 4 and 8 after surgery while the rats in the
fourth group stayed non-dialyzed (No HD). Renal function was monitored
by single shot inulin clearance on the day following dialysis.
Inulin clearance
Group Membrane
Cu
N
12
ml/min/100 g
Day 5 Day 9
0.84 0.11 1.06 0.09
Group I He 12 0.82 0.08 1.20 0.18
ARF PAN
No HD
Cu
12
12
12
0.77 0.09 1.35 0.25
0.78 0.15 1.40 0.20
1.57 0.16a 1.64 0.17
Group II He 12 1.68 0.23 1.40 0.22
Sham PAN
No HD
12
12
2.00 0.22a 1.80 0.21
2.14 0.83" 1.97 0.76
a P < 0.01 vs. corresponding sham group
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In the AIRF group no difference in the severity of renal failure in the
different subgroups could be observed. Dialysis had no effect on the
degree and rates of recovery from AIRF compared to non-dialyzed rats
with AIRF. Furthermore, dialysis had no effect on renal function in sham
operated rats. We conclude that in the model of ischemic acute renal
failure, the severity of renal failure and the rate and degree of recovery are
independent of the type of membrane used in hemodialy.sis.
Identification of novel gene products differentially expressed during
renal organogenesis. M. Kretzler, G. Fan, J.P. Bnggs and L.B. Holzman,
Division of Nephrology, Department of Internal Medicine, University of
Michigan, Ann Arbor, Michigan, USA. Renal organogenesis is a complex
process requiring multiple interacting programs of gene expression. To
date, identification of participating genes has been mainly based on
homology. However, developmentally expressed, tissue specific genes may
not be detected by these approaches. In order to identify cellular markers
useful in studying renal organogenesis, we used the unbiased technique of
differential display polymerase chain reaction (DD-PCR) to obtain ex-
pression patterns of gene products over the entire process of kidney
organogenesis. Embryonic mouse kidneys were freshly dissected at E11.5,
E13.5, E15.5 and E17.5 days after conception and from adult animals. Five
hundred and eighty-three DD-PCR products were reproducibly displayed
with 20 pairs of an anchored oligo dT-primer and one of 20 random
lO-mers. One constitutively and 22 differentially expressed products were
isolated, re-amplified, subcloned and sequenced. The constitutively ex-
pressed product showed 98% homology with the 3'prime end of the mouse
ATP-ADP translocator. None of the 22 differentially expressed products
showed significant homology with known sequences in the genetic data-
bases. To reconfirm the expression patterns determined by DD-PCR,
semiquantitative RT-PCR was performed using sequence specific 18-22-
mers. Nineteen of the 22 clones were expressed during kidney develop-
ment and 11 showed patterns of steady-state mRNA expression similar to
that observed by DD-PCR. RT-PCR comfirmed considerable gene to
gene variability in time of expression onset (E11.5-E17.5), time of peak
expression (E15.5, E17.5, adult) and level of expression (3 orders of
magnitude). In conclusion, our approach has allowed the identification of
novel eDNA sequence markers differentially expressed during kidney
development. Further characterization of the pattern of expression of
these sequences should yield markers useful in defining developmental
processes and model systems.
Podocyte damage is a major step in the development of glomeruloscle-
rosis in the Fawn-hooded rat. W. Kriz, H. Hosser, and A.P. Provoost,
Institute of Anatomy and Cell Biology, University of Heidelberg, Heidelberg,
Germany; and Department of Pediatric Surgery, Erasmus University, Rotter-
dam, The Netherlands. Fawn-hooded rats (FHH) develop systemic hyper-
tension, proteinuria and focal/segmental glomerulosclerosis at a young
age. The development of sclerosis is widely believed to be the consequence
of glomerular hypertension. The present study analyzes the sequence of
structural lesions finally terminating in sclerosis. The kidneys of FHH-rats
(N = 8) in comparison to Wistar rats (WAG) as controls (N = 7), both at
about the same age of 24 weeks, were fixed by total body perfusion with
glutaraldehyde and processed for light and electron microscopy by stan-
dard procedures. Just before the day of sacrifice systemic blood pressures
(mm Hg; measured by tail plethysmography) were 141 15 in FHH
versus 106 6 in WAG rats, albuminuria (mg/day/100 g body wt) was 36.6
26.1 versus 1.4 0.5, respectively. Glomerular damage was seen in all
FHH-rats. The inter-animal variability in the degree of glomerular
damage was remarkable, with some animals showing only a few damaged
glomeruli while others had severe lesions in the majority of glomeruli. The
lesions are distributed focally and range from mild to severe including
glomerulosclerosis. Early lesions consist in mesangial expansion and
capillary ballooning frequently restricted to a single lobule of a glomeru-
lus. In more advanced damaged glomeruli the lesions in podocytes
dominate. They consist in simplification of the foot process pattern
("fusion" of foot processes), flattening of podocyte cell bodies ("pancake
podocytes"), pseudocyst formation, and finally of detachments of podo-
cytes from the GBM. Prescierotic lesions (local hyalinosis and thrombosis
of glomerular capillaries) are always seen in conjunction with tuft adhe-
sions of Bowman's capsule. Early adhesions clearly demonstrate that the
fixation of the tuft to Bowman's capsule is effected by parietal glomerular
cells which attach to the GBM of "naked" capillary loops. Segmental
sclerosis exclusively develops in adherent tuft regions. Mesangial prolif-
eration may be encountered locally but does not appear to contribute
decisively to the sclerosis development. In conclusion, in the FHH rat
damage to podocytes appears to be the crucial event starting the devel-
opment of glomerulosclerosis.
Duplexsonography in essential hypertension. Age-dependence of intra.
renal resistance index (RI). B. Krumme, T Kirschner, K Gondolf P.
Schollmeyer, and E. Keller, Department of Nephrology, University Hospital
Freiburg, Freiburg, Germany. The intrarenal resistance index (RI) facili-
tates the diagnosis of unilateral renal artery stenosis with duplexsonogra-
phy, which is increased in most renal parenchymal diseases. However,
there are no data about the RI in patients with essential hypertension. The
aim of this study was first to evaluate normal values in patients with
essential hypertension, and second to examine the influence of blood
pressure, renal function (measured by serum creatinine) and age on the
RI. Methods: In a period of 2 years, 508 kidneys of 254 patients (age:
17—83 years, 108 females, 146 males) with essential hypertension were
examined with duplexsonography. Three interlobular and segmental ar-
teries were scanned in each kidney using a 2.5—3.5 MHZ transducer. The
mean RI of each kidney and the side-to-side difference was calculated.
Statistical analysis (Mann-Whitney test P < 0.05) was performed in 8
groups separated for age. Results: The mean blood pressure of all 254
patients was 109.4 8.3 (STD) mm Hg, with a mean number of 1.9 0.8
(STD) antihypertensive drugs and mean serum creatinine of 1.00 0.17
(STD) mg/dl. There was no difference in these parameters between the
several groups according to age. The mean RI of all patients was 65.9
0.91 (STD) % with a mean side-to-side difference of 1.8 1.5 (STD) %.
The rise in age correlated with an increasing RI and was significantly
different up to 40 years (P < 0.001).
Age N RI STD Age N RI STD
<20 years (6) 56.7 4.4% 51—60 years (67) 66.8 6.5%
21—30 years (23) 57.3 4.5% 61—70 years (46) 73.2 8.3%
31—40 years (25) 58.8 4.2% 71—80 years (21) 78.1 7.4%
41—50 years (64) 61.8 5.7% >81 years (2) 83.2 0.9%
Conclusion: The intrarenal RI, measured by duplexsonography, mainly
depends on age in essential hypertensive patients, although blood pressure
and serum creatinine are without any influence. This dependence may be
the result of the reduced elasticity of the intrarenal vessels in the elderly
and should be considered in the duplexsonographic diagnosis of renal
parenchymal disease.
Tumefactive megalocytic interstitial nephritis in a patient with Esche-
richia coli bacteremia. G. Krupp, U. Gobel, W. Schneider, P. Kreitch, H.
HaIler, and F. C. Luft, First Department of internal Medicine, Krankenhaus
Berlin-Buch, Franz Voihard Clinic, Free University of Berlin, and Max
Delbruck Center, Berlin-Buch, Germany. We describe an unusual case of
anuric acute renal failure in a 45 year old alcoholic, nondiabetic man who
entered the hospital with fever and hypotension. He had no prior history
of renal disease. Cultures of blood and urine yielded Escherichia coli.
Antibiotic therapy and dialysis were initiated. An ultrasound examination
of the kidneys showed large, plump, smooth renal outlines with a swollen,
homogeneous renal cortex. The collecting system showed no sign of
obstruction. The patient became progressively hypotensive, hypoxemic,
and died of gram-negative sepsis on the third hospital day. At post
mortem, both kidneys showed megalocystic interstitial nephritis with
pseudotumor formation. Rather than foam cells, as seen in xanthogranu-
lomatous pyelonephritis, the parenchyma was filled with a monotonous
sea of macrophages, which were filled with a PAS positive material. No
Michaelis-Gutman bodies, as would be expected in malakoplakia, were
observed. Electron microscopy showed the presence of lysosomes contain-
ing myeloid figures, termed phagolysosomes, filled with granular debris.
This exceptionally rare form of interstitial nephritis represents an extreme
form of macrophage proliferation. We suggest that a unique mode of
macrophage activation is responsible. Details of the histopathology and
clinical aspects will be presented.
Stimulation of mRNA expression of the molecular chaperone HSP7O
protects renal proximal tubular cells from acute ischemic injury. M.
Kuhlmann, R. Betz, R. Hanselmann, and H. KOhier, Division of Nephrology
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and Human Genetics, University of Hombu,g/Saar, Homburg/Saar, Ger-
many. In reaction to external stress, for example heat, procaryotic and
eucaryotic cells synthesize phylogenetical highly conserved heat shock
proteins (HSP). HSP7O is recognized as an inducer of thermotolerance.
We studied whether stimulation of HSP7O gene transcription provides
protection from ischemic injury in a proximal tubular epithelial cell line
(BSC1). BSC1 cells were heated for 30 minutes at temperatures ranging
from 37—46°C followed by 120 minutes at 37°C for regeneration. Expres-
sion of 1-ISP7O mRNA significantly increased with 42°C, with a maximum
at 43°C. The effect of duration of heat treatment at 42°C followed by 120
minutes at 37°C was tested. There was a significant increase in HSP7O
message after 45 minutes at 42°C, with a peak at 90 minutes. The amount
of total cellular HSP7O message increased over 5 hours post hyperthermia
followed by a rapid decline towards baseline levels. Intracellular HSP7O
protein levels (Western blot) were significantly increased 15 hours after
treatment at 42°C for 60 minutes. Immunohistochemical staining for
HSP7O protein revealed a granular, perinuclear distribution pattern. The
susceptibility of HSP7O expressing BSC cells towards ionomycin-induced
(5 sM, for 60 mm) ischemia-like injury was examined. HSP7O expressing
BSC cells showed significantly lower LDH release compared to control
BSC cells (26 5% vs. 76 14%; P 0.05). Protection provided by
HSP7O was superior to 5 mM glycine (46 8%). Our data indicate: specific
stimulation of HSP7O synthesis protects BSC cells from ischemic injury.
The protection provided by HSP7O is transient and depends on quality and
quantity of the transcription stimulus.
Furosemide-induced diuresis increases pH gradient between collecting
duct urine and vasa recta blood in the papilla of rat kidney. G. Kuramochi,
U Kersting, W.H. Dantzler, and S. Silbernagi, Department of Physiology,
University of Wurzburg; Würzburg, Germany; and Department of Physiology,
University of Arizona, Tucson, Arizona, USA. pH of the collecting duct
urine, of descending and ascending vasa recta blood and of renal artery
blood was measured using liquid-exchange pH microelectrodes in the
exposed papilla of rat kidney. Urine from the unexposed kidney was
collected, and urine flow rate and urine osmolality were determined. Rats
were infused with isotonic rat Ringer solution at 0.02 ml/min. Diuresis was
induced by furosemide infusion (0.1 mg/mI).
Antidiuresis Diuresis
pH collecting duct urine 6.02 0.05 (26) 5.16 0.09 (7)
pH descending vasa recta
pH ascending vasa recta
6.71 0.06 (16)
6.57 0.05 (16)"
6.84 0.04 (6)
6.87 0.05 (6)°
pH renal artery 7.33 0.03 (25) 7.38 0.11 (7)
Urine osmolality mOsm/kg 1-120 1489 56 (25) 558 18 (7)
Urine flow rate i.lIrnin 2.47 0.21 (25) 9.13 0.97 (7)
° significantly different from control; b significantly different from the
descending vasa recta blood (P < 0.01).
We found that pH of vasa recta blood was acidic in renal papilla during
antidiuresis. In addition, pH of ascending vasa recta blood was signifi-
cantly lower than that of the descending one. During diuresis, pH of
collecting duct urine decreased by about 1 pH unit. On the other hand, pH
of vasa recta blood, particularly ascending portion, increased significantly
compared with control, We, therefore, conclude that the renal papillary
pH gradient between collecting duct urine and vasa recta blood increases
significantly during furosemide-induced diuresis.
On-line measurement of electric bio-impedance: A mean to prevent
cardiovascular complications in chronic hemodialysis (HD). K Kunz, P.
Petitjean, F. Heibel, and 7'. Hannedouche, Service de Néphrologie, Hôpital
Civil, CHRU Strasbourg, Strasbourg, France. Background: Cardiovascular
instability during hemodialysis often presents as a fall in blood pressure,
muscle cramps, or fatigue, which may all be related to water imbalance
between the intra- and extracellular, or the intra- and extravascular
compartments, and may be preceded by a decline in plasma volume (PV).
Objectives: Evaluation of electric bio-impedance as a surrogate of intra-
dialytic plasma volume changes with respect to clinical complications.
Patients: Eighty-nine patients on maintenance hemodialysis, aged 22—84
years. Methods: We compared two measuring devices, BIA 101 and IPEC
5000-1, operating at 50 kHz (using 4 skin patch electrodes), and 5 kHz
(using needle electrodes in the arterial line of the extracorporal circuit),
respectively. Blood samples were taken for RBC, Na, K and total protein.
The Na concentration of the dialysate was also measured and kept
constant at 141 2 mmol/liter. Results: Hb and Het highly correlate with
impedance (Z) at 5 kHz (r = 0.87; r2 = 0.73; P < 0.000 1), and furthermore
dZ correlates with dHct (r = 0.84; r2 = 0.71; P < 0.001); the correlation
between PV calculated from Hct, and PV derived from measurement of
(Z) was significant (r = 0.70; r2 = 0.49; P < 0.01; (N = 39). A decrease in
impedance-derived PV over 20% leads more frequently to a fall in BP or
muscle cramps. Discriminant analysis shows that relative decline in PV
(%) is a stronger parameter to distinguish between complicated and
uncomplicated HD sessions than the hourly ultrafiltration rate per body
weight (mI/hr/kg) (96% vs. 67% classified correctly). Positional artifacts
are a major drawback of the 50 kHz method. Conclusions: On-line electric
bio-impedance measurement at 5 kI-Iz can reliably monitor PV changes
during routine HD sessions and hence predict the appearance of clinical
complications.
The relationship of blood pressure and insulin sensitivity in patients
treated with cyclosporine A (CSA). B. Kutkuhn, M. Hollenbeclç Adina
Voiculescu, Michael Koch, Peter Heering, and B. Grabensee, Medizinische
Klinik und Poliklinilc, Klinik für Nephrologie, Heinrich-Heine-Universitat
Düsseldorf; Germany. Decreased insulin sensitivity has been described as a
possible main cause of arterial hypertension. We conducted a sequential
study in patients before (A) and during the course of CsA treatment (B)
to investigate blood pressure and insulin sensitivity in CsA induced
hypertension. In ten patients undergoing keratoplasty with normal renal
function and no other drug intake (age 21—73) glucose tolerance was
studied before and during CsA therapy. For this reason i.v. glucose
tolerance test was performed in order to obtain the glucose clearance
(K-value) and insulin sensitivity by determination of the sensitivity index
(SI) (minimal model method). Further variables studied were: 24-hour
blood pressure monitoring, body mass index (BMI), HbA1C, serum lipids,
and endogenous creatinine clearance. No significant difference was de-
tected in serum lipids, HbA1C and BMI before and during the course of
CsA treatment. Arterial blood pressure (MAP) increased during CsA
therapy, while the K-value and the SI decreased.
N = 10 Without CsA CsA treatment
K-value 1.65 1.62 NS
SI 3.6 2.4P<0.05
MAP mm Hg 91.0 96.OP<0.05
CsA ng/ml 143
After age correction there was evidence of a negative correlation of blood
pressure and SI (r =
—0.4; P < 0.05). Conclusion: In patients without
renal disease CsA induced an increase in mean arterial blood pressure.
We were able to demonstrate a correlation between insulin sensitivity and
arterial blood pressure in secondary hypertension induced by CsA.
Undifferentiated connective tissue disease (UCTU) and membranous
glomerulonephritis (MGN). Peter Lamprecht and Hans-Ulrich Gutsche,
Institute of Clinical Nephrology, Heide, Germany. We report on a patient
with MGN on the basis of UCTD. Thus far, this collagen disorder has not
been found to cause renal involvement of the kind of MGN. A 67 year old
woman presented with a nephrotic syndrome due to MGN. She had a
twelve month history of ankle and face edema that progressed to anasarca
of the thighs and stem, She exhibited symmetrical pallor of the fingers
without cyanosis, combined with skin sclerosis and dystrophy of the nails.
Creatinine was 128 pmol/liter, and Cr was 30 mI/mm. Urinalysis revealed
a hematuria of glomerular origin and an unselective proteinuria of 3.7 g/dl,
resulting in a serum albumin of 1.8 g/Iiter and a selective deficiency of IgG
(546 mg/dl) and 1gM (46 mg/dl), but normal IgA (386 mgldl) and a 10-fold
increase in IgE (1112 mg/dl). Cholesterol was 824 and triglycerides were
464 mg/dl. Rheumatoid factors, complement factors (c3 and c4), as well as
an ANA screening were unremarkable, including antibodies against
double strain DNA, anti-RNP, anti-SM and anti-Scl-70 antibodies. A skin
biopsy gave no results in favor of scieroderma. A kidney biopsy disclosed
a second degree MGN with increased eosinophilic granulocytes in capil-
lary loops and interstitium, and small, interstitial clusters of lymphocytes.
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There was a distinct interstitial fibrosis and fibrotic changes of Bowman's
space. Immunofluorescent stains were positive for intracapillary IgA and
IgG. Interstitial plasma cells also stained positive for IgA and IgG.
Electron microscopy showed a widened basement membrane with dense
subepithelial deposits, occasionally with small spikes, and scattered de-
posits in the parietal part of Bowman's capsule. At present the patient is
under treatment with the alternating prednisolone-chiorambucil protocol
of Ponticelli et al due to the second degree MGN with neprotic syndrome.
Since no obliterative arteriopathy or sclerodernia like involvement of the
kidneys was observed, no treatment with ACE inhibitors was initiated.
UCTD may progress into scleroderma (SD) or mixed connective tissue
disease (MCTD). UCTD with Raynaud phenomenon and SD-like skin
lesions has not yet been described with MGN, as it has been reported for
MCTD.
Pharmacokinetics of the nonionic contrast agent iopentol in adults with
renal insufllciency—Etfects of hemodialysis after contrast media applica-
tion. T Lehnert, K Gondoif T Schdffner, P. Schollmeyer, and E. Keller,
Department of Nephrology, University of Freiburg, Freiburg, Germany.
Preexisting renal insufficiency is a major risk factor for contrast media
(CM)-induced nephropathy. The aim of this study was to investigate the
influence of hemodialysis on the pharmacokinetics of lopentol with
possible renoprotective effects. Seven patients with renal insufficiency [Car
47 mI/mm 10.6 (± SaM), 12—94 ml/min (range)j, who underwent an
arterial angiography were monitored. Three patients were hemodialyzcd
for 3 hours, beginning 0.5—2 hours after the last CM bolus (filter: high-flux,
polysulfone; single needle; blood flow: 250/300 mI/mm). The iopentol
levels in plasma and urine and creatinine clearance were followed-up for
120 hours. In 6 patients (including 3 patients with hemodialysis) Cr
decreased to 45% (21 mI/mm 3.3) within 72 hours after CM application,
rising to 83% (39 mI/mm 9.9) within 5 days. For the kinetics the
following data were obtained: total clearance (Cl): 49 ml/min 9.9 (25—96
mi/mm); volume of distribution (V): 39.1 5.2 (25—65 liter); elimination
half-life (t112): 11.2 h 2.1 (4.4—21.6 hr). The dialysis clearance (Cld) was
72, 70 and 72 mI/mm, respectively. The fraction of the extracorporal
eliminated dose was 31 4%. In conclusion, our data show that iopentol
can be eliminated sufficiently by hemodialysis. However, hemodialysis had
no effect on the course of creatinine clearance. Further investigations are
required to confirm these results.
Hemoperfusion in intoxication with propafenone. G. Lenz, F. Saul, B.
Lenfers, A. Wiemeyer, and B. LOsse, Departments of Internal Medicine,
Cardiology and Nephrology, Stadtische Kliniken Dortmund, Dortmund,
Germany. There are only a few reports available concerning intoxication
with propafenone, an antiarrythmic agent of class I C. Consequently, there
are no therapeutic recommendations for secondary elimination of
propafenone. Till now the elimination by hemoperfusion did not seem to
be promising. Case report: A 23 year old patient ingested (with the intent
to commit to suicide) 21 g of propafenone. As soon as 20—30 minutes after
ingestion (plasma level 3.6 jg/ml), a primary gift elimination by lavage was
done. The typical signs of intoxication were shown by the patient, such as
hypotension and a slow ventricular tachycardia (VT) with maximal wide
ventricular beats. The secondary elimination was started 2 hours 40
minutes after ingestion by hemoperfusion and continued about 4 hours
with a flow rate of 200 mI/mm. After a phase of changing between sinus
rhythm and VT over 1 hour 20 minutes, a stable sinus rhythm (PQ 0.24 s,
ORS 0.14 s) developed in the now stable patient. After 2 hours 30 minutes
PQ 0.18 s QRS 0.12 s. The plasma level after 4.5 hours of hemoperfusion
decreased to 1.0 jsg/ml. Summary: In patients with high dose propafenone
intoxication immediately primary elimination with lavage is necessary.
Because of the quick resorption a therapy by hemoperfusion is recom-
mended as early as possible.
End-stage renal failure from diabetic nephi-opathy—Epidemiological
dimension of the problem. f. Lippert, A. Schwarzbeck; P. Schneider, and E.
Ritz, Department of Internal Medicine, Ruperto-Carola- University, Heidel-
berg; and Dialysis Centers from Mannheim-Kafertal, Schwetzingen, and
Weinheim, Germany. According to the EDTA registry, 21% of the dialysis
patients in Germany suffer from diabetes and presumed diabetic nephrop-
athy. This is an underestimate based on our clinical experience. We
assessed all patients newly admitted to renal replacement therapy in 1993
in the four dialysis centers of the "lower Neckar" area (approx. 1.2 million
inhabitants) and all patients admitted to the renal clinic for evaluation of
elevated serum creatinine (catchment area 300,000 inhabitants): 118
patients were admitted for dialysis; 40.6% (48/118) had diabetes, 8.4%
type I and 32.2% type II; 17/48 (35.4%) of diabetics were female, and
31/48 (64.6%) were male. The average age was 63.2 13.6 years. In the
renal clinic 37 patients with newly diagnosed renal insufficiency had 2 hour
values on OGIT > 160 mg/dl or clinically manifest diabetes mellitus.
Thus, in Germany, 40 diabetics/million/year go into terminal renal failure,
but approximately 120 diabetics/million/year develop de novo renal failure.
This discrepancy points to high patient attrition, presumably from cardio-
vascular mortality prior to end-stage renal failure. The data show that in
Germany: terminal renal failure in diabetic patients (predominantly type
II) is much more frequent than reported; and that future reduction of
mortality in the preterminal stage can even cause a further increase.
Coronary risk factors in chronic hemodialyzed patients. F. Ldbbecke,
U. Richter, A. Frettloh, F. -I?. Matthias, N. Katz, V Wizemann, and G.
Schütterle, Center of Internal Medicine, Institute of Clinical Chemistiy,
Justus-Liebig-University; and Georg-Haas-Center, GieJ3en, Germany. The
relevance of so-called "risk factors" for the development of coronary heart
disease (CHD) remains to be clarified for chronic uremic patients (CUP).
Therefore, we compared the levels of various risk factors of a non-diabetic
hemodialyzed CUP group with normal angiography (CHD—, N = 15) with
those of CUP with at least 1 coronary stenosis of >50% (CHD+). Total
cholesterol, HDL, LDL, VLDL, LP(a), Apo A and B, serum triglycerides,
oral glucose tolerance, fibrinogen, plasminogen, a2-antiplasmin, coagula-
tion factor VII and VIII, D-dimers, t-PA, PAl-antigen, HbAI, and 24 hour
blood pressure recordings were determined. HDL was significantly lower
in CHD + (35 4 mg/dl vs. 49 4 mg/dl) as well as tissue plasminogen
activator (t-PA; 6.4 1.3 vs. 8.7 1.7 ng/ml; mean SEM, P < 0.05).
Plasminogen activator inhibitor (PAl), however, was slightly lower in
CHD+ (11.2 3 vs. 17.8 3.8). All other variables as well as further risk
factors, such as tobacco smoking, were very similar in both groups.
Diagnosis of tubulointerstitial damage and interstitial nephritis using
highly discriminating urine electrophoresis. H. Mann, H. Melzer, H.
Kierdorf D. Servais, M. Ritze,feld, and I. Stefanidis, Medizinische Klinik II,
Aachen, Germany. Filtered proteins which normally are reabsorbed by
tubular cells are excreted by the urine when tubular function is impaired.
In the case of tubular damage these proteins can be determined in native
urine using highly discriminating urine electrophoresis with silver staining
even in total protein concentrations <50 mg/liter (method according to
Melzer). Documentation of urinary protein patterns is performed using
laserdensitometry. Findings of SDS gel electrophoretic analyses in 200
patients with tubulo-toxic damage are shown which are caused by analge-
sics, cyclosporine, FK 506, cancer polychemotherapy, as well as in
interstitial nephritis (analgesic nephropathy, sarcoidosis, diabetes). In
most cases total proteinuria was <100 mg/day. In all cases tubulointersti-
tial damage could be verified using this optimized method of gel electro-
phoresis. It is concluded that highly discriminating gel electrophoresis with
consecutive laserdensitometiy is the choice for diagnosis of tubulointer-
stitial kidney damage.
Frequency of lymphoma after kidney transplantation in Basel. L.
Ménat, A. Bock, F. Brunner, and G. Thiel, Department of Nephrology,
University Hospital Basel, Basel, Switzerland. An increased incidence of
lymphoproliferative disorders, particularly non-Hodgkin's lymphomas,
was observed in kidney and other organ transplant recipients under high
dose immunosuppression. Especially multiple treatments with antilym-
phocytic antibodies (AB) seem to be a risk factor for the development of
a lymphoma. We analyzed retrospectively all patients with lymphoma after
kidney transplantation between June 1967 and June 1994 in Basel. In this
period, 911 patients were transplanted and 9 patients developed 10
lymphomas (frequency: 1.1%). Lymphomas were diagnosed after a mean
time of 7.2 years after transplantation (range: 6 months—21 years), Three
lymphomas were localized in the upper gastrointestinal tract, 2 in the
brain, 2 in lymph nodes, and 1 each in the liver, the spleen and the lung.
Six patients died within 6 months after diagnosis of lymphoma and one
died after 6 years. One patient is surviving on maintenance dialysis after
cessation of immunosuppression and transplant nephrectomy and one
patient is surviving with excellent transplant function 23 years after
transplant and 11 years after splenectomy and chemotherapy. Six out of 9
patients with lymphoma received an antilymphocytic antibody therapy: 2
patients had an induction therapy with ATG (1 patient also had a rejection
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therapy with 14 doses of OKT 3 and 7 doses of ATG) and 4 patients with
a treatment for at least 20 days with ALS (4 patients during 20, 36, 150 and
230 days, respectively). In 3 Out of 9 patients a lymphoma developed
without any antilymphocytic antibody therapy including, 1 patient with a
transplant related HIV infection. Comparing initial immunosuppressive
therapy, there are 5 patients with lymphoma of 532 patients who received
antilymphocytic antibody therapy versus 4 patients with lymphoma of 379
patients without initial antibody therapy. Summary and conclusion: Most
lymphomas occurred between years 4 and 8 after transplantation. Only 3
of 9 patients survived more than 6 months after diagnosis. No correlation
was apparent between initial immunosuppressive regimen and develop-
ment of lymphoma.
Physiological parameters determining urinary excretion of renal tubu-
lar brush border enzymes. U.F. Mondorf K Frey, P. Richter, E. Frömter,
and WA. Mondoif Department of Medicine, Department of Physiology,
University Frankfurt am Main, Frankfurt am Main, Germany. Urinary
excretion of renal tubular brush border enzymes has been intensively
investigated in the past with the aim of evaluating renal injury (nephro-
toxic agents, acute renal failure and organ transplantation). Although it is
generally accepted that the level of enzymuria correlates well with the
degree of renal injury, the influence of physiological alterations in kidney
function is not well defined. To find out whether changes in GFR, altered
membrane turnover, medullary washout, or other factors might be respon-
sible, we investigated the rate of excretion of alanin-aminopeptidase
(AAP) and urea as a function of urine flow (Va) in 10 healthy volunteers
(age 21—25 years). Following a 3 hour thirst period the subjects were
hydrated for another 3 hours and then returned to control. Simultaneously
the clearances of inulin, p-aminohippurate (PAH) and creatinine were
determined. AAP activity was measured spectrometrically as described.
AAP excretion increased with Vu from a nearly flow-independent mini-
mum of 4.05 mU/mm to values of up to 12.62 mU/mm with almost
constant slope (average correlation coefficient: 0.92). Comparing low (0.99
mI/mm) and high (12.14 mI/mm) V,, rates the increase in AAP excretion
was 2.87-fold, while urea excretion increased only 1.74-fold and creatinine
excretion as well as inulin and PAH clearance remained constant. To test
for medullary washout which is thought to explain the increase of urea
excretion with Vu, we also measured AAP excretion during a 5 hour
period of elevated V (8 mI/mm). In this period, however, AAP excretion
remained virtually constant at the elevated level of 6.08 mU/mm. We
conclude that the observed increase in urinary AAP excretion with
diuresis cannot be neglected in prognostic studies and Cannot be corrected
by relating AAP rate to a simultaneously measured rate of creatinine
excretion. Changes in GFR with related changes in proximal tubular AAP
release as well as medullaiy washout are not responsible for this effect.
The flow dependence of AAP excretion can best be explained by a
mathematical model of constant proximal tubular delivery and concentra-
tion dependent absorption by endocytosis or destruction by membrane-
bound proteases during passage of the enzyme along the distal tubule
and/or collecting duct.
Cholesterol loading of rat mesangial cells leads to increased degrada-
tion of lipoprotein(a). U.F. Mondorf R. Siekmeier, W. Marz, H. Scharnagel,
W. GroJ3, and W. Schoeppe, Department of Medicine, Division of Nephrol-
ogy, Gustav Embden Center of Biological Chemistry, and Johann Wolfgang
Goethe University, Frankfurt am Main, Germany. Lp(a) has been associated
with the development of atherosclerosis. Similarities between atheroscle-
rosis and glomerulosclerosis have been postulated. Elevated Lp(a) serum
concentration has been found in patients with renal disease. In the present
study we investigated the interaction of Lp(a) with rat mesangial cells.
Mesangial cells were isolated from Sprague Dawley rats by differential
sieving. Degradation experiments were performed at 37°C after 24 hours
in RPM! containing 10% LPDS. Cells were incubated 4—6 hours with
125J-Lp(a) in the presence or absence of a 20-fold molar excess of
unlabeled competitors. Proteolytic degradation of 1J-Lp(a) excreted into
the medium was measured. The results of 37°C competition studies
showed that a 20-fold excess of unlabeled Lp(a) was an excellent
competitor and inhibited degradation of 10 .rWml 125J-Lp(a) by 83% (N =
6). LDL also inhibited degradation of 10 iWml 125J-Lp(a) by 74% (N = 6).
To mimic the effects of hyperlipidemia in respect to down-regulation of
the LDL receptor and hydroxymethylglutaryl-CoA reductase and up-
regulation of the acyl-CoA:cholesterol, acyltransferase (ACAT) cells were
preincubated with unlabeled LDL. However, '25J-Lp(a) degradation (5
sg/ml) was increased 2.6-fold in mesangial cells that had been preincu-
bated 12 hours before Lp(a) addition with unlabeled LDL (100 sg LDL
cholesterol/mI). To further evaluate whether this increase in degradation
was due to delivery and accumulation of free cholesterol, cells were
preincubated 12 hours with 25-hydroxycholesterol (5 g/ml). Here we
found a 3.2-fold increase in 125J-Lp(a) degradation. We conclude that the
LDL receptor is involved in the uptake of Lp(a). Cholesterol loading of
mesangial cells enhances the uptake and degradation of Lp(a). This
enhanced uptake is not mediated by the LDL receptor but by other
receptors. These findings may help explain the role of Lp(a) in the
presence of hyperlipidemia and renal disease.
Continuous hemofiltration in patients with acute renal failure. S.
Morgera, P. Heering, T. Szentandrasi, K Ivens, M. Heintzen, H-P. Schul-
theijl, and B. Grabensee, Medizinische Klinik und Poliklinilç Klinik für
Nephrologie, and Klinik fur Kardiologie, Pneumologie und Angiologie der
Heinrich Heine Universitat, Düsseldorf Germany. Introduction: In patients
with multiorgan failure (MOF) the application of a lactate based substi-
tution fluid has become a standard method in continuous venovenous
hemofiltration therapy. We compared the impact of an acetate based
hemofiltration fluid versus a lactate based hemofiltration fluid in patients
with acute renal failure (ARF). Methods and results: In the period from
April 1993 to June 1994, 81 ventilated, patients were treated with the
CVVH. Thirty patients with either a chronic renal disease or a duration of
CVVH therapy of less than 48 hours were excluded from the study.
Thirty-two patients were treated with an acetate based hemofiltration fluid
(group 1), and 19 patients were treated with a lactate based hemofiltration
fluid substitution (group 2). A daily monitoring of arterial pH, bicarbon-
ate, creatinine, plasma urea, plasma lactate as well as the apache II score
were performed. The mean CVVH duration was 11.5 9.5 days, and
overall lethality was about 60%. The mean apache II score prior to therapy
was 17.0 3.8, with no difference between both groups. There was no
significant correlation between apache II score at the beginning of therapy
and the patient outcome. The mean plasma creatinine level was 3.4 0.7
mg/dl, and the mean plasma urea (BUN) was 62 14 mg/dl. The
evaluation of bicarbonate and arterial pH showed that starting from the
second day of CVVH therapy, group 2 had a significantly higher bicar-
bonate level than group 1 with 24.6 3.1 mmol/liter versus 20.5 3.1
mmol/liter on day 2, 26.5 2.5 inmol/liter versus 20.9 2.5 mmol/liter on
day 4, and 26.4 4.8 mmol/liter versus 21.4 2.9 mmol/liter on day 6,
respectively. Arterial pH showed significant differences in both groups on
days 2, 4, 6 and 8. Conclusion: Patients with MOF who were treated with
CVVH based on lactate based substitution fluid showed significantly
higher bicarbonate and arterial pH levels than the acetate based control
study group. In the underlying period no difference in cardiovascular
stability or long time prognosis was evident.
Circulating adhesion molecules (CAM) ICAM.1, VCAM-1 and E-
selectin in Wegener's granulomatosis (WG) and systemic lupus erythem-
atosus (SLE) with renal involvement. C. Mrowka, T.H. Ittel, and H.-G.
Sieberth, Medical Clinic II, Aachen, Germany. Introduction: The adhesion
of immunocompetent and inflammatory cells is mediated by adhesion
molecules on the surface of leukocytes and endothelial cells in systemic
disorders with renal manifestation, such as WG and SLE. The release of
these molecules into the blood circulation might promote the develop-
ment of vasculitis and tissue injury by dc-adhesion and transendothelial
cell-migration. Method: The serum concentrations of CAM (cICAM-1,
cVCAM-1, cE-selectin) were measured by ELISA in WG and SLE and
correlated with disease activity and results of renal biopsy. Results: Ia:
c-ANCA positive active WG (N = 19); Ib: WG in remission (N = 6); Ic:
WG with rapidly progressive glomerulonephritis RPGN, cellular crescents
(N = 10); Id: WG with RPGN, fibrocellular crescents (N = 9); ha: active
SLE (N = 30); lIb: SLE in remission (N = 20); TIc: SLE with renal biopsy
and lupus nephritis LN (N = 10); SLE with crescentic LN (N = 3/10); III:
Healthy control (N = 10).
ha Tb Ic Id ha hlb TIc III
cICAM-1 499° 347 572° 310 267 319 312 245
cVCAM-1 1129° 1047° 1262° 1114 893° 1049° 1247° 582
cE-selectin 68 83° 56 69 55 55 90 48
a P < 0.05 vs. control; median value; Mann-Whitney U-test; (ng/ml)
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Conclusion: cICAM-1 and cVCAM-1 are significantly elevated in WG.
However, only cICAM-1 levels decrease significantly during remission. In
SLE, cVCAM-1 levels are significantly raised, independent of the disease
activity. Elevated cICAM-1 levels in WG with RPGN and "fresh" cellular
crescent formation reflect the ongoing acute tissue inflammation in
contrast to "older" fibrocellular crescents without raised cICAM-1 levels.
cVCAM-1 is significantly elevated in vasculitic renal injury independent of
the underlying disease. cE-selectin levels are rarely elevated (crescentic
LN), and the functional consequences are unclear.
Incidence of thrombosis caused by the loss of coagulation regulatory
proteins in CAPD patients. B. Mukhtar, S. Näther, W. Koall, J. Drescher,
and B. Osten, Department of Nephrology, Martin-Luther-University of Halle,
Halle, Germany. A well-known disadvantage of CAPD is increased protein
loss via dialysate. To clarify whether the depletion of coagulation regula-
tory proteins and other factors is accompanied by increment in the
incidence of thrombosis and thromboembolic complications (TEC) in
CAPD patients, 10 patients undergoing CAPD (3 males, 7 females, mean
age 46.3 years) were investigated. Quick test, antithrombin III (AT III),
plasma viscosity (PV), protein C, protein S and 24 hour protein excretion
in urine and dialysate were determined before the beginning of the CAPD
as well as every 4 weeks after the start of the dialysis over 6 months.
Regular clinical and Doppler ultrasonical examinations of the peripheral
vessels were performed to exclude thrombosis. Results are shown in the
table.
Time Quick AT III PV
Before 100 5.25a 116 7.6 1.35 0.06
1 month 122 337a 113 19.9 1.37 0.14
2 months 125 20.9a 112.5 14.3 1.37 0.09
3 months 113 21.25' 110 10.5 1.36 0.11
4 months 118 23.7a 118.5 8.4 1.33 0.06
5 months 112 24.0" 110 14.0 1.33 0.09
6 months 127.5 28.5" 114 22.0 1.36 0.15
Time Protein C Protein S Protein U/day
Before 121.5 20.9 132 29.3 1.28 0.95
1 month 132 25.3 151.5 29.6 0.68 1.73
2 months 125 23.2 134.5 49.0 1.31 0.89
3 months 130 25.3 150 26.8 0.88 0.74
4 months 126 20.4 160 30.1 0.76 0.74
5 months 123 15.9 138 28.9 0.72 0.76
6 months 127 17.4 150 49.3 0.73 0.71
Values are mean SD. a Denotes significance.
Protein loss in dialysate ranged between 11.2-46 g/day. Clinical and
Doppler examinations revealed no evidence of thrombosis or TEC in all
patients. Conclusions: Despite high daily protein loss, no significant
depletion of clotting regulatory proteins was detected. Higher incidences
of thrombosis and TEC were not observed in this group of patients.
Amplification of nitric oxide synthase expression by nitric oxide in
interleukin lfi-stimulated rat mesangial cells. H. Muhl and J.M
Pfeilschifter, Department of Pharmacology, Biozentrum, and University of
Base!, Basel, Switzerland. Nitric oxide (NO) plays an important role in
immunological reactions as a host defense mechanism against tumor cells
and invasive microorganisms, but it may also damage healthy tissue. The
excessive formation of NO in interleukin 1f3 (IL-1j3)-stimulated renal
mesangial cells not only alters glomerular filtration, but may also cause
tissue injury and thus contribute to the pathogenesis of certain forms of
glomerulonephritis. We report here that although alone NO has no
evident effect on NO synthase expression, it potently augments IL-13-
stimulated NO synthase expression in mesangial cells. NO donors such as
sodium nitroprusside and S-nitroso-N-acetyl-D,L-penicillamine markedly
increase IL-113-induced NO synthase mRNA and protein levels as well as
enzyme activity. Furthermore, inhibition of NO synthesis by different
pharmacological approaches reduces IL-1/3-induced NO synthase expres-
sion, thus suggesting that NO functions in a positive feedback loop that
speeds up and strengthens its own biosynthesis. We suggest that this
potent amplification mechanism forms the basis for the excessive forma-
tion of NO in acute and chronic inflammatory diseases.
Differential localization of various heat shock proteins (HSP6O, HSP73,
HSP72, HSP27) in rat kidney. E. Muller, A. Ohno, K Thurau, and F.-X
Beck, Physiologisches Institut der Universitat München, Munchen, Germany.
Heat shock proteins (HSP5) synthesized in physiological states modulate
protein folding and targeting in unstressed cells and respond to a variety
of stress factors (heat, toxic agents, ischemia, and possibly osmotic stress).
We studied the distribution of four different members of the HSP family
in rat kidney: HSP6O; HSP73 and HSP72 (the constitutively expressed
form and the major stress-inducible form of the HSP7O family, respec-
tively) and HSP27. Western blot analysis with specific antibodies revealed
a characteristic distribution pattern for each HSP. HSP6O is detected in
the whole kidney with highest amounts in the renal cortex, half as much in
the outer medulla, and 6-fold less in the inner medulla. HSP73 is
homogeneously distributed throughout the whole kidney. Large amounts
of the inducible HSP72, which is usually expressed only following stress
exposure, are present in the medullar of normal kidneys. The largest
fraction of HSP72 is present in the inner medulla and half this amount is
detected in the outer medulla. Only low levels of H5P72 are observed in
the cortex. H5P27 is present in the whole kidney with highest amounts in
the inner medulla, half as much in the outer medulla, and 6-fold less in the
cortex. HSP27 exists in 1 non-phosphorylated and several phosphorylated
isoforms. We investigated the phosphorylation state of HSP27 in the
different zones of the kidney using isoelectric focusing followed by
Western blot analysis. In the cortex HSP27 can be detected predominantly
in its phosphorylated form with only small amounts of non-phosphorylated
protein. In the medulla most of the HSP27 is not phosphorylated. The
heterogeneous intrarenal distribution of the constitutively expressed HSPs
(HSP6O, HSP73 and HSP27), as well as the distinct phosphorylation
pattern of HSP27, may reflect different states of metabolic activity in the
kidney. The high content of the inducible H5P72 in the medulla of
normally concentrating rat kidneys is compatible with the medullary
environment (high urea and salt concentrations) being stressful for kidney
cells.
Expression of ECM-degrading proteinases and their inhibitors in
human renal fibroblasts. GA. Muller, F. Rehkugler, M. Nesper and G.
Engler-Blum, Zentrum für Innere Medizin, Abteilung für Nephrologie und
Rheumatologie, Geoi-August-Universitat, GOttingen, Germany. Many in-
flammatory and non-inflammatory renal diseases are associated with
interstitial fibrosis, which is characterized by dilation of the peritubular
interstitium and tubular atrophy. In this process the expression of several
extracellular matrix proteins and ECM degrading proteinases is changed.
Therefore, we analyzed the expression of different ECM degrading
proteinases and their inhibitors in human renal fibroblasts after stimula-
tion with cytokines and growth factors like IL-6, TGF/3, PDGF and
GM-CSF. As probes for Northern blot analysis, oligonucleotides against
mRNA sequences of collagenase 1 and 2, tissue plasminogen activator
(tPA), urokinase plasminogen activator (uPA), and stromelysine 1, 2 and
3 and their inhibitors were used. The results demonstrate that after four
hours of stimulation with PDGF the expression of the inhibitors uPA-I,
tPA-I, Col-I and TIMP (tissue inhibitor of metalloproteinase) is increased
in human renal fibroblasts. In further experiments we want to examine
how the changed expression of ECM degrading proteinases and their
inhibitors influences the increased deposition of ECM products.
The conversion from Sandimmun to Sandimmun neoral in patients
with stable renal allografts: Results after three months. H.-H. Neumayer,
L. Farber, P. HaIler, R. Kohnen, A. Maibucher, A. Schuster, J. Volimar, and
J. Waiser, Department of Nephrology, 4th Medical Clinic, Friedrich-Alex-
ander- University Erlangen-Nurnberg; Sandoz AG Numberg; and Imerem Co.
Nurnberg, Nümbe,g, Germany. The new galenic formulation of cyclospo-
rifle (C5A) prepared as microemulsion (Sandimmun-Neoral, SN) shows a
significantly improved correlation between AUC and both trough level
and dose. Furthermore, SN exhibits a considerably reduced variability
regarding AUC, Cm,,, tm,,,, and Cmin, thus leading to an improved
predictability of systemic drug exposure. However, although the bioavail-
ability is increased by 20—30% on average, it may lead to a drug
overexposure, not only in malabsorbing patients. In order to assess safety
and establish a procedure to switch patients safely from Sandimmun to
SN, we initialized an open, stratified (transplant age) clinical trial enrolling
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300 patients from our out-patient clinic under real life conditions.
Patients' documentation and subsequent data entry were performed using
an on-line computer device. Initially, patients were switched from Sand-
immun to SN on a 1:1 conversion of their daily dose, Safety parameters
including serum creatinine, GFR, and uric acid; ALT and blood pressure
were documented on day I (baseline) and thereafter on days 4, 8, 15, 29
and at month 3. If required, dose adjustments aiming at the therapeutic
window (through levels: 80—120 nglml) (TDX) were performed starting at
day 8. Major results are given in the table.
Day/month
1 4 8 15 29 M3
CsA dose mg/day 204 205 205 196" 177" 175"
Trough level ng/ml 114
Creatinine mg/dl 1.52
117b
1.54
120'
l.S4
115
1.54
112
1.54
110
1.45"
GFR mI/mm 63 62 62" 62 63 68"
MBP mm Hg 106 104 104 103" 104 102"
ALT U/liter 12 12 12 12 12 12
Uric acid_mg/dl 8.2 NS NS 8.3a 8.5" 8.3
Mean, "p 0.05, "p 0.01, "P 0.001.
The overall tolerability of SN was very good. Conclusions: 1:1 conversion
from Sandimmun to SN proved to be safe. In order to avoid drug
overdosing and deterioration of kidney function, we recommend safety
monitoring and dose adjustments 2—3 times within 4 weeks after conver-
sion. Since mean dose is decreased by 14.2%, we recommend an initial
dose reduction of 10% for patients within a stated therapeutic window.
Long-term observations seem to be necessary to estimate further benefits
and risks. As a consequence, our trial will be extended at least up to 1 year.
We believe that introduction of SN results in a better adherence to an
even more distinct therapeutic range.
Oral calcitriol bolus therapy in predialysis chronic renal failure. N.
(]lrich and W. Erich, Departement of Nephrology, Landeskrankenhaus
Feldkirch, Austria. By the time end-stage renal disease evolves, most
patients are suffering from secondary hyperparathyroidism leading to
severe complications of renal osteodystrophy during long-term dialysis
treatment. Thus, prophylaxis or early treatment of secondary hyperpara-
thyroidism appears mandatory. Besides intestinal phosphate binding
therapy with calcium carbonate, early substitution of 1,25 (OH)2 D3(calcitriol) is important, because this vitamin D metabolite inhibits
synthesis and secretion of parathyroid hormone (PTH) as well as prolif-
eration of parathyroid cells. Recent experimental studies showed an
adventage of intermittent bolus therapy over the usual daily treatment
with calcitriol. We examined the effect of low dose oral calcitriol bolus
therapy in patients with chronic renal insufficiency. Twenty patients with
serum creatinine of 2.8 to 7.5 mgldl (mean SD 5.23 1.61) and
creatinine clearance 48—8 mI/mm (18.2 9.7) were treated with oral
calcitriol 0.5 jzg twice a week for a 6 month period. All patients were on
phosphate binding therapy with calcium carbonate. Plasma aluminum
level was maintained in the normal range. Serum intact PTFI after 6
months of calcitriol therapy decreased from 270 157 to 265 175 pg/ml,
which was statistically insignificant (NS). Serum calcium increased from
2.14 0.20 to 2.20 0.16 mmol/liter (NS) and serum phosphate from 1.59
0.39 to 1.86 0.50 mmol/liter (NS). Alkaline phosphatase decreased
from 160 78 to 126 52 U/liter (P < 0.05) and serum osteocalcin from
120 54 to 110 58 ng/ml (NS). No hypercalcemic episode could be
observed. There was no acceleration of the progression of renal insuffi-
ciency. Conclusion: Intermittent low dose oral calcitriol bolus therapy of
2 X 0.5 mg per week reduces the progression of secondary hyperparathy-
roidism without severe side effects in patients with chronic renal failure,
The decrease of alkaline phosphatase and osteocalcin points to a reduc-
tion of pathologic increased bone turnover.
Effects of ischemia on organic osmolytes and free amino acids in kidney
cortex and outer medulla. A. Ohno, G.J. Albrecht, M.-L. Fraelç and F.-X.
Beck, Physiologisches Institut und Klinik für HNO-Kranke der Universiiät
München, Munchen, Germany. Disturbance of cell volume regulation may
contribute importantly to the development and maintenance of post-
ischemic acute renal failure. Medullary organic osniolytes and free amino
acids have been implicated in cell volume regulation and several amino
acids (alanine and glycine) have been shown to exert protective effects on
anoxia-induced cell damage. To examine the effect of renal ischemia and
subsequent reflow on organic osmolytes (glycerophosphorlycholine, be-
tame and inositol) and free amino acids (glutamine, glutamate, taurine,
alanine, glycine and aspartate), these compounds were measured in cortex
and outer medulla by high performance liquid chromatography. Four
groups of male Wistar rats were studied: untreated controls, 60 minute
renal ischemia, 60 minute ischemia followed by reflow for 60 minutes or 24
hours. In the cortex, organic osmolyte contents were not affected by
ischemia and subsequent reperfusion. However, total organic osmolytes in
the outer medulla were lower by 15 mmol/kg wet weight (ww) both after
1 and 24 hour reperfusion. The sum of the measured free amino acids
tended to increase during 60 minute ischemia both in cortex (15.3 1.6 vs.
12.0 1.7 mmollkg ww in controls; mean SaM) and outer medulla (12.2
2.4 vs. 9.1 1.4 mmol/kg ww in controls). These values decreased after
I or 24 hour reperfusion. Glycmne contents of the cortex were also
significantly diminished in the reperfusion period. These data show that
osmotically active organic solutes are lost from the Outer medulla in the
reperfusion period following renal ischemia. It is possible that the observed
changes in osmolyte and amino acid composition and the ischemia-indueed
decrease in cortical glycine contents contribute to the initiation and/or
maintenance of post-ischemic acute renal failure.
A novel missense mutation in the vasopressin V2-receptor (V2R) gene
of a patient with congenital nephrogenic diabetes insipidus (CNDI). A.
Oksche, J. Dickson, R. Schülein, H. Seyberth, and W. Rosenthal, Rudolf-
Buchheim-Institut für Pharmakologie, Giej3en; and Zentrum für Kinderheil-
kunde, Marburg, Germany. CNDI is usually an X-linked recessive disorder
in which the kidney fails to respond to arginine vasopressin (AVP).
Sequence analysis of the V2R gene has revealed a number of mutations
segregating with the disease within affected families. We analyzed the
V2R gene in a male patient without family history. Genomic DNA was
prepared from EDTA blood. The V2R gene was amplified by PCR, the
product (2070 bp) gel-purified and directly cloned into the TA cloning
vector pCRII (Invitrogen). Sequencing revealed a T —* C transition at
nucleotide 727 (EMBL entry L22206), leading to predicted substitution of
leucine 44 by proline (L44P). The exchange takes place in the first
transmembrane region, in close vicinity to the interface of plasma
membrane and extracellular space. Kyte-Doolittle analysis of the mutant
receptor predicts a decrease in hydrophobicity in the region of the
mutation. Secondary structure analysis according to Gamier shows an
extension of f3 sheets and a corresponding reduction of a helices, Since
current models suggest a crucial role for the first transmembrane domain
in membrane targeting of proteins without cleavable signal sequence, the
L44P mutation may impair targeting of the V2R to the plasma membrane.
Inhibition of DNA synthesis and proliferation in human adult mesang-
ial cells (haMC) by verapamil. SR. Orth, S. Bonisch, and E. Ritz,
Department of Internal Medicine, Ruperto Carola University, Heidelberg,
Germany. In several models of renal damage, inhibition of progression of
renal failure was found with verapamil (and less consistently dihydropy-
ridine type calcium channel blockers). Good arguments were provided for
involvement of non-hemodynamic mechanisms, particularly inhibition of
hyperplasia/hypertrophy. We examined haMC as a model relevant for
human glomerular disease. Under basal conditions and after stimulation
(FCS, PDGF-AB, Ang II, EGF) DNA synthesis (3H-thymidine), cell
growth (cell counts) and protein synthesis (3H-methionine) were mea-
sured. In parallel, the proximal tubular cell line OK was examined. haMC
were incubated in MCDB-302 medium without serum at different concen-
trations of io"—io- M L-verapamil and solvent, respectively. After 12,
24, 36 and 48 hour, 3H-thymidine incorporation was measured and after
24, 48, 72 hour cell counts. After 36 hours, L-verapamil (10- M)
dose-dependently diminished 3H-thymidine incorporation (for example,
afterFCS minus 68 12%, PDGF minus 55 6%, EGF minus 40 5%,
Ang II minus 31 11%. Cell counts were reduced monotonously and
significantly by verapamil. Similar findings were obtained with OK cells. In
conclusion, therapeutically relevant concentrations of L-verapamil inhibit
proliferation of stimulated glomerular and tubular cells.
Swelling of rat mesangial cells (MC) induces a Ca24' dependent C1
conductance. H. Pavenstadt, M Huber, K-G. Fischer, J. Leipziger, R.
Greger, and P. Schollmeyer, Departments of Nephrology and Physiology,
University of Freiburg, Freiburg, Germany. MC have many structural,
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secretory, and metabolic functions. Most of these functions are accompa-
nied by changes of cellular volume, and therefore MC have to be capable
of controlling their cellular volume. We examined the effect of cell
swelling on membrane voltage (Vm), ion currents, and cytosolic calcium
activity ([Ca2}) in MC. Vm and ion currents were simultaneously
measured with the patch clamp technique in the fast whole cell configu-
ration in MC in primary culture. Control Vm was —45 1 mV (N = 87).
Cell swelling induced by hypotonic solution (from 300 to 190 mOsm/liter)
caused a depolarization of Vm from —48 ito —29 1 mV (N = 68)
and increased the inward and outward currents from ii 2 to 30 4 nS
and 10 2 to 27 3 nS (N = 44), respectively. The effect of swelling on
Vm was increased in a bath with a reduced extracellular Cl of 30
mmol/liter (by 42 4%, N = 8) and inhibited in a solution with a reduced
extracellular Ca2 concentration of 106 mol/liter (by 69 9%, N 7).
In microfluorescence measurements, hypotonic cell swelling induced a
sustained increase of [Ca2F]j (N = 19), which was inhibited in an
extracellular Ca2 free solution. The data indicate that in MC, swelling
induces a Ca2 influx from extracellular, whereas a release of Ca2 from
intracellular stores is absent. The calcium influx induced by cell swelling
activates a Cl conductance, resulting in a depolarization of Vm.
Dexamethasone differentially affects interleukin ljI and cAMP induced
nitric oxide synthase expression in renal mesangial cells. D. Kunz, G.
Walker, and J.M. Pfeilschifter, Department of Pharmacology, Biozentmm,
University of Basel, Basel, Switzerland. Inducible nitric oxide synthase
(iNOS) is expressed in renal mesangial cells in response to 2 principal
classes of activating signals that interact in a synergistic fashion. These 2
groups of activators comprise inflammatory cytokines such as interleukin
1/3 (IL-1f3) or tumor necrosis factor a and agents that elevate cellular
levels of cAMP. We examined whether dexamethasone differentially
affects 1NOS induction in response to IL-i/I and a membrane-permeable
cAMP analogue, No, 0-2'-dibutyiyladenosine 3',5'-phosphate (Bt2cAMP).
Nanomolar concentrations of dexamethasone suppress IL-i/I as well as
Bt2cAMP-induced iNOS protein expression and nitrite production, the
stable end product of nitric oxide (NO) formation. In contrast, dexameth-
asone prevents induction of iNOS mRNA in response to Bt2cAMP
without affecting an IL-I /3-triggered increase in iNOS mRNA levels.
These data suggest that dexamethasone acts at different levels, depending
on the stimulus used to suppress iNOS induction in mesangial cells.
Long-term safety of high dose oral treatment with the new loop diuretic
torasemide in patients with advanced chronic renal failure. W. Boesken, J.
Kult, A. Kuhn, W. Meyer-Sabeilek, L. Piesche, and R. Van Der Does,
Krankenhaus der Barmherzigen Brfider, Trier; Caritas-Krankenhaus, Bad
Mergentheim; Clinical Research, Boehringer Mannheim GmbH, Mannheim;
and 1ST GmbH, Mannheim, Germany. The long-term treatment of patients
with advanced renal failure with high dose diuretics has raised safety
concerns (for example, toxic neuromyeloencephalopathy associated with
muzolimine therapy). Therefore, the safety of a 1 year treatment with high
oral doses of the new loop diuretic torasemide (200 mg o.d.) in 135
patients (mean age 56 14 years, 91 males/44 females) with advanced
chronic renal failure (mean serum creatinine 9.0 3.1 mg/dl) was
investigated based on intraindividual comparisons. Nephritis, nephrotic
syndrome and nephrosis were the most common underlying diseases,
including glomerulonephritis, renal sclerosis and diabetic nephropathy
(48.1%), followed by other diseases of the urinary system (12.6%), and
hypertension (8.1%). In the present study changes in the neurological
status were investigated by clinical assessment after a 1 year treatment
with torasernide as compared with findings before initiation of torasemide
therapy. In particular, function of the cranial nerves, motor function,
reflex status, coordination, function of the sensory system, patients'
reports on symptoms pertaining to the sensory system, mental function
and patients' reports on episodes related to convulsive disorders were
assessed and evaluated. The highest prevalence of pathological findings at
baseline was noted from the examination of the sensory system (23.0% of
the patients), followed by pathological symptoms as to sensory history
reported by the patients (18.5%) and abnormal findings with respect to
cranial nerves and reflex status (17.0%, each). Changes related to these
functional systems were very infrequent and deteriorations were well
balanced by improvements. Improved/deteriorated functions with respect
to sensory system (N = 4/5), sensory history (N = 1/3), function of cranial
nerves (N = 1/2) and reflex status (N = 1/0) were found at study end. No
changes in coordination and episodes of convulsive disorders were noted.
The aforementioned data are not indicative of any untoward effects of
high dose (200 mg p.o. o.d.) long-term (1 year) torasemide treatment on
neurological functional parameters. In general, torasemide was well
tolerated and safe in patients with chronic renal failure of whom almost all
had multiple diseases and concomitant treatments.
Short-term high dose intravenous treatment with the new loop diuretic
torasemide in patients with advanced chronic renal failure. J. Kuit, W.
Boesken, A. Kuhn, W. Meyer-Sabeilek, and L. Piesche, Caritas-Krankenhaus,
Bad Mergentheim; Krankenhaus der Barmhe,zigen Bruder, Trier; and Clin-
ical Research, Boehringer Mannheim GmbH, Mannheim, Germany. The
acute treatment of patients with advanced renal failure requires high
intravenous doses of loop diuretics. The efficacy and safety of a 7 day
treatment with high intravenous doses of torasemide (200 mg o.d.) in 43
patients (mean age 60 11 years, 25 males/18 females) with advanced
chronic renal failure (mean serum creatinine 6.9 2.3 mg/dl) were
investigated based on intraindividual comparisons. Primary efficacy pa-
rameter was the fractional volume excretion, and secondary efficacy
parameters were the excretion of electrolytes (Na, K, Cl,
PO43), body weight and edema status. Efficacy parameters were investi-
gated at baseline (day 2), after the ist (day 3) and after the 7th
administration (day 9) of torasemide. The safety parameters of blood
pressure/pulse and serum/blood laboratory were documented at baseline
(day 2), after the 1st (day 3) and after the 6th administration (day 8) of
torasemide:
Mean values
N = 43 Baseline
After 1st
administration
of torasemide
After 7th
administration
of torasemide
FEUVoI % 14.3 21.1 l8.i'
UVol mi/day 1303 2125 1664
FENa % 7.5 12.6 10.1
UNa mmol/day 99 183 132
Body weight kg 72.3 71.2 68.9C
SBP/DBP mm Hg 158/87 146/85 145/82C
Abbreviations are: U,01, urine volume; FEUVOI, fractional volume
excretion; UNa, sodium excretion; FEUNa, fractional sodium excretion.
aP = 0.0001 compared to baseline; 5P = 0.0012 compared to baseline;
C Sitting systolic/diastolic blood pressure (SBPiDBP) and body weight
were determined after the 6th administration of torasemide (day 8)
Parallel to stimulated diuresis and the decrease of body weight the status
of peripheral edema improved. Treatment with torasernide did not
deteriorate laboratory parameters (Na, K, Ca , Cl, P043, creati-
nine, Hb, Hk, erythrocytes, leukocytes, platelets). The short-term admin-
istration of high-dose intravenous torasemide (200 mg o.d.) is safe and
efficacious for increasing the residual diuresis and/or for treatment of
peripheral edema in patients with advanced chronic renal failure. In
addition, the high bioavailability of torasemide (80—90%) compared with
furosernide (40—60%) allows a change-over to chronic oral treatment
without any further dose adjustment.
Influence of sodium intake on albuminuria in essential hypertension. J.
Plum, H. Roewemeier, M Hollenbeck, and B. Grabensee, Department of
Nephrology, Heinrich-Heine-University of Düsseldorf Düsseldorf Germany.
The development of microalbuminuria has been regarded as a relevant
prognostic criterion for the incidence of secondary hypertensive organ
damage in essential hypertensives. However, there is only little informa-
tion about the influence of dietary salt restriction on microalbuminuria in
humans. We investigated 26 patients (aged 43.3 14.9 years) with
clinically verified essential hypertension (systolic > 160 and/or diastolic
> 95 mm Hg, BMI 25.7 4.4 kg/rn2, history of hypertension 83.7 82.7
months). During the study period of at least 14 days patients remained
without any medication if it was clinically tolerable (N = 16). In 10
patients an antihypertensive monotherapy was given (vasodilators). All
patients received a sodium restricted diet of <50 rnmol NaC1/24 hr
(natriuresis 26.4 16.0 mmol/24 hr) followed by a sodium enriched diet
of >200 mmol/24 hr (natriuresis 302.8 108.9 mmol/24 hr) for at least 7
days each. At the end of each phase 24 hour blood pressure recording was
done by an oscillometric ambulant pressure monitor (ABPM) and pro-
teinuria, albuminuria, glomerularfiltration rate (GFR), renal plasma flow
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(ERPF) and plasma levels of ANP were measured. During the low salt
diet mean blood pressure (MAP) was 98.5 11.4mm Hg and significantly
increase to 102.2 11.6 mm Hg after switching to a high salt diet (P <
0.05). Proteinuria was higher during sodium enriched diet compared to
sodium depletion (75.5 70.4 vs. 68.0 22.4 mg/24 hr). Albuminuria was
even more sensitive to a shift from low to high sodium intake increasing
from 16.7 22.1 to 28.6 48.9 mg/24 hr (P < 0.01). In patients with
preexisting microalbuminuria (>20 mg/24 hr, N = 8) the albuminuric
effect of high sodium intake was more distinct (low sodium 26.2 30.7
high sodium 70.3 74.9 mg124 hr, P < 0.01) than in the group with a still
physiologic albumin excretion. A significant correlation between the
change in MAP or salt sensitivity and the modulation of albuminuria could
not be found. After switching from a low to a high salt diet GFR increased
from 115.6 24.8 mI/mm to 126.9 23.4 mi/mm (P < 0.001), and ERPF
from 378.9 88.9 to 402.1 83.3 mI/mm (P < 0.05). The filtration
fraction remained unchanged (32% vs. 31%). Plasma ANP concentrations
increased from 59 19 to 89 25 pg/mI (P < 0.01). Besides a moderate
decrease in arterial pressure a low sodium diet resulted in a significant
change in renal hemodynamics and was followed by a reduction of
albuminuria. Particularly those hypertensives with a preexisting mi-
croalbuminuria had a marked improvement. Further studies must show
whether a dietary approach to albuminuria is effective in influencing the
progression of nephrosclerosis or concomitant arteriosclerotic diseases.
Use of bioelectrical impedance analysis (BIA) for the evaluation of body
fluid composition in hemodialysis and CAPD patients. J. Plum, M. Lübbe,
and B. Grabensee, Department of Nephrology, Heinrich-Heine-University of
Düsseldorf Düsseldorf Germany. Bioelectrical impedance analysis (BIA)
represents a new, non-invasive measure for the estimation of lean body
mass, total body water (TBW) and extracellular fluid (ECF). Therefore, it
could be a helpful means to determine dry weight in patients undergoing
hemodialysis or CAPD. We investigated body water compositions using
the bioimpedance analysis (4 point electrode instrument, RJL-Akem
system, measuring at 1 MHz and 5 kHz) in 14 healthy volunteers (age: 33
10 years, 9 males and 5 females) and 14 patients undergoing hemodi-
alysis (age: 39 19 years, 6 males and 8 females residual diuresis: 412
378 mI/day) and 15 patients undergoing continuous ambulatory peritoneal
dialysis (CAPD) (age: 50 15 years, 5 males and 10 females, residual
diuresis 738 358 mI/day). ECF was calculated by the formula: ECF =
S2/R (S = bodyheight, R = resistance). The sensitivity of BIA to register
changes in body fluid composition in heniodialysis (HD) patients was
evaluated by measuring before and after HD (ultrafiltration: 1,250 764
ml, range: 300—3900 ml). ECF results determined by BIA were simulta-
neously evaluated by measuring the inulin distribution space in HD
patients. In CAPD patients we measured body fluid composition during
dwell time and after drainage.
BIA Inulin
ECFTBW ECF
Normals 563 203 212 47 205 42
HD
Before HD 634 197° 289 67b 278 59'-'
After HD 536 214 251 42 241 37°
CAPD
During dwell time
After drainage
789 ios'
728 93°
307 54"
293 45"
Results of body fluid measurement (mI/kg lean body mass) in normals,
HD and CAPD patients. Level of significance compared to normals: a p <
0.05; hp < 0.01.
BIA indicated a loss of TBW of 1.70 0.80 liter after HD. The correlation
with the real UF rate (1.25 0.76 liter) was r = 0.77, P < 0.001. The
correlation between the ECF(BIA)/ECF (inulin) was r = 0.71 in normals,
r = 0.81 before HD and r = 0.63 after HD (P < 0.01). A significant
reduction of the phase (measured by BIA: 3.4 0.4°, normal range:
4.5—15°) was found in HD and CAPD patients with clinical signs of
overhydration. Our data show that BIA could be a simple non-invasive
method for the evaluation of total and extracellular body water (TBW,
ECF). When comparing B1A with the classical inulin dilution method,
comparable results for ECF can be expected. The results further indicate
that in CAPD patients TBW and ECF are significantly higher compared to
both normals and HD patients.
Influence of ANP on natriuresis, albuminuria and glomerular perme-
ability in the nephrotic syndrome. J. Plum, Y. Mirzaian, and B. Grabensee,
Department of Nephrology, Heinrich-Heine-University of Düsseldorf Düssel-
dorf Ger,nany. The pathophysiological role of atrial natriuretic peptide
(a-ANP) in the formation of edema by sodium rerention and the influence
on proteinuria and renal hemodynamics in the nephrotic syndrome (N.S.)
is still controversial. Up to now there has been no information about the
influence of elevated plasma ANP levels on glomerular permeability in the
human N.S. The effect of a 2 hour, continuous low dose infusion of ANP
(0.005 gfkgxmin) yielding plasma levels within the physiological range
was studied in 15 patients with a primary N.S. (age 34 9 years, serum
creatinine 1.3 mgldl) and in 8 healthy controls (age 24 2 years). The
influence on natriuresis, albuminuria and renal hemodynaniics (GFR,
ERPF, FF, glomerular sieving coefficient) was monitored. The latter
parameter was determined by measuring fractional clearances of polydis-
perse neutral dextran. Patients with the N.S. had significantly elevated
Glomerular sieving coefficient as a function of the effective radius of
neutral dextrhn in patients with the N.S. (N — 15) before (A) and after ()
administration of low dose a-ANP (0.005 Mg/kg . mm). X so. < 0.05
basal plasma ANP levels compared to controls (166 78 vs. 73 18
pg/mI, P < 0.01). During ANP infusion plasma levels increased to 252
95 pg/nil in controls and 434 130 pg/mI in the N.S. The metabolic ANP
clearance was reduced in the N.S. compared to normals. Natriuresis was
equally stimulated in the N.S. (0.175 0,100 mmol/min to 0.327 0.247
mmol/min) as in normals. Low dose ANP infusion did not significantly
alter GFR, ERPF and FF in both groups. However, there was a significant
increase of albuminuria during ANP infusion in the N.S. (34 25%, P <
0.05, controls: 43 38%, P < 0.05). As a correlate for the proteinuric
effect of ANP we found a significant increase of fractional dextran
clearances above an effective radius of >60 A. The results indicate that
related to the dose given there is no primary resistance against the
natriuretic effect of ANP in the N.S. However, with regard to the higher
plasma ANP levels reached, natriuresis is relatively reduced compared to
normals. Furthermore, ANP significantly enhances albuminuria in the
N.S. as well as in normals. This effect cannot be attributed to an increase
in GFR or FF but to an increase in glomerular permeability.
Limitations in GFR measurement by inulin clearance using a steady
state method without urine collection. J. Plum, G. Schoning, and B.
Grabensee, Department of Nephrology, Heinrich-Heine-Universisy of Düssel-
dorf Düsseldorf Germany. The assessment of glomerular filtration rate
(GFR) by the measurement of inulin clearance has been established as a
definitive method for half a century. However, there are some methodical
specialties due to a concentration dependent, non-linear elimination rate
of inulin that should be taken into account. The determination of inulin
I,
Einstein-Stokes radius, angstrôms
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clearance by calculating with steady state plasma concentrations during
constant infusion according to Schnurr Ct al was compared to the
conventional technique of urine collection. Using the steady state method
the proband was initially given a bolus injection of inulin followed by a
continuous infusion over 2 hours (adapted to renal function in order to
reach plasma levels of about 20 rngldl). In the steady state situation it is
assumed: infused dose-renal elimination. Applying the conventional tech-
nique the clearance was calculated from 2 hourly sampled urine fractions
during constant infusion. Both methods were performed in 49 healthy
volunteers (age 27.4 7.7 years, BMI 21.8 2.6 kg/rn2) and in 47 patients
with the nephrotic syndrome (N.S.) (age 37.8 12.9 years, BMI 25.4 4.7
kg/rn2). We found that in healthy persons both techniques yielded identical
clearance data. The mean difference of the steady state method compared
to urine collection was —5 mI/mm (median), 95% confidence interval
between +2 and —12 mI/mm (N.S.). In patients with the N.S. significantly
higher values were obtained with the steady state method: +21 mI/mm,
95% confidence interval between 15 and 26 mI/mm (P < 0.001). In N.S.
patients with a serum creatinine >1.3 mg/dl the difference between the
two methods was still higher than in those patients with a normal serum
creatinine < 1.3 mg/dl (28 vs. 19 mI/mm). In N.S. patients with impaired
renal function the clearance data obtained by the steady state method (68
18 mI/mm) even surpassed the value determined by measuring creati-
nine clearance (60 25 mI/mm). A significant influence of the N.S. and of
renal insufficiency on the dynamics of steady state development could be
shown by regression analysis. The results indicate that GFR measurement
by the steady state method gives reliable results in healthy persons,
whereas the value is overestimated in patients with the nephrotic syn-
drome, particularly in those with concomitant renal failure.
Intraperitoneal production of inflammatory cytokines and their soluble
receptor fractions in CAPD patients without peritonitis. J. Plum, W.
Withold, T Busch, K Brenner, H. Reinauer, and B. Grabensee, Department
of Nephrology, Institute for Clinical Chemistry and Laboratory Diagnostics,
Heinrich-Heine-University of Düsseldorf Düsseldorf Germany. Intraperito-
neal macrophages and the peritoneal mesothelial cells constitute the first
barrier in a case of peritonitis. The investigation of an intraperitoneal
production of inflammatory and anti-inflammatory cytokines and their
soluble receptor fractions gains interest for a more profound knowledge
about local defense mechanisms. Little is known about the systemic and
intraperitoneal in vivo production of cytokines in non-inflammatory states
in patients undergoing CAPD. In 12 CAPD patients not suffering from
peritonitis in the preceding 6 months (dialysate leukocyte count < 100/j.tl,
dwell time: 2—10 hr) we examined the dialysate/serum (plasma) concen-
tration of cytokines (IL-1/3, IL-irA, IL-6, IL-8, TNF-a) and the soluble (s)
fractions of cytokine receptors (R) (sIL-6 R, sTNF RI, sTNF Ru) with
commercially available enzyme immunoassays (AMI/R&D Systems/Brit-
ish Bio-Technology Products). The dialysate/serum ratios of the perme-
ability markers, albumin, IgG and f32-microglobulmn, were determined
immunonephelometrically. In CAPD patients we found significantly in-
creased serum concentrations of IL-6 with 6.8 3.0 pg/mI (normals: x =
1.6 range 0.4—10.1 pg/mI), TNFr with 5.6 1.0 pg/mi (normals: x = 1.9,
range 0.2—7.1 pg/mI), IL-6 R with 58.8 11.5 ng/ml (normals: 13.5—45.9
pg/mi), sTNF RI with 20.18 4.32 nglml (normals: 0.75—1.97 ng/ml), and
sTNF Rh with 20.27 3.82 ng/mi (normals 1.8—5.31 ng/mi). Normal
serum concentrations were found for IL-113, IL-IrA, and IL-8. The
moiecuiar weights of the substances measured ranged between 8 kD
(IL-8) and 75 kD (sTNF Rh). A linear relationship was given between the
hydrodynamic radii, r, of the permeability markers (16.2—54 A) and the
reciprocal value of the dialysate/serum (D/S) quotient, thereby suggesting
a restricted diffusion along the peritoneal membrane. There was a
significant linear relationship between the D/S ratio of TNFa, IL-6 R,
sTNF RI, sTNF Rh and the D/S ratio of the corresponding protein
markers (0.98 > r > 0.73). In non-inflammatory situations these sub-
stances seem to be primarily transported into the peritoneal fluid by
diffusion. In contrast, neither IL-113, IL-I rA, IL-6 or IL-8 dialysate
concentrations correlated to the marker molecules mentioned. IL-6 and
IL-8 dialysate levels even surpassed the serum values, indicating a
significant intraperitoneal production. Our results demonstrate that in
ESRF patients on CAPD, elevated plasma levels of inflammatory cyto-
kines are detectable even in non-inflammatory states. The appearance of
inflammatory mediators in the dialysate seems to be mainly due to
diffusion across the peritoneal membrane. Evidence of a local synthesis is
given for IL-6 and IL-8.
Staphyloccus-effective antibiotic prophylaxis in patients with central-
venous dialysis catheters. W. Pommer, A. Lepszy, and M. Molzahn,
Humboldt-Hospital, Berlin, Germany. In a prospective randomized trial,
including all consecutive patients with central-venous dialysis catheters
seen in a 16 month period in our institution (N = 100), we studied the
effect of prophylactic antibiotic treatment (PAT) with teicoplanin (tc)
once a week (800 mg i.v. at the time of catheter insertion, followed by 400
mg each week) (treatment group, N = 50) on incidental catheter-related
infections (CR1) (N = 50 controls). For the bacterial monitoring blood
cultures were taken at the time of catheter placement, at weeks 1—3 during
dialysis treatment, and if infection was suspected clinically. Catheter tips
were cultured after catheter removal. The catheter exit-site was monitored
at each dialysis session. Study endpoint was suspected or definitive CR1 or
occurrence of tc-related adverse drug reactions (ADR). Results (tc group
vs. controls): Mean age, sex, global clinical assessment at study entrance,
acute renal failure (34% vs. 28%), risk factors, that is immunosuppression
(10% vs. 2%) and diabetes (26% vs. 28%), number of catheter changes, S.
aureus carrier (16% vs. 22%), showed no significant differences. Mean
observation in the tc group was 32.7 days (SD 33.8, max. 166), in controls
19.3 days (SD 17.2, max. 70) (P < 0.05). ADR occurred in 6/50 patients
with tc. Symptomatic CR1 followed by staphylococci-effective treatment
was diagnosed in 4/50 controls (8%) with negative blood cultures and in
6/50 controls (12%) with Staph. coag. negative bacteremia (no case in the
tc group) (P < 0.05). Additionally, asymptomatic Staph. coag. negative
bacteremia was found in 12/50 controls (24%) and in 4/50 with tc (8%) (P
< 0.05). Cultures of the catheter tips revealed Staph. coag. negative in
46.2% of the controls and in 40% of the tc group (NS). Conclusion:
Symptomatic or asymptomatic CR1 with staphylococci is observed fre-
quently (44% of our untreated group) in patients with a central venous
dialysis access. PAT with tc decreased this risk significantly while the risk
of catheter colonization remained unaffected. Adverse drug reactions may
limit the value of PAT with tc.
Measurement of the sulcus fluid flow rate (SFFR) in peritoneal dialysis
(PD) patients: A new method of evaluating exit-site (ESI) and sinus-tract
infections (STI). W. Pommer, M. Kehn, M. Brauner, C. GroJ3e-Siestmp, and
M Molzahn, Humboldt Hospital and Rudolf Virchow University Hospital,
Berlin, Germany. Measuring the SFFR to evaluate the tissue reaction in
xenografts was first described by Knabe (1990) and applied to examine ESI
in a small series of PD patients (Knabe et al 1991). We have modified this
method and studied its value in the evaluation of ESI and STI in a larger
group of PD patients (N = 27). Methods: SFFR was measured over a 3
minute period using a standardized strip of filter paper applied to the
convex and the concave side of the catheter exit-site (N = 32 simultanous
measurements) followed by fixation of the paper strips using a 0.2%
alcoholic solution of ninhydrine. Exit-site was classified by a score system
(0 = inconspicuous, 1—2 = equivocal, 3—4 = infected). Sinus-tract was
evaluated by ultrasound sonography. ESI was proven by bacterial swaps,
and STI was suspected from liquid formation surrounding the course of
the catheter tunnel. Results: The measurement at the convex side of the
exit-site underestimates SFFR due to dehydration and crust formation
(median 0.8 mm, range 0—6.0 mm; concave side: median 3.4 mm, range
0.7—6.0mm). SFFR < 3 mm (N = 10) indicated the absence of ESI or STI
at the time of evaluation and during the last 10 weeks. SFFR > 3 mm are
found in ESI (N = 3), STI (N = 4), and in deep sulcus formation without
signs of ESI or STI (N = 10). Conclusion: SFFR measurement at the
concave side of the catheter exit-site is helpful in the detection and
monitoring of ESI and STI. The value of standard SFFR is limited in cases
with deep sulcus formations.
Prediction of 2-year graft function by measuring urinary proteins. R.
Preuss, J. Steinhoff L. Fricke, J. Hoyer, and K Sack, Department of Internal
Medicine, and Department of Sugeiy, Medical University of Lübeclç Lübeclç
Germany. Introduction: The best immunosuppression after renal trans-
plantation (RT) is still debated and it is still unclear which patient will
profit from long-term cyclospormne (CsA) therapy. In a previous study we
have shown that patients receiving long-term CsA therapy have higher
levels of alpha 1-microglobulmn in urine (a1m) than patients treated with
azathioprmne, and this was attributed to the nephrotoxic effects of CsA. We
also found that in patients under triple therapy, consisting of CsA,
azathioprine and prednisolone, n1m 4 months post-transplant correlates
to the 1-year graft function. Methods: In a prospective study of 44 patients
under triple therapy we measured urinary proteins (IgG, albumin, cs1m) 4
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months after RT by using highly sensitive inimunoluminometric assays.
Patients were divided into 2 groups with respect to their a1m excretion
(group A with n1m 42 mg/g creatinine and group B with a1m > 42 mg/g
creatinine) and followed up until 2 years after RT. Results: 2 years
post-transplant group A had a significant lower serum creatinine [125
(86—233) vs. 216 (150—546) mol/liter, P> 0.0001], albumin in urine [16.1
(3—213) vs. 104 (7—602) mg/g creatinine, P 0.01] and a1m [12.9 (3—90)
vs. 80.9 (20—586) mg/g creatinine, P < 0.0001] than group B. In group A
transplant function remained unchanged over 2 years, while group B
showed a significant reduction of graft function between the 1 and 2 year
after RT [161 (151—212) vs. 226 (150—546) jsmol/liter, P < 0.01]. (Values
as medians and 95th percentile). Conclusions: a1m 4 months after RT is
an excellent marker to predict graft function after 2 years. By measuring
a1m 4 months after RT we could identify a group of patients with a high
risk of chronic graft dysfunction in a two year period after RT.
Sonographic findings in adult patients with medullary nephrocalcino-
sis. J. Riehi, B. Schneider, D. Bongartz, and H.-G. Sieberth, Department of
Internal Medicine II, Klinikum der RWTHAachen, Germany. Introduction:
Any calcium deposit in the region of the renal parenchyma is referred to
as a nephrocalcinosis (NC). NC occurs either in primary form as the result
of a disturbed calcium metabolism or in secondary form as dystrophic NC
caused by calcification of necrotic parenchyma zones in the kidneys.
B-mode sonography has proven especially useful for detecting echo-
enhanced changes in the renal parenchyma and can be used to distinguish
between characteristic findings for a medullary or cortical NC. Patients:
Sonographic symptoms of a medullaiy NC were found in 8 out of >2000
patients with renal diseases undergoing sonographic tests (3.5/3.75 MHz
transducer) as part of in-patient or polyclinic treatment. Sonographic
diagnosis of a medullary NC is based on the detection of high-echo
pyramids or characteristic high-echo rings in the renal parenchyma.
Results: We report on 8 patients in whom medullaiy NC on the basis of
various primary diseases was detected by means of sonographic diagnosis
(2 primary hyperparathyroidism, 1 renal tubular acidosis, 1 vitamin
D-resistant rickets, 1 hypercalcemia with unclear etiology, 2 chronic renal
insufficiency in patients on chronic maintenance hemodialysis, 1 pyelone-
phritis of transplanted kidney). In 2 patients NC was accompanied by
hypercalcemia and renal pelvis calculi. It was possible to differentiate
between a marginally accentuated "ring sign" and a more planar, very
pronounced echo enhancement in the region of the renal pyramids.
Conclusions: The presence of a medullary NC can generally be confirmed
with adequate reliability on the basis of sonographic findings. Coincidental
sonographic identification of NC (with or without accompanying nephro-
lithiasis) is a rare but characteristic finding. In normally-sized kidneys, it
should be taken as indicating a causative disease which can lead to a
primary NC. If there are predisposing diseases, B-mode ultrasonography
confirms or eliminates a suspected medullary NC.
Renin immunochemistry, sodium excretion and relative heart weight in
magnesium deficiency in rats. P.M. Rob, K Sac/c and R. Nobilin,g
Universities of Lübeck and Heidelbeig, Lflbeck and Heidelberg, Germany.
SD rats (6/group) were given a magnesium (Mg) Mg depleted (Mgd), or
a Mg standard (Mgst) or a Mg enriched diet (Mge), 20 mg/kg/day CsA or
olive oil p.o. Anti-renin antibody was applied and percentage of renin-
positive glomeruli (RI) was taken. Sodium excretion (NaU; flame pho-
tometry), relative heart weight (HW), and total Mg content of the femur
(AAS) were measured, Femur Mg decreased due to CsA in Mgd and Mgn.
RI significantly increased due to CsA in all dietary groups (Mgd 30.3
2.6% vs. 19.6 3.7%; Mgst 13.0 3.1% vs. 26.5 2.1%; Mge 26.7
1.7% vs. 14 1.9%). NaU decreased in Mgd + CsA (44.5 13.9 vs. 124
19.4 mmol/liter), and in Mgst + CsA (83.2 17.2 vs. 148.7 10.8
mmol/liter) in respective controls and HW increased significantly in Mgd
and Mgst (5.3 0.8 vs. 3.8 0.4 and 4.0 0.4vs. 3.1 0.3). In animals
with a plentiful Mg supply, there were no significant differences in NaU
and HW between CsA and controls, thus indicating that CsA associated
hypertension is related to the Mg status: Mg deficiency—alimentary or
drug-induced—enhances the hypertensive effect of CsA via sodium
retention.
Improvement of autoregulatory reserve during the development of
inherited autosomal dominant polycystic kidney disease (Han: SPRD). C.
Braun, P. Rohmeiss, C. Lfldecke, M. Strauch, and N. Gretz, Nephrologische
Klinik, K/inikum Manheim, Universität Heidelberg, Mannheim, Germany.
Introduction: The progression of chronic renal failure is often due to
secondary changes in renal hemodynamics. Whether changes in the
regulation of renal blood flow are of pathogenetic importance in the
course of inherited autosomal dominant polycystic kidney disease is not
known. The Han: SPRD rat is a new model for polycystic kidney disease,
which develops end-stage renal failure within 16 months. Therefore, we
investigated in the present study the autoregulation of renal blood flow in
Han: SPRD rats during the development of the disease, Methods: All
experiments were performed in conscious chronically instrumented Han:
SPRD rats (age: 3 and 9 months; N = 7each group) and their genetic age
matched controls (SD rats, N = 7 each group). The rats were instru-
mented with catheters in the a/v femoralis, a transonic flow probe on the
left renal artery, and an inflatable cuff around the aorta above the orifice
of the right renal artery. Renal perfusion pressure was lowered in 5 mm
Hg steps by a servo-controlled electropneumatic device. GFR was mea-
sured by inulin single shot method. Results: GFR in 3 and 9 month old
Han: SPRD rats was significantly lower compared to SD rats; however,
Han: SPRD rats did not reveal a further decline in GFR between 3 and 9
months. At the age of 9 months Han: SPRD revealed a significant shift of
the RBF autoregulation curve to the left compared to 3 month old Han:
SPRD and 9 months old SD; no difference in the autoregulation of RBF
was found at the age of 3 months between the groups. Conclusion: Han:
SPRD rats developed an early impairment of their renal function,
Although cystic degeneration of the kidney progresses, no further decline
in GFR up to the age of 9 months is observed. The improvement of the
autoregulatory reserve (shift of the RBF autoregulation curve to the left)
in older Han: SPRD could be an important factor to protect the glomeruli
from hemodynamic damages and by this mechanism slower progression of
chronic renal failure.
Role of endothelin (ET) in inherited autosomal dominant polycystic
kidney disease (Han: SPRD): overexpression of ET-B receptors in cyst-
epithelia—increase of renal blood flow after ET-antagonist bosentan. P.
Rohmeiss, B. Hocher, V. Vogt, V. Burst, C. Braun, P. Gross, A. Distler, M.
Strauch, and N. Gretz, Nephrologische Klinik, Klinikum Mannheim, Univer-
sität Heidelberg, Mannheim; Abteilung für Innere Medicine, Klinikum Steg-
litz, Berlin; Medizinische Klinik III, Nephrologie, Universitdts-Klinikum,
Dresden, Germany. Introduction: The endogenous endothelin (ET) system
plays an important role in the progression of chronic renal failure.
Hemodynamic and proliferative effects of the endothelin system seem to
be of importance in this context. The Han: SPRD rat is a new model for
inherited autosomal polycystic kidney disease, which progresses to end-
stage renal failure within 16 months. Therefore, we investigated in the
present study the role of ET in this model. The following issues were
addressed: (1) expression of ET-receptor-subtypes (A/B) in cyst epithelia
and vessels of these animals. (2) Effects of ET-receptor blockade with the
oral ET antagonist bosentan on renal hemodynamics. Methods: (1) By
means of receptor-subtype-specific autoradiography we investigated the
expression of ET-receptor-subtypes in cysts and vessels of Han: SPRD rats
(N = 7). (2) All experiments were performed in conscious and chronically
instrumented Han: SPRD rats (N = 7) as compared to their genetic
controls (SD, N = 7). Both groups received increasing bolus injections
(0.3, 1, 3, 10, 100 mg/kg) of bosentan iv. We measured mean arterial blood
pressure (MAP), heart rate (HR) and renal blood flow (RBF). Results: (1)
Han: SPRD rats revealed an overexpression of ET-B receptors in cyst
epithelia. (2) Bosentan induced a dose-dependent decrease in MAP in
both groups without changes in HR. In Han: SPRD rats we observed
dose-dependent significant increases in RBF (max: 2.5 1.2 mI/mm; 100
mg/kg), whereas no effects on RBF were seen in SD. Conclusion: Our
results suggest an important role of the ET system in the regulation of
renal blood flow in Han: SPRD. A possible proliferative role of ET as
indicated by the overexpression of ET-B receptors in cyst epithelia should
be investigated in a long-term treatment study with bosentan.
Oxygen radicals as a marker for biocompatibility of dialysis mem-
branes. AR. Rosenkranz, E. Templ, 0. Traindl and G.J. Ziabinger,
Department of Internal Medicine III, Division of Nephrology and Dialysis,
and Institute of Immunology, University of Vienna, Vienna, Austria. Produc-
tion of reactive oxygen intermediates (ROl) by neutrophils (PMN) in vivo
was examined by a whole blood assay using dichlorofluorescin-diacetate
(DCFH-DA) in 10 patients each dialyzed consecutively with 2 different
dialyzer membranes. Hemodialysis (HD) with cuprophan membrane(CM) led to a significantly (P < 0.001) more pronounced ROl production
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by PMN (2.4 0.5 fold increase in intracellular oxidation of DCFH-DA)
compared to HD with polysulfone membranes (PM; 1.5 0.2 fold). HD
with CM induced a decrease in PMN count by about 90%, whereas PM
induced a decrease by only 25% (P < 0.001). In CM patients maximal ROl
production coincided with the nadir in PMN count. All patients dialyzed
with CM showed a clear increase in serum levels of Bb fragments, whereas
PM dialyzed patients did not. In this respect, however, no clear time
relationship was seen to the kinetics of ROT production nor to the
disappearance of PMN from the circulation. Evaluating a direct effect of
the dialysis membranes on PMN demonstrated that incubation of PMN
with hollow fibers of the CM but not of the PM in the absence of plasma
induces significant ROT production. Our study thus indicates that ROl
production by PMN during HD correlates to membrane biocompatibility.
Because of the time relationship of ROT formation to the effects of HD on
PMN counts, and since contact between PMN and CM even in the
absence of plasma leads to ROl formation, the hypothesis that comple-
ment factors are exclusively responsible for PMN activation during HD
with CM has to be questioned, and an independent role of ROl formation
in that process is proposed.
Can the poor results of pediatric donor (PD) kidneys be improved by
age matching? Th. Rudy, K Albrecht, and F W. Eigler, Department of
General Surgety, University Hospitals, Essen, Germany. A higher proportion
of technical failures is responsible for the poorer results of pediatric donor
(PD) kidneys. Hyperperfusion of pediatric kidneys in adult recipients
might be one of the reasons. Methods: In a retrospective analysis, the
results of cadaveric PD kidneys (age <16 years) under conventional
immunosuppression (1972—1983, N = 142) and with CsA (1984—1994, N =
115) were analyzed in a first step without respect to the recipient age. The
control groups were adult (15 < age < 50 years) donor kidneys (AD)
transplanted in the same periods (N = 322 and N = 489, respectively). In
a second step the same grafts were reanalyzed in respect to the corre-
sponding aged pediatric and adult recipients. Results: Under immunosup-
pression of CsA PD kidneys yielded 10% poorer 10 year graft survival
compared to AD kidneys. Pediatric recipients yielded 10% better 10 year
graft survival compared to adult recipients under conventional immuno-
suppression, but only 4% better graft survival under CsA. The best results
yielded transplantations of AD kidneys on pediatric recipients. Conclu-
sions: The age matching of PD kidneys on pediatric recipients reduced the
negative impact of PD kidneys, but AD kidneys nevertheless yielded better
results in pediatric recipients. PD kidneys therefore should preferably be
transplanted into pediatric recipients. Yet kidneys of AD remain the best
choice for pediatric recipients.
Role of G-proteins in the regulation of organic osmolyte efflux from
isolated rat renal IMCD cells. B. Ruhfus and R.KH. Kinne, Max-Planck-
institut für Molekulare Physiologie, Dortmund, Germany. The pathways of
the regulation of the release of organic osmolytes, that is sorbitol,
myoinositol, betaine and glycerophosphorylcholine (GPC) still remain
unknown. Therefore, we used a G-protein inhibitor, pertussis toxin (PTX),
and a G-protein stimulator, mastoparan, to analyze whether G-proteins
play a role in organic osmolyte effiux. Inner medullary collecting duct cells
(IMCD) from rat kidney were isolated in a 600 mOsm buffer and
incubated for 10 minutes at 37°C in either isotonic or hypotonic medium
(300 mOsm). After centrifugation organic osmolytes were quantified with
a Sugar Pak I column (Millipore, Waters) by HPLC in both the superna-
tants and cell pellets. Cells preincubated for 1 hour with PTX (50 ng/ml)
showed a decrease of 73.7% (P < 0.05) in the release of sorbitol (control
131 27.7 mol/g protein x 10 mm) and of 50.7% (P < 0.05) in the effiux
of betaine (control 47.3 5.8 mol/g protein X 10 mm) during the
hypotonic shock. The efflux of myoinositol and GPC remained unchanged.
When cells were treated for 1 hour with mastoparan (10 ILM) they showed
a significantly increased release of sorbitol and betaine from 59.3 12.2
to 180.7 38.1 j.mol/g protein x 10 mm (P < 0.05) and from 15.8 2.9
to 32.3 4.7 jmol/g protein x 10 mm (P < 0.05) during incubation in
isotonic medium. GPC effiux was increased from 101.4 8.0 to 156.9
41.9 imol/g protein x 10 mm (NS) whereas myomnositol flux was not
affected. Even during a hypotonic shock mastoparan increased the effiux
of sorbitol, betaine and GPC to a small extent. These observations lead to
the conclusion that at least sorbitol and betaine efflux might be regulated
by a PTX-sensitive G-protein which can be stimulated by mastoparan. The
release of GPC appears to be slightly activated by mastoparan but is not
sensitive to PTX, suggesting that a non-PTX sensitive G-protein might be
involved. No G-proteins seem to participate in the regulation of myoinosi-
tol effiux.
Renal a2-autoreceptor subtypes, transjunctional modulation and aden-
osine in SHR and WKY (12—14 weeks). C. Bohmann, U. Schaible, P.
Schollmeyer, and L.C. Rump, University Klinik Freiburg, Innere Medizin 1V
Freiburg, Germany. Neuronally released norepinephrine (NE) inhibits its
own release in rat kidney directly by activation of prejunctional a2-
autoreceptors and indirectly by activation of postjunctional a1-adrenocep-
tors and consecutive release of transjunctional inhibitory mediators like
adenosine. Mainly on the basis of radioligand binding studies, a2-adreno-
ceptors can be subdivided into 4 subtypes (a2A_D). Since a2A and azu are
to a great extent homologous, they may represent species variations of one
and the same receptor. The aim of the present study was to investigate
whether there are any differences between renal SHR and WKY a2-
autoreceptor subtypes or the a1-adrenoceptor-mediated transjunctional
inhibition of NE release by adenosine. Kidneys were isolated and the renal
nerves were stimulated electrically (1 Hz, 30s). The renal nerve stimula-
tion-induced outflow of endogenous NE (determined by HPLC-ECD) was
significantly greater in SHR (707 31 pg/g kidney, N = 46) than in WKY
(502 28 pglg kidney, N = 54). The a2-adrenoceptor antagonist
rauwolscine (0.01—1 /LM) increased NE release more potently in SHR than
in WKY. However, the a2-adrenoceptor agonist UK 14304 (0.01—1 /tM)
inhibited NE release in SHR and WKY with identical EC50 and Em
values. a-Adrenoceptor antagonists shifted the concentration response
curve for UK 14304 to the right. The rank order of affinities (phentol-
amine > rauwolscine > WB 4101 > prazosin) was identical in SHR and
WKY. The a1-adrenoceptor preferring antagonist prazosin (0.03—3 M)
enhanced NE release to a significant greater extent in WKY than in SHR.
This effect was not observed in the presence of the P1—purinoceptor
antagonist 8-(p-sulfophenyl)theophylline (100 iM). These results indicate
that a1-adrenoceptor mediated transjunctional automodulation by aden-
osine is defective in SHR kidneys. In comparison with data from radioli-
gand binding and molecular cloning studies, renal a2-autoreceptors of
SHR and WKY belong to the a2-subtype with identical sensitivity. The
greater facilitation effect of rauwolscine in SHR seems to be solely due to
interruption of more pronounced autoinhibition by NE due to higher
intrasynaptic NE levels in this strain.
Inhibition of fibrinolysis and prostaglandin synthesis in endothelin
induced acute renal failure. F. Ruschitzka, E. Schulz, M Hermann, C.
Zuchner, J. Schrader, and G.A. Muller, Department of Nephrology/Rheuma-
tology, Centre of Internal Medicine, University of Goettingen, Goettingen,
Germany. The potent endothelial vasoconstrictor endothelin-1 (ET) plays
an important role in the pathogenesis of acute renal failure. This study is
designed to investigate the interaction of prostanoids and the fibrinolysis
system in the prevention of ET induced renal failure. In 24 anesthesized
pigs divided into 4 groups, the influence of 4 i.v. bolus infusions of ET (1.5
pg/kg) alone (group 1), after pretreatment with indomethacin (IM) (2
mg/kg) (group 2), epsilon-ammno-capronic-acid (EACA) (150 mg/kg)
(group 3) or IM and EACA (group 4) on coagulation parameters (factor
VIII, antithrombin III, precallikrein, fibrin monomers, aPTT, euglobulin
lysis time, PAl and tPA), prostaglandins and serum electrolytes was
investigated. Creatinine clearance, urine volume measurement, and blood
gas analysis were performed hourly. ET infusion caused a typical biphasic
blood pressure (BP) profile. Groups 2 and 4 demonstrated a uniphasic
profile and a long lasting increase of BP with a significant higher delta BP
in group 4 (P < 0.01 vs. group 1). FT increased PGI2 and PGE22 levels
(P < 0.05) while prostaglandin synthesis was totally blocked in groups 2
and 4. ET initially also induced a status of hypercoagulability and
hyperfibrinolysis resulting in a final DIC. At the end of the experiment
serum potassium was elevated, while creatinine clearance, urine volume
(P < 0.05), serum calcium, sodium, standard bicarbonate and blood pH
significantly (P < 0.01) decreased. Interestingly, reduction of renal
function was more pronounced in the EACA and TM pretreated animals
(P < 0.05 vs. groups 1, 2 and 3). Diminished protective fibrinolysis and loss
of vasodilatatory prostanoids predisposes to FT induced acute renal
failure.
Genetic analysis of HLA-DRB1 and PKD-1 gene in Japanese adult
polycystic kidney disease families. M. Sada, S. Takahara, D. Li, S. Hone,
T Tsuji, and A. Okuyama, Department of Surgical Research, National
Cardiovascular Center, Osaka, Japan. Adult polycystic kidney disease
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(APKD) is a congenital renal maldevelopment with mild hypertension and
cardiac hypertrophy, and is thought to be inherited as a Mendelian
dominant trait. Recent reports show that the PKD-1 gene, cross-linked
a-globin gene on chromosome 16 short arm, is considered the gene
responsible for the development of APKD in the caucasian population.
According to the analysis of caucasian PCK patients, more than 90% of
patients are linked with PKD-1 gene, and the renal functions of these
patients linked with PKD-1 gene are poor. In this study, we have examined
the HL.A-DRB1 and PKD-1 genes in Japanese APKD families, and
analyzed the correlation between familial inheritance of these genes and
prognosis of renal function. Thirty-five APKD families, including 70
APKD patients and 97 normal family members, having at least 2 APKD
patients relatively within the third degree, had genotyping performed
about the first domain of the DRI3 chain using PCR-RFLP methods. From
the analysis of APKD families, DRB1*1501, 1302, 1401, and 0803 alleles,
observed in high frequency in APKD patients, were found in 30 out of 35
families. In 30 families, more than 85% of APKD patients had either of
these alleles, and 32% of these APKD patients had both haplotypes of
these 4 alleles. Twenty-three APKD families were examined for a poly-
morphism of the microsatellite SM7 marker close-linked PKD-1 gene
using the PCR silver staining method. In 23 APKD families, 14 out of 23
families had inherited PKD-1 gene and 5 families were not linked with
PKD-1 gene. From analysis of the correlation between prognosis of renal
function and DRBI alleles and PKD-1 gene, APKD patients having
DRB*1302, 1401, and 1501 alleles and linked with PKD-l gene had poor
function, although APKD patients having DRB1*0803 and/or linked with
PKD-1 gene had good function. These findings strongly suggested some of
the DRB1 alleles may play an important decision of renal function rather
than PKD-1 gene in Japanese familial onset APKD.
Taurine reabsorption in short Henle loops of rat kidney is Na and C1
dependent and inhibited by furosemide. S. Silbernagi, K Volker, and W.H.
Dantzler, Departments of Physiology, University of WOrzbu Wurzburg,
Gennany, and University of Arizona, Tucson, Arizona, USA. To investigate
the fractional unidirectional reabsorption (FR) of taurine (Tau) in
nephron sections beyond the late proximal tubule (LP), we microinfused
3H-Tau and '4C-inulin in a Ringer-like solution (MOPS buffered to pH
6.7) into LP, early distal (ED) and late distal (LD) tubule segments of rat
kidney in vivo and in situ. FR1 of 3H-Tau (%) was determined by dividing
the ratio of 3H/'4C in the final urine of the ipsilateral kidney by that in the
infusate and subtracting the result from 1 (X 100 = %). The infusates were
as follows: 0.01 mr'n Tau (control); (a) +50 mt Tau; (b) —Na (replaced
by choline); (c) —Cl (replaced by gluconate); (d) +i0 M furo-
semide. Results are SEM (N):
FRom of 0.01 mM 3H-Tau (%)
Control a b c d
LP 93 0.7 (10) 13 3.4 (9) 46 9.5 (5) 55 3,3 (10) 41 t 3 (5)
ED 16±3.3(10) 6+2.3(8) 15±2.6(5) 3±3.9(6) 7(2)
LD 8±2.2(6) — — — —
Thus, FR,,,,1 of Tau (1) is high in short loops of Henle, where it is (2)
carrier-mediated, (3) at least partly Na and (3) Cl dependent, and (4)
at least partly dependent on normal function of the luminal Na-2CI-
Ktcotransporter of the thick ascending limb, TAL. (5) There is a small
FR,,,,1 of Tau in the distal convoluted tubule and in the collecting duct.
Results (1)—(4) are compatible with (i) transport of Tau by the furo-
semide-sensitive cotransporter, or (ii) Cl -driven exit of Tau at the
basolateral side of the TAL cells.
The role of mesothelial cells in the peritoneal fibrinolytic system of
CAPD patients. 7'. Sitter, M Spannagi, and E. Held, Medizinische Klinilç
Klinikum Innenstadt, Ludwig-Maximilians-Universitdt, Munich, Germany.
Irritations of the peritoneum during CAPD cause an inflammatory
response of the serosal surfaces with outpouring of fibrinous exsudate.
Thereby the peritoneal fibrinolytic capacity determines whether fibrin
deposits are lysed or become organized with proliferation of fibroblasts
resulting in fibrosis. We have compared the concentrations of soluble
fibrin (Fb) and fibrin degradation products (FbDP) in the dialysate of
CAPD patients with (N = 18) and without peritonitis (N = 5). In the
peritonitis group the absolute amounts of Fb and FbDP were significantly
higher compared to patients without peritonitis (Fb: 993 697 vs. 173
136 g/ml; FbDP: 16 6 vs. 6 5 Lg/ml), and the ratio between Fb and
FbDP was elevated. This can be interpreted as an imbalance between
generation and degradation of fibrin. To further study the role of
mesothelial cells (MC) in the changes in fibrinolysis parameters observed
during peritonitis, we have tested the effect of the inflammatory mediators
LPS (10 sgJml), IL-ia (10 U/mI) and TNFa (1000 U/mI) on the synthesis
of t-PA and its inhibitor, PAL-i in cultured human peritoneal MC. All
these mediators decreased the synthesis of t-PA during 24 hour incuba-
tion: TNFa (33% 6% of control, N = 3), IL-la (49% 8%, N = 3)and
LPS (71% 3%, N = 3). Concomitant with the decrease in t-PA
synthesis, an increase in PAl-i production was observed: TNFa (182%
14% of control), IL-la (147% 16%) and LPS (125% 4%). The
changes in t-PA and PM-I protein concentrations in the presence of
inflammatory mediators were paralleled by comparable changes in the
corresponding mRNA levels. Furthermore, low concentrations of 1'NFa
were sufficient to rapidly induce tissue factor, a membrane associated
glycoprotein, that initiates the coagulation cascade by interacting with
factor VII or VIla. Our results demonstrate that MC play an important
role in intraperitoneal coagulation and fibrinolysis. Peritoneal fibrin
deposition in CAPD patients during peritonitis may be explained as a
consequence of increased PAl-i and decreased t-PA synthesis of the
mesothelium caused by a direct effect of inflammatory mediators.
Direct vasoconstrictive effect of insulin on rat renal resistance arteries.
C. Spieker, T. Lemke, M. Tepel, and W. Zidelç Medizinische University
Poliklinik, Münster, Germany. Objective: To test whether a direct vasocon-
strictor effect of insulin on resistance vessels may underlie the link
between hyperinsulinemia and primary hypertension. Isometric tension of
small resistance vessels was studied in isolated resistance vessels from
renal medulla with internal diameters between 200 and 250 m from 30
male norinotensive Wistar Kyoto rats aged 3—6 months using a small
vessel myograph (Mulvany et al, 1977). Integrity of endothelium was
proven by testing vessel relaxation to acetylcholine (1—100 nM) after
aipha-adrenergic vasoconstriction. 50 ng/mI of insulin generated a tension
of 77 16 MM/mm (P < 0.01). Maximal tension was achieved with 4,000
ngJml of insulin (123 29 sM/mm). Maximum KCI-induced tension was
12.3 0.045 mi/mm. The insulin-induced contraction was also observed
in calcium-free, EGTA-containing solution and after application of nife-
dipine. The contraction was not altered in presence of the alpha-receptor-
blocker phentolamine or the serotonin S2 receptor blocker ketanserin. We
conclude that insulin has a direct vasopressor effect on resistance vessels.
By this mechanism hyperinsulinemia may contribute to the development
of primary hypertension.
Influence of age on rejection episodes in renal transplant patients. C.
Spieker, M Barenbrock B. Suwelack and W. Zidek, Medizinische Univer-
sily-Poliklinik; MOnster, Germany. To investigate the effect of age on
allograft rejections, the data of 136 renal allograft recipients, who had
been transplanted in our clinic in 1989, were analyzed. The frequency of
allograft rejections was significantly lower in the patient group aged >55
years (N = 55, age 56.6 5.4 years) than in the patient group aged <50
years [N = 81, age 35.2 10.9 years, ii of 55 (20%) patients vs. 40 of 81
(49%) patients with rejections, P < 0.01]. The graft survival during the first
year was 87% (7 graft losses) in the older group and 83% (14 graft losses)
in the younger group. The most frequent cause of graft loss in the older
group was due to transplant vascular thrombosis (4 of 7 graft losses), but
in the younger group was due to allograft rejections (9 of 14 graft losses).
By logistic regression, the influence of the covariables, recipient age,
donor age, mismatches and cold ischemia time on allograft rejection was
analyzed. The deviation from ideal donor age (10—50 years) was defined as
variable for donor age. The analysis revealed a highly significant inverse
correlation between the recipient age and allograft rejections (r = —0.68,
P < 0.001). A significant correlation was also shown between ideal donor
age deviation and allograft rejections (r = 0.48, P < 0.05). Allograft
rejections occurred in case of donor age < 10 years in 9 of 12 patients
(75%), in case of donor age >50 years in 19 of 32 patients (59%) (but in
23 of 92 patients (24%) with ideal donor age transplantation). HLA
mismatches and cold ischemia time did not correlate with the occurrence
of allograft rejections (r = 0.17; r = 0.26; NS). The results demonstrate
that the frequency of allograft rejections decreases with recipient age.
Graft losses due to rejections seem to be less frequent in older transplant
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recipients. Non-optimal donor age is also associated with higher risk of
allograft rejections.
Factors influencing post-transplant hypertension. C. Spieker, M Baren-
brock, B. Suwelack, and W. Zidelç, Medizinische University-Poliklinik;
Münster, Germany. Objective: To examine factors predisposing to the
development of post-transplant hypertension after renal transplantation.
In 80 renal transplant patients (51 hypertensive, 29 normotensive) the
influence of renal function, number of rejection episodes within the 1st
year after transplantation, hemoglobin content, antihypertensive therapy,
and cyclosporine A whole blood concentrations on the development of
post-transplant hypertension was examined. To this purpose, a multivari-
ate regression analysis was performed, with the above mentioned param-
eters as independent variables and systolic or diastolic blood pressure as
dependent variable. Between the above mentioned factors and diastolic
blood pressure a significant correlation was found (multiple correlation
coefficient r = 0.47, P = 0.0024). In this model of multivariate regression
only 2 factors, namely serum creatinine concentration and hemoglobin
content, showed a significant influence on diastolic blood pressure (he-
moglobin: P = 0.02, serum creatinine: P = 0.003). Between systolic blood
pressure and the above factors there was no statistically significant
multivariate correlation (P = 0.21). The findings show that immunosup-
pressive treatment (steroid dosage, cyclosporine A levels) and the number
of rejection episodes did not significantly influence blood pressure. The
important role of renal function was to be expected. Importantly, hemo-
globin content has an impact on blood pressure independent of renal
function.
Immunotactoid-like glomerulopathy with massive librillary deposits in
the liver and bone marrow in monoclonal gammopathy. E.H. StrØm, A. C.
Mayr, P.11. Krause, and MJ. Mihatsch, Institute for Pathology, University of
Basel, Basel, Switzerland, and Department of Medicine and Institute for
Pathology, Neukölln Hospital, Berlin, Germany. Fibrillaiy deposits of
different sizes may be found in a variety of glomerular diseases. Amyloid-
osis, being a systemic disease, is the most common entity. Recently,
non-amyloid glomerular fibrillary deposits with slightly variable ultrastruc-
tural appearance have been identified. Fibrillary glomerulonephritis
(FGN) or immunotactoid glomerulopathy (IGP) are suggested terms for
this condition, where it is still under debate whether this represents 1 or 2
entities. The condition is infrequently associated with a systemic disease,
and extrarenal fibrillaiy deposits are rarely observed. Here we present an
autopsy case of a woman with an IgG-kappa monoclonal gammopathy,
who presented with liver enlargement, ascites and anemia. Later, she
developed nephrotic syndrome and died after 6 months with massive
cholestasis. At autopsy, there was extensive thickening of the glomerular
capillary walls with deposition of a PAS positive material with strong
immune reactivity to IgG and kappa. By electron microscopy, extensive
osmiophilic deposits of exclusively long, straight fibrils with a diameter of
21 nm were observed in the subendothelial space. No clear cut tubular
substructure could be seen in the fibrils. Similar deposits were massively
present between hepatocytes and as a network in the bone marrow. This
case study indicates that fibrillary deposits may be a systemic manifesta-
tion in FGN or IGP, at least when associated with a monoclonal
gammopathy.
The prevalence of cyclosporine-associated arteriolopathy (CAA) in
renal transplant biopsies from 1981 to 1992. E.H. StrØm, G. Thie4 and
M.J. Mihatsch, Institute for Pathology, University of Basel, and Dept. of
Nephrology, Cantonal Hospital, Basel, Switzerland. Cyclosporine (C5A)
nephrotoxicity can be separated into functional and structural changes.
Among the structural changes, tubular lesions are seldomly seen in
transplant (tp) biopsies, probably due to the lower CsA doses being used
nowadays. Vascular changes, with protein deposits replacing necrotic
smooth muscle cells in the afferent arteriole, so-called CAA, are still
observed in many biopsies. In this retrospective study we investigated the
prevalence and degree of CAA in 400 tp biopsies from 349 patients who
received cadaveric kidneys in Basel from 1981 to 1990. The patients were
treated with CsA according to the treatment protocol in use at the given
time, with initial high dose until 1985, when the dose was lowered to 3 to
6 mg/kg124 hr. The biopsies were grouped into five 2-year periods, and
each group was stratified according to the time of biopsy after tp (<15,
—30, —90, —180, —360 days, —2, —4, —9 years). When pooling the post-tp
intervals into 3 groups (<90 days, —<1 year and >1 year), we observed a
prevalence of CAA exceeding 50% in all post-tp intervals from the first
2-year period (1981—1982). A significant decrease was noted from 1982 to
1988, down to 12.9, 19.0 and 36.4%, respectively, in the 3 post-tp time
intervals from kidneys being transplanted in 1987—1988. Likewise, the
number of arterioles affected by CAA decreased from a maximum of more
than 20% in 1981—1982 to less than 7% in 1987—1988. A slight increase in
both the prevalence and degree of CAA was then noted in biopsies from
1989—1990. In conclusion, a significant decrease in the prevalence and
severity of CAA has been observed over the 12 years studied. Although
affecting few arterioles, CAA is still present in tp biopsies in spite of low
dose of CsA given.
Characterization of cytokine autoantibodies in CRF patients. G. Sun-
der-Plassmann, Universitdtsklinik für Innere Medizin III, Universitat Wien,
Wien, Austria. The aim of the present study was to evaluate functional
properties of cytokine autoantibodies (aab) in CRF patients. IL-i- and
IL-6-aab were detected by second antibody precipitation. The neutralizing
capacity of IL-i aab serum was studied by flow cytometry analysis of IL-i
induced expression of E-selectin (CD62E) on human umbilical vein
endothelial cells (HUVEC). Results of these inhibition studies were
confirmed with IgG from aab positive sera, purified by affinity chroma-
tography. Functional studies on IL-6 dependent B9 cell proliferation were
performed with IL-6 aab positive sera, and quantitated with the colon-
metric MIT assay. IL-i induced expression of CD62E on HUVEC
(considered 100% positive cells) was inhibited by each IL-i aab positive
sample (N = 13; anti-IL-i activity: 7.62—57.52% binding). Inhibition of
CD62E expression by IL-i aab ranged from 0.11 to 80.22% positive cells
(0.15—92.31% mean fluorescence intensity). A strong correlation of
CD62E expression with IL-i aab concentration was observed (P < 0.05).
Furthermore, IgG eluates from aab positive patients inhibited CD62E
expression to 41.0 23.1% positive cells if compared with 83.7 5.7%
positive cells of the IgG depleted serum samples. IgG eluates and IgG
depleted sera derived from anti-IL-i negative serum samples had no
major influence on CD62E expression (79.9 28.5% and 77.9 16.8%,
respectively). IL-6 aab sera (N = ii; anti-IL-6 activity: 5.85—53.28%
binding) had no inhibitory effect on B9 cell proliferation (1:1000: 102.1
7.1%, 1:100: 106.8 9.2%, 1:10: 146.2 26.6% proliferation). We
conclude that IL-i aab in CRF patients deliver inhibitory activity on IL-i
at least in vitro. IL-6 aab were not found to influence IL-6 dependent
proliferation of B9 cells.
Optimizing EPO therapy with low dose i.v. iron administration in
hemodialysis (HD) patients. G. Sunder-Plassmann, and W.H. Hörl, Uni-
versitätskinik für Innere Medizin III, University of Wien, Wien, Austria.
Dosage, route of administration and monitoring of iron and EPO therapy
are controversial topics in nephrology. A 22 month iv. iron substitution
trial consisting of 4 study periods was initiated in severe iron-depleted HD
patients on EPO therapy. Target Hb was 10—11 g/dl. Within the first
period (6 months), 52 patients were treated with high dose iron formulas
(repeated cycles with 10 X 100 mg iron at each HD). During the 2nd cycle
(6 months), the repleted iron pool in iv. iron pretreated patients was
maintained with 10, 20, or 40 mg iron i.v. at each HD. In the 3rd cycle (4
months) EPO was randomized for i.v. and s.c. administration. During the
4th cycle (2 months) iron substitution was drawn out to clarify whether
severe iron overload had occurred. Vigorous iron therapy lessened the
weekly EPO demand for about 70% in the first study period. During the
2nd period iron storage pools could successfully be maintained. Ferritin
levels and transferrin saturation were 545 522 g/1iter and 26 15% at
the beginning and 704 363 .tg/liter and 21 7% at the end of this study
period. Randomization for iv. or s.c. administration of EPO in the third
study period revealed a similar efficacy for both routes in well-nourished
patients (albumin >40 g/liter) with PTH levels <100 pg/mI. EPO demand
remained between 50 and 60 U/kg/week in these patients until the end of
this period. In the 4th study period, iron withdrawal led to a rapid decrease
of ferritin and transferrin saturation values (to 62 and 73%, respectively).
Continuous i.v. low dose iron therapy turned out to be a very effective,
economical and safe treatment schedule for hemodialysis patients. The i.v.
and s.c. route of EPO is of similar efficacy in well-nourished, iron repleted
patients without hyperparathyroidism.
Studies on structural changes of the carotid artery in patients with
chronic renal failure. B. Suwelac/ç J. Witta, M. Barenbroc/ç and KH. Rahn,
Department of Medicine, University of Münster, Münster, Germany. The
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major cause of mortality in hemodialysis patients is cardiovascular disease.
Extracranial cerebrovascular disease is estimated to cause up to 50% of
ischemic strokes. Little is known about the structural changes of the
carotid artery in asymptomatic patients with chronic renal failure (CRF)
on hemodialysis. Whether uremia or hemodialysis treatment itself leads to
progression of arteriosclerosis still remains uncertain. In 11 patients with
CRF and 11 healthy normotensive controls at the same age (22—65 years),
we studied the carotid artery (CA) with a non-invasive high resolution
B-mode ultrasound technique. Patients had been in the hemodialysis
program for 1—5 years. Upon examination blood pressure was normal
(<140/90 mm Hg). Prior to hemodialysis treatment patients had been
hypertensive. Vessel wall thickness was imaged in the near and far wall of
3 arterial segments (common CA, bifurcation, internal CA) for both
carotid arteries using an 8 Mhz transducer. The maximum intimal-medial
thickness (IMTmax) was measured at 9 of 12 possible different sites.
IMTmax (1.63 0.49 mm; mean SD) was significantly higher in
hemodialysis patients (P < 0.01) when compared with age related controls
(0.85 0.17 mm; mean SD). Throughout the study each examination
was evaluated for the presence of plaque with calcification in each arterial
segment. In 9 of 11 hemodialysis patients we found 1—8 arteriosclerotic
plaques. None of the controls had plaques. The results show that the
intimal-medial thickness of the carotid artery is significantly increased in
patients with end-stage renal failure as compared with healthy controls.
Apart from metabolic disturbances, structural changes of the artery wall
could be caused by hypertension preceding the Onset of hemodialysis
therapy.
No evidence for plasma lipid peroxidation during LDL apheresis by
heparin-induced extracorporeal LDL precipitation (HELP). V. Schettler,
E. Wieland, P. Schuif-Wemer, and G.A. Muller, Departments of Nephrology,
Rheumatology, and Clinical Chemistry, Georg-August-University, Gottingen,
Germany. The heparin-induced extracorporeal precipitation of low density
lipoprotein (HELP) is a well-established clinical apheresis procedure to
markedly reduce cholesterol levels. The biocompatibility of this apheresis
system was investigated by the determination of lipid peroxidation prod-
ucts. Both lipid hydroperoxides (LPO) and thiobarbituric acid reactive
substances (TBARS) were determined before (SA) and after (EA) 38
aphereses in 21 patients undergoing regular HELP treatment. Although
HELP patients had significantly elevated TBARS compared to 93 healthy
controls, no significant differences were observed between HELP patients
and 104 patients suffering from angiographically assessed coronary heart
disease (CHD) but not included in the HELP program. No lipid hydroper-
oxides were detected in the plasma of HELP patients neither before nor
after the extracorporeal treatment. After the LDL apheresis TBARS were
significantly decreased compared to the values before the treatment.
There was also no evidence for the formation of lipid hydroperoxides
within the HELP circuit.
Condition
LPO
nmol/liter
TBARS
juno//liter
Controls (N = 101) <50 1.66 0.50
CHD (N = 104) <50 3.24 0.8i
HELP-SA (N = 38) <50 3.13 0.64a
HELP-EA (N = 38) <50 2.60 0.52"'
a compared to controls (P < 0.05); 'compared to CHD (P < 0.05)
It is therefore suggested that plasma lipids are not oxidized by the
HELP-procedure.
Influence of HCV, HBsAg and bacterial infections on soluble CD14
(sCD14) in serum of patients with chronic hemodialysis. i.E. Scherberich,
A. Mazu, M. Tauber, and W. Schoeppe, Abteilung fur Nephrologie Univer-
sit atsklinik Frankfurt/Main, Germany. In order to elucidate the influence of
hemodialysis on monocytes, a soluble form of CD14 was assessed by
ELISA in the serum of 41 RCDT patients repeatedly before and after
hemodialysis treatment. The mean pre-dialysis serum concentration of
sCD14 in all patients was higher compared to 65 healthy volunteers (6.49
1.8 vs. 2.18 0.5 mg/liter). Serum sCD14 was especially high in a
subgroup of 7 patients with PCR positive hepatitis C: 8.64 2.1 mg/liter
(<0.01); by contrast, the mean sCD14 value of ii HBsAg carriers (5.90
1.1 mg/liter) was not different from that of 22 dialysis patients without
hepatitis (6.09 1.4 mg/liter). CRP, liver enzymes and LDH did not differ
within the 3 groups; however, serum IgG was increased in patients with
HCV (1.927 476 mg/dl) compared to patients without hepatitis (HCV—,
HBV—; P < 0.05) but was not different from HBS-Ag+ carriers (1.726
655). Pre-dialysis serum concentrations of sCD14 correlated with the
duration of chronic dialysis treatment (years) of all patients studied (r:
0.51, P < 0.001). This correlation was stronger in the hepatitis-free group
(r: 0.64). In 11 patients on acetate dialysis, sCD14 values, corrected for
hemoconcentration, rose during treatment (pre/post values P < 0.05),
whereas no changes were observed in 26 patients under dialysis with
HCO3 buffer. Furthermore, patients suffering from bacterial infections
revealed an additional and rapid increment of serum 5CD14, which
correlated with CRP serum concentrations (r: 0.71, P < 0.001). Including
FACS data on CD14 membrane expression our results support the view
that elevated sCD14 reflects an "activation" of monocytes in RCDT
patients partially depending on the dialysis regime and underlying viral(HCV+) and bacterial infections.
Absence of an effect of cGMP activating agonists on membrane voltage
of principal cells of rat CCD. E. Schlatter, J. Hirsch, R. K/eta, S. Haxelmans,
and W-G. Forssmann, Medizinische Poliklinik D, Universitdt Münster,
MOnster; and Niedersachsisches Institut für Peptidforschung, Hannover,
Germany. Recently we described K channels in the basolateral mem-
brane of rat CCD which are activated by cGMP and nitroprusside. In this
study we examined whether agonists which are known to stimulate cellular
cGMP in other cells could be physiological agonists in this nephron
segment. Membrane voltages (Vm) of freshly isolated principal cells (PC)
of rat CCD were measured using the slow whole-cell patch clamp
technique. Vm of 35 PC was —71 2 mV in control condition. Human and
rat guanylin, human and rat ANP, human BNP, human CNP, rat
urodilatin (each 500 jug/liter, N = 6), bradykinin (1 jimol/liter, N 13), or
endothelin (1 jrmol/liter, N = 5) had no significant effect on Ym in this
study. Neither the liberator of nitric oxide SIN-i (50 j.molIliter, N = 8)
nor the inhibitor of the NO synthase L-NAME (1 mmol/liter, N = 10)
changed V, significantly. In summary, guanylin which increases cGMP in
the intestine and natriuretic peptides, does not control membrane con-
ductances and thus Vm in principal cells of rat CCD. In addition,
stimulation or inhibition of NO synthesis by SIN-i or L-NAME has no
influence on Vm in these cells. The question of which agonists physiolog-
ically control the basolateral K conductance and possibly also the luminal
Na conductance via cGMP as second messenger in rat CCD remains to
be answered.
Regulation of the Na/H exchange in isolated rat CCD cells by ADH,
angiotensin II, and diadenosines. E. Schlatter, R. Kleta, S. Haxelmans, H.
SchlOter, and W. Zidek, Medizinische Poliklinik D, Universitdt Munster,
Munster, Germany. Na/H exchange is regulated by agonists activating
PKA or PKC in various cells. Principal cells of rat CCD possess a Na/H
exchanger in the basolateral membrane to regulate intracellular pH (pH1).
In this study the effects of ADH (10 nmol/liter), angiotensin II (Ang II, 0.1
smol/liter), ATP (5 j.rmol/liter), and diadenosine polyphosphates (Ap3A,
Ap4A, Ap5A, Ap6A, each 5 jmol/liter) on pH1 recovery from an acid load
(20 mmol/liter NH4/NH1) and on intracellular Ca2 ([Ca2]1) were
examined. pH1 and [Ca2}1 of freshly isolated rat CCD cells were
measured using the fluorescent dyes BCECF and fura-2 and a photon
counting tube. Removal of NH4/NH3 transiently acidified pH by 0.48
0.06 pH units (N = 38).pH1 recovered by 0.22 0.03 pH U/mm in control
and 0.04 0.02 pH U/mm with 1 mmol/liter amiloride. pH1 recovery was
decreased by 0.13 0.04 (N = 9), 0.05 0.02 (N = 10), and 0.06 0.02(N = 12) pH U/mm with ADH, ATP, and Ap3A, respectively. Ap4A,
Ap5A, Ap6A, and Ang II increased pH, recovery by 0.05 0.02 (N = 9),
0.11 0.05 (N = 13), 0.15 0.04 (N = 11), 0.07 0.03 (N = 8) pH U/mm
compared to control, respectively. Ap5A (N = 10) and Ap6A (N = 7),
both 5 jLmol/liter increased [Ca2]1 moderately (N = 5). ADH increased
[Ca2}, half-maximally at 10 nmollliter (N = 13). Ang 11(0.1 jmol/liter,
N = 9) and ATP (5 tmol/liter, N = 5) had no effect on [Ca2]1. These data
suggest that Na/H exchange activity in principal cells of rat CCD is
inhibited by agonists which activate PKA (ADH) and is stimulated by
agonists which increase [Ca2 F]. and possibly PKC (Ang II, Ap5A, Ap6A
and probably Ap4A). The mechanism for the slight reduction in the
activity of the Na/H exchanger by ATP and Ap3A remains to be
clarified.
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Clinical course of 23 patients with Wegener's granulomatosis (WG) and
microform of polyarteritis nodosa (mPAN) in a 10 year period. Th.
Schleiffer, B. Burkhard, P. Klooker, M Baldus, M. Star/c, and H. Brass,
Medizinische Klinik A, Klinikum Ludwigshafen, Ludwigschafen, Germany.
During 1983 to 1993, 15 patients were diagnosed with WG and 8 patients
with mPAN. All WG patients had signs of ear-nose-throat lesions, such as
chronic rhinitis, sinusitis, perforation of nasal septum, otitis media,
associated meningitis, and gum ulcers. 13/15 patients had renal lesions,
and 8 of these had histologically proven extracapillary-necrotizing glomer-
ulonephritis. 8/15 patients were dialyzed permanently or transiently; in 2
cases chronic dialysis could be stopped after partial recovery of renal
function. After 1986 all patients were serologically positive for ANCA;
except for 2 MPO-ANCA patients all others had cANCA. After a mean
observation period of 3.5 years (630 patient months), 7/15 (47%) WG
patients died a mean 12.3 months after diagnosis. The pre-diagnostic
period after initial symptoms was longer for diseased patients (7.4 years)
than for patients in remission (2.2 years). Patients with mPAN had various
initial symptoms of pulmonary, cardiac, or cutaneous vasculitic origin. 6/8
patients had a rapidly progressive glomerulonephritis and 5/8 patients
required transient or chronic dialysis. Serology revealed a positive MPO-
ANCA titer in all patients. After a mean observation period of 5.8 years
(556 patient months), 4/8 (50%) patients died. In conclusion, we found a
high mortality rate for both WG and mPAN within 3 to 5 years after
diagnosis, especially among patients requiring dialysis. Intensive immuno-
suppression should be used in conjunction with ANCA serology, which
facilitated diagnosis of 85% of all cases after 1986.
Specific catalytic activity of cathepsin S in proximal tubules of the rat
kidney. H. Schmid, S. Utermann, M. Koop, and P. Mayer, Institute of
Pathology and Department of Dermatology, University of Tubingen, Tübin-
gen, Germany. Cathepsin S (EC 3.4.22.27) is a lysosomal cysteine protein-
ase which is expressed to a lesser extent than cathepsins B and L in the rat
kidney. In order to elucidate the function of this enzyme, its specific
catalytic activity was determined and localized within the rat kidney. The
synthetic substrates Z-Phe-Arg-AMC and Z-Val-Val-Arg-AMC, which
are hydrolyzed by cathepsins B, L and 5, were used at concentrations
around saturation. The following procedures are able to differentiate
between the activities of these enzymes: cathepsin B is inhibited com-
pletely by 3 M urea. 0.5 j.M Z-Phe-Phe-CHN2 inhibits cathepsin L
completely and cathepsin S incompletely. At pH 7.5 and 37°C, cathepsin
S is stable for 1 hour. This is in contrast to cathepsins B and L. At pH 7.5,
the total enzymatic activity of rat kidney homogenate was relatively high as
assayed with both substrates. It was 5-fold higher in the cortex than in the
medulla. It consists of 90—95% cathepsin B activity as determined with
both substrates by being inhibited by 3 M urea as well as by being absent
after preincubation for 1 hour at 37°C. The residual activity of 5—10% was
confirmed as cathepsin S activity by the determination of the Michaelis
constant and by the fact that it is inhibited (30—35%) by 0.5 M
Z-Phe-Phe-CHN2. In proximal tubules microdissected from lyophilized
rat kidney sections, the activity of cathepsin S was found to be highest in
the convoluted part. This corresponds to the distribution pattern of the
activities of cathepsins B and L.
Is endothelium function altered in human essential hypertension? RE.
Schmieder, H. Weihprecht, C. Gatzka, G. Weidinger, and H. Schobel,
University of Erlangen-Nurnbe,g, Nurnberg, Germany. The debate whether
endothelium function is impaired in human essential hypertension is
controversial. All studies have so far used forearm blood flow (assessed by
plethysmography) as the parameter for endothelium-dependent vasodila-
tion. We measured arterial compliance (change in diameter over pressure
for each arterial pulse) after intraarterial infusion of acetylcholine (ACH:
3, 12, 48, 192 jzg/min) and sodium nitroprusside (NP: 200, 800, 3200
ng/min) to determine endothelium function. In 13 normotensive subjects
and 11 young essential hypertensives arterial compliance of radial artery
was directly assessed by a new high precision device (NIUS 02). Results:
Arterial compliance was not different under resting conditions and was
also not different during increasing of ACH and NP between normoten-
sive and hypertensive subjects. The change of arterial compliance at each
individual concentration of ACH and NP was also similar between
normotensive and hypertensive subjects. After a single oral dose of a
combination of ACE inhibitor spirapril and calcium entry blocker israd-
ipine (ISPRI), however, the increase in arterial compliance in response to
intraarterial ACH (192 sgImin) was enhanced in normotensives (NT), but
not in hypertensives (HT) (NT: + 0.52 0.33 vs. HT: —0.12 0.57 mI/mm
Hg x iO, P < 0.045). In conclusion, arterial compliance which is
dependent on the interaction between endothelium and vascular smooth
muscle cells was not altered between normotensive and hypertensive
young subjects under baseline conditions. However, after blockade of the
angiotensin converting enzyme and of voltage-dependent calcium chan-
nels a blunted response to acetylcholine was seen in hypertensive subjects,
suggesting an impaired endothelial function reserve in essential hyperten-
sion.
Low turnover renal osteopathy as a complication of long-term hemo-
dialysis. W. Schulz, K Schulten, G. Werthmann, H.J. Deuber, and G.
Delling, III. Medizinische Clinic, Hospital of Bamberg and Institute of
Nephrology and Osteology; and Department of Osteopathology, Institute of
Pathology, University of Hamburg, Hamburg, Germany. Introduction: At
least 10% of patients on chronic hemodialysis suffer from or develop low
turnover osteopathy. Patients and Methods: In 50 patients on chronic
hemodialysis suffering from low turnover osteopathy, the following pa-
rameters were evaluated: calcium, phosphate, alkaline phosphatase,
parathormone, 1,25(OH)2 and 25(OH)-D3, bone histology (iliac crest
biopsy, x-ray of hand and pelvis, and bone mineral content (SPA) of the
forearm. Results: These patients suffer from severe concomitant diseases,
such as liver cirrhosis, malnutrition, resection of stomach and/or intestine,
malignancies, diabetes mellitus, are under corticoid therapy, suffer from
postmenopausal and predialytic osteoporosis, and are old. Dialysis in-
duces osteopathy by calcium bath, vitamin D (metabolites and analogs)
with the necessity of parathyroidectomy. Symptoms are diffuse pains of
joints, extremities, and spine and fractures. Prophylaxis is possible by
individualized calcium bath and avoiding suppression of parathyreoidal
function. Therapeutic approaches are calcium bath less than 1.2 mmol/
liter because maintaining calcium bath of 1.2 mmol/liter has been insuf-
ficiently stimulated parathyroid activity during 10 months. The only
indication for fluorides is given by osteopenia without signs of hyperthy-
roidism in bone histology. PTH fragments are not yet available for
therapeutic use. Conclusion: Due to the increasing incidence of severe
concomitant diseases in patients on chronic hemodialysis the prevalence
of low turnover osteopathy is rising. This complication is difficult to be
treated if osteopenia has developed. Therefore, baths with low calcium
concentrations should be used.
Serum concentration of phosphate—the critical prognostic parameter
after parathyroidectomy in patients on long-term hemodialysis. W.
Schulz, T. Kunzmann, G. Werthmann, and H.J. Deuber, III. Medizinische
Clinic, Hospital of Bamberg, Institute of Nephrology and Osteology, Bamberg,
Germany. Introduction: There is discussion about the indication for,
follow-up, and complications of parathyroidectomy regarding the predom-
inantly methodical, less pathophysiological reasons for a relapse of
hyperparathyroidism. Patients and methods: During the periods 1978—
1991 and 1991—1994, 33 and 22 patients, respectively, were parathyroid-
ectomized surgically and chemically, respectively. All patients had been on
hemodialysis for 60—120 months. Follow-up was done by evaluating
concentrations of calcium, phosphate, alkaline phosphatase, intact
parathormone, 25(OH)D3, and 1,25(OH)2D3 in serum, x-ray of hand and
pelvis, and bone mineral content of the forearm (SPA). Patients were
grouped according to phosphate serum concentrations prior to and after
parathyroidectomy. Results: In patients with renal hyperparathyroidism
(12 out of 33) there was no decline of phosphate concentrations and
normalization of vitamin D metabolism, respectively. During the period of
1991—1994, parathyroidectomy was done surgically or chemically and
perioperative intravenous calcitriol therapy was done. Postoperative de-
cline of phosphate concentrations correlates both with rising
1,25(OH)2D3 and declining parathormone concentrations. Medical sur-
veillance and patient compliance were of extremely important. Conclu-
sions: Crucial factors in the postoperative course of hyperparathyroidism
are perioperative and long-term follow-up surveillance after parathyroid-
ectomy. Phosphate concentrations prior to and after parathyroidectomy
may be used as prognostic indices. Intravenous application of calcitriol
suppresses the remaining hyperparathyroidism and therefore prevents the
development of a renal hyperparathyroidism. Chemical parathyroidec-
tomy offers an alternative for critically ill patients.
Mitogenic effect of extracellular ATP on cultured mesangial cells: Role
of the metabolites adenosine, purine nucleosides and purine bases. E.
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Schuize-Lohoff M. Bitzer, A. Ogilvie, and R.B. Sterzel, University of Erlan-
gen-Nurnberg, Erlangen, Germany. Stimulation of the P2u receptor by ATP
results in activation of phospholipase C (PLC), MAP-kinase and c-fos.
Recent data indicate that ATP exerts its mitogenic effect on mesangial
cells (MCs) by at least one additional mechanism. ATP is degraded to
ADP, AMP and adenosine (Ado) by mesangial ecto-nucleotidases. We
examined whether these metabolites contribute to the mitogenic effect of
ATP. ADP, AMP and Ado (10—100 M) stimulated—alone and synergis-
tically with PDGF—the proliferation of rat MCs (X-fold increase in
3H-thymidine uptake at 48 hr): PDGF (100 ng/ml): 2.5X; ATP (100 jiM):
2.0x; ATP+PDGF: 6.9X; ADP (100 jiM): 1.7X; ADP+PDGF: 7.OX;
AMP (100 jiM): 1.7x; AMP+PDGF: 6.5X; Ado (100 jiM): 1.6x;
Ado+PDGF: 6.8x. Direct cell counting confirmed the mitogenic effect of
the ATP metabolites. The mitogenic effect of Ado was neither mimicked
by the Ado receptor agonists (CHA 1 jiM; NECA 10 jiM), nor was it
inhibited by Ado Al and A2 receptor blockers (CPX 1 M; DMPX 100
jiM). Ado (10-400 tiM) did not induce activation of PLC and c-fos. The
purine nucleotides GTP and ITP, the purine nucleosides guanosine and
inosine, as well as the purine bases adenine, guanine and hypoxanthine,
exhibited mitogenic effects which were similar to ATP and Ado (for
example, synergism in combination with PDGF). Uric acid, which is not
further metabolized, as well as the pyrimidines UTP, CTP, cytidine,
uridine, cytosine and uracil, had no or a very poor mitogenic effect.
S-(4-nitrobenzyl)-6-thioinosine (50 jiM; NBTI), an inhibitor of the nude-
oside transporter, reduced the uptake of 3H-Ado in MCs by 80%. NBTI
inhibited Ado-induced MC proliferation by 70—100%. We conclude that
ATP exerts its mitogenic effect not only directly via stimulation of P2
receptors but also via its metabolites. Ado is a mitogen by itself and Ado
uptake may be required for the mitogenic effect, The exact mechanisms
which mediate mitogenicity remain to characterized.
Excessive bicarbonate losses induced by theophyllin combined with
urinary tract infection in a pancreas/kidney transplanted diabetic patient
with pancreatic fluid draining via the bladder. H.-J. Schure/ç, M Hartwig,
and K Landgraf St. Bonifatius Hospital, Department Nephrology, Lingen;
and Medizinische Klinik Innenstadt, Ludwig-Maximilians-UniversitOt, Mu-
nich, Germany. To suppress EPO production, a 37 year old diabetic man
was treated with 400 mg theophyllin p.o. During a highly febrile urinaly
tract infection, excessive losses of bicarbonate (>200 mmol) occurred via
the urinary bladder, towards pancreatic fluid which had been drained.
Even an oral substitution of 15 g NaHCO3 was not sufficient to balance
losses. Interruption of theophyllin treatment brought about the steady
state with a standard bicarbonate of 20 mmol/liter when 4.5 g of NaHCO3
were orally substituted as usual. A provocation test performed after
informed consent exhibited a manyfold increase of bicarbonate secretion
via urinary bladder by a factor of 2—7. Theophyllin combined with secretin
stimulates bicarbonate and fluid secretion significantly under experimental
conditions. A likely reason for the observed clinical phenomenon is a
combination of the inhibition of the phosphodiesterase (theophyllin) and
a stimulation of secretion of fluid and bicarbonate triggered by the urinary
tract infection (secretin). Thus, by the drainage of pancreatic fluid via
urinary bladder, dramatic losses of bicarbonate may result in a significant
metabolic acidosis. Recently, we observed a similar episode in the same
patient during a urinary tract infection alone.
Polarized ion transport during migration of transformed renal epithe-
hal cells. A. Schwab, K Gabriel, F. Finsterwalder, and H. Oberleithner,
Physiologisches Instilut, Wurzburg, Germany. Oscillating K channels and
active Na+K+2Cl_ cotransporters are prerequisites for migration of
transformed renal epithelial (MDCK-F) cells. The aim of our study was to
reveal whether changes of cell volume link migration to oscillating K
channels. The mean cell volume of migrating MDCK-F cells (1600 jim3)
was estimated by combining atomic force (determination of cell height)
and video microscopy (determination of surface area). We deduced
volume changes from patch clamp and microelectrode experiments. Based
on these experiments we calculated that each K channel burst caused a
loss of 20% of cell K. Since K was accompanied by Cl or HC03 the
cell shrank. Volume recovery was partially mediated by the Na-K-2CF
cotransporter. In order to relate volume changes to migration, we
postulated a polarized distribution of K channels and cotransporters.
This hypothesis was tested by locally superfusing migrating MDCK-F cells
at the front or at the rear end with the K channel blocker charybdotoxin
(CTX). Local superfusion of the front with CTX did not inhibit migration,
whereas cells slowed down by 65% (N = 10) when the rear end was
exposed to CTX. Local block of the cotransporter with bumetanide was
effective with respect to migration only at the front of the cell reducing
migration rate by 55% (N = 10). We conclude that K channels and the
Na-K-2Cl cotransporter are polarized on the cell surface causing
shrinkage of the rear end and swelling of the front, respectively.
Biochemical characterization of urinary proteins after renal transplan-
tation. I. Stefanidis, B. Heintz, G. Stocker, H.-D. Haubeck, W. Probst, and
H.-G. Sieberth, Medizinische Klinik II, Institut für Klinische Chemie und
Pathobiochemie der R WTHAachen, Aachen, Germany. Acute renal failure
after renal transplantation (RTX) is thought to be mainly caused by
ischemic tubular damage. However, morphological changes are apparent
at tubular and glomerular structures. The aim of the present study was to
investigate a possible role of heparan sulfate proteoglycan (HS-PG),
measured as HS-PG excretion rate, on the permeability of glomerular and
tubular basement membranes in patients after RTX showing immediate
graft function. Time dependent changes in proteinuria were quantified in
8 patients (47 9 years, cold ischemia 15.5 6.8 hr; time for surgical
anastomosis 35 1 mm). Urinary excretion rates (UER) of total proteins,
of albumin, of HS-PG (mg/mmol creatinine) and of low molecular weight
(a1-microglobulin, 132-microglobulin) and high molecular
UER of proteins (g/mmol creatinine) and of HS-PG after RTX
lhr 2hr 3hr 7hr
Total protein 7.2 4.5 2.6 0.72
Albumin 5.8 2.5 0.9 0.34
a1-microglobulin 0.082 0.090 0.086 0.048
132-microglobulin 0.015 0.012 0.015 0.012
Transferrin 0.48 0.15 0.05 0.02
a2-macroglobulin 0.0101 0.0059 ND 0.0019
IgG 1.2 0.36 0.13 0.04
HS-PG mg/mmol 0.114 0.153 0.083 0.026
UER of proteins (g/mmol creatinine) and of HS-PG after RTX
10
Total protein 24 hr 2 days 4 days days
Total protein 0.32 0.28 0.14 0.12
Albumin 0.14 0.09 0.03 0.04
a1-microglobulin 0.044 0.056 0.028 0.029
/32-microglobulin 0.010 0.009 0.005 0.003
Transferrin 0.0042 0.0041 0.0014
a2-macroglobulin 0.0008 ND ND ND
IgG 0.01 0.01 0.003 0.0009
HS-PG mglmmol 0.022 0.025 0.041 0.065
weight proteins (transferrin, lgG, a2-macroglobulin) were analyzed quan-
titatively and by gel-electrophoresis. The gel-electrophoretic pattern
shows a change from a severe unselective to a mild selective glomerular
and tubular proteinuria within 24 hours. Changes in albumin and low
molecular weight proteins UER were paralleled (r = 0.9). Immediately
after RTX a glomerular and tubular proteinuria up to 7.2 g/mmol
creatinine was found. After 10 days in all patients a mild tubular
proteinuria persists, while the initial unselective glomerular proteinuria
disappeared after 24 hours, For HS-PG in the initial phase (up to 7 hr) an
increased excretion is seen and is explained by the ischemia-induced
damage of glomerular and tubular basement membranes. In the second
phase low levels of HS-PG excretion were found. In the course of the
repair process of the glomerular basement membrane, HS-PG is synthe-
sized de novo. This phase is paralleled by the change from the unselective
to the selective glomerular proteinuria. The possible explanation may
consist in a different time course of repair mechanism of the ischemic
lesions of the tubuhi and glomeruli. Whereas in the glomeruli the lesions
are restricted mainly to the basement membrane, in the tubuli additional
lesions may exist.
Hepatitis B and C after kidney transplantation. A. Schwarz, K Schultz,
and G. Offermann, Department of Medicine, University Klinikum Steglitz,
Berlin, Germany. After kidney transplantation, the course of chronic viral
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hepatitis is influenced by immunosuppression. In a cross-sectional study,
we examined 385 kidney transplant outpatients from March 1993 to April
1994 for the presence of hepatitis B and C. Antibody to hepatitis C virus
(anti-HCV) was measured in the 2nd generation ELISA, and HCV-RNA
by PCR (Roche). HB5Ag was positive in 18/385 patients (5%). Anti-HCV
was found in 55/385 patients (14%); of these patients, 43 were also
HCV-RNA positive (78%). HB5Ag and HCV-RNA were demonstrated in
3/385 patients (1%). Patients with either HB5Ag or HCV-RNA had blood
transfusions significantly more often than those without hepatitis (10 or
more transfusions, 44% or 39% resp. vs. 16%, P = 0.003); in addition,
HBsAg-positive patients had longer dialysis duration before transplanta-
tion (53 48 vs. 27 30 months, P < 0.05). Increased serum transami-
nase level was found significantly more often in HBsAg or HCV-RNA-
positive patients than in those without hepatitis (77% or 44%, respectively
vs. 8%, P < 0.001) and higher in HB5Ag-positive than in HCV-RNA-
positive patients (77% vs. 44%, P < 0.05). There was liver cirrhosis in 2/18
(11%) HBsAg-positive and 4/43 (9%) HCV-RNA-positive patients and
was, thus, more frequent in both groups than in 3/315 (1%) patients
without hepatitis (P < 0.001). Conclusion: Hepatitis C occurs more often
than hepatitis B in patients after kidney transplantation. Risk factors for
hepatitis B and C are blood transfusions and, in addition, the length of
time previously on dialysis for hepatitis B. Under immunosuppression,
equally frequent liver cirrhosis occurs with hepatitis B and C. However,
hepatitis B is more frequently accompanied by an increased serum
transaminase level than hepatitis C.
Alterations of atrial natriuretic peptide, brain natriuretic peptide and
C-type natriuretic peptide plasma concentrations during hemodialysis. C.
Haug, A. Metzele, J. Steffgen, L. Binner, andA. Grünert, Institute of Clinical
Chemistiy and Department of Internal Medicine II, University of Ulm, Ulm;
Department of Nephrology, University of Gottingen, Gottingen, Germany.
Atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and
C-type natriuretic peptide (CNP) exhibit a striking structural similarity.
All 3 peptide hormones exert vasodilatory effects, whereas ANP and BNP
also exert diuretic and natriuretic effects. In the present study, the plasma
concentrations of ANP, BNP and CNP have been determined in patients
with dialysis-dependent chronic renal failure. Blood samples were with-
drawn before hemodialysis, 2 hours after the beginning and at the end of
hemodialysis. ANP, BNP and CNP plasma concentrations were measured
by radioimmunoassay (Peninsula) after Sep Pak C18 extraction. The mean
fluid removal was 1.96 0.21. ANP and BNP plasma concentrations
decreased significantly (P < 0.001) during hemodialysis [ANP (pg/ml):
240.2 28.7, 166.7 21.3, 133.0 15.5, controls: 60.3 4.0; BNP
(pg/mI): 192.1 24.9, 178.6 23.0, 167.2 21.8, controls: 10.7 1.0; n
= 30, means SEM]; however, the plasma concentrations of both peptides
were still significantly elevated after hemodialysis compared with control
values. CNP plasma concentrations in patients with chronic renal failure
did not differ significantly from control values and showed a slight, but not
significant, increase during hemodialysis [4.6 0.9, 5.9 2.3, 6.9 1.6,
controls: 5.1 0.6; N = 10, means SEM (pg/ml)I. The present data
provide support that the extracellular fluid volume expansion seems to
play an important role in the elevation of ANP and BNP plasma
concentrations in patients with renal insufficiency. The persisting elevation
of ANP and BNP plasma concentrations after hemodialysis suggests that
factors other than extracellular fluid volume expansion as a decreased
renal clearance might also be involved in the elevation of ANP and BNP
plasma levels in chronic renal failure.
More adverse renal prognosis of autosomal dominant polycystic kidney
disease (ADPKD) in families with primary hypertension. E. Stier, St.
Geberth, M. Zeier, G. Mayer, T.J. Ittel, W.H. Hörl, and E. Ritz, Departments
Internal Medicine, Heidelberg and Aachen, Germany, and Vienna, Austria.
Marked variability of age at renal death is noted in autosomal dominant
polycystic kidney disease (ADPKD). We tested the hypothesis that
coexistence of primary hypertension and ADPKD within families is
associated with earlier renal death. Out of a total of 162 ADPKD patients
treated in one Austrian and three German centers, 57 propositi were
identified whose families provided: (i) information concerning blood
pressure; (ii) documentation of presence or absence of ADPKD in both
parents; and (iii) age at renal death in the propositus. In parents, carrier
status was verified by sonography or autopsy. Hypertension of the
unaffected parent was defined as BP above 140/90 mm Hg or antihyper-
tensive treatment, respectively. Age at renal death was defined as start of
renal replacement therapy. Median age at renal death of 23 offspring (11
male, 12 female) from families with a history of primary hypertension of
the non-affected parent was lower than that of 34 offspring (16 male, 18
female) from families without a known history of primary hypertension of
the non-affected parent [that is, 49 years (26—64) vs. 54 years (28—82); P
< 0.031. The data are consistent with the notion that genetic predisposi-
tion to primary hypertension is associated with earlier onset of renal
failure in families with ADPKD.
Transdifferentiation: A new aspect in renal fibrogenesis. F. Strutz, F.
Ziyadeh, R. Caron, J. Tomaszewski, and E.G. Neilson, Departments of
Nephrology and Rheumatology, University of Gottingen and University of
Pennsylvania, Philadelphia, Pennsylvania, USA. Renal fibrogenesis plays a
major role in the progression of chronic renal disease. However, the cells
responsible for the deposition of interstitial matrix have not been identi-
fied with certainty. Recently, we have cloned a fibroblast specific protein
(FSP1) and generated a fibroblast-specific antibody. Now we have exam-
ined the role of fibroblasts in two experimental models of renal disease:
anti-tubular basement membrane (anti-TBM) and anti-glomerular base-
ment membrane disease (anti-GBM). Mice were harvested at 4, 6, 8, 10
and 13 weeks after induction of anti-TBM disease, and 1, 3, 5, 7, 10, 14 and
28 days after induction of anti-GBM disease. Immunostains with the
anti-FSP1 antibody demonstrated a robust proliferative response of
fibroblasts. Moreover, 13 weeks after induction of anti-TBM disease and
14 and 28 days after induction of anti-GBM disease, selected tubular cells
turned FSPJ positive, a possible indication of transdifferentiation. At these
time points interstitial collagen formation as demonstrated by trichrome
staining was at its peak. Transdifferentiation is already known to play a
major role in development and hepatic fibrosis. To further characterize
this process, we performed additional in vitro experiments. Primary distal
tubular (NP1) and transformed proximal tubular cells (MCT) were
cultured in three dimensional collagen gels. After culture under these
conditions for 5—7 days, cells started to loose expression of cytokeratin and
showed de novo expression of FSPJ and the mesenchymal marker
vimentin as demonstrated by immunofluorescence. In conclusion, our
results demonstrate for the first time that the process of transdifferentia-
tion may play a role in the process of renal fibrogenesis.
On the origin of fibroblasts: A molecular biological approach. F. Strutz,
C. Lo, and E.G. Neilson, Departments of Nephrology and Rheumatology,
University of Gottingen and University of Pennsylvania, Philadelphia, Penn-
sylvania, USA. The embryonic origin of renal fibroblasts is poorly under-
stood due to the lack of fibroblast specific markers. Recently, our group
has cloned a fibroblast specific protein (FSPJ) by differential hybridiza-
tion. FSP1 expression was examined in embryonic cell lines and tissue by
Northern blots and in Situ hybridizations. Northern blot analyses of several
embryonic cell lines demonstrated FSP1 expression in NIH/3T3 fibroblasts
but not in embryonic stem cells, F9 teratocarcinoma cells and PYS
(parietal yolk sac)-2 cells. In situ hybridizations of mouse embryos at days
8.5, 12.5 and 13.5 were performed using [35S]rUTP sense/antisense
riboprobes. There was no FSP1 expression detectable in 8.5 day old mouse
embryos. However, at day 12.5, FSPI was expressed in the periodontal
mesenchyme, the leptomeningeal membrane, around the scieratomes, the
urachus, and and in certain caudal areas of the dermis. All positively
identified tissues were of mesodermal origin. At day 13.5, FSP1 expression
was exclusively detectable in the periodontal mesenchyme, the thymus
(which is rich in fibroblasts at that time), certain areas of the myotomes,
and the supporting capsules of the kidney and adrenal gland. Only very
few cells stained positive in the kidney itself. In summary, our results
confirm the mesodermal origin of fibroblasts. However, cells of mesoder-
mal origin show rather late and very specific expression of the fibroblast
marker FSPJ. We conclude from these findings that fibroblasts are
specialized cells that cannot be viewed as simple mesodermal stem cells.
Regular dialysis treatment in Eastern Germany in 1993, versus GDR in
1989. H. Thieler, Klinikum Erfurt, Erfurt, Germany. This report compares
the data about regular dialysis treatment in December 1989 versus
December 1993 on the basis of questionnaires, which were answered by
106 of the 110 dialysis facilities for adults (96% response) in Eastern
Germany—excluding Berlin. The number of dialysis facilities increased
from 53 to 110 (208%), or 7.7 units p.m.p. While in 1989 almost all centers
had been state units, at the end of 1993 37% of the dialysis facilities were
private, 30% belonged to non-profit dialysis organizations, and 33% were
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hospital-based. The rooming conditions have improved dramatically, and
the equipment (including the artificial kidneys) has the highest standard at
present. The number of dialysis stations rose from 602 to 1,624 (270%).
The prevalence of patients in regular dialysis treatment increased from
2,127 to 4,707 (221%), or 329 patients p.m.p. 130 new patients p.m.p.
started RDT in 1993 (incidence), in comparison to only 67 patients p.m.p.
in 1989 (in Thuringen). Dialysis modus in RDT: In 1989, in the GDR
99.1% of the patients were treated by hemodialysis, because there was no
equipment and material available for other dialysis modalities. At the end
of 1993, 92.1% of the patients were on center hemodialysis, 0.1% on home
hemodialysis, 2.3% in hemofiltration, and 5.5% on peritoneal dialysis
(predominantly CAPD). The advancements of RDT in Eastern Germany
since the change of the political system and the reunification are a unique
process.
Dramatic decrease of hepatitis B prevalence in the East German
dialysis facilities between 1989 and 1993. H. Thieler and F. Brunner,
Klinikum Er/urt, Erfurt, Germany; and Kantonsspital, Base!, Switzerland.
This study compares the hepatitis B situation in the dialysis facilities for
adults in the GDR (including East Berlin) at the end of 1989, and in
Eastern Germany (excluding East Berlin) at the end of 1993. It is based for
1989 on the EDTA data (response 88%), and for 1993 on questionnaires
(response 96%). In 1989, there existed hepatitis B patients in 82% of all
dialysis centers (in 46 Out of 56 centers), as compared to 58% in 1993 (in
62 out of 106 centers). In 1989, 21% of all regular dialysis patients (485 out
of 2,301) were hepatitis B antigen-positive, in 1993 only 4.7% (219 out of
4,707). Hepatitis C antibodies were found in 9.5% of all dialysis patients,
but in 25% of hepatitis B patients, and in 8.8% of the patients negative for
hepatitis B antigen. In 1989, 124 new infections with hepatitis B were
registered (56/1,000 dialysis patients), versus only 12 new infections in
1993 (2.5/1,000 patients). In 1989, 6 staff members acquired hepatitis B, in
contrast to no new infections in 1993. The dramatic improvement of the
hepatitis B situation in the East German dialysis facilities since the
reunification became possible by the substantial improvement in person-
nel, equipment and rooming conditions, as well as by the hepatitis B
vaccination of the patients—possible since 1989 and 1990.
Chronic renal replacement therapy in Eastern Germany in 1993, versus
GDR in 1989. H. Thieler, and H. Smit, Klinikum Erfitrt, Erfurt, and Deutsche
Stiftung Organtranspiantation (DSO) Neu-Isenbuig, Germany. This compar-
ison (December 1993 vs. December 1989) is based on the evaluation of
questionnaires, answered by 106 of the 110 dialysis facilities (96%) in
Eastern Germany—excluding Berlin, and on the data of the DSO. The
number of regular dialysis patients increased from 2,127 to 4,707 (221%),
or 329 patients p.m.p. The number of patients with functioning renal grafts
rose from 773 to 1,311 (170%), or 92 patients p.m.p. So, on renal
replacement therapy (RRT) there were 2,900 patients at the end of 1989,
versus 6,018 patients at the end of 1993 (208%), that is, 421 patients p.m.p.
Of the patients in RRT, 78% were on dialysis treatment, and 22% had a
functioning graft. The following data are taken from the DSO and include
East Berlin. In 1989, 254 patients in the GDR, and in 1993, 306 patients
from Eastern Germany were transplanted (20 patients p.m.p.) Of these
306 transplantations, 267 were performed in East German transplantation
facilities. Their number rose from 4 to 6. On waiting lists for a renal graft,
there were 619 patients at the end of 1989, versus 969 patients at the end
of 1993 (157%). The progress in Eastern Germany since the reunification
is much more impressive in dialysis treatment than it is in renal transplan-
tation.
Life-threatening anaphylactic reaction post-parathyroidectomy in a
dialysis patient with heparin-associated thrombocytopenia (HAT). U
Tholl, A. Greinacher, K Overdic/ç, G. Feyera bend, D. SOlter, and M Anlauf
Medical Clinic II, ZKI-I Reinkenheide Bremerhaven; Institute for Clinical
Immunology and Transfusion Medicine, Justus-Liebig University, Giessen;
and Dialysis-Clinic, Cuxhaven, Germany. The case of a 36 year old dialysis
patient (chronic glomerulonephritis) with 9 years of hemodialysis (func-
tioning renal transplant 1991—1992), and with an increased requirement of
heparin due to coagulation within the extracorporeal blood lines is
demonstrated. Under use of a polysulfone dialyzer (F6, Fresenius), 15,000
units of heparin were administered. The course was complicated by the
occurrence of an atraumatic soft tissue bleeding. During the first dialysis,
immediately after subtotal parathyroidectomy (tert. HPT, renal osteopa-
thy IIIc, Prof. Delling, Hamburg), an anaphylactic reaction which required
reanimation and respirator treatment occurred. Anaphylactic reactions
recurred immediately after start of dialysis, even with use of ETO-fee
dialyzers and low molecular weight heparin (Fragmin, 10000 aFXa units
bolus). A decrease of platelets 15 minutes after start of dialysis (from
215/ni down to 59/nl) led to the tentative diagnosis of a heparin-associated
thrombocytopenia (HAT). The HAT antibody was evident in the HIPA
test. Hereby a cross-reaction against LMW heparin was shown; however,
not against the LMW-heparin Org 10172 (Orgaran®). The following
dialysis under use of Org 10172 as well as during the further course under
phenprocoumon proceeded without complications. An activation of the
kallikrein-bradykinin system after blood-membrane contact was supposed
as the cause for the severe anaphylaxis, which was potentiated by the HAT
antibodies and heparin as well as a postoperatively low serum-calcium
concentration (1.4 to 1.8 mmol/liter). Additionally, an inhibited bradyki-
nm metabolism due to use of ACE inhibitors for several years (captopril
12.5 mg) may be of consequence.
The role of lysosomal cysteine proteinases in cellular hypertrophy
induced by NH4CI in cultured renal tubule cells (LLC-PK1). H. Ling, S.
Vamvakas, M. Gekle, L. Schaefer, M. Teschner, R.M. Schaefer, and A.
Heidland, Division of Nephrology, Institute of Toxicology and Institute of
Physiology, University of Wueizbu,, Wuerzburg, Germany. An increase in
renal ammoniagenesis has been implicated in renal hypertrophy associ-
ated with various clinical states, such as metabolic acidosis, diabetic
nephropathy and renal insufficiency. In Vitro studies have shown that
ammonia induces cellular hypertrophy in tubular epithelial cells. To study
its role on cellular protein turnover in LLC-PK1 cells, we investigated the
effect of NH4C1 on the activities of cathepsin B, H and L + B as well as
on the protein degradation rate and protein synthesis. Methods: Protein-
ase activities were measured by using fluorogenic peptidyl substrates.
Protein synthesis and degradation were determined by using [14C]-
phenylalanine. Cytosolic and lysosomal pH were determined by using
BCECF and FITC, respectively. Results: 20 mM NH4C1 induced a cellular
hypertrophy in LLC-PK1 cells, as defined by an increase in cellular protein
content and in cell size (protein: 25.5 1.3%, cell size: 10.4 0.1% after
48 hours). This hypertrophy was associated with suppression of cathepsin
B and L + B activities (B: —57.0 0.9%, L + B: —54.5 1.5% after 48
hr) and a subsequent reduction of the protein degradation rate (—59.7
4.1% after 48 hr) without enhanced protein synthesis. In additional
experiments, cellular hypertrophy was not blunted by the protein synthesis
inhibitor cycloheximide (10 LM). Determinations of intracellular pH
showed that 20 mM NH4CI induced a transient rise in the cytosolic pH but
a persistent elevation in the lysosomal pH; this corresponds well with the
requirement of an acidic pH in lysosomes for optimal function of the
cathepsins. Conclusions: The NH4CI-induced cellular hypertrophy in
LLC-PK1 cells is caused by suppression of the lysosomal acidic protein-
ases (cathepsin B and L + B activities) and a subsequent reduction of the
protein degradation rate due to elevation of the lysosomal pH.
Suppressing role of transforming growth factor 131 (TGF-131) on
proteinase activity in cultured tubule cells—Potential role of protein
kinase C.H. Ling, S. Vamvakas, and L. Schaefer, U Oldakowska-Jedynalc
M Teschne, R.M Schaefer, and A. Heidland, Division of Nephrology and
Institute of Toxicology, University of Wuezburg, Wuerzbutg, Germany. A
growing body of evidence has implicated TGF-f31 in the accumulation of
extracellular matrix in the kidney. An elevated expression and protein of
TGF-131 has also been demonstrated in various renal diseases. To assess
the potential role of TGF-/31 on the protein turnover in LLC-PKI cells, we
investigated the effects of TGF-J31 on lysosomal cysteine proteinases—the
activities of cathepsin B, H and L + B, which are involved in the
degradation of extracellular matrix and cellular protein. Methods: Pro-
teinase activities were measured by using fluorogenic peptidyl substrates.
Protein synthesis and degradation were determined by using ['4C]-
phenylalanine. Results: TGF-/31 (1—10 ng/mI) exerted an inhibitory effect
on cathepsin B and L + B activities in a time- and dose-dependent
manner, when exposed to either basolateral or apical side of LLC-PK1
cells (basolateral side: B: —23.2%, L + B: —19.9%; apical side: B:
—28.2%, L + B: —22.6%). Exposure of TGF-pl to both cell sides
potentiated the suppression of the enzyme activities (B: —37.8%, L + B:
37.4%). In parallel, a significant reduction of the protein degradation rate
(—23.0%) as well as an enhanced protein synthesis with an increase of
cellular protein content (+ 23.2%) and cell size have been observed.
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Co-exposure of TGF-f31 with 10—6 verapamil did not prevent the inhibi-
tion of the proteinase activities. However, the inhibitors of protein kinase
C staurosporine (106) and protein kinase C1.9 (10—6) abolished the
TGF-J31-induced suppression of the enzyme activities; using the activator
of protein kinase C PDB (10—6) the inhibition could be mimicked and
potentiated. Conclusion: The TGF-1-induced cellular hypertrophy is not
only caused by enhanced protein synthesis but also by reduced protein
degradation due to suppression of the proteinase activities. This inhibition
may be mediated by an activation of protein kinase C rather than by a rise
of cytosolic calcium.
Changes in the kinetics and biopotency of luteinizing hormone in
hemodialyzed men during treatment with recombinant human erythro.
poietin (rHuEPO). B. van Kaick; F. Schaeftr, J.D. Veldhuis, G. Stein, K
Schärer, W.R. Robertson, and E. Ritz, Germany. To investigate the effect of
recombinant human erythropoietin (rHuEPO) on the hypothalamo-pitu-
itary-gonadal axis in end-stage renal failure, we assessed plasma LH
concentration release by frequent blood sampling (every 10 mm), both
during an 8 hour baseline period and after stimulation with an i.v. bolus of
GnRH. Seven adult hemodialyzed men were studied before and after
partial correction of anemia by rHuEPO treatment. LH was determined
by an in vitro Leydig cell bioassay (bio-LH). Pulsatile bio-LH secretion and
clearance characteristics were assessed by multi-parameter deconvolution
analysis. While the rHuEPO treatment did not lead to a change in average
concentrations of plasma bio-LH, the mass of hormone released per
secretory burst more than doubled, and the estimated bio-LH production
rate increased from 8.8 2.3 to 15.6 5.2 lU/liter hr (P < 0.05). The
lack of change in mean plasma bio-LH is explained by a simultaneous
decrease in plasma half-life from 106 27 mm to 67 19 mm (P < 0.02).
The decrease in plasma half-life of bio-LH was closely associated with the
rise in hematocrit, suggesting an effect of the increased red cell mass on
LH distribution space and elemination kinetics. As a consequence of the
changes in hormone kinetics, the incremental amplitudes of the plasma
concentration pulses of bio-LH increased from 112 to 121% of nadir levels
(P < 0.05), resulting in a more distinctly pulsatile pattern of hormone
signals. The ratio of bioactive to immunoreactive LH increased under
rHuEPO from 2.0 0.6 to 2.7 0.5 (P < 0.05), indicating greater
biopotency of the circulating hormone. In contrast to basal bio-LH
production, the GnRH stimulated production rate, an index of maximal
secretory capacity of the gonadotroph, was similar before and after
rHuEPO (33 6.3 vs. 29 7.9 lU/liter hr). The ratio of testosterone and
sex-hormone binding globulin, an index of free testosterone, increased
significantly under rHuEPO from 0.4 0.04 to 0.6 0.1 (P < 0.0001). In
conclusion, rHuEPO treatment causes a distinct decrease in the plasma
half-life of bio-LH and a quantitative and qualitative increase in LH signal
strength delivered to the target tissue as a result of greater secretory burst
mass, incremental plasma pulse amplitude, and relative biopotency. The
described changes lead to a more sufficient stimulation of the end-organ
which is reflected in the increase of free testosterone levels.
Determinants of left ventricular hypertrophy in renal transplant recip-
ients. G. Vogt-Ladner, H.P. Schobel, H.H. Neumayer, and R.E. Schmieder,
Medizinische Klinik IV, Universität Erlangen, Nurnbeg, Germany. Objec-
tive: Left ventricular hypertrophy (LVH) is an independent cardiovascular
risk factor, even in patients with secondary hypertrophy. Design and
Methods: To analyze determinants of LVH in renal transplant recipients,
we investigated 40 adult patients (age 46 11 years) half a year after renal
transplantation within a prospective study. In each patient we determined
24 hour ambulatory BP profile (Spacelab 90207), endocrine factors
(plasma renin activity, parathormone, vitamin D 1,25-OH) and left
ventricular structure (by 2-D guided M-Mode echocardiography, accord-
ing to PENN convention). Results: Left ventricular mass (LVM, average
value 267 73 g) was higher, the greater systolic pressure over 24 hours
(0.37, P < 0.01), the greater diastolic pressure over 24 hours (r = 0.26,P < 0.05), and the thicker the patient was (r = 0.36, P < 0.01). LVM did
not correlate with hematocrit, plasma renin activity, parathormone and
vitamin D 1,25-OH. Of interest, there existed an association between the
degree of LVH and function of the transplanted kidney: serum creatinine
correlated closely with LVM (r = 0.55, P < 0.001). Renal transplant
patients with a still open arteriovenous (AV) shunt had a higher LVM
than patients with a closed AV shunt (290 74 vs. 227 64g, P < 0.02),
whereas systolic and diastolic pressure, body mass index and endocrine
factors of patients with open and closed AV shunt were similar. Conclu-
sions: Despite being on antihypertensive medication, LVH was strongly
determined by the level of arterial pressure. Our results therefore
underline the importance of consequent blood pressure and weight
control to normalize LVM post-renal transplantation. It appears further
that from cardiovascular viewpoint closure of an open AV shunt (if kidney
function is stable) has to be considered to achieve regression of the left
ventricular hypertrophy.
Acute renal failure in pre-eclampsia—A pathological concept. T Voig-
mann, Department of Gynecology and Obstetrics of the Ernst-Moritz-Arndt-
University, Greifswald, Germany. With an occurrence of 55—70%, pre-
eclampsia is the most common course of acute renal failure in obstetrics.
The generalized vasoconstriction, increased vessel reactivity, and distur-
bances of microcirculation in pre-eclampsia are associated with a high
sensitivity of the vasa efferentia concerning AT2 and eicosanoids. An
increase of filtration fraction and a decrease of the renal plasma flow
result. There is a high concentration of albumin within the ultrafiltrate due
to the increased permeability of the glomeruli. The return of albumin
occurs partially as pinocytosis and is a membrane-consuming process in
connection with lysosomal digestive processes in the cell. Consumption of
membranes and enzymes during albumin resorption is a productive
process and there is a high peritubular 02 demand and together with the
decrease of renal plasma flow the peritubular 02 supply decreases. The
result is a peritubular hypoxia which has been shown in histopathological
examinations and has been proven by an increased level of erythropoietin.
Under this circumstance the activity of some special enzymes (glycosi-
dases) decreases in the proximal tubulus, and so there is an inhibition of
the splitting of Tamm-Horsfall protein from the lectin-binding site on the
membrane of the distal tubulus. The accumulation of Tamm-Horsfall
protein in connection with the presence of albumin and other changes of
the surroundings leads to the formation of cylinders which can cause
obstruction of distal segments of the tubulus. It is possible that oliguria!
anuria can be caused by this pathophysiological mechanism.
The urinary Tamm-Horsfall protein excretion in pregnant women
during third trimester of pregnancy. T Volginann, and W. Straube,
Department of Gynecology and Obstetrics of the Ernst-Moritz-Arndt-Univer-
shy, Greifswald, Germany. Several different authors have shown distur-
bances in renal excretion of Tamm-Horsfall protein (THP) in hypertensive
pregnant women. There is, however, a lack of information on the specificy
of THP as well as on the relation between renal disturbances and criteria
of the well-being of the newborn. The main aim of this study was to
evaluate the relevance of THP for diagnostic and prognostic purposes in
cases of pre-eclampsia. Ninety-two pregnant women have been examined
during the third trimester of pregnancy by using the ELISA test (ELIAS,
Freiburg) in order to find out if and when THP excretion decreases in 24
hour urine samples and if there is a correlation between these changes and
clinical and paraclinical parameters as well as the health of the newborn.
Results: There were no differences found in THP excretion between
healthy (N = 12; age 27 6; weeks of gestation 38 3; 29 4mgTHP/24
hr) and hypertensive women (N = 29; age 26 5; weeks of gestation 36
3; 31 3 mg THP/24 hr) and women suffering from pre-eclampsia(N = 8; age 31 6; weeks of gestation 31 3; 31 6 mg THP/24 hr).
There was, however, a decreased THP in pregnant women with protein-
uria (N = 29; age 26 3; weeks of gestation 36 4; 20 3 mg THP/24
hr. In 22 patients (age 26 4;weeks of gestation 36 3) a THP excretion
lower than 15 mg/24 hr has been measured. Only 8 out of those patients
were hypertensive. In this group there was a positive correlation (P <
0.05) between the THP excretion and the umbilical-arterial-pH of the
newborn as well as the THP excretion and the APGAR score 1 minute
postnatally.
Successful pregnancy in a patient on CAPD. A. Vychytil, M. Haag-
Weber, C. Dadak; M Hermon, W. Woloczszuk; and W.H. Horl, Departments
of Medicine IJI/Nephrology, Gynecology and Obstetrics, and Pediatrics,
Ludwig Boltzmann Institute of Clinical Endocrinology, University of Vienna,
Vienna, Austria. Although several case reports have been published,
pregnancy in a CAPD patient is still a rare event. The diagnosis of
pregnancy is harder to make because gastrointestinal symptoms and
irregularities of menstruation are common during dialysis therapy. Fur-
thermore, there are only a few reports on erythropoietin treatment during
gravidity. We report the case of a 25-year-old CAPD patient, who was
diagnosed as being 9 weeks pregnant 6 months after the initiation of
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CAPD. Throughout the pregnancy CAPD treatment was continued and
the patient tolerated it very well. The filling volume had to be reduced
(from 1,750 ml to 1,500 ml, 1.36%) and the number of exchanges had to
be increased to 5 times a day maximum (instead of 4). We were able to
keep serum BUN levels under 50 mgldl almost all the time. Erythropoietin
administration, which had been started before the pregnancy, was contin-
ued with a dosage of 200 lU/kg/week, from week 25 on 350 lU/kg/weekly
and from week 27 on 500 lU/kg/weekly. Under this therapy constantly
increased plasma levels of erythropoietin (70—110 mU/mi) were mea-
sured. In the 24th week of gestation a retroplacental hematoma (11.5 x
3.3 x 2.6 cm) with partial abruptio placentae was diagnosed. This may
partly have accounted for the higher EPO requirement from this date on.
The sonography also showed a marked polyhydramnion. Our patient's
pregnancy was further complicated by the occurrence of hypertension,
which was treated with Dihydralazin, with occasional addition of Atenolol.
In the 28th week of gestation a 32 cm, 773 g male infant was spontaneously
delivered. The APGAR score was 7 after 1 minute and 9 after 5 minutes.
The hematocrjt of the newborn was 60%. Ultrasound examination showed
a volvolus, and on the following day a part of the small intestine had to be
surgically removed and an enterostomy was established. Furthermore, a
mesenterial leak was detected during the operation. Postoperative devel-
opment was uneventful, and the infant was discharged from the hospital
two months after birth weighing 2,400 g.
The effect of kidney transplantation on serum lipoprotein. T Wale/c C.
Doehn, B. Kreft, L. Fricke, J. Steinhoff and E.F, Stange, Medizinische Klini/ç
Medizinische Universität Lubeclç, Lubec/c Germany. We conducted a
prospective study to gain further insight into the process of transplant
atherosclerosis which often occurs in patients with "chronic rejection" of
kidney transplants. Risk factors, such as blood pressure, duration of
ischemia, CMV infection, cyclosporine serum levels and smoking habits
were determined. Furthermore, we monitored changes of lipoprotein
levels. In 32 patients with end-stage renal disease (age 48 13 years)
lipoprotein (a) [Lp(a)] serum levels were increased (median 21.6 vs. 15.5
mg/dl) as compared to a control population (N = 117, creatinine clearance
67.1 21 mI/mm, age 53.7 8 years) und decreased after kidney
transplantation [NTX] (day 1 post-op: median 14.2 mg/dl, day 21 post-op:
median 5.5 mg/dl). In accordance with recent studies a reduction of Lp(a)
serum levels after kidney transplantation is observed. However, our data
suggest that this Lp(a) reduction is not caused by increased renal excretion
of Lp(a) after NTX for two reasons: Lp(a) serum levels decreased after
renal transplantation before renal function improved (mean onset of graft
function: day 8 post-op). Furthermore, measurements of Lp(a) in serum
and urine by time-resolved immunofluorescence (TRIFMA) in a control
group revealed a positive correlation between Lp(a) in serum and urine
(r = 0.55; P < 0.01; linear regression analysis), but no relationship
between Lp(a) urine levels and creatinine clearance. The obligate immu-
nosuppressive medication with glucocorticoids after NTX could be con-
sidered as a possible non-genetic factor affecting Lp(a) serum levels in
patients after kidney transplantation. Further studies are required to
understand the role of lipoproteins in transplant atherosclerosis.
Inhibitory effect of 12(R)-HETE on ion transport in rat colon. M.
Wegmann, H. W Seyberth, and A. KOckerling, University Childrens Hospital,
Marbug, Germany. 12(R)-hydroxyeicosatetraenoic acid [12(R)-HETE], a
cytochrome P450 metabolite of arachidonic acid, has been described to be
a potent inhibitor of Na-K-ATPase in rat kidney and bovine cornea!
epithelium. We investigated the effect of 12(R)-HETE on furosemide-
sensitive and Na-K-ATPase-dependent epithelial ion transport using
rat intestinal chloride secretion as a model. Colonic segments were
stripped from their muscular layers and electrogenic ion transport was
measured as short circuit current (I) by the Ussing technique. In
unstimulated tissues I was 6.9 1.8 th.Jcm2 (mean SEM). Active
chloride secretion was induced by theophylline 10 M (iI5. 113.3 3.2
cA/cm2, P < 0.001) and could be inhibited by furosemide (3 x iO M,
—44.6 1.4 gA/cm2, P < 0.001, N = 8) and ouabain (10—s M,
—40.8 4 gA/cm2, P = 0.001, N = 5) in a dose-dependent manner. A
similar effect was observed after addition of 12(R)-HETE 3 x 10 M
which significantly decreased I by 30.6 1.4 gA/cm2 (P < 0.00 1, N = 5).
In contrast, 3 X i0 M of 12(R)-HETE just led to a slight inhibition of I,,,,
not different from that caused by the solvent ethanol (zI5 —10.3 3.2 vs.
—6,8 1.8 g.AJcm2, N = 5). To identii' the effect of 12(R)-HETE as
Na-K-ATPase-dependent, amiloride-sensitive sodium absorption was
i uced by aldosterone 3 X iO M 189.6 53.4). As expected,
ouabain decreased 'Sc by a mean of 87.6% while furosemide and,
surprisingly, 12(R)-HETE had no effect. We conclude that 12(R)-HETE
affects intestinal active chloride secretion by a mechanism different from
Na-K-ATPase inhibition. This might also play an important role in
furosemide-sensitive renal electrolyte and water transport and its tubular
disorders.
Bacterial spectrum of urinary tract infections of kidney transplant
patients. U Welling H. Hohage, and KH. Rahn, Medizinische Poliklinik der
Westfalischen Wilhelms Universitat, Munster, Germany. Urinary tract infec-
tions are dangerous complications after kidney transplantation. Fre-
quently antibiotic treatment has to be initiated without a resistogram to
avoid an infection of the transplant kidney. In the present study resisto-
grams of 112 patients (84 male, 28 female) during 1990 and 1993 were
examined. Seventy patients had double immunosuppression, and 42 had
triple drug therapy. During the observation period only 67 patients had no
urinary tract infection. In total, 154 infections were observed, of which 50
were Escherichia coli and 49 Staphylococcus epidermidis. Furthermore, 17
infections with Staphylococcus haemolyticus, 15 with Enterococcusfaecalis,
7 with Proteus mirabilis, 6 with Staphylococcus aureus, and 6 with Pseudo-
monas aeruginosa were observed. While 42% of Escherichia coli infections
showed resistance to amoxicillin, 4% were resistant to norfioxacine,
whereas 60% of Staphylococcus aureus infections were resistant to amoxi-
cilline and 43% to norfioxacine. The results dramatically demonstrate that
33% of all urinary tract infections are resistant to amoxicillin treatment,
which is one of the most frequently used antibiotics.
Role of tissue factor expression in the pathogenesis of interstitial
fibrosis in the kidney. T. Wendt, P.P. Nawroth, Y. Zhang, A. Bierhaus, Y.
Deng, R. Waldherr, T Teske, and G. Stein, Clinic of Internal Medicine IV
University of Jena, Jena; and Department of Medicine and Pathology,
University of Heidelberg, Heidelberg, Germany. Proliferation is associated
with procoagulant changes and fibrin deposition. In a model of unilateral
ureteral ligation, the expression of the tissue factor, the central initiator of
coagulation in in situ hybridization and immunohistology, was studied.
After 20 days, fibrin deposition was observed around the vessels, in the
interstitial space, and less frequently in the glomerulus and the tubular
systems in the ligated kidneys, and unspecifically in the contralatera! and
sham operated kidneys. Within 5 days after ligation, tissue factor expres-
sion was induced in the operated, but not in the sham operated kidneys.
Tissue factor positivity was observed in vascular endothelial cells, in the
vessel wall, in the tubular epithelial cells, in glomerular capsular cells,
intracapsularly and interstitially. Tissue factor induction was due to
increased synthesis, compared to sham operated kidneys and the level of
mRNA hybridizable to a tissue factor riboprobe increased. The tissue
factor gene is under control of the transcription factors AP-1 and NFkB.
When extracts of operated organs were compared with sham operated or
contralateral kidneys in band shift experiments, an increase in AP-1 and
NFkB binding to their respective sites in the tissue factor gene was
observed. Thus, activity leads to increased AP-1 and NFkB expression in
the kidney, resulting in increased tissue factor transcription and transla-
tion and at least in increased fibrin deposition.
Relevance of non-immunologic factors of organ-donor and recipient
concerning transplant function. A. Westhoff B. Bulling R. Willers, and B.
Grabensee, Department of Nephrology, Duesseldorf University, Duesseldorf
Germany. The use of highly effective immunosuppressive drugs today
leads to primary acceptance of the transplant. The relevance of non-
immunologic factors concerning graft rejection and long-term survival
remains unclear. Methods: In a retrospective study we looked for initial
kidney function in 200 graft recipients. Organ donation was performed as
well in our center (N = 68, 34%) as obtained by Eurotransplant allocation(N = 132, 66%). Recipient selection followed the criteria of best HLA
compatibility. In the first 12 postoperative months the follow-up of 133
patients was registered. Results: The prevalence of postoperative acute
renal failure (ARF) was 47.5% (95/200). 1.29 0.37 mg/dl was measured
as the best serum creatinine within the first year after ARF versus '1.14
0.30 mg/dl after primary function (PF). There was no further significance
of graft function after the end of 12 months (ARF: 1.55 0.86 vs. PF: 1.60
0.75 mg/dl). Donor's age was proven as the most decisive aspect
concerning prognosis of transplant function. Statistical procedure using
Mantel-Haenszel X2-test showed that increased donor age resulted in
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poorer graft function after the first year. As a threshold value a serum
creatinine of 1.5 mg/dl was choosen.
Donor age, years
<20 20 40 40  60 60
N=15 N=49 N=57 N=12
Recipient's graft function
after 1 year:
Serum creatinine 1.5 mg/dl 86.7% 85.7% 50.9% 25.0%
Pat. % (13/15) (42/49) (29/57) (3/12)
Serum creatinine >1.5 mg/dl 13.3% 14.3% 49.1% 75%
Pat. % (2/15) (7/49) (28/57) (9/12)
P < 0.0001 (Mantel-Haenszel X2-test)
In Contrast to these results graft function was not significantly influenced
either by recipient's age, by age difference, by duration of cold ischemic
time, by kind of perfusate, by degree of catechalime therapy, by extent of
organ donation, nor by origin of the graft (local or shipped). Differences
in donor's age did not cause a different incidence of rejection episodes of
the recipients. Conclusions: Long-term transplant function is not only a
result of immunologic compatibility but also influenced by the age of the
organ donor. Postoperative ARF has no detrimental effect on kidney
function in the first year. Other non-immunologic factors leading to a
progressive deterioration of the graft are not detectable.
Mobilization of intracellular calcium by endogenous ouabain-like fac-
tor (OLF) in inner medullary collecting duct (IMCD) cells. K Wier,nann,
A. Backer, H. Meyer-Lehnert, and H.J. Kramer, Medizinische University
Poliklini/ç Bonn, Germany. It is speculated that OLF plays a role in the
pathogenesis of volume-dependent hypertension. We therefore studied
the effects of OLF on calcium mobilization in cultured IMCD cells which
play a crucial role in the long-term regulation of body fluid volume. OLF
was isolated from the urine of healthy subjects on high sodium intake
(>400 mmol/day). A polar OLF-1 and a more apolar OLF-2 were
obtained after gel chromatography on Sephadex G-25 and G-i0 by
subsequent reverse-phase HPLC which both strongly inhibited porcine
Na-K-ATPase in vitro. tCa21 was quantitated by the fura-2 method in
IMCD cells isolated by hypotonic treatment and density gradient centrif-
ugation from fresh porcine kidneys. OLF-2 resulted in a biphasic rise in
[Ca2j1 from 74 20 to an initial peak (after 15 sec) of 322 56 flM and
a subsequent rise from 131 33 after 2 minutes to 216 52 nm (N = 7)
after 5 minutes confirming our previous observations in vascular smooth
muscle cells. Similarly, the fraction with the OLF-i also produced a
biphasic rise in [Ca2]. In contrast, lower doses of OLF-1 more specifi-
cally induced a slow increase in [Ca2j1 from 39 ito 169 21 nM within
5 minutes, similar to the dose-dependent rise in [Ca2} by ouabain which
increased [Ca2]1 from 72 to 175 n at i0 M and to 221 nM at 106
(N = 4). For comparison, endothelin (ET-1), iO M, which also acts at the
IMCD to modulate water absorption, revealed an initial rise of [Ca2']
from 48 8 to 387 36 nM, but maintained [Ca2]1 subsequently at a
constant level of approximately 200 n. Thus, both OLF-i and OLF-2 at
higher concentrations show biphasic effects on [Ca2]1. OLF-1, whose
inhibition of Na-K-ATPase activity varies in parallel with sodium intake, at
low concentrations reveals similar effects as ouabain, that is it produces a
slow rise in [Ca2]1 as expected from inhibition of Na-K-ATPase. This
OLF, therefore, may represent a physiologic endogenous inhibitor of
membrane sodium transport contributing to the pathogenesis of volume-
dependent hypertension.
Malignant tumors after renal transplantation—A long-term study on
1200 transplant patients. M. Wiesel5, M Zeier, G. Opelz, E. Ritz, and G.
Staehler, Departments of Urology, Nephrology and Immunology, The Uni-
versity of Heidelberg, Heidelberg, Germany. Malignant tumors are well-
known as long-term complications after renal transplantation. Since 1967,
1,200 patients were followed in our transplant unit at the University of
Heidelberg. Malignant tumors were diagnosed exclusively by histology.
Altogether, 19 out of 1,200 patients (1.6%) developed a malignant tumor.
Most of the patients (12 out of 19) were exclusively treated with
azathioprine and methylprednisolone. Only 5 patients were treated with
cyclosporine A and methylprednisolone, while two patients had a combi-
nation of cyclosporine A and azathioprine. In a median of 5.5 years (1—13)
after renal transplantation a malignant tumor developed. The most
common tumors were those of the skin (N = 6; N = 3 before 1980), 4
tumors of the urinary bladder, 2 hepatocellular carcinomas, 2 pancreatic
carcinomas and 2 malignant tumors of the brain. Tumors of the female
and male reproductive tract were 1 in both genders. In 1 patient leukemia
was diagnosed. Twelve of 19 patients died from the carcinoma. Summary:
Malignant tumors of the skin are common, and this is in line with other
studies published previously. Another important side of the development
of tumors is the urinary bladder; this is due to a long-term azathioprine
medication (all patients were treated at least 10 years with azathioprine).
Conclusion: After 10 years of renal transplantation patients should be
referred to a dermatologist as well as to a urologist for a routine
cystoscopy.
Reactivated EBV infection in renal transplant recipients: serodiagnosis
by using the anti-EBNAI/anti-EBNA2 ratio. B. Winkelspecht, N. Muller-
Lantzsch, and H. KOhler, Internal Medicine IV Nephrology, Department of
Virology, University of the Saarland, Homburg/Saar, Germany. Reactivation
of latently persistent EBV infection is observed frequently in immuno-
compromised individuals. Post-transplant lymphoproliferative disorder
(PTLD), an EBV-associated lymphoproliferation, occurs in 1—3% of renal
transplant recipients. Moreover, EBV might be involved in the genesis of
graft rejection. One hundred nine renal transplant recipients were inves-
tigated for the occurrence of reactivated EBV infection. Additionally, pre-
and post-transplant sera of 12 patients were selected for a longitudinal
study to detect possible changes of serological patterns. The anti-EBNAI/
anti-EBNA2 ratio was used as a serological marker of EBV reactivation.
Antibody titers were determined by an indirect immunofluorescence assay
employing insect cells infected with recombinant baculovirus expressing
the EBV encoded nuclear antigen 1 and 2 (EBNA1, EBNA2). Reactivated
EBV infection was diagnosed in 23.5% of patients as compared to 5% in
the healthy control group and 52% in HI V-positive individuals. Clinical
parameters had no significant impact on this rate of reactivation. In the 12
patients studied longitudinally, we were not able to detect significant
changes of the anti-EBNA1/anti-EBNA2 ratio over the course of time.
Post-transplant immunosuppressive therapy did not result in an increased
prevalence of reactivation-like serological patterns. We conclude that
reactivation of EBV infection already occurs in advance of iatrogenic
immunosuppression following renal transplantation because of an im-
paired function of the immune system due to uremia. Further investiga-
tions regarding patients with chronic renal failure are needed. The
serological approach itself seems not to have a predictive value for
detecting PTLD in renal transplant recipients.
Influence of isolectric point (p1) on glomerular deposition of antibodies
and immune complexes. R. Woitas, T. Morioka, S. Batsford, and A. Vogt,
Department of Immunology, Institute of Hygiene and Microbiology, Univer-
sity of Freiburg, Freiburg, Germany. The affinity of macromolecules for the
glomerular basement membrane (GBM) is size- and charge-dependent.
We tested the critical p1 (the lowest required p1) for glomerular deposi-
tion of monomeric antibodies (Ab) and soluble immune complexes (IC).
For this purpose renal perfusion studies were performed in male Wistar
rats using a mixture of radiolabeled, affinity purified native and cationic
anti-HSA-Ab (p1 range 4  9.5); and soluble IC (HSA-anti-HSA-Ab) (p1
range 4—9.3) prepared with the same Ab mixture. Glomeruli were
isolated, bound radioactivity was quantified and the glomeruli subjected to
acid elution. Eluates were run on a slab gel isoelectric focusing followed by
autoradiography afterwards. In this model the critical p1 for glomerular
deposition of monomeric Ab was pH > 8.2; below this value there was no
significant deposition. Ab eluted from glomeruli of animals receiving IC
were focusing on a p1 range of pH 4—9.3; 24.4% of the eluted Ab showed
a p1 lower than pH 8.2. Size analysis of IC showed a mean size of 430 kD,
indicating that they consisted of 2 Ab molecules and 2 antigen molecules
(Ab2Ag2). In conclusion, our data show that the critical p1 for glomenilar
deposition of macromolecules is lower than commonly accepted and that
immune complex mediated neutral and anionic antibodies can bind to the
GBM in significant amounts. These findings give evidence for a patho-
genic role of circulating IC in lupus nephritis and provide a possible
explanation for neutral and anionic Ab detected along with cationic Ab in
glomerular eluates of lupus mice.
Cyclosporine A (CsA) induced inhibition of proliferation in cultured
renal cells is mediated by transfonning growth factor beta (TGFp). G.
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Wolf G. Zahner, and R.A.K Stahl, Department of Medicine, Division of
Nephrology and Osteology, University Hospital Eppendoif Hamburg, Ger-
many. We have previously shown that CsA inhibited the proliferation of
cultured proximal tubular cells (MCT cells) and tubulointerstitial fibro-
blasts (TFB). Since TGFI3 has an antiproliferative effects in MCT cells, we
tested whether the anti-mitogenic effects of CsA may be mediated by
endogenous induction of TGF/3. TGF3 was measured in culture superna-
tants by a specific ELISA. Incubation with CsA for 24 hours induced a
dose-dependent increase of TGF/3 in culture supernatants (MCT cells:
controls 9.3 1.0,500 ng/ml CsA 13.7 1.1, 1,000 ng/ml CsA 19.3 6.1*,
1,500 ng/ml CsA 15.0 0.7**, 2,000 ng/ml CsA 24.0 8.34*, 3,000 ng/ml
CsA 21.2 0.6** pg TGFJ3,/1,000 cells; TFB: controls 5.4 0.9,500 ng/ml
CsA 5.9 0.1, 1,000 nglml CsA 7.8 2.2*, 1,500 ng/ml CsA 7.7 0.3*,
2,000 ng/ml CsA 8.0 0.5*, 3,000 ng/ml CsA 9.7 0.4** pg TGFJ31/1000
cells; * < 0.05, **p < 0.01 vs. controls, N = 5). These data were further
confirmed using the mink cell bioassay. CsA (2,000 ng/ml for 24 hr)
induced increases in steady-state levels of TGF mRNA, Thirty sg/ml of
a neutralizing anti-TGFp1_3 antibody (Ab) abolished the CsA (24 hr)
mediated inhibition of proliferation (MCT cells: controls 65.3 2.6, 500
ng/ml CsA 57.8 4.2, 1,000 ng/ml CsA 55.0 2.6*, 2,000 ng/ml CsA 49.3
2.9*, controls + anti-TGF/3 Ab 67.0 5.2,500 ng/ml CsA + anti-TGFp
Ab 69.3 3.6#, 1,000 ng/ml CsA + anti-TGF/3 Ab 71.0 1.4#, 2,000
nglml CsA + anti-TGF/3 Ab 66.5 3.7# x 1,000 cells; TFB: controls 16.0
0.9,500 nglml CsA 11.0 1.5*, 1,000 ng/ml CsA 9.3 1.0*, 2,000 ng/ml
CsA 8.3 0.8*, controls + anti-TGFj3 Ab 18.1 0.7, 500 ng/ml CsA +
anti-TGFj3 Ab 13.6 1.3, 1,000 ng/ml CsA + anti-TGF3 Ab 15.1 0.8#,
2,000 ng/ml CsA + anti-TGFI3 Ab 14.0 0.6# X 1,000 cells; * < 0.05 vs.
controls, #P < 0.05 vs. CsA without anti-TGFf3 Ab, N = 8). Similar results
were obtained using incorporation of 3[H]thymidine. Western blotting of
cell lysates of CsA stimulated MCT cells revealed a decrease of cell
cycle-specific kinase cdc2t In summary, our results suggest that the CsA
induced inhibition of proliferation in MCT cells and TFB is mediated by
TGFI3. These observations may be important in the development of
interstitial fibrosis observed during C5A nephropathy.
Does L-arginine alter proteinuria and renal hemodynamics in patients
with chronic glomerulonephritis and hypertension? S.C. Wolf CM. Erley,
S. Kenner, E.D. Berger, and T. Risler, Section of Nephrology and Hyperten-
sion, University of Tuebingen, Tuebingen, Germany. Endogenous nitric
oxide (EDRF) plays an important role in the regulation of systemic and
renal blood pressure by an alteration of vascular tone. To assess the effect
of L-Arginine (160 tmol/min iv. for 3 hours), the precursor of EDRF, on
blood pressure, protein excretion and renal function (GFR, RPF), we
performed a prospective, double-blind, placebo-controlled study. Eigh-
teen patients with chronic g!omerulonephritis (51.3 11.5 years), renal
insufficiency (GFR < 65 mI/mm), and hypertension were investigated for
changes in GFR and RPF by continuous inulin and PAH clearances and
for changes in permselectivity by determination of protein excretion.
Placebo basal Placebo after
MAPmmHg 118±13 121±12
GFR mI/mm 54 23 53 22
RPF ml/min 299 102 288 93
Protein excretion mg/mm 1.3 1.0 1.5 1.1
Albumin excretion mg/mm 1.4 2.8 0.5 0.7
IgG excretion mg/mm 0.08 0.06 0.05 0.04
L-Arginine basal L-Arginine after
MAPmmH 119±13 122±13
GFRm1/min 55± 19 56
RPF mI/misi 327 192 335 101
Protein excretion mg/mm 2.7 2.4 1.6 1.0
Albumin excretion mg/mm 1.0 1.2 0.7 O.S'
IgG excretion mg/mm 0.11 0.11 0.08 0.06a
L-Arginine infusion results in a reduction of proteinuria (P < 0.05, t-test).
There is no significant effect on renal hemodynamics and mean arterial
pressure (MAP). Comparing the excretion of the endogenous proteins,
only albuminuria is decreased statistical significant ("P < 0.01), whereas
IgG excretion is reduced slightly (P < 0.05). This can be considered as an
indicator of a special influence on the mesangial cells or the basement
membrane of the glomerulus itself by EDRF. In conclusion, L-Arginine
reduces protein-excretion without significant alterations in renal hemody-
namics and so might prevent a decline in renal failure.
Effects of prostaglandin El (PGE1) on proteinuria, glomerular perme-
ability and renal hemodynamics in patients with chronic glomerulone-
phritis. S.C. Wolf CM. Erley, ED. Berger, S. Kenner, and T Risler, Section
ofNephrology and Hypertension, University of Tuebingen, Tuebingen, Ger-
many. Prostaglandin El is known to be one of the vasoactive agents in the
kidney which regulates glomerular pressure. To find out the effect of
prostaglandin El (4 ng/kg/min iv. for 3 hours) on proteinuria, changes in
permselectivity and renal hemodynamics, we performed a double-blind,
placebo-controlled, prospective study investigating 18 patients with gb-
merulonephritis (age 51.3 11.5 years), renal insufficiency (GFR < 65
mI/mm) and hypertension. GFR and RPF were measured by continous
inulin and PAR clearances. Changes in glomerular permeability were
determined by protein excretion, namely IgG and albumin.
Placebo basal Placebo after
MAP mm Hg 118± 13 121± 12
GFR mI/mm 54 23 53 22
RPF mI/mi,, 299 102 288 93
Protein-excretion (mg/mm) 1.3 1.0 1.5 1.1
Albumin-excretion (mg/mm) 1.4 2.8 0,5 0.7
IgG-excretion (mg/mm) 0.08 0.06 0.05 0.04
MAP mm Hg
PGE1 basal PGE1 after
119 11 120 11
GFR mI/mm 62 40 57 25
RPF mI/mm 324 145 309 101
Protein-excretion (mg/mm) 2.6 2.6 1.6 l.3a
Albumin-excretion (mg/mm) 1.1 1.8 0.6 1.0"
IgG-excretion (mg/mm) 0.14 0.20 0.07 Ø,Q9*
PGE1 infusion reduces proteinuria ('P < 0.05, t-test) without changes in
renal hemodynamics and MAP. Regarding the excretion of the endoge-
nous proteins, albuminuria is reduced highly significantly ("P < 0.01) in
comparison to the decrease of lgG excretion (P < 0.05), indicating a
special influence on the endothelial cells or the basement membrane by
PGE1 in this dosage. These results demonstrate that PGE1 could be
important in providing renal function in patients with chronic glomerulo-
nephritis by reducing proteinuria.
Extracorporeal detoxication as supportive treatment in acute opiate
intoxications? R. Wronski, A. Hecker, A. Heydom, and W. Niedennayer,
Clinics of Internal Medicine and Nephrology, Christian-A lbrechts-Universitat,
Kiel, Germany. The conventional treatment of acute opiate overdoses and
intoxications is the primary detoxification and antidote therapy. After
incorporation of large amounts of opiates, this management can be
insufficient. In regard to efficiency of secondary detoxification, clinical
experiences are limited. Case report: Unknown amounts of codeine and
morphine led to coma scale Ill/tV (Proudfoot) in 4 patients. Their blood
levels were 300—700 ng/ml of codeine and 2630 ng/ml of morphine.
Codeine was eliminated renally at an average rate of 12—30 mg/12 hr in
comparison to 120 mg codeine and 250 mg morphine, which were
eliminated in 4 hours using hemodialysis. In vitro Experiences: In in vitro
experiences we evaluated the efficiency of hemodialysis and hemoperfu-
sion using 2 mg/liter solution of codeine. It was possible to retrieve
95—98% of codeine from the solution in 4 hours. Conclusions: In
experimental and clinical studies the greater efficiency of extracorporeal
detoxification could be evaluated. But the indications for the use of these
methods are limited. The prevention of lethal complications in the early
stage of severe opiate intoxication is the only useful indication for
extracorporeal detoxification.
Dinucleotides activate phospholipase C via AP4A receptors and stim-
ulate the proliferation of cultured mesangial cells. S. Zanner, E. Schuize-
LohoffA. Ogilvie, and RB. Sterzel, University Erlangen-Numberg, Erlangen,
Germany. Dinucleotides (Ap3A, Ap4A, Ap5A, Ap6A) are stored and
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released from platelets and contribute to the regulation of the vascular
tone. We examined the effect of dinucleotides on proliferation of rat
mesangial cells (MCs) in culture. Ap3A, Ap4A and Ap6A (10—100 M)
increased DNA synthesis 1.2—1.4X at 48 hr (x-fold increase in 3H-
thymidine uptake). In combination with maximal concentrations of
PDGF-BB, b-FGF, EGF, 5-HT and ET-1, we found a synergistic increase
in DNA synthesis (for example, 5-HT 1 /LM: 2.7x, Ap4A 100 .sM 1.5X,
5-HT + Ap4A: 6.5X). Direct cell counts confirmed the synergistic
mitogenic effect of the dinucleotides. By contrast, Ap5A (10—100 l.tM)
inhibited MC proliferation. To examine whether dinucleotides might
directly activate signal transduction pathways in MCs, we studied activa-
tion of phospholipase C [PLC; determination of tritiated inositol phos-
phates (IPs) in prelabeled MCs]. Dinucleotides (10—100 .rM) induced
generation of IPs with a maximum at 60 sec. The rank order of potency
was Ap4A >> Ap3A = Ap5A = Ap6A. This effect was found in 50% of
the tested MC isolates. However, dinucleotides were mitogenic in all MC
isolates independent from a positive PLC response. Dinucleotides were
degraded to ATP, ADP, AMP and adenosine by mesangial ectonucleoti-
dases within 24 hours. These metabolites were mitogenic by themselves.
Simultaneous addition of the dinucleotides plus 5-HT, as well as preincu-
bation with dinucleotides for 48 hours and subsequent addition of 5-HT
(when the dinucleotides are degraded), produced identical synergistic
increases in DNA synthesis in MCs. These results demonstrate that PLC
is activated by dinucleotides in MCs, possibly by binding to a specific
Ap4A receptor. However, PLC is unlikely to be involved in the mitogenic
effect of dinucleotides on MCs. Our findings support the concept that
dinucleotides exert mitogenic and co-mitogenic effects on MCs through
metabolites, such as ATP, ADP, AMP and adenosine.
Osseous malformations associated with nephronophthisis. I. Zauner, J.
Gerling, and H.P.H. Neumann, Medizinische Klinilç, Abteilung IV, and
Augenklinik der Universitat, Freiburg, Germany. Nephronohthisis is an
autosomal recessive disease typically presenting with salt loosing nephritis
and leading to end-stage renal failure in childhood. Frequently associated
is retinitis pigmentosa, but skeletal anomalies are seldom. The patient
presented here was initially admitted with growth retardation and brady-
dactylia, but NPH wasn't diagnosed before age 19 by renal biopsy. The
reviewed NPH literature gave evidence that osseous malformations are
frequently observed in NPH associated with retinitis pigmentosa. A
continuous gene syndrome similar to the NPH oesophageal leiomyoma-
tosis disorder may be the underlying genetic defect.
Plasma and urine endothelin-1 before and after unilateral nephrectomy
in humans. Z. Matthias, L. Bemd, B. Andreas, and T Gilbert, Kantonsspital
Basel Universitätskiiniken, F. HoJJlnann-La Roche Ltd., Base!, Switzerland.
Endothelin-1 (ET-1) is assumed to play an important role in renal
pathophysiology after unilateral nephrectomy (Nx). We therefore studied
alterations in plasma ET-1 (pET-i) levels and urine ET-1 (uET-1)
excretion in living related kidney donors (KD) before and after Nx. In 10
KD pET-i, uET-1, glomerular filtration rate (GFR, by inulin clearance)
and renal plasma flow (RPF, by PAH clearance), were measured 1—4 days
before and 6—14 days after Nx. Mean kidney donor age was 39—72 years
(Mean SD 55 10 years).
Mean SD
Before Nx
(calculated for
two kidneys)
Before Nx
(calculated for
one kidney) After Nx
uET-1 excretion pg/mm 157.8 54.2 78.9 27.1 170.5 92,4b
pET-i pg/mi
ET-1 clearance mI/mm
24.3 2.8
6.5 2.0
24.3 2.8
3.3 1.0
24.3 3.1
7.1 3.8"
GFR mI/mm 86.5 15.5 43.2 7.8 57.8
RPF mi/mm 443.1 103.2 221.6 51.6 296.9
Fractional ET-1 clearance 0.08 0.02 0.08 0.02 0.13 0.08''
a P < 0.05 vs. both kidneys before Nx; "P < 0.05 vs. one kidney before
Nx
Plasma ET-1, uET-1 excretion and ET-1 clearance remained unchanged
after Nx; however, ET-i excretion and clearance per kidney increased two
times. Fractional ET-1 clearance was significantly higher after Nx. Renal
adaption after kidney donation includes for one kidney doubling of uET-1
excretion and ET-1 clearance to baseline values before Nx. This increase
apparently does not interfere with glomerular hyperfiltration and hyper-
perfusion, ET-1 hyperexcretion per kidney may point to an augmented
FT-i production in the tubular department.
Proteinuria and albuminuria in renal cyclosporine associated arteriol-
opathy (CAA). Results of a prospective analysis in bone marrow trans-
plantation. Z. Matthias, B. Andreas, G. Alois, M. Michael, and T. Gilbert,
Department of Internal Medicine and Pathology, Kantonsspital Base!, Uni-
versity of Base!, Base!, Switzerland. The diagnosis of CAA in renal
transplantation is based on histology. We wondered whether inulin
clearance (GFR), proteinuria (Prot) and/or albuminuria (Aib) are helpful
for the diagnosis of CAA. In renal transplantation it is impossible to assign
the finding of increased Prot and/or Alb to CAA, since effects of
cyclosporine A (C5A) toxicity are often indistinguishably combined with
components of rejection and/or recurrent renal disease. We therefore
investigated the diagnostic value of Prot and Alh prospectively in bone
marrow transplant patients (BMT) treated with CsA (allogenic BMT
all-BMT) or without CsA (autologous BMT = aut-BMT). Methods: In 8
all-BMT and 5 aut-BMT, the latter as controls for the sequela of
nephrotoxic drugs beside CsA, the following parameters were determined
prospectively before BMT and 6 months after transplantation: GFR, Prot
and AIb. A renal core biopsy was performed at 6 months after BMT in all
patients. The evaluation was performed without knowledge of treatment.
Results: (1) CAA was found in 6 out of 8 all-BMT (mild CAA in 1,
moderate in 4, severe in 1), and in none of the 5 aut-BMT. (2) GFR was
decreased by 35% baseline in all all-BMT with CAA, but also in one of
2 all-BMT without CAA, and in none of aut-BMT. (3) Prot was borderline
elevated >150 mg/day (range 158—235 mg/day) in all CAA patients, but
also in one out of 2 all-BMT without CAA. (4) Three out of 6 patients with
CAA had borderline elevated Aib of >20 mg/day (27, 28 and 33 mg/day).
Three other all-BMT with CAA had however a normal Alb (<20 mg/day),
similar to 2 all-BMT without CAA, and all aut-BMT. Conclusions: (1) A
fall in GFR of 40% baseline value and a borderline elevated Prot was
seen in all cases of CAA after BMT. (2) Measuring AIb did not add any
further diagnostic precision. (3) CAA must be suspected, when GFR falls
below 35% baseline. A renal core biopsy is the only reliable way to confirm
it.
Comparison of plasma and urine endothelin-1 in living related kidney
donors and recipients. Z. Matthias, L. Bemd, B. Andreas, and T Gilbert,
Kantonsspital Base! Universitdtsk!iniken, F. Hoffinann-La Roche Ltd., Base!,
Switzerland. Cyclosporine A (C5A) is reported to increase urine endothe-
lin-i (uET-1) excretion. To investigate differences in plasma endothelin-1
(pET-i) and uET-1 excretion between patients with and without CsA, we
compared living related kidney donors (1(D) and their respective kidney
recipients (KR), as a control group, 1 year after surgery. In 12 pairs of KD
and KR glomerular filtration rate (GFR, by inulin clearance), pET-i and
uET-i excretion, as well as blood pressure (BP) and CsA trough levels,
were measured at 1 year after surgery (Mean SD 391 32 days).
Mean SD KD (N = 12) KR (N = 12)
uET-1 excretion pg/mm 111.2 53.1 109.3 52.2
pET-i pg/mi 26.7 4.1 31.9 8.3a
ET-i clearance mI/mm 4.3 2.4 3.7 2.1
GFR mI/mm 65.0 16.8 60.3 29.4
fractional ET-i clearance 0.07 0.03 0.08 0.06
BP systolic mm Hg 133 16 146 19
BP diastolic mm Hg 83 12 86 7
a P < 0.05 Wilcoxon matched pairs test
CsA trough levels in KR were 199 113 ng/ml (range 59—471 ng/ml); CsA
was applied at a dose of 4.3 1.5 mg/kg/day (range 1.9—6.6 mg/kg/day).
Patient age was 51 14 years in KD and 44 11 years in KR. Significant
differences between KD and KR were found regarding elevated pET-i
levels and systolic BP in KR. Despite CsA therapy in KR there is no
significant difference in uET-1 excretion between KR and KD. The
coincidence of significantly elevated pET-I and systolic BP in KR suggests
a possible systemic role of ET-1.
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Interaction of urodilatin and enclothelin in the renal microcirculation
of the rat. K Endlich and M. Steinhausen, I. Institute of Physiology,
University of Heidelbe,, Heide1be,, Germany. We have recently shown that
urodilatin (URO), like ANF, induces dilation of preglomerular vessels
and constriction of efferent arterioles (EA) in the split hydronephrotic
kidney model. Vasodilation by URO/ANF is mediated by binding to
NPR-A (natriuretic peptide receptor A) and activation of guanylate
cyclase. The mechanism of constriction is unclear. Therefore, we studied
a possible interaction of URO and endothelin (ET) in the microcircula-
tion of cortical (C) and juxtamedullary (JM) glomeruli of the hydrone-
phrotic kidney of anesthetized female Wistar rats. We measured diame-
ters of different vessels by intravital microscopy and glomerular blood flow
(GBF) by the dual-slit technique. ET-1 [up to a maximum 5 i0 M to
reduce GBF by 73 3% (C) and 71 3% (JM), mean SEM, N = 61
constricted preglomerular vessels by a maximum of 26 4% and EA by
maximum 18 3% (C) and 15 1% (JM). About two-thirds of
preglomerular constriction were reversed by addition of 2 i0 M URO,
whereas EA remained unaffected (C) or even slightly dilated (JM). In a
second series (N = 7) blockade of NO synthase (10—s M L-NAME)
constricted preglomerular vessels by a maximum of 18 3% and EA by
a maximum of 9 2% (C) and 12 2% (JM), and reduced GBF by 51
4% (C) and 54 6% (JM). Under this condition, URO (0.4 and
0.9 lO— mol kg min i.v.) also reversed preglomerular constric-
tion, but further decreased EA diameter by a maximum of 22 2% (C)
and 15 2% (JM). In a third series (N = 7) URO (0.4, 0.9, and 2.0 10'
mol kg min' i.v.) dilated preglomerular vessels but had no effect on
EA in the presence of ET receptor antagonists (106 M BQ 123 and IRL
1038). After washout of ET antagonists, identical infusion of URO again
dilated preglomerular vessels, but now constricted EA by a maximum of 11
2% (C) and 7 2% (JM). Our results indicate that the urodilatin-
induced constriction of the efferent arteriole is mediated by endothelin.
Glomerular proteolysis and protein synthesis in glomerulosclerosis of
Milan normotensive rats. U Eisenberger, S. Kastner, K Lubbe, P. Schlenke,
B. Reller, L.M. Fels, and H. Stolte, Division of Nephrology, Medical School,
Hannover, Germany. The Milan normotensive strain (MNS) rat spontane-
ously develops early, progressive glomerulosclerosis (OS) without any
indication of immunological injury or systemic hypertension. In a long-
term study (12—48 weeks), the balance of glomerular protein synthesis and
proteolysis during the development of GS was investigated in MNS rats
and compared to their ancestor Wistar strain (W). Isolated, purified
glomeruli (glom) were used to measure protein and DNA content
(method of Schmidt-Thannhauser), collagen content (hydroxyprolin quan-
tification), total glomerular proteolytic activity (azocasein test), specific
cysteine proteinases (fluorometric enzyme assay), and protein synthesis(incorporation of radiolabeled amino acids). Total protein content signif-
icantly increased in MNS rats during the whole observation period
compared to control strain. Collagen content started to increase after 24
weeks (MNS:6.4 2.3 vs. W:3.0 2.4 .tg hydroxyprolin/1,000 glom). The
total glomerular proteolytic activity was significantly lower in MNS rats in
week 12, 24 and 36 (38.5 11.3, 37.7 12.1, 46.4 8.7 U/hr/1,000 glom)
compared to Wistar rats (56.7 8.4, 77.6 21.8, 74.35 19.3 U/hr/i ,000
glom). Parallel, specific activities of cysteine proteinases cathepsin B and
L showed significantly decreased values for MNS rats (24 weeks:3.1 0.9
pmol NMec/glom), in relation to Wistar rats (24 weeks:5.1 1.8 pmol
NMec/glom). Calculating the ratio of protein synthesis to proteolytic
degradation, the protein synthesis revealed to be net increased in MNS
rats. In conclusion, diminished glomerular proteolytic activity in MNS rats
results in a net increased protein synthesis, subsequently causing an
accumulation of glomerular proteins, especially collagen. Hence, de-
creased activity of glomerular proteinases, like cathepsin B and L, could
be an important pathogenetic factor in progressive US.
